activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1727536	CHEMBL859734	Inhibition of human Axl kinase at 3 uM in presence of 10 uM ATP	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Inhibition	%	-10.0	CHEMBL4895	Homo sapiens	Inhibition	%	-10.0
	1727536	CHEMBL859734	Inhibition of human Axl kinase at 3 uM in presence of 10 uM ATP	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Inhibition	%	-10.0	CHEMBL4895	Homo sapiens	Inhibition	%	-10.0
	1734229	CHEMBL871595	Residual activity at human Axl at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	74.0	CHEMBL4895	Homo sapiens	Activity	%	74.0
	1769379	CHEMBL910899	Inhibition of Axl kinase	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	uM	1.0
	1790069	CHEMBL855330	Percentage activity of human Axl in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	134.0	CHEMBL4895	Homo sapiens	Activity	%	134.0
	1790119	CHEMBL873747	Inhibition of Axl	B	CC(CO)NC(=N)c1c(O)nsc1Nc1ccc(Nc2ccccc2)cc1		CHEMBL253116	=	IC50	nM	389.0	CHEMBL4895	Homo sapiens	IC50	nM	389.0
	1790289	CHEMBL873747	Inhibition of Axl	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2ccccc2)cc1		CHEMBL437331	=	IC50	nM	455.0	CHEMBL4895	Homo sapiens	IC50	nM	455.0
	1996182	CHEMBL899842	Inhibition of Axl at 10 uM	B	CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL400211	<	Inhibition	%	30.0	CHEMBL4895	Homo sapiens	Inhibition	%	30.0
	2025116	CHEMBL886941	Inhibition of human Axl at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	104.0	CHEMBL4895	Homo sapiens	Inhibition	%	104.0
	2025237	CHEMBL886941	Inhibition of human Axl at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	97.0	CHEMBL4895	Homo sapiens	Inhibition	%	97.0
	2025238	CHEMBL886941	Inhibition of human Axl at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	100.0	CHEMBL4895	Homo sapiens	Inhibition	%	100.0
	2025239	CHEMBL886941	Inhibition of human Axl at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	106.0	CHEMBL4895	Homo sapiens	Inhibition	%	106.0
	2079226	CHEMBL927242	Inhibition of Axl after 11 mins by fluorescence polarization	B	CC1CCN(c2cc(N3CCN(C)CC3)ccc2NC(=O)c2cc(C#N)c[nH]2)CC1		CHEMBL254702	=	IC50	nM	6.4	CHEMBL4895	Homo sapiens	IC50	uM	0.0064
	2080209	CHEMBL928480	Inhibition of Axl kinase	B	CCN(CC)CCOc1ccc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc1		CHEMBL253292	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	2122202	CHEMBL951156	Inhibition of Axl	B	CN1CCN(c2ccc(Nc3ncc4c(=O)c(C(N)=O)cn(-c5ccc6c(c5)CCC6)c4n3)cc2)CC1		CHEMBL414001	>	IC50	nM	300.0	CHEMBL4895	Homo sapiens	IC50	uM	0.3
	2122209	CHEMBL951156	Inhibition of Axl	B	CN1CCN(Cc2ccc(Nc3ncc4c(=O)c(C(N)=O)cn(-c5ccc6c(c5)CCC6)c4n3)cc2)CC1		CHEMBL256893	>	IC50	nM	500.0	CHEMBL4895	Homo sapiens	IC50	uM	0.5
	2147104	CHEMBL934736	Inhibition of Axl kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Inhibition	%	59.0	CHEMBL4895	Homo sapiens	Inhibition	%	59.0
	2147195	CHEMBL927939	Activity of human Axl kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	41.0	CHEMBL4895	Homo sapiens	Activity	%	41.0
	2206970	CHEMBL990565	Inhibition of Axl	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	294.0	CHEMBL4895	Homo sapiens	IC50	nM	294.0
	2240267	CHEMBL973570	Inhibition of Axl by radiometric assay	B	CS(=O)(=O)O.O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL518051	=	IC50	nM	84.0	CHEMBL4895	Homo sapiens	IC50	nM	84.0
	2393705	CHEMBL959563	Inhibition of Axl	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	IC50	nM	1.1	CHEMBL4895	Homo sapiens	IC50	nM	1.1
	2394496	CHEMBL943609	Inhibition of Axl by fluorescence polarization competition immunoassay	B	CN1CCN(CCc2ccc(Nc3ncc4c(=O)c(C(N)=O)cn(-c5ccc6c(c5)CCC6)c4n3)cc2)CC1		CHEMBL403776	>	IC50	nM	500.0	CHEMBL4895	Homo sapiens	IC50	uM	0.5
	2394497	CHEMBL943609	Inhibition of Axl by fluorescence polarization competition immunoassay	B	CONC(=O)c1cn(-c2ccc3c(c2)CCC3)c2nc(Nc3ccc(CCN4CCN(C)CC4)cc3)ncc2c1=O		CHEMBL505830	>	IC50	nM	500.0	CHEMBL4895	Homo sapiens	IC50	uM	0.5
	2394498	CHEMBL943609	Inhibition of Axl by fluorescence polarization competition immunoassay	B	CONC(=O)c1cn(-c2ccc3c(c2)CCC3)c2nc(Nc3ccc(C4CCN(CC(=O)O)CC4)cc3)ncc2c1=O		CHEMBL452965	>	IC50	nM	500.0	CHEMBL4895	Homo sapiens	IC50	uM	0.5
	2394501	CHEMBL943609	Inhibition of Axl by fluorescence polarization competition immunoassay	B	CONC(=O)c1cn(-c2ccc3c(c2)CCC3)c2nc(Nc3ccc(C4CCN(C)CC4)cc3)ncc2c1=O		CHEMBL492809	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	uM	1.0
	2395448	CHEMBL961275	Binding affinity to AXL at 10 uM by Ambit binding assay relative to control	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Activity	%	10.0	CHEMBL4895	Homo sapiens	Activity	%	10.0
	2470114	CHEMBL1032257	Inhibition of AXL at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4895	Homo sapiens	INH	%	10.0
	2476644	CHEMBL1035908	Binding affinity to human AXL at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	33.2	CHEMBL4895	Homo sapiens	Activity	%	33.2
Not Evaluated	2476847	CHEMBL1035908	Binding affinity to human AXL at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4895	Homo sapiens	Activity		
	2477866	CHEMBL986216	Binding affinity to human AXL	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Kd	nM	596.0	CHEMBL4895	Homo sapiens	Kd	nM	596.0
Not Evaluated	2478686	CHEMBL1035908	Binding affinity to human AXL at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4895	Homo sapiens	Activity		
	2479744	CHEMBL1035908	Binding affinity to human AXL at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	0.5	CHEMBL4895	Homo sapiens	Activity	%	0.5
	2480541	CHEMBL1035908	Binding affinity to human AXL at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	11.4	CHEMBL4895	Homo sapiens	Activity	%	11.4
Active	2480743	CHEMBL1035908	Binding affinity to human AXL at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL4895	Homo sapiens	Activity		
	2506929	CHEMBL942604	Inhibition of Axl at 10 uM	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4c(N5CCN(C)CC5)cccc4[nH]3)n[nH]c2c1		CHEMBL474619	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	2506930	CHEMBL942604	Inhibition of Axl at 10 uM	B	CN1CCN(c2cccc3nc(-c4n[nH]c5cc(-c6ccc(N)cc6)ccc45)[nH]c23)CC1		CHEMBL480391	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	2511964	CHEMBL969666	Inhibition of human Axl at 1 uM assessed as residual enzyme activity	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	=	Activity	%	54.0	CHEMBL4895	Homo sapiens	Activity	%	54.0
	2512029	CHEMBL970566	Inhibition of Axl at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	46.0	CHEMBL4895	Homo sapiens	INH	%	46.0
	2567224	CHEMBL973707	Inhibition of human Axl kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	66.0	CHEMBL4895	Homo sapiens	Activity	%	66.0
Not Evaluated	2577365	CHEMBL1035908	Binding affinity to human AXL at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4895	Homo sapiens	Activity		
	2582041	CHEMBL964767	Inhibition of human AXL	B	N=C(N)SCCCn1c(=O)c2c(c1=O)n1c3ccccc3cc1c1cccc3ccn2c31		CHEMBL489083	=	IC50	nM	4400.0	CHEMBL4895	Homo sapiens	IC50	uM	4.4
	2593570	CHEMBL1035908	Binding affinity to human AXL at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	0.2	CHEMBL4895	Homo sapiens	Activity	%	0.2
Not Evaluated	2593773	CHEMBL1035908	Binding affinity to human AXL at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL4895	Homo sapiens	Activity		
Not Evaluated	2593836	CHEMBL1035908	Binding affinity to human AXL at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4895	Homo sapiens	Activity		
	2594039	CHEMBL1035908	Binding affinity to human AXL at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	2.7	CHEMBL4895	Homo sapiens	Activity	%	2.7
Not Evaluated	2594982	CHEMBL1035908	Binding affinity to human AXL at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4895	Homo sapiens	Activity		
Not Evaluated	2595251	CHEMBL1035908	Binding affinity to human AXL at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4895	Homo sapiens	Activity		
Not Evaluated	2596179	CHEMBL1035908	Binding affinity to human AXL at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4895	Homo sapiens	Activity		
	2596382	CHEMBL1035908	Binding affinity to human AXL at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	1.1	CHEMBL4895	Homo sapiens	Activity	%	1.1
Not Evaluated	2597651	CHEMBL1035908	Binding affinity to human AXL at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL4895	Homo sapiens	Activity		
Not Evaluated	2597854	CHEMBL1035908	Binding affinity to human AXL at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4895	Homo sapiens	Activity		
	2721554	CHEMBL1060962	Inhibition of Axl at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	2899857	CHEMBL1060237	Binding constant for AXL kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	340.0	CHEMBL4895	Homo sapiens	Kd	nM	340.0
	2899858	CHEMBL1060237	Binding constant for AXL kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899859	CHEMBL1060237	Binding constant for AXL kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	570.0	CHEMBL4895	Homo sapiens	Kd	nM	570.0
	2899860	CHEMBL1060237	Binding constant for AXL kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	390.0	CHEMBL4895	Homo sapiens	Kd	nM	390.0
	2899861	CHEMBL1060237	Binding constant for AXL kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899862	CHEMBL1060237	Binding constant for AXL kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899863	CHEMBL1060237	Binding constant for AXL kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	3800.0	CHEMBL4895	Homo sapiens	Kd	nM	3800.0
	2899864	CHEMBL1060237	Binding constant for AXL kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899865	CHEMBL1060237	Binding constant for AXL kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	5700.0	CHEMBL4895	Homo sapiens	Kd	nM	5700.0
	2899866	CHEMBL1060237	Binding constant for AXL kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899867	CHEMBL1060237	Binding constant for AXL kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899868	CHEMBL1060237	Binding constant for AXL kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899869	CHEMBL1060237	Binding constant for AXL kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	920.0	CHEMBL4895	Homo sapiens	Kd	nM	920.0
	2899870	CHEMBL1060237	Binding constant for AXL kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899871	CHEMBL1060237	Binding constant for AXL kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	3500.0	CHEMBL4895	Homo sapiens	Kd	nM	3500.0
	2899872	CHEMBL1060237	Binding constant for AXL kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899873	CHEMBL1060237	Binding constant for AXL kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899874	CHEMBL1060237	Binding constant for AXL kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899875	CHEMBL1060237	Binding constant for AXL kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899876	CHEMBL1060237	Binding constant for AXL kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	2200.0	CHEMBL4895	Homo sapiens	Kd	nM	2200.0
	2899877	CHEMBL1060237	Binding constant for AXL kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899878	CHEMBL1060237	Binding constant for AXL kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899879	CHEMBL1060237	Binding constant for AXL kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899880	CHEMBL1060237	Binding constant for AXL kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	440.0	CHEMBL4895	Homo sapiens	Kd	nM	440.0
	2899881	CHEMBL1060237	Binding constant for AXL kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899882	CHEMBL1060237	Binding constant for AXL kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	620.0	CHEMBL4895	Homo sapiens	Kd	nM	620.0
	2899883	CHEMBL1060237	Binding constant for AXL kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899884	CHEMBL1060237	Binding constant for AXL kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899885	CHEMBL1060237	Binding constant for AXL kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899886	CHEMBL1060237	Binding constant for AXL kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899887	CHEMBL1060237	Binding constant for AXL kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899888	CHEMBL1060237	Binding constant for AXL kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	4500.0	CHEMBL4895	Homo sapiens	Kd	nM	4500.0
	2899889	CHEMBL1060237	Binding constant for AXL kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	6.8	CHEMBL4895	Homo sapiens	Kd	nM	6.8
	2899890	CHEMBL1060237	Binding constant for AXL kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	84.0	CHEMBL4895	Homo sapiens	Kd	nM	84.0
	2899891	CHEMBL1060237	Binding constant for AXL kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	9.0	CHEMBL4895	Homo sapiens	Kd	nM	9.0
	2899892	CHEMBL1060237	Binding constant for AXL kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	210.0	CHEMBL4895	Homo sapiens	Kd	nM	210.0
	2899893	CHEMBL1060237	Binding constant for AXL kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	2899894	CHEMBL1060237	Binding constant for AXL kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	250.0	CHEMBL4895	Homo sapiens	Kd	nM	250.0
	2921433	CHEMBL1052187	Inhibition of AXL assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	95.0	CHEMBL4895	Homo sapiens	Activity	%	95.0
Active	2925559	CHEMBL1050147	Inhibition of Axl	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	2993554	CHEMBL1040929	Inhibition of human recombinant Axl	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	IC50	nM	9100.0	CHEMBL4895	Homo sapiens	IC50	nM	9100.0
	3052532	CHEMBL1047783	Residual activity of AXL at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	89.0	CHEMBL4895	Homo sapiens	Residual activity	%	89.0
	3052784	CHEMBL1047810	Residual activity of AXL at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	54.0	CHEMBL4895	Homo sapiens	Residual activity	%	54.0
	3054093	CHEMBL1066611	Residual activity of AXL at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	117.0	CHEMBL4895	Homo sapiens	Residual activity	%	117.0
	3055380	CHEMBL1047783	Residual activity of AXL at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	88.0	CHEMBL4895	Homo sapiens	Residual activity	%	88.0
	3055632	CHEMBL1047810	Residual activity of AXL at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	125.0	CHEMBL4895	Homo sapiens	Residual activity	%	125.0
	3056937	CHEMBL1066611	Residual activity of AXL at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	96.0	CHEMBL4895	Homo sapiens	Residual activity	%	96.0
	3058257	CHEMBL1047783	Residual activity of AXL at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	71.0	CHEMBL4895	Homo sapiens	Residual activity	%	71.0
	3058509	CHEMBL1047810	Residual activity of AXL at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	57.0	CHEMBL4895	Homo sapiens	Residual activity	%	57.0
	3062443	CHEMBL1048636	Binding affinity to human AXL at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	58.0	CHEMBL4895	Homo sapiens	Activity	%	58.0
	3063578	CHEMBL1045164	Binding affinity to human AXL at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	8.0	CHEMBL4895	Homo sapiens	Activity	%	8.0
	3063668	CHEMBL1038879	Binding affinity to human AXL at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	81.0	CHEMBL4895	Homo sapiens	Activity	%	81.0
	3065849	CHEMBL1069279	Inhibition of AXL at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL4895	Homo sapiens	INH	%	0.0
	3066915	CHEMBL1069279	Inhibition of AXL at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	0.0	CHEMBL4895	Homo sapiens	INH	%	0.0
	3072855	CHEMBL1066611	Residual activity of AXL at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	104.0	CHEMBL4895	Homo sapiens	Residual activity	%	104.0
	3104125	CHEMBL1066391	Inhibition of recombinant AXL by TR-FRET assay	B	C[C@@H](Oc1ccc2ncc(/C=C/C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL602471	=	IC50	nM	570.0	CHEMBL4895	Homo sapiens	IC50	uM	0.57
	3104151	CHEMBL1066391	Inhibition of recombinant AXL by TR-FRET assay	B	C[C@@H](Oc1ccc2ncccc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL600795	=	IC50	nM	14000.0	CHEMBL4895	Homo sapiens	IC50	uM	14.0
	3104198	CHEMBL1066391	Inhibition of recombinant AXL by TR-FRET assay	B	C[C@@H](Oc1ccc2ncc(C3CC3C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL602472	=	IC50	nM	430.0	CHEMBL4895	Homo sapiens	IC50	uM	0.43
	3213782	CHEMBL1107586	Inhibition of AXL at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	5.0	CHEMBL4895	Homo sapiens	INH	%	5.0
	3224740	CHEMBL1102603	Inhibition of AXL at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	3225011	CHEMBL1102603	Inhibition of AXL at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
Not Active	3293112	CHEMBL1108235	Inhibition of AXL at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)Cc1ccccc1CC2=O		CHEMBL1096459		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	3293128	CHEMBL1108235	Inhibition of AXL at 10 uM	B	O=C1Cc2ccccc2Cc2cc(Nc3ccc(F)cc3F)ccc21		CHEMBL1096460		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	3293144	CHEMBL1108235	Inhibition of AXL at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)Cc1ccccc1CC2=O		CHEMBL1096466		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	3293160	CHEMBL1108235	Inhibition of AXL at 10 uM	B	O=C1Cc2ccccc2Cc2cc(Nc3ccccc3)ccc21		CHEMBL1096672		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	3293176	CHEMBL1108235	Inhibition of AXL at 10 uM	B	Nc1ccc(Nc2ccc3c(c2)Cc2ccccc2CC3=O)cc1		CHEMBL1096769		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	3293192	CHEMBL1108235	Inhibition of AXL at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)C(=O)Cc1ccccc1C2		CHEMBL1096770		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	3293208	CHEMBL1108235	Inhibition of AXL at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)Cc1ccccc1C(=O)C2		CHEMBL1096771		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	3293224	CHEMBL1108235	Inhibition of AXL at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)Cc1ccccc1C(=O)C2		CHEMBL1097085		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	3293240	CHEMBL1108235	Inhibition of AXL at 10 uM	B	O=C1Cc2ccc(Nc3ccccc3)cc2Cc2ccccc21		CHEMBL1097086		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	3293256	CHEMBL1108235	Inhibition of AXL at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)CC(=O)c1ccccc1C2		CHEMBL1097087		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	3293272	CHEMBL1108235	Inhibition of AXL at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)CC(=O)c1ccccc1C2		CHEMBL1097088		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	3293288	CHEMBL1108235	Inhibition of AXL at 10 uM	B	O=C1Cc2cc(Nc3ccccc3)ccc2Cc2ccccc21		CHEMBL1096988		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	3293304	CHEMBL1108235	Inhibition of AXL at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)Oc1ccccc1NC2=O		CHEMBL1098461		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	3293320	CHEMBL1108235	Inhibition of AXL at 10 uM	B	Nc1cc(F)ccc1Nc1ccc2c(c1)Oc1ccccc1NC2=O		CHEMBL1098462		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	3293336	CHEMBL1108235	Inhibition of AXL at 10 uM	B	O=C1Cc2ccccc2Cc2cc(-c3ccccc3)ccc21		CHEMBL1096442		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	3293352	CHEMBL1108235	Inhibition of AXL at 10 uM	B	O=C1Cc2ccccc2Cc2cc(NCc3ccccc3)ccc21		CHEMBL1097171		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	3307970	CHEMBL1119373	Inhibition of human AXL	B	Cc1cn(-c2cc(NC(=O)Nc3ccc(-c4nc5[nH]ncc5[nH]4)c(C)c3)cc(C(F)(F)F)c2)cn1		CHEMBL1084036	=	Inhibition	%	6.0	CHEMBL4895	Homo sapiens	INH	%	6.0
	3331835	CHEMBL1168794	Inhibition of AXL at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	3333250	CHEMBL1168794	Inhibition of AXL at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	3334655	CHEMBL1168794	Inhibition of AXL at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	3336075	CHEMBL1168794	Inhibition of AXL at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	3337458	CHEMBL1168794	Inhibition of AXL at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	3337706	CHEMBL1168794	Inhibition of AXL at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	3339038	CHEMBL1168794	Inhibition of AXL at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	3339294	CHEMBL1168794	Inhibition of AXL at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	=	Inhibition	%	93.0	CHEMBL4895	Homo sapiens	INH	%	93.0
	3340603	CHEMBL1168794	Inhibition of AXL at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	3342019	CHEMBL1168794	Inhibition of AXL at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	3358462	CHEMBL1174076	Inhibition of AXL at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	2.9	CHEMBL4895	Homo sapiens	INH	%	2.9
	3358904	CHEMBL1174076	Inhibition of AXL at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.1	CHEMBL4895	Homo sapiens	INH	%	0.1
	3400007	CHEMBL1217204	Inhibition of human Axl at 10 uM	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL1214141	=	Inhibition	%	69.0	CHEMBL4895	Homo sapiens	INH	%	69.0
	3407746	CHEMBL1219787	Inhibition of AXL at 1 uM by radiometric method	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215218	<	Inhibition	%	10.0	CHEMBL4895	Homo sapiens	INH	%	10.0
	3407747	CHEMBL1219787	Inhibition of AXL at 1 uM by radiometric method	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215346	<	Inhibition	%	10.0	CHEMBL4895	Homo sapiens	INH	%	10.0
	3445036	CHEMBL1244732	Binding affinity to AXL	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	35.0	CHEMBL4895	Homo sapiens	Kd	nM	35.0
	3446236	CHEMBL1244574	Inhibition of AXL	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	174.0	CHEMBL4895	Homo sapiens	IC50	nM	174.0
	3446269	CHEMBL1244323	Inhibition of AXL at 10 mM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	86.0	CHEMBL4895	Homo sapiens	INH	%	86.0
	3447995	CHEMBL1249777	Inhibition of human Axl activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	5.0	CHEMBL4895	Homo sapiens	INH	%	5.0
	3448071	CHEMBL1249777	Inhibition of human Axl activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	0.0	CHEMBL4895	Homo sapiens	INH	%	0.0
	3448885	CHEMBL1244732	Binding affinity to AXL	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	620.0	CHEMBL4895	Homo sapiens	Kd	nM	620.0
	3449109	CHEMBL1244732	Binding affinity to AXL	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	9.0	CHEMBL4895	Homo sapiens	Kd	nM	9.0
	3449394	CHEMBL1244732	Binding affinity to AXL	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	4500.0	CHEMBL4895	Homo sapiens	Kd	nM	4500.0
	3449568	CHEMBL1244732	Binding affinity to AXL	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	3449992	CHEMBL1244732	Binding affinity to AXL	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	3450920	CHEMBL1244732	Binding affinity to AXL	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	uM	10.0
	5120426	CHEMBL1648178	Inhibition of human Axl at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	110.0	CHEMBL4895	Homo sapiens	INH	%	110.0
	5123789	CHEMBL1649029	Inhibition of AXL at 1 uM	B	CCN1C(=O)CCC(C)(C)c2ccc(Nc3ncc(Cl)c(Nc4c(F)cccc4C(=O)NC)n3)cc21		CHEMBL1644812	=	Inhibition	%	100.0	CHEMBL4895	Homo sapiens	INH	%	100.0
	5152473	CHEMBL1656384	Inhibition of Axl by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	5152498	CHEMBL1656384	Inhibition of Axl by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651521	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	6264912	CHEMBL1799795	Inhibition of AXL at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL4895	Homo sapiens	INH	%	65.0
	6265636	CHEMBL1799795	Inhibition of AXL at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	<	Inhibition	%	65.0	CHEMBL4895	Homo sapiens	INH	%	65.0
Not Active	6307615	CHEMBL1816866	Inhibition of recombinant AXL assessed as 33Pi incorporation after 60 mins by scintillation counting	B	C=C[C@]1(C)C=C2[C@@H](O)[C@@H]3OC(=O)[C@@]4(C)CC[C@H]5C[C@]5([C@@H]34)[C@@]2(O)C(=O)C1		CHEMBL1812030		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	6307616	CHEMBL1816866	Inhibition of recombinant AXL assessed as 33Pi incorporation after 60 mins by scintillation counting	B	C=C[C@@]1(C)C=C2C(=O)C(O)=C3[C@](C)(C(=O)O)CC[C@@H]4C[C@]34[C@]2(O)C(=O)C1		CHEMBL516554		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	6307617	CHEMBL1816866	Inhibition of recombinant AXL assessed as 33Pi incorporation after 60 mins by scintillation counting	B	Cc1cc(O)cc2oc3cc(O)cc(O)c3c(=O)c12		CHEMBL466154	>	IC50	nM	100000.0	CHEMBL4895	Homo sapiens	IC50	uM	100.0
	6307618	CHEMBL1816866	Inhibition of recombinant AXL assessed as 33Pi incorporation after 60 mins by scintillation counting	B	Cc1c(O)c(O)cc2oc3cc(O)cc(O)c3c(=O)c12		CHEMBL454440	=	IC50	nM	6600.0	CHEMBL4895	Homo sapiens	IC50	uM	6.6
	6340973	CHEMBL1827559	Activity of AXL kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	96.0	CHEMBL4895	Homo sapiens	Activity	%	96.0
	6350150	CHEMBL1825361	Inhibition of AXL in human HEK293 cells assessed as growth factor-induced autophosphorylation by sandwich ELISA method	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	294.0	CHEMBL4895	Homo sapiens	IC50	nM	294.0
	6350151	CHEMBL1825362	Inhibition of AXL at 1 uM	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Inhibition	%	93.0	CHEMBL4895	Homo sapiens	INH	%	93.0
	6350152	CHEMBL1825363	Inhibition of AXL	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	<	IC50	nM	1.0	CHEMBL4895	Homo sapiens	IC50	nM	1.0
	6386369	CHEMBL1839846	Inhibition of recombinant AXL	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	7567235	CHEMBL1908537	Binding constant for AXL kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	490.0	CHEMBL4895	Homo sapiens	Kd	nM	490.0
	7567694	CHEMBL1908537	Binding constant for AXL kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7568165	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7569208	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7569668	CHEMBL1908537	Binding constant for AXL kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	7.8	CHEMBL4895	Homo sapiens	Kd	nM	7.8
	7570140	CHEMBL1908537	Binding constant for AXL kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7570161	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	110.0	CHEMBL4895	Homo sapiens	Kd	nM	110.0
	7570588	CHEMBL1908537	Binding constant for AXL kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	9.0	CHEMBL4895	Homo sapiens	Kd	nM	9.0
	7571184	CHEMBL1908537	Binding constant for AXL kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7571641	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7572138	CHEMBL1908537	Binding constant for AXL kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7572554	CHEMBL1908537	Binding constant for AXL kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	12.0	CHEMBL4895	Homo sapiens	Kd	nM	12.0
	7573165	CHEMBL1908537	Binding constant for AXL kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	12.0	CHEMBL4895	Homo sapiens	Kd	nM	12.0
	7573656	CHEMBL1908537	Binding constant for AXL kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	5.3	CHEMBL4895	Homo sapiens	Kd	nM	5.3
	7574125	CHEMBL1908537	Binding constant for AXL kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	620.0	CHEMBL4895	Homo sapiens	Kd	nM	620.0
	7574533	CHEMBL1908537	Binding constant for AXL kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7575143	CHEMBL1908537	Binding constant for AXL kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	5300.0	CHEMBL4895	Homo sapiens	Kd	nM	5300.0
	7575162	CHEMBL1908537	Binding constant for AXL kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	4000.0	CHEMBL4895	Homo sapiens	Kd	nM	4000.0
	7575633	CHEMBL1908537	Binding constant for AXL kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	140.0	CHEMBL4895	Homo sapiens	Kd	nM	140.0
	7576098	CHEMBL1908537	Binding constant for AXL kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7576506	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	160.0	CHEMBL4895	Homo sapiens	Kd	nM	160.0
	7577134	CHEMBL1908537	Binding constant for AXL kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	0.093	CHEMBL4895	Homo sapiens	Kd	nM	0.093
	7577612	CHEMBL1908537	Binding constant for AXL kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	180.0	CHEMBL4895	Homo sapiens	Kd	nM	180.0
	7578082	CHEMBL1908537	Binding constant for AXL kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	1200.0	CHEMBL4895	Homo sapiens	Kd	nM	1200.0
	7578487	CHEMBL1908537	Binding constant for AXL kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	250.0	CHEMBL4895	Homo sapiens	Kd	nM	250.0
	7578683	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7579057	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7579507	CHEMBL1908537	Binding constant for AXL kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	3500.0	CHEMBL4895	Homo sapiens	Kd	nM	3500.0
	7579981	CHEMBL1908537	Binding constant for AXL kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7580450	CHEMBL1908537	Binding constant for AXL kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7580853	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	210.0	CHEMBL4895	Homo sapiens	Kd	nM	210.0
	7581041	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7581426	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7581871	CHEMBL1908537	Binding constant for AXL kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7582342	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	3300.0	CHEMBL4895	Homo sapiens	Kd	nM	3300.0
	7582806	CHEMBL1908537	Binding constant for AXL kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	82.0	CHEMBL4895	Homo sapiens	Kd	nM	82.0
	7583206	CHEMBL1908537	Binding constant for AXL kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7583387	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	340.0	CHEMBL4895	Homo sapiens	Kd	nM	340.0
	7583784	CHEMBL1908537	Binding constant for AXL kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7584229	CHEMBL1908537	Binding constant for AXL kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7584700	CHEMBL1908537	Binding constant for AXL kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7585717	CHEMBL1908537	Binding constant for AXL kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7586125	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7586571	CHEMBL1908537	Binding constant for AXL kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	1800.0	CHEMBL4895	Homo sapiens	Kd	nM	1800.0
	7587054	CHEMBL1908537	Binding constant for AXL kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7587678	CHEMBL1908537	Binding constant for AXL kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	420.0	CHEMBL4895	Homo sapiens	Kd	nM	420.0
	7588097	CHEMBL1908537	Binding constant for AXL kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	35.0	CHEMBL4895	Homo sapiens	Kd	nM	35.0
	7588550	CHEMBL1908537	Binding constant for AXL kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	Kd	nM	300.0	CHEMBL4895	Homo sapiens	Kd	nM	300.0
	7588579	CHEMBL1908537	Binding constant for AXL kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7589030	CHEMBL1908537	Binding constant for AXL kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7589643	CHEMBL1908537	Binding constant for AXL kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7590067	CHEMBL1908537	Binding constant for AXL kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	3800.0	CHEMBL4895	Homo sapiens	Kd	nM	3800.0
	7590566	CHEMBL1908537	Binding constant for AXL kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	6300.0	CHEMBL4895	Homo sapiens	Kd	nM	6300.0
	7591017	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7591616	CHEMBL1908537	Binding constant for AXL kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	570.0	CHEMBL4895	Homo sapiens	Kd	nM	570.0
	7592068	CHEMBL1908537	Binding constant for AXL kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7592541	CHEMBL1908537	Binding constant for AXL kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	440.0	CHEMBL4895	Homo sapiens	Kd	nM	440.0
	7592994	CHEMBL1908537	Binding constant for AXL kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	52.0	CHEMBL4895	Homo sapiens	Kd	nM	52.0
	7593576	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7594048	CHEMBL1908537	Binding constant for AXL kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7594521	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7594973	CHEMBL1908537	Binding constant for AXL kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	4500.0	CHEMBL4895	Homo sapiens	Kd	nM	4500.0
	7595109	CHEMBL1908537	Binding constant for AXL kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7595553	CHEMBL1908537	Binding constant for AXL kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	5700.0	CHEMBL4895	Homo sapiens	Kd	nM	5700.0
	7596027	CHEMBL1908537	Binding constant for AXL kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7596498	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7596945	CHEMBL1908537	Binding constant for AXL kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	6.8	CHEMBL4895	Homo sapiens	Kd	nM	6.8
	7597081	CHEMBL1908537	Binding constant for AXL kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	390.0	CHEMBL4895	Homo sapiens	Kd	nM	390.0
	7597534	CHEMBL1908537	Binding constant for AXL kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7598007	CHEMBL1908537	Binding constant for AXL kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	190.0	CHEMBL4895	Homo sapiens	Kd	nM	190.0
	7598477	CHEMBL1908537	Binding constant for AXL kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL4895	Homo sapiens	Kd	nM	10000.0
	7598919	CHEMBL1908537	Binding constant for AXL kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	84.0	CHEMBL4895	Homo sapiens	Kd	nM	84.0
	7951350	CHEMBL1926223	Inhibition of recombinant human AXL	B	Cc1ccc(O)cc1CC[C@@H]1[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/CC(C)C		CHEMBL1922224	=	IC50	nM	21900.0	CHEMBL4895	Homo sapiens	IC50	uM	21.9
	7951351	CHEMBL1926223	Inhibition of recombinant human AXL	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/CC(C)C		CHEMBL518060	=	IC50	nM	14700.0	CHEMBL4895	Homo sapiens	IC50	uM	14.7
	7951352	CHEMBL1926223	Inhibition of recombinant human AXL	B	C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@H](CCc3cc(O)ccc3C)C(=O)CC[C@@]21C)C(C)C		CHEMBL1922225	=	IC50	nM	20200.0	CHEMBL4895	Homo sapiens	IC50	uM	20.2
	7951353	CHEMBL1926223	Inhibition of recombinant human AXL	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C		CHEMBL456936	=	IC50	nM	32600.0	CHEMBL4895	Homo sapiens	IC50	uM	32.6
	7951354	CHEMBL1926223	Inhibition of recombinant human AXL	B	Cc1ccc(O)cc1CC[C@H]1[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC[C@H]1O		CHEMBL517956	=	IC50	nM	16900.0	CHEMBL4895	Homo sapiens	IC50	uM	16.9
	7951355	CHEMBL1926223	Inhibition of recombinant human AXL	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1C[C@H](O)[C@@H]2[C@H](C)CCCC(C)C		CHEMBL456294	>	IC50	nM	100000.0	CHEMBL4895	Homo sapiens	IC50	uM	100.0
	7951356	CHEMBL1926223	Inhibition of recombinant human AXL	B	C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@H](CCc3cc(O)ccc3C)[C@H](O)CC[C@@]21C)C(C)C		CHEMBL515982	>	IC50	nM	100000.0	CHEMBL4895	Homo sapiens	IC50	uM	100.0
	7951357	CHEMBL1926223	Inhibition of recombinant human AXL	B	Cc1ccc(O)cc1CC[C@H]1[C@@H]2C[C@H](O)[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC[C@H]1O		CHEMBL464351	>	IC50	nM	100000.0	CHEMBL4895	Homo sapiens	IC50	uM	100.0
	7959679	CHEMBL1932330	Inhibition of AXL	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	uM	30.0
	7959680	CHEMBL1932330	Inhibition of AXL	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	uM	30.0
	7987134	CHEMBL1936138	Inhibition of Axl	B	O=C(c1cc2cc(F)ccc2[nH]1)N1C[C@]2(CCN(C3CCCNC3)C2)c2ccccc21		CHEMBL1933538	=	IC50	nM	19400.0	CHEMBL4895	Homo sapiens	IC50	uM	19.4
	7987156	CHEMBL1936138	Inhibition of Axl	B	O=C(c1cc2ccc(F)cc2[nH]1)N1C[C@]2(CCN(C3CCNC3)C2)c2ccccc21		CHEMBL1933550	=	IC50	nM	5250.0	CHEMBL4895	Homo sapiens	IC50	uM	5.25
	7987178	CHEMBL1936138	Inhibition of Axl	B	C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccccc5[nH]4)c4ccccc43)C2)CN1		CHEMBL1933551	=	IC50	nM	18400.0	CHEMBL4895	Homo sapiens	IC50	uM	18.4
	7987210	CHEMBL1936138	Inhibition of Axl	B	C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccc(F)cc5[nH]4)c4ccccc43)C2)CN1		CHEMBL1933552	=	IC50	nM	23800.0	CHEMBL4895	Homo sapiens	IC50	uM	23.8
	7996679	CHEMBL1944010	Inhibition of AXL at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	98.0	CHEMBL4895	Homo sapiens	INH	%	98.0
	7996742	CHEMBL1944010	Inhibition of AXL at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939492	=	Inhibition	%	99.0	CHEMBL4895	Homo sapiens	INH	%	99.0
	8013049	CHEMBL1947298	Inhibition of AXL using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	8039266	CHEMBL1953262	Inhibition of AXL	B	COc1ccc(C(=O)NC[C@@H](O)CO)cc1/C=C/c1ccc(Cl)cc1		CHEMBL1949788	>	IC50	nM	50000.0	CHEMBL4895	Homo sapiens	IC50	uM	50.0
	8039267	CHEMBL1953262	Inhibition of AXL	B	COc1ccc(C(=O)NC[C@H](O)CO)cc1/C=C/c1ccc(Cl)cc1		CHEMBL1949789	>	IC50	nM	50000.0	CHEMBL4895	Homo sapiens	IC50	uM	50.0
	8059499	CHEMBL1958985	Inhibition of AXL	B	Nc1nc(Nc2ccc([C@H]3CC[C@H](N4CCOCC4)CC3)cc2)nn1-c1ccccn1		CHEMBL1835870	=	Ki	nM	40.0	CHEMBL4895	Homo sapiens	Ki	uM	0.04
	8061356	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-4.39	CHEMBL4895	Homo sapiens	Inhibition	%	-4.39
	8061533	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	6.34	CHEMBL4895	Homo sapiens	Inhibition	%	6.34
	8061864	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	-1.45	CHEMBL4895	Homo sapiens	Inhibition	%	-1.45
	8062055	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	-2.84	CHEMBL4895	Homo sapiens	Inhibition	%	-2.84
	8062395	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	-6.37	CHEMBL4895	Homo sapiens	Inhibition	%	-6.37
	8062557	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-2.51	CHEMBL4895	Homo sapiens	Inhibition	%	-2.51
	8062879	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.22	CHEMBL4895	Homo sapiens	Inhibition	%	1.22
	8063235	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	3.04	CHEMBL4895	Homo sapiens	Inhibition	%	3.04
	8063402	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-2.69	CHEMBL4895	Homo sapiens	Inhibition	%	-2.69
	8063734	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-3.37	CHEMBL4895	Homo sapiens	Inhibition	%	-3.37
	8063916	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	19.15	CHEMBL4895	Homo sapiens	Inhibition	%	19.15
	8064255	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	-1.86	CHEMBL4895	Homo sapiens	Inhibition	%	-1.86
	8064465	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.96	CHEMBL4895	Homo sapiens	Inhibition	%	-0.96
	8064827	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.18	CHEMBL4895	Homo sapiens	Inhibition	%	0.18
	8064993	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-2.97	CHEMBL4895	Homo sapiens	Inhibition	%	-2.97
	8065333	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-1.2	CHEMBL4895	Homo sapiens	Inhibition	%	-1.2
	8065508	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	-5.2	CHEMBL4895	Homo sapiens	Inhibition	%	-5.2
	8065732	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	-1.04	CHEMBL4895	Homo sapiens	Inhibition	%	-1.04
	8065847	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	-3.9	CHEMBL4895	Homo sapiens	Inhibition	%	-3.9
	8066057	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	2.48	CHEMBL4895	Homo sapiens	Inhibition	%	2.48
	8066281	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.45	CHEMBL4895	Homo sapiens	Inhibition	%	-0.45
	8066417	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	3.31	CHEMBL4895	Homo sapiens	Inhibition	%	3.31
	8066583	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-1.95	CHEMBL4895	Homo sapiens	Inhibition	%	-1.95
	8066807	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-2.35	CHEMBL4895	Homo sapiens	Inhibition	%	-2.35
	8066931	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	-0.21	CHEMBL4895	Homo sapiens	Inhibition	%	-0.21
	8067330	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	-5.56	CHEMBL4895	Homo sapiens	Inhibition	%	-5.56
	8067451	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	-3.3	CHEMBL4895	Homo sapiens	Inhibition	%	-3.3
	8067675	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-2.22	CHEMBL4895	Homo sapiens	Inhibition	%	-2.22
	8067885	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.17	CHEMBL4895	Homo sapiens	Inhibition	%	2.17
	8068020	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	2.0	CHEMBL4895	Homo sapiens	Inhibition	%	2.0
	8068408	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-2.1	CHEMBL4895	Homo sapiens	Inhibition	%	-2.1
	8068533	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	9.52	CHEMBL4895	Homo sapiens	Inhibition	%	9.52
	8068757	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-1.93	CHEMBL4895	Homo sapiens	Inhibition	%	-1.93
	8068931	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	-1.71	CHEMBL4895	Homo sapiens	Inhibition	%	-1.71
	8069280	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.78	CHEMBL4895	Homo sapiens	Inhibition	%	0.78
	8069351	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	20.71	CHEMBL4895	Homo sapiens	Inhibition	%	20.71
	8069575	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	15.02	CHEMBL4895	Homo sapiens	Inhibition	%	15.02
	8069736	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-1.77	CHEMBL4895	Homo sapiens	Inhibition	%	-1.77
	8070086	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-1.26	CHEMBL4895	Homo sapiens	Inhibition	%	-1.26
	8070258	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	-6.33	CHEMBL4895	Homo sapiens	Inhibition	%	-6.33
	8070607	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-1.3	CHEMBL4895	Homo sapiens	Inhibition	%	-1.3
	8070905	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	58.84	CHEMBL4895	Homo sapiens	Inhibition	%	58.84
	8071062	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-3.23	CHEMBL4895	Homo sapiens	Inhibition	%	-3.23
	8071412	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.81	CHEMBL4895	Homo sapiens	Inhibition	%	-0.81
	8071585	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	-3.32	CHEMBL4895	Homo sapiens	Inhibition	%	-3.32
	8071809	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	-6.59	CHEMBL4895	Homo sapiens	Inhibition	%	-6.59
	8071934	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	2.69	CHEMBL4895	Homo sapiens	Inhibition	%	2.69
	8072248	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.41	CHEMBL4895	Homo sapiens	Inhibition	%	-0.41
	8072405	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-2.47	CHEMBL4895	Homo sapiens	Inhibition	%	-2.47
	8072629	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	-7.01	CHEMBL4895	Homo sapiens	Inhibition	%	-7.01
	8072754	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.83	CHEMBL4895	Homo sapiens	Inhibition	%	0.83
	8073145	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	-1.16	CHEMBL4895	Homo sapiens	Inhibition	%	-1.16
	8073270	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	13.68	CHEMBL4895	Homo sapiens	Inhibition	%	13.68
	8073613	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-1.65	CHEMBL4895	Homo sapiens	Inhibition	%	-1.65
	8073846	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.25	CHEMBL4895	Homo sapiens	Inhibition	%	1.25
	8074222	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	-3.64	CHEMBL4895	Homo sapiens	Inhibition	%	-3.64
	8074352	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.33	CHEMBL4895	Homo sapiens	Inhibition	%	-0.33
	8074576	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.68	CHEMBL4895	Homo sapiens	Inhibition	%	1.68
	8074733	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	-5.91	CHEMBL4895	Homo sapiens	Inhibition	%	-5.91
	8074860	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	46.61	CHEMBL4895	Homo sapiens	Inhibition	%	46.61
	8075084	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.7	CHEMBL4895	Homo sapiens	Inhibition	%	1.7
	8075195	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	2.86	CHEMBL4895	Homo sapiens	Inhibition	%	2.86
	8075432	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.88	CHEMBL4895	Homo sapiens	Inhibition	%	1.88
	8075656	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.53	CHEMBL4895	Homo sapiens	Inhibition	%	1.53
	8075797	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	-4.48	CHEMBL4895	Homo sapiens	Inhibition	%	-4.48
	8076163	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.07	CHEMBL4895	Homo sapiens	Inhibition	%	0.07
	8076311	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.68	CHEMBL4895	Homo sapiens	Inhibition	%	1.68
	8076669	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	5.43	CHEMBL4895	Homo sapiens	Inhibition	%	5.43
	8076771	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.1	CHEMBL4895	Homo sapiens	Inhibition	%	-0.1
	8076995	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.84	CHEMBL4895	Homo sapiens	Inhibition	%	1.84
	8077242	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	1.96	CHEMBL4895	Homo sapiens	Inhibition	%	1.96
	8077370	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	-3.02	CHEMBL4895	Homo sapiens	Inhibition	%	-3.02
	8077745	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.8	CHEMBL4895	Homo sapiens	Inhibition	%	1.8
	8077888	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	-5.54	CHEMBL4895	Homo sapiens	Inhibition	%	-5.54
	8078251	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	1.86	CHEMBL4895	Homo sapiens	Inhibition	%	1.86
	8078577	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-1.8	CHEMBL4895	Homo sapiens	Inhibition	%	-1.8
	8078827	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	8.92	CHEMBL4895	Homo sapiens	Inhibition	%	8.92
	8078943	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	-4.6	CHEMBL4895	Homo sapiens	Inhibition	%	-4.6
	8079167	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1	Outside typical range	CHEMBL270164	=	Inhibition	%	-13.42	CHEMBL4895	Homo sapiens	Inhibition	%	-13.42
	8079325	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	2.21	CHEMBL4895	Homo sapiens	Inhibition	%	2.21
	8079467	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	-2.35	CHEMBL4895	Homo sapiens	Inhibition	%	-2.35
	8079691	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-4.98	CHEMBL4895	Homo sapiens	Inhibition	%	-4.98
	8079830	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	1.05	CHEMBL4895	Homo sapiens	Inhibition	%	1.05
	8080159	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.54	CHEMBL4895	Homo sapiens	Inhibition	%	2.54
	8080411	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	1.97	CHEMBL4895	Homo sapiens	Inhibition	%	1.97
	8080750	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	-3.58	CHEMBL4895	Homo sapiens	Inhibition	%	-3.58
	8080914	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	3.2	CHEMBL4895	Homo sapiens	Inhibition	%	3.2
	8081273	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-2.42	CHEMBL4895	Homo sapiens	Inhibition	%	-2.42
	8081417	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	17.05	CHEMBL4895	Homo sapiens	Inhibition	%	17.05
	8081744	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.38	CHEMBL4895	Homo sapiens	Inhibition	%	0.38
	8081996	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	13.18	CHEMBL4895	Homo sapiens	Inhibition	%	13.18
	8082333	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	-5.04	CHEMBL4895	Homo sapiens	Inhibition	%	-5.04
	8082506	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.6	CHEMBL4895	Homo sapiens	Inhibition	%	3.6
	8082853	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	-4.44	CHEMBL4895	Homo sapiens	Inhibition	%	-4.44
	8083009	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	65.98	CHEMBL4895	Homo sapiens	Inhibition	%	65.98
	8083233	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	-2.66	CHEMBL4895	Homo sapiens	Inhibition	%	-2.66
	8083332	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-0.83	CHEMBL4895	Homo sapiens	Inhibition	%	-0.83
	8083586	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	4.13	CHEMBL4895	Homo sapiens	Inhibition	%	4.13
	8083810	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	4.86	CHEMBL4895	Homo sapiens	Inhibition	%	4.86
	8083920	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	-3.77	CHEMBL4895	Homo sapiens	Inhibition	%	-3.77
	8084105	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	8.06	CHEMBL4895	Homo sapiens	Inhibition	%	8.06
	8084329	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	0.46	CHEMBL4895	Homo sapiens	Inhibition	%	0.46
	8084447	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	-1.14	CHEMBL4895	Homo sapiens	Inhibition	%	-1.14
	8084832	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	3.27	CHEMBL4895	Homo sapiens	Inhibition	%	3.27
	8084930	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.1	CHEMBL4895	Homo sapiens	Inhibition	%	0.1
	8085154	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.68	CHEMBL4895	Homo sapiens	Inhibition	%	1.68
	8085410	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	5.07	CHEMBL4895	Homo sapiens	Inhibition	%	5.07
	8085518	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	0.24	CHEMBL4895	Homo sapiens	Inhibition	%	0.24
	8085742	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	-2.82	CHEMBL4895	Homo sapiens	Inhibition	%	-2.82
	8085931	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	36.8	CHEMBL4895	Homo sapiens	Inhibition	%	36.8
	8086046	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	-6.03	CHEMBL4895	Homo sapiens	Inhibition	%	-6.03
	8086270	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	-3.44	CHEMBL4895	Homo sapiens	Inhibition	%	-3.44
	8086432	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-5.65	CHEMBL4895	Homo sapiens	Inhibition	%	-5.65
	8086755	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-1.17	CHEMBL4895	Homo sapiens	Inhibition	%	-1.17
	8086966	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-6.04	CHEMBL4895	Homo sapiens	Inhibition	%	-6.04
	8087348	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-4.46	CHEMBL4895	Homo sapiens	Inhibition	%	-4.46
	8087462	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-3.9	CHEMBL4895	Homo sapiens	Inhibition	%	-3.9
	8087824	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-0.55	CHEMBL4895	Homo sapiens	Inhibition	%	-0.55
	8087966	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	-7.98	CHEMBL4895	Homo sapiens	Inhibition	%	-7.98
	8088190	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	-9.66	CHEMBL4895	Homo sapiens	Inhibition	%	-9.66
	8088338	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-4.02	CHEMBL4895	Homo sapiens	Inhibition	%	-4.02
	8088690	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	-8.48	CHEMBL4895	Homo sapiens	Inhibition	%	-8.48
	8088783	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	-0.67	CHEMBL4895	Homo sapiens	Inhibition	%	-0.67
	8089007	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.96	CHEMBL4895	Homo sapiens	Inhibition	%	0.96
	8089135	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	5.22	CHEMBL4895	Homo sapiens	Inhibition	%	5.22
	8089507	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.02	CHEMBL4895	Homo sapiens	Inhibition	%	1.02
	8089627	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.9	CHEMBL4895	Homo sapiens	Inhibition	%	-0.9
	8089851	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-0.86	CHEMBL4895	Homo sapiens	Inhibition	%	-0.86
	8090031	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	5.17	CHEMBL4895	Homo sapiens	Inhibition	%	5.17
	8090196	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-1.56	CHEMBL4895	Homo sapiens	Inhibition	%	-1.56
	8090587	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-1.08	CHEMBL4895	Homo sapiens	Inhibition	%	-1.08
	8090726	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.78	CHEMBL4895	Homo sapiens	Inhibition	%	-0.78
	8090950	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-2.29	CHEMBL4895	Homo sapiens	Inhibition	%	-2.29
	8091155	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	-3.92	CHEMBL4895	Homo sapiens	Inhibition	%	-3.92
	8091292	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	-1.76	CHEMBL4895	Homo sapiens	Inhibition	%	-1.76
	8091671	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-3.83	CHEMBL4895	Homo sapiens	Inhibition	%	-3.83
	8091787	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-6.45	CHEMBL4895	Homo sapiens	Inhibition	%	-6.45
	8092011	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	-5.15	CHEMBL4895	Homo sapiens	Inhibition	%	-5.15
	8092148	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-4.72	CHEMBL4895	Homo sapiens	Inhibition	%	-4.72
	8092523	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	-7.56	CHEMBL4895	Homo sapiens	Inhibition	%	-7.56
	8092671	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.04	CHEMBL4895	Homo sapiens	Inhibition	%	-0.04
	8093024	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	-5.82	CHEMBL4895	Homo sapiens	Inhibition	%	-5.82
	8093336	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	-4.91	CHEMBL4895	Homo sapiens	Inhibition	%	-4.91
	8093476	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	6.29	CHEMBL4895	Homo sapiens	Inhibition	%	6.29
	8093839	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	5.18	CHEMBL4895	Homo sapiens	Inhibition	%	5.18
	8094183	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.78	CHEMBL4895	Homo sapiens	Inhibition	%	1.78
	8094363	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.06	CHEMBL4895	Homo sapiens	Inhibition	%	0.06
	8094538	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.45	CHEMBL4895	Homo sapiens	Inhibition	%	2.45
	8094762	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	3.89	CHEMBL4895	Homo sapiens	Inhibition	%	3.89
	8094918	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-0.92	CHEMBL4895	Homo sapiens	Inhibition	%	-0.92
	8095282	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	16.19	CHEMBL4895	Homo sapiens	Inhibition	%	16.19
	8095485	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	-1.88	CHEMBL4895	Homo sapiens	Inhibition	%	-1.88
	8095626	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	8.88	CHEMBL4895	Homo sapiens	Inhibition	%	8.88
	8095850	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	58.1	CHEMBL4895	Homo sapiens	Inhibition	%	58.1
	8095998	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	-3.79	CHEMBL4895	Homo sapiens	Inhibition	%	-3.79
	8096339	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	-8.0	CHEMBL4895	Homo sapiens	Inhibition	%	-8.0
	8096478	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-3.54	CHEMBL4895	Homo sapiens	Inhibition	%	-3.54
	8096702	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-2.39	CHEMBL4895	Homo sapiens	Inhibition	%	-2.39
	8096858	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	-6.81	CHEMBL4895	Homo sapiens	Inhibition	%	-6.81
	8097005	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-4.04	CHEMBL4895	Homo sapiens	Inhibition	%	-4.04
	8097229	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.51	CHEMBL4895	Homo sapiens	Inhibition	%	1.51
	8097316	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-8.67	CHEMBL4895	Homo sapiens	Inhibition	%	-8.67
	8097536	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.31	CHEMBL4895	Homo sapiens	Inhibition	%	1.31
	8097686	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	2.41	CHEMBL4895	Homo sapiens	Inhibition	%	2.41
	8097910	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	3.03	CHEMBL4895	Homo sapiens	Inhibition	%	3.03
	8098043	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.47	CHEMBL4895	Homo sapiens	Inhibition	%	-0.47
	8098387	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.14	CHEMBL4895	Homo sapiens	Inhibition	%	0.14
	8098567	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.57	CHEMBL4895	Homo sapiens	Inhibition	%	1.57
	8098976	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	42.43	CHEMBL4895	Homo sapiens	Inhibition	%	42.43
	8099120	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	-2.71	CHEMBL4895	Homo sapiens	Inhibition	%	-2.71
	8099486	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	-3.01	CHEMBL4895	Homo sapiens	Inhibition	%	-3.01
	8099680	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-4.43	CHEMBL4895	Homo sapiens	Inhibition	%	-4.43
	8100051	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	-3.91	CHEMBL4895	Homo sapiens	Inhibition	%	-3.91
	8100197	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	-3.18	CHEMBL4895	Homo sapiens	Inhibition	%	-3.18
	8100537	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	-6.06	CHEMBL4895	Homo sapiens	Inhibition	%	-6.06
	8100901	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.46	CHEMBL4895	Homo sapiens	Inhibition	%	0.46
	8101061	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	-7.91	CHEMBL4895	Homo sapiens	Inhibition	%	-7.91
	8101427	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.73	CHEMBL4895	Homo sapiens	Inhibition	%	-0.73
	8101612	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-9.61	CHEMBL4895	Homo sapiens	Inhibition	%	-9.61
	8101865	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	-2.43	CHEMBL4895	Homo sapiens	Inhibition	%	-2.43
	8102244	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	4.05	CHEMBL4895	Homo sapiens	Inhibition	%	4.05
	8102375	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.32	CHEMBL4895	Homo sapiens	Inhibition	%	-0.32
	8102599	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.5	CHEMBL4895	Homo sapiens	Inhibition	%	0.5
	8102719	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.71	CHEMBL4895	Homo sapiens	Inhibition	%	-0.71
	8102897	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.76	CHEMBL4895	Homo sapiens	Inhibition	%	0.76
	8103121	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.06	CHEMBL4895	Homo sapiens	Inhibition	%	2.06
	8103317	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	-1.29	CHEMBL4895	Homo sapiens	Inhibition	%	-1.29
	8103455	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	0.06	CHEMBL4895	Homo sapiens	Inhibition	%	0.06
	8103679	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-1.82	CHEMBL4895	Homo sapiens	Inhibition	%	-1.82
	8103829	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	-1.92	CHEMBL4895	Homo sapiens	Inhibition	%	-1.92
	8104014	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-4.53	CHEMBL4895	Homo sapiens	Inhibition	%	-4.53
	8104238	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-5.74	CHEMBL4895	Homo sapiens	Inhibition	%	-5.74
	8104386	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	-6.6	CHEMBL4895	Homo sapiens	Inhibition	%	-6.6
	8104532	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-3.81	CHEMBL4895	Homo sapiens	Inhibition	%	-3.81
	8104756	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-1.27	CHEMBL4895	Homo sapiens	Inhibition	%	-1.27
	8104870	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-5.46	CHEMBL4895	Homo sapiens	Inhibition	%	-5.46
	8105234	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.96	CHEMBL4895	Homo sapiens	Inhibition	%	-0.96
	8105400	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	-7.29	CHEMBL4895	Homo sapiens	Inhibition	%	-7.29
	8105762	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-1.68	CHEMBL4895	Homo sapiens	Inhibition	%	-1.68
	8106042	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.64	CHEMBL4895	Homo sapiens	Inhibition	%	1.64
	8106207	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	3.21	CHEMBL4895	Homo sapiens	Inhibition	%	3.21
	8106431	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-2.11	CHEMBL4895	Homo sapiens	Inhibition	%	-2.11
	8106587	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	7.82	CHEMBL4895	Homo sapiens	Inhibition	%	7.82
	8106940	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.53	CHEMBL4895	Homo sapiens	Inhibition	%	-0.53
	8107061	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.7	CHEMBL4895	Homo sapiens	Inhibition	%	0.7
	8107457	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-0.22	CHEMBL4895	Homo sapiens	Inhibition	%	-0.22
	8107658	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	-3.0	CHEMBL4895	Homo sapiens	Inhibition	%	-3.0
	8108017	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-2.93	CHEMBL4895	Homo sapiens	Inhibition	%	-2.93
	8108175	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	-4.3	CHEMBL4895	Homo sapiens	Inhibition	%	-4.3
	8108574	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	6.96	CHEMBL4895	Homo sapiens	Inhibition	%	6.96
	8108721	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	-5.23	CHEMBL4895	Homo sapiens	Inhibition	%	-5.23
	8109087	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.96	CHEMBL4895	Homo sapiens	Inhibition	%	-0.96
	8109201	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-3.22	CHEMBL4895	Homo sapiens	Inhibition	%	-3.22
	8109425	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	-7.26	CHEMBL4895	Homo sapiens	Inhibition	%	-7.26
	8109555	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.46	CHEMBL4895	Homo sapiens	Inhibition	%	0.46
	8109726	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-8.27	CHEMBL4895	Homo sapiens	Inhibition	%	-8.27
	8109950	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-3.62	CHEMBL4895	Homo sapiens	Inhibition	%	-3.62
	8110082	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	-6.45	CHEMBL4895	Homo sapiens	Inhibition	%	-6.45
	8110361	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.6	CHEMBL4895	Homo sapiens	Inhibition	%	1.6
	8110751	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	3.68	CHEMBL4895	Homo sapiens	Inhibition	%	3.68
	8110909	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	7.73	CHEMBL4895	Homo sapiens	Inhibition	%	7.73
	8111256	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	9.63	CHEMBL4895	Homo sapiens	Inhibition	%	9.63
	8111383	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.9	CHEMBL4895	Homo sapiens	Inhibition	%	0.9
	8111607	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.65	CHEMBL4895	Homo sapiens	Inhibition	%	0.65
	8111773	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.55	CHEMBL4895	Homo sapiens	Inhibition	%	1.55
	8111978	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	-1.8	CHEMBL4895	Homo sapiens	Inhibition	%	-1.8
	8112339	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-2.14	CHEMBL4895	Homo sapiens	Inhibition	%	-2.14
	8112507	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	-2.36	CHEMBL4895	Homo sapiens	Inhibition	%	-2.36
	8112731	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	-4.87	CHEMBL4895	Homo sapiens	Inhibition	%	-4.87
	8112903	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.99	CHEMBL4895	Homo sapiens	Inhibition	%	-0.99
	8113055	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.11	CHEMBL4895	Homo sapiens	Inhibition	%	3.11
	8113279	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	-7.46	CHEMBL4895	Homo sapiens	Inhibition	%	-7.46
	8113415	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.46	CHEMBL4895	Homo sapiens	Inhibition	%	1.46
	8113763	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	-4.55	CHEMBL4895	Homo sapiens	Inhibition	%	-4.55
	8113879	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.65	CHEMBL4895	Homo sapiens	Inhibition	%	0.65
	8114279	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	-6.74	CHEMBL4895	Homo sapiens	Inhibition	%	-6.74
	8114411	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	-6.19	CHEMBL4895	Homo sapiens	Inhibition	%	-6.19
	8114635	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	-6.97	CHEMBL4895	Homo sapiens	Inhibition	%	-6.97
	8114687	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.41	CHEMBL4895	Homo sapiens	Inhibition	%	0.41
	8114911	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	3.11	CHEMBL4895	Homo sapiens	Inhibition	%	3.11
	8115077	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	-3.96	CHEMBL4895	Homo sapiens	Inhibition	%	-3.96
	8115242	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	7.15	CHEMBL4895	Homo sapiens	Inhibition	%	7.15
	8115466	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	7.46	CHEMBL4895	Homo sapiens	Inhibition	%	7.46
	8115586	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	25.52	CHEMBL4895	Homo sapiens	Inhibition	%	25.52
	8115943	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.17	CHEMBL4895	Homo sapiens	Inhibition	%	0.17
	8116102	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	1.56	CHEMBL4895	Homo sapiens	Inhibition	%	1.56
	8116305	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	-3.9	CHEMBL4895	Homo sapiens	Inhibition	%	-3.9
	8116529	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	-1.51	CHEMBL4895	Homo sapiens	Inhibition	%	-1.51
	8116663	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.56	CHEMBL4895	Homo sapiens	Inhibition	%	0.56
	8117059	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	-2.44	CHEMBL4895	Homo sapiens	Inhibition	%	-2.44
	8117230	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.55	CHEMBL4895	Homo sapiens	Inhibition	%	1.55
	8117612	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	-6.1	CHEMBL4895	Homo sapiens	Inhibition	%	-6.1
	8117742	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.79	CHEMBL4895	Homo sapiens	Inhibition	%	0.79
	8118104	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1	Outside typical range	CHEMBL1785004	=	Inhibition	%	-16.45	CHEMBL4895	Homo sapiens	Inhibition	%	-16.45
	8118220	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	1.56	CHEMBL4895	Homo sapiens	Inhibition	%	1.56
	8118444	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	-6.59	CHEMBL4895	Homo sapiens	Inhibition	%	-6.59
	8118616	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	-5.12	CHEMBL4895	Homo sapiens	Inhibition	%	-5.12
	8118976	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	-6.25	CHEMBL4895	Homo sapiens	Inhibition	%	-6.25
	8119247	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	17.59	CHEMBL4895	Homo sapiens	Inhibition	%	17.59
	8119406	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	37.3	CHEMBL4895	Homo sapiens	Inhibition	%	37.3
	8119797	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.38	CHEMBL4895	Homo sapiens	Inhibition	%	1.38
	8119916	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.38	CHEMBL4895	Homo sapiens	Inhibition	%	0.38
	8120279	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.41	CHEMBL4895	Homo sapiens	Inhibition	%	0.41
	8120439	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	6.57	CHEMBL4895	Homo sapiens	Inhibition	%	6.57
	8120663	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.41	CHEMBL4895	Homo sapiens	Inhibition	%	0.41
	8120864	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	-4.23	CHEMBL4895	Homo sapiens	Inhibition	%	-4.23
	8120992	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.26	CHEMBL4895	Homo sapiens	Inhibition	%	-0.26
	8121216	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.13	CHEMBL4895	Homo sapiens	Inhibition	%	0.13
	8121388	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-5.65	CHEMBL4895	Homo sapiens	Inhibition	%	-5.65
	8121555	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.12	CHEMBL4895	Homo sapiens	Inhibition	%	-0.12
	8121942	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	-6.14	CHEMBL4895	Homo sapiens	Inhibition	%	-6.14
	8122063	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.26	CHEMBL4895	Homo sapiens	Inhibition	%	1.26
	8122287	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-3.19	CHEMBL4895	Homo sapiens	Inhibition	%	-3.19
	8122425	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-4.58	CHEMBL4895	Homo sapiens	Inhibition	%	-4.58
	8122769	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	-6.03	CHEMBL4895	Homo sapiens	Inhibition	%	-6.03
	8122936	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	-7.53	CHEMBL4895	Homo sapiens	Inhibition	%	-7.53
	8123302	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-8.08	CHEMBL4895	Homo sapiens	Inhibition	%	-8.08
	8123580	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	63.71	CHEMBL4895	Homo sapiens	Inhibition	%	63.71
	8123730	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	-1.48	CHEMBL4895	Homo sapiens	Inhibition	%	-1.48
	8123954	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	10.56	CHEMBL4895	Homo sapiens	Inhibition	%	10.56
	8124121	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	3.99	CHEMBL4895	Homo sapiens	Inhibition	%	3.99
	8124240	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.38	CHEMBL4895	Homo sapiens	Inhibition	%	0.38
	8124464	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	-0.07	CHEMBL4895	Homo sapiens	Inhibition	%	-0.07
	8124603	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.14	CHEMBL4895	Homo sapiens	Inhibition	%	1.14
	8124992	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.46	CHEMBL4895	Homo sapiens	Inhibition	%	2.46
	8125193	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	-2.27	CHEMBL4895	Homo sapiens	Inhibition	%	-2.27
	8125547	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.08	CHEMBL4895	Homo sapiens	Inhibition	%	0.08
	8125715	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-7.04	CHEMBL4895	Homo sapiens	Inhibition	%	-7.04
	8125879	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.32	CHEMBL4895	Homo sapiens	Inhibition	%	0.32
	8126103	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.6	CHEMBL4895	Homo sapiens	Inhibition	%	1.6
	8126267	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	-4.14	CHEMBL4895	Homo sapiens	Inhibition	%	-4.14
	8126606	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	23.47	CHEMBL4895	Homo sapiens	Inhibition	%	23.47
	8126742	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	-3.83	CHEMBL4895	Homo sapiens	Inhibition	%	-3.83
	8127088	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	-7.4	CHEMBL4895	Homo sapiens	Inhibition	%	-7.4
	8127255	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	-5.13	CHEMBL4895	Homo sapiens	Inhibition	%	-5.13
	8127479	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	-6.71	CHEMBL4895	Homo sapiens	Inhibition	%	-6.71
	8127621	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-1.95	CHEMBL4895	Homo sapiens	Inhibition	%	-1.95
	8127909	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.02	CHEMBL4895	Homo sapiens	Inhibition	%	0.02
	8128285	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	-0.49	CHEMBL4895	Homo sapiens	Inhibition	%	-0.49
	8128452	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-2.08	CHEMBL4895	Homo sapiens	Inhibition	%	-2.08
	8128795	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	11.4	CHEMBL4895	Homo sapiens	Inhibition	%	11.4
	8128932	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.59	CHEMBL4895	Homo sapiens	Inhibition	%	1.59
	8129156	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.02	CHEMBL4895	Homo sapiens	Inhibition	%	1.02
	8129327	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.32	CHEMBL4895	Homo sapiens	Inhibition	%	1.32
	8129516	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	-3.44	CHEMBL4895	Homo sapiens	Inhibition	%	-3.44
	8129879	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.65	CHEMBL4895	Homo sapiens	Inhibition	%	1.65
	8130040	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-3.79	CHEMBL4895	Homo sapiens	Inhibition	%	-3.79
	8130436	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	2.22	CHEMBL4895	Homo sapiens	Inhibition	%	2.22
	8130596	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	-3.64	CHEMBL4895	Homo sapiens	Inhibition	%	-3.64
	8130936	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-5.49	CHEMBL4895	Homo sapiens	Inhibition	%	-5.49
	8131075	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	24.67	CHEMBL4895	Homo sapiens	Inhibition	%	24.67
	8131299	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	-6.79	CHEMBL4895	Homo sapiens	Inhibition	%	-6.79
	8131419	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	-7.71	CHEMBL4895	Homo sapiens	Inhibition	%	-7.71
	8131810	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	-5.62	CHEMBL4895	Homo sapiens	Inhibition	%	-5.62
	8131951	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12	Outside typical range	CHEMBL273564	=	Inhibition	%	-10.48	CHEMBL4895	Homo sapiens	Inhibition	%	-10.48
	8132237	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	4.22	CHEMBL4895	Homo sapiens	Inhibition	%	4.22
	8132608	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.27	CHEMBL4895	Homo sapiens	Inhibition	%	3.27
	8132776	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	4.02	CHEMBL4895	Homo sapiens	Inhibition	%	4.02
	8133121	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.22	CHEMBL4895	Homo sapiens	Inhibition	%	1.22
	8133483	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.47	CHEMBL4895	Homo sapiens	Inhibition	%	0.47
	8133655	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	2.27	CHEMBL4895	Homo sapiens	Inhibition	%	2.27
	8133835	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	-3.75	CHEMBL4895	Homo sapiens	Inhibition	%	-3.75
	8134059	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	11.93	CHEMBL4895	Homo sapiens	Inhibition	%	11.93
	8134207	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	2.44	CHEMBL4895	Homo sapiens	Inhibition	%	2.44
	8134367	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-3.11	CHEMBL4895	Homo sapiens	Inhibition	%	-3.11
	8134591	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-3.64	CHEMBL4895	Homo sapiens	Inhibition	%	-3.64
	8134775	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	2.95	CHEMBL4895	Homo sapiens	Inhibition	%	2.95
	8134935	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	16.34	CHEMBL4895	Homo sapiens	Inhibition	%	16.34
	8135159	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	-5.03	CHEMBL4895	Homo sapiens	Inhibition	%	-5.03
	8135274	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-5.8	CHEMBL4895	Homo sapiens	Inhibition	%	-5.8
	8135639	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	-4.58	CHEMBL4895	Homo sapiens	Inhibition	%	-4.58
	8135760	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-8.81	CHEMBL4895	Homo sapiens	Inhibition	%	-8.81
	8135984	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1	Outside typical range	CHEMBL269450	=	Inhibition	%	-10.67	CHEMBL4895	Homo sapiens	Inhibition	%	-10.67
	8136152	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	-6.24	CHEMBL4895	Homo sapiens	Inhibition	%	-6.24
	8136296	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	45.32	CHEMBL4895	Homo sapiens	Inhibition	%	45.32
	8136520	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	-7.21	CHEMBL4895	Homo sapiens	Inhibition	%	-7.21
	8136586	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.45	CHEMBL4895	Homo sapiens	Inhibition	%	-0.45
	8136810	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	3.71	CHEMBL4895	Homo sapiens	Inhibition	%	3.71
	8136945	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-2.18	CHEMBL4895	Homo sapiens	Inhibition	%	-2.18
	8137108	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.52	CHEMBL4895	Homo sapiens	Inhibition	%	-0.52
	8137332	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	2.01	CHEMBL4895	Homo sapiens	Inhibition	%	2.01
	8137452	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.45	CHEMBL4895	Homo sapiens	Inhibition	%	2.45
	8137824	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.83	CHEMBL4895	Homo sapiens	Inhibition	%	0.83
	8137990	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.78	CHEMBL4895	Homo sapiens	Inhibition	%	1.78
	8138393	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-5.39	CHEMBL4895	Homo sapiens	Inhibition	%	-5.39
	8138541	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	2.96	CHEMBL4895	Homo sapiens	Inhibition	%	2.96
	8138923	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-2.93	CHEMBL4895	Homo sapiens	Inhibition	%	-2.93
	8139108	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	4.47	CHEMBL4895	Homo sapiens	Inhibition	%	4.47
	8139491	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	-1.94	CHEMBL4895	Homo sapiens	Inhibition	%	-1.94
	8139605	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	-6.0	CHEMBL4895	Homo sapiens	Inhibition	%	-6.0
	8139829	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	-6.09	CHEMBL4895	Homo sapiens	Inhibition	%	-6.09
	8139970	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	-4.66	CHEMBL4895	Homo sapiens	Inhibition	%	-4.66
	8140317	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	-6.97	CHEMBL4895	Homo sapiens	Inhibition	%	-6.97
	8140476	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	-4.88	CHEMBL4895	Homo sapiens	Inhibition	%	-4.88
	8140843	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	-5.79	CHEMBL4895	Homo sapiens	Inhibition	%	-5.79
	8141145	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.85	CHEMBL4895	Homo sapiens	Inhibition	%	3.85
	8141275	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-5.55	CHEMBL4895	Homo sapiens	Inhibition	%	-5.55
	8141659	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	13.16	CHEMBL4895	Homo sapiens	Inhibition	%	13.16
	8141778	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.01	CHEMBL4895	Homo sapiens	Inhibition	%	-0.01
	8142002	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	3.27	CHEMBL4895	Homo sapiens	Inhibition	%	3.27
	8142163	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	1.61	CHEMBL4895	Homo sapiens	Inhibition	%	1.61
	8142331	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	2.38	CHEMBL4895	Homo sapiens	Inhibition	%	2.38
	8142555	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	3.82	CHEMBL4895	Homo sapiens	Inhibition	%	3.82
	8142731	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-2.54	CHEMBL4895	Homo sapiens	Inhibition	%	-2.54
	8142880	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	2.35	CHEMBL4895	Homo sapiens	Inhibition	%	2.35
	8143104	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	4.77	CHEMBL4895	Homo sapiens	Inhibition	%	4.77
	8143259	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	-4.2	CHEMBL4895	Homo sapiens	Inhibition	%	-4.2
	8143446	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	-5.83	CHEMBL4895	Homo sapiens	Inhibition	%	-5.83
	8143670	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	-7.49	CHEMBL4895	Homo sapiens	Inhibition	%	-7.49
	8143829	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	-5.69	CHEMBL4895	Homo sapiens	Inhibition	%	-5.69
	8144167	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-6.75	CHEMBL4895	Homo sapiens	Inhibition	%	-6.75
	8144306	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	-4.13	CHEMBL4895	Homo sapiens	Inhibition	%	-4.13
	8144660	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	-6.84	CHEMBL4895	Homo sapiens	Inhibition	%	-6.84
	8144813	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	-5.35	CHEMBL4895	Homo sapiens	Inhibition	%	-5.35
	8145037	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	-4.04	CHEMBL4895	Homo sapiens	Inhibition	%	-4.04
	8145174	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	-7.43	CHEMBL4895	Homo sapiens	Inhibition	%	-7.43
	8145487	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	21.37	CHEMBL4895	Homo sapiens	Inhibition	%	21.37
	8145611	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.04	CHEMBL4895	Homo sapiens	Inhibition	%	2.04
	8145835	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	5.23	CHEMBL4895	Homo sapiens	Inhibition	%	5.23
	8145996	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	4.33	CHEMBL4895	Homo sapiens	Inhibition	%	4.33
	8146340	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.61	CHEMBL4895	Homo sapiens	Inhibition	%	1.61
	8146500	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	8.45	CHEMBL4895	Homo sapiens	Inhibition	%	8.45
	8146891	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	12.77	CHEMBL4895	Homo sapiens	Inhibition	%	12.77
	8147060	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	-3.46	CHEMBL4895	Homo sapiens	Inhibition	%	-3.46
	8147426	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-3.39	CHEMBL4895	Homo sapiens	Inhibition	%	-3.39
	8147579	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	-3.04	CHEMBL4895	Homo sapiens	Inhibition	%	-3.04
	8147990	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	-5.02	CHEMBL4895	Homo sapiens	Inhibition	%	-5.02
	8148148	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	-3.9	CHEMBL4895	Homo sapiens	Inhibition	%	-3.9
	8148486	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-7.91	CHEMBL4895	Homo sapiens	Inhibition	%	-7.91
	8148625	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-4.21	CHEMBL4895	Homo sapiens	Inhibition	%	-4.21
	8148849	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-1.65	CHEMBL4895	Homo sapiens	Inhibition	%	-1.65
	8148987	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	-7.67	CHEMBL4895	Homo sapiens	Inhibition	%	-7.67
	8149370	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-6.1	CHEMBL4895	Homo sapiens	Inhibition	%	-6.1
	8149504	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	-5.93	CHEMBL4895	Homo sapiens	Inhibition	%	-5.93
	8149826	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	-1.68	CHEMBL4895	Homo sapiens	Inhibition	%	-1.68
	8150175	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	16.09	CHEMBL4895	Homo sapiens	Inhibition	%	16.09
	8150335	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	28.56	CHEMBL4895	Homo sapiens	Inhibition	%	28.56
	8150679	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	10.86	CHEMBL4895	Homo sapiens	Inhibition	%	10.86
	8150844	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	22.94	CHEMBL4895	Homo sapiens	Inhibition	%	22.94
	8151068	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	66.82	CHEMBL4895	Homo sapiens	Inhibition	%	66.82
	8151231	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	3.54	CHEMBL4895	Homo sapiens	Inhibition	%	3.54
	8151408	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	-3.39	CHEMBL4895	Homo sapiens	Inhibition	%	-3.39
	8151770	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-4.33	CHEMBL4895	Homo sapiens	Inhibition	%	-4.33
	8151924	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-4.48	CHEMBL4895	Homo sapiens	Inhibition	%	-4.48
	8152148	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-2.69	CHEMBL4895	Homo sapiens	Inhibition	%	-2.69
	8152336	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	-4.28	CHEMBL4895	Homo sapiens	Inhibition	%	-4.28
	8152494	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	-3.91	CHEMBL4895	Homo sapiens	Inhibition	%	-3.91
	8152718	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	-3.74	CHEMBL4895	Homo sapiens	Inhibition	%	-3.74
	8152832	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-6.66	CHEMBL4895	Homo sapiens	Inhibition	%	-6.66
	8153195	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-3.61	CHEMBL4895	Homo sapiens	Inhibition	%	-3.61
	8153332	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	-8.36	CHEMBL4895	Homo sapiens	Inhibition	%	-8.36
	8153713	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-5.07	CHEMBL4895	Homo sapiens	Inhibition	%	-5.07
	8153846	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	-8.56	CHEMBL4895	Homo sapiens	Inhibition	%	-8.56
	8154070	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	-6.19	CHEMBL4895	Homo sapiens	Inhibition	%	-6.19
	8154167	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.31	CHEMBL4895	Homo sapiens	Inhibition	%	1.31
	8154517	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	60.5	CHEMBL4895	Homo sapiens	Inhibition	%	60.5
	8154676	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-1.87	CHEMBL4895	Homo sapiens	Inhibition	%	-1.87
	8154900	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.81	CHEMBL4895	Homo sapiens	Inhibition	%	-0.81
	8155020	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-1.61	CHEMBL4895	Homo sapiens	Inhibition	%	-1.61
	8155420	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.67	CHEMBL4895	Homo sapiens	Inhibition	%	0.67
	8155581	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	6.55	CHEMBL4895	Homo sapiens	Inhibition	%	6.55
	8155759	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	-2.55	CHEMBL4895	Homo sapiens	Inhibition	%	-2.55
	8155983	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	-2.77	CHEMBL4895	Homo sapiens	Inhibition	%	-2.77
	8156121	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-3.01	CHEMBL4895	Homo sapiens	Inhibition	%	-3.01
	8156333	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.72	CHEMBL4895	Homo sapiens	Inhibition	%	1.72
	8156557	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	-6.86	CHEMBL4895	Homo sapiens	Inhibition	%	-6.86
	8156707	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	-3.61	CHEMBL4895	Homo sapiens	Inhibition	%	-3.61
	8157074	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	-3.58	CHEMBL4895	Homo sapiens	Inhibition	%	-3.58
	8157194	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	-3.17	CHEMBL4895	Homo sapiens	Inhibition	%	-3.17
	8157559	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	-3.79	CHEMBL4895	Homo sapiens	Inhibition	%	-3.79
	8157689	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	19.21	CHEMBL4895	Homo sapiens	Inhibition	%	19.21
	8157913	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	-2.18	CHEMBL4895	Homo sapiens	Inhibition	%	-2.18
	8158074	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	8.25	CHEMBL4895	Homo sapiens	Inhibition	%	8.25
	8158324	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	-4.46	CHEMBL4895	Homo sapiens	Inhibition	%	-4.46
	8158706	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	1.21	CHEMBL4895	Homo sapiens	Inhibition	%	1.21
	8158875	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-7.5	CHEMBL4895	Homo sapiens	Inhibition	%	-7.5
	8159234	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-7.05	CHEMBL4895	Homo sapiens	Inhibition	%	-7.05
	8159354	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	-2.18	CHEMBL4895	Homo sapiens	Inhibition	%	-2.18
	8159578	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-4.74	CHEMBL4895	Homo sapiens	Inhibition	%	-4.74
	8159709	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	-5.6	CHEMBL4895	Homo sapiens	Inhibition	%	-5.6
	8160074	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-5.46	CHEMBL4895	Homo sapiens	Inhibition	%	-5.46
	8160211	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	-5.02	CHEMBL4895	Homo sapiens	Inhibition	%	-5.02
	8160585	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	2.47	CHEMBL4895	Homo sapiens	Inhibition	%	2.47
	8160879	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	-1.05	CHEMBL4895	Homo sapiens	Inhibition	%	-1.05
	8161029	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	-1.83	CHEMBL4895	Homo sapiens	Inhibition	%	-1.83
	8161396	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	-2.3	CHEMBL4895	Homo sapiens	Inhibition	%	-2.3
	8161521	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	-6.56	CHEMBL4895	Homo sapiens	Inhibition	%	-6.56
	8161745	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	-5.88	CHEMBL4895	Homo sapiens	Inhibition	%	-5.88
	8161883	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	-0.36	CHEMBL4895	Homo sapiens	Inhibition	%	-0.36
	8162237	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	-1.8	CHEMBL4895	Homo sapiens	Inhibition	%	-1.8
	8162397	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.85	CHEMBL4895	Homo sapiens	Inhibition	%	0.85
	8162650	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	-5.66	CHEMBL4895	Homo sapiens	Inhibition	%	-5.66
	8163022	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	-4.15	CHEMBL4895	Homo sapiens	Inhibition	%	-4.15
	8163191	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-2.71	CHEMBL4895	Homo sapiens	Inhibition	%	-2.71
	8163415	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	-4.77	CHEMBL4895	Homo sapiens	Inhibition	%	-4.77
	8163549	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-9.27	CHEMBL4895	Homo sapiens	Inhibition	%	-9.27
	8163896	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-2.08	CHEMBL4895	Homo sapiens	Inhibition	%	-2.08
	8164030	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	9.62	CHEMBL4895	Homo sapiens	Inhibition	%	9.62
	8164394	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.07	CHEMBL4895	Homo sapiens	Inhibition	%	-0.07
	8164549	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	-0.41	CHEMBL4895	Homo sapiens	Inhibition	%	-0.41
	8164773	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	-0.03	CHEMBL4895	Homo sapiens	Inhibition	%	-0.03
	8164917	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	6.29	CHEMBL4895	Homo sapiens	Inhibition	%	6.29
	8165211	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	10.81	CHEMBL4895	Homo sapiens	Inhibition	%	10.81
	8165352	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	-4.88	CHEMBL4895	Homo sapiens	Inhibition	%	-4.88
	8165576	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	-4.9	CHEMBL4895	Homo sapiens	Inhibition	%	-4.9
	8165719	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	10.05	CHEMBL4895	Homo sapiens	Inhibition	%	10.05
	8166069	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	-1.28	CHEMBL4895	Homo sapiens	Inhibition	%	-1.28
	8166207	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	-0.57	CHEMBL4895	Homo sapiens	Inhibition	%	-0.57
	8166561	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	-4.03	CHEMBL4895	Homo sapiens	Inhibition	%	-4.03
	8166886	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.16	CHEMBL4895	Homo sapiens	Inhibition	%	1.16
	8166974	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	-4.01	CHEMBL4895	Homo sapiens	Inhibition	%	-4.01
	8167198	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	-6.28	CHEMBL4895	Homo sapiens	Inhibition	%	-6.28
	8167339	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	42.44	CHEMBL4895	Homo sapiens	Inhibition	%	42.44
	8167727	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	-1.11	CHEMBL4895	Homo sapiens	Inhibition	%	-1.11
	8167860	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	-7.61	CHEMBL4895	Homo sapiens	Inhibition	%	-7.61
	8168208	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	-2.41	CHEMBL4895	Homo sapiens	Inhibition	%	-2.41
	8168349	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	57.43	CHEMBL4895	Homo sapiens	Inhibition	%	57.43
	8168573	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	-6.77	CHEMBL4895	Homo sapiens	Inhibition	%	-6.77
	8168709	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.58	CHEMBL4895	Homo sapiens	Inhibition	%	1.58
	8169097	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	33.8	CHEMBL4895	Homo sapiens	Inhibition	%	33.8
	8169239	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	-3.54	CHEMBL4895	Homo sapiens	Inhibition	%	-3.54
	8169543	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	53.55	CHEMBL4895	Homo sapiens	Inhibition	%	53.55
	8169901	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	-4.63	CHEMBL4895	Homo sapiens	Inhibition	%	-4.63
	8170046	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	-0.91	CHEMBL4895	Homo sapiens	Inhibition	%	-0.91
	8170395	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	-3.51	CHEMBL4895	Homo sapiens	Inhibition	%	-3.51
	8170535	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	-3.83	CHEMBL4895	Homo sapiens	Inhibition	%	-3.83
	8170759	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-2.5	CHEMBL4895	Homo sapiens	Inhibition	%	-2.5
	8170894	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	-0.19	CHEMBL4895	Homo sapiens	Inhibition	%	-0.19
	8171091	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	27.52	CHEMBL4895	Homo sapiens	Inhibition	%	27.52
	8171315	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	0.91	CHEMBL4895	Homo sapiens	Inhibition	%	0.91
	8171532	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	-2.93	CHEMBL4895	Homo sapiens	Inhibition	%	-2.93
	8171673	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	47.37	CHEMBL4895	Homo sapiens	Inhibition	%	47.37
	8172050	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-2.89	CHEMBL4895	Homo sapiens	Inhibition	%	-2.89
	8172182	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	-5.29	CHEMBL4895	Homo sapiens	Inhibition	%	-5.29
	8172406	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	-8.65	CHEMBL4895	Homo sapiens	Inhibition	%	-8.65
	8172534	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	-2.9	CHEMBL4895	Homo sapiens	Inhibition	%	-2.9
	8172900	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	0.42	CHEMBL4895	Homo sapiens	Inhibition	%	0.42
	8173036	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.32	CHEMBL4895	Homo sapiens	Inhibition	%	1.32
	8173425	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	-5.41	CHEMBL4895	Homo sapiens	Inhibition	%	-5.41
	8173566	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	0.24	CHEMBL4895	Homo sapiens	Inhibition	%	0.24
	8173790	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	-3.55	CHEMBL4895	Homo sapiens	Inhibition	%	-3.55
	8173877	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	-2.52	CHEMBL4895	Homo sapiens	Inhibition	%	-2.52
	8174233	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	-3.94	CHEMBL4895	Homo sapiens	Inhibition	%	-3.94
	8174381	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	22.09	CHEMBL4895	Homo sapiens	Inhibition	%	22.09
	8174605	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-3.58	CHEMBL4895	Homo sapiens	Inhibition	%	-3.58
	8174727	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	-0.34	CHEMBL4895	Homo sapiens	Inhibition	%	-0.34
	8175094	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-2.43	CHEMBL4895	Homo sapiens	Inhibition	%	-2.43
	8175230	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	-4.19	CHEMBL4895	Homo sapiens	Inhibition	%	-4.19
	8175454	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	0.39	CHEMBL4895	Homo sapiens	Inhibition	%	0.39
	8175486	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	-6.88	CHEMBL4895	Homo sapiens	Inhibition	%	-6.88
	8175710	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	-3.55	CHEMBL4895	Homo sapiens	Inhibition	%	-3.55
	8175873	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	-2.86	CHEMBL4895	Homo sapiens	Inhibition	%	-2.86
	8176026	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	85.53	CHEMBL4895	Homo sapiens	Inhibition	%	85.53
	8176250	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	-7.21	CHEMBL4895	Homo sapiens	Inhibition	%	-7.21
	8176399	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.49	CHEMBL4895	Homo sapiens	Inhibition	%	1.49
	8176755	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%		CHEMBL4895	Homo sapiens	Inhibition	%	
	8176885	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.5	CHEMBL4895	Homo sapiens	Inhibition	%	-0.5
	8177109	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.26	CHEMBL4895	Homo sapiens	Inhibition	%	-0.26
	8177251	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-8.81	CHEMBL4895	Homo sapiens	Inhibition	%	-8.81
	8177389	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	2.37	CHEMBL4895	Homo sapiens	Inhibition	%	2.37
	8177613	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	10.96	CHEMBL4895	Homo sapiens	Inhibition	%	10.96
	8177777	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	6.36	CHEMBL4895	Homo sapiens	Inhibition	%	6.36
	8178141	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	-2.44	CHEMBL4895	Homo sapiens	Inhibition	%	-2.44
	8178229	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	9.57	CHEMBL4895	Homo sapiens	Inhibition	%	9.57
	8178453	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	-3.4	CHEMBL4895	Homo sapiens	Inhibition	%	-3.4
	8178580	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	-5.3	CHEMBL4895	Homo sapiens	Inhibition	%	-5.3
	8178953	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-0.85	CHEMBL4895	Homo sapiens	Inhibition	%	-0.85
	8179076	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	-3.44	CHEMBL4895	Homo sapiens	Inhibition	%	-3.44
	8179300	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	-3.57	CHEMBL4895	Homo sapiens	Inhibition	%	-3.57
	8179444	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	-1.05	CHEMBL4895	Homo sapiens	Inhibition	%	-1.05
	8179805	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-1.63	CHEMBL4895	Homo sapiens	Inhibition	%	-1.63
	8180062	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	-5.95	CHEMBL4895	Homo sapiens	Inhibition	%	-5.95
	8180216	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	-1.13	CHEMBL4895	Homo sapiens	Inhibition	%	-1.13
	8180596	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	-1.85	CHEMBL4895	Homo sapiens	Inhibition	%	-1.85
	8180744	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.79	CHEMBL4895	Homo sapiens	Inhibition	%	0.79
	8181101	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	-7.59	CHEMBL4895	Homo sapiens	Inhibition	%	-7.59
	8181456	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.11	CHEMBL4895	Homo sapiens	Inhibition	%	0.11
	8181596	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-3.63	CHEMBL4895	Homo sapiens	Inhibition	%	-3.63
	8181959	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	40.01	CHEMBL4895	Homo sapiens	Inhibition	%	40.01
	8182122	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	-5.15	CHEMBL4895	Homo sapiens	Inhibition	%	-5.15
	8182486	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-5.49	CHEMBL4895	Homo sapiens	Inhibition	%	-5.49
	8182802	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	-1.68	CHEMBL4895	Homo sapiens	Inhibition	%	-1.68
	8182924	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	-4.72	CHEMBL4895	Homo sapiens	Inhibition	%	-4.72
	8183148	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	-3.79	CHEMBL4895	Homo sapiens	Inhibition	%	-3.79
	8183297	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	-3.48	CHEMBL4895	Homo sapiens	Inhibition	%	-3.48
	8183650	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	8.69	CHEMBL4895	Homo sapiens	Inhibition	%	8.69
	8183792	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	-5.22	CHEMBL4895	Homo sapiens	Inhibition	%	-5.22
	8184152	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-0.23	CHEMBL4895	Homo sapiens	Inhibition	%	-0.23
	8184418	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl	Outside typical range	CHEMBL1909344	=	Inhibition	%	-12.54	CHEMBL4895	Homo sapiens	Inhibition	%	-12.54
	8184565	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-2.49	CHEMBL4895	Homo sapiens	Inhibition	%	-2.49
	8184789	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-0.12	CHEMBL4895	Homo sapiens	Inhibition	%	-0.12
	8184946	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	-9.81	CHEMBL4895	Homo sapiens	Inhibition	%	-9.81
	8185095	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	14.82	CHEMBL4895	Homo sapiens	Inhibition	%	14.82
	8185319	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.21	CHEMBL4895	Homo sapiens	Inhibition	%	-0.21
	8185450	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12	Outside typical range	CHEMBL237347	=	Inhibition	%	-14.49	CHEMBL4895	Homo sapiens	Inhibition	%	-14.49
	8185805	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	10.54	CHEMBL4895	Homo sapiens	Inhibition	%	10.54
	8185944	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	-8.55	CHEMBL4895	Homo sapiens	Inhibition	%	-8.55
	8186168	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	-6.73	CHEMBL4895	Homo sapiens	Inhibition	%	-6.73
	8186309	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	-1.84	CHEMBL4895	Homo sapiens	Inhibition	%	-1.84
	8186473	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	-3.07	CHEMBL4895	Homo sapiens	Inhibition	%	-3.07
	8186697	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	-5.65	CHEMBL4895	Homo sapiens	Inhibition	%	-5.65
	8186836	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	-7.82	CHEMBL4895	Homo sapiens	Inhibition	%	-7.82
	8187158	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	-2.07	CHEMBL4895	Homo sapiens	Inhibition	%	-2.07
	8187506	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	-4.17	CHEMBL4895	Homo sapiens	Inhibition	%	-4.17
	8187654	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	-1.98	CHEMBL4895	Homo sapiens	Inhibition	%	-1.98
	8188007	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	7.56	CHEMBL4895	Homo sapiens	Inhibition	%	7.56
	8188150	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	-1.64	CHEMBL4895	Homo sapiens	Inhibition	%	-1.64
	8188374	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	-3.81	CHEMBL4895	Homo sapiens	Inhibition	%	-3.81
	8188509	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-1.8	CHEMBL4895	Homo sapiens	Inhibition	%	-1.8
	8188783	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-5.96	CHEMBL4895	Homo sapiens	Inhibition	%	-5.96
	8189155	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	-0.67	CHEMBL4895	Homo sapiens	Inhibition	%	-0.67
	8189311	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	-5.61	CHEMBL4895	Homo sapiens	Inhibition	%	-5.61
	8189684	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.14	CHEMBL4895	Homo sapiens	Inhibition	%	0.14
	8189816	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-8.14	CHEMBL4895	Homo sapiens	Inhibition	%	-8.14
	8190040	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-7.98	CHEMBL4895	Homo sapiens	Inhibition	%	-7.98
	8190172	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	-9.46	CHEMBL4895	Homo sapiens	Inhibition	%	-9.46
	8190536	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	-7.51	CHEMBL4895	Homo sapiens	Inhibition	%	-7.51
	8190673	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	-3.4	CHEMBL4895	Homo sapiens	Inhibition	%	-3.4
	8191061	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	-4.91	CHEMBL4895	Homo sapiens	Inhibition	%	-4.91
	8191199	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	-5.4	CHEMBL4895	Homo sapiens	Inhibition	%	-5.4
	8191423	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	-0.6	CHEMBL4895	Homo sapiens	Inhibition	%	-0.6
	8191519	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	-0.54	CHEMBL4895	Homo sapiens	Inhibition	%	-0.54
	8191865	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	-4.65	CHEMBL4895	Homo sapiens	Inhibition	%	-4.65
	8192014	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	-2.3	CHEMBL4895	Homo sapiens	Inhibition	%	-2.3
	8192238	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	-1.28	CHEMBL4895	Homo sapiens	Inhibition	%	-1.28
	8192367	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	4.83	CHEMBL4895	Homo sapiens	Inhibition	%	4.83
	8192735	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	-3.18	CHEMBL4895	Homo sapiens	Inhibition	%	-3.18
	8192871	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.34	CHEMBL4895	Homo sapiens	Inhibition	%	1.34
	8193143	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-6.25	CHEMBL4895	Homo sapiens	Inhibition	%	-6.25
	8193512	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	-0.23	CHEMBL4895	Homo sapiens	Inhibition	%	-0.23
	8193669	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	-7.48	CHEMBL4895	Homo sapiens	Inhibition	%	-7.48
	8193893	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	-2.91	CHEMBL4895	Homo sapiens	Inhibition	%	-2.91
	8194042	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.14	CHEMBL4895	Homo sapiens	Inhibition	%	0.14
	8194397	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	-6.97	CHEMBL4895	Homo sapiens	Inhibition	%	-6.97
	8194528	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	-1.51	CHEMBL4895	Homo sapiens	Inhibition	%	-1.51
	8194895	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	-6.8	CHEMBL4895	Homo sapiens	Inhibition	%	-6.8
	8195028	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	-4.58	CHEMBL4895	Homo sapiens	Inhibition	%	-4.58
	8195252	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	-5.39	CHEMBL4895	Homo sapiens	Inhibition	%	-5.39
	8195416	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	-4.61	CHEMBL4895	Homo sapiens	Inhibition	%	-4.61
	8195779	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	-6.62	CHEMBL4895	Homo sapiens	Inhibition	%	-6.62
	8195877	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	-1.91	CHEMBL4895	Homo sapiens	Inhibition	%	-1.91
	8196101	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	-0.71	CHEMBL4895	Homo sapiens	Inhibition	%	-0.71
	8196218	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	-5.03	CHEMBL4895	Homo sapiens	Inhibition	%	-5.03
	8196592	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	-5.33	CHEMBL4895	Homo sapiens	Inhibition	%	-5.33
	8196720	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.74	CHEMBL4895	Homo sapiens	Inhibition	%	2.74
	8197085	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	-5.59	CHEMBL4895	Homo sapiens	Inhibition	%	-5.59
	8197222	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.45	CHEMBL4895	Homo sapiens	Inhibition	%	0.45
	8197446	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-1.43	CHEMBL4895	Homo sapiens	Inhibition	%	-1.43
	8197497	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-7.77	CHEMBL4895	Homo sapiens	Inhibition	%	-7.77
	8197721	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	-4.61	CHEMBL4895	Homo sapiens	Inhibition	%	-4.61
	8197861	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.24	CHEMBL4895	Homo sapiens	Inhibition	%	0.24
	8198242	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-7.95	CHEMBL4895	Homo sapiens	Inhibition	%	-7.95
	8198380	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	4.04	CHEMBL4895	Homo sapiens	Inhibition	%	4.04
	8198734	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl	Outside typical range	CHEMBL1909357	=	Inhibition	%	-10.38	CHEMBL4895	Homo sapiens	Inhibition	%	-10.38
	8198865	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	-4.63	CHEMBL4895	Homo sapiens	Inhibition	%	-4.63
	8199089	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	-2.89	CHEMBL4895	Homo sapiens	Inhibition	%	-2.89
	8199237	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	-8.08	CHEMBL4895	Homo sapiens	Inhibition	%	-8.08
	8199595	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	-5.96	CHEMBL4895	Homo sapiens	Inhibition	%	-5.96
	8199758	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	-5.53	CHEMBL4895	Homo sapiens	Inhibition	%	-5.53
	8200120	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	-3.37	CHEMBL4895	Homo sapiens	Inhibition	%	-3.37
	8200448	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-0.26	CHEMBL4895	Homo sapiens	Inhibition	%	-0.26
	8200563	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	-3.16	CHEMBL4895	Homo sapiens	Inhibition	%	-3.16
	8200937	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	-3.51	CHEMBL4895	Homo sapiens	Inhibition	%	-3.51
	8201067	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	3.68	CHEMBL4895	Homo sapiens	Inhibition	%	3.68
	8201291	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	1.31	CHEMBL4895	Homo sapiens	Inhibition	%	1.31
	8201426	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-5.69	CHEMBL4895	Homo sapiens	Inhibition	%	-5.69
	8201783	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	1.01	CHEMBL4895	Homo sapiens	Inhibition	%	1.01
	8202062	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-5.05	CHEMBL4895	Homo sapiens	Inhibition	%	-5.05
	8202202	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.44	CHEMBL4895	Homo sapiens	Inhibition	%	2.44
	8202593	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-3.95	CHEMBL4895	Homo sapiens	Inhibition	%	-3.95
	8202718	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-7.67	CHEMBL4895	Homo sapiens	Inhibition	%	-7.67
	8202942	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-8.99	CHEMBL4895	Homo sapiens	Inhibition	%	-8.99
	8203072	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	-7.44	CHEMBL4895	Homo sapiens	Inhibition	%	-7.44
	8203427	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	-8.43	CHEMBL4895	Homo sapiens	Inhibition	%	-8.43
	8203573	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	-3.19	CHEMBL4895	Homo sapiens	Inhibition	%	-3.19
	8203931	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	-6.13	CHEMBL4895	Homo sapiens	Inhibition	%	-6.13
	8204097	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	-3.22	CHEMBL4895	Homo sapiens	Inhibition	%	-3.22
	8204321	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	-3.72	CHEMBL4895	Homo sapiens	Inhibition	%	-3.72
	8204458	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	-5.44	CHEMBL4895	Homo sapiens	Inhibition	%	-5.44
	8204787	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-0.77	CHEMBL4895	Homo sapiens	Inhibition	%	-0.77
	8204902	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	-3.29	CHEMBL4895	Homo sapiens	Inhibition	%	-3.29
	8205126	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	-3.87	CHEMBL4895	Homo sapiens	Inhibition	%	-3.87
	8205275	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	-3.58	CHEMBL4895	Homo sapiens	Inhibition	%	-3.58
	8205635	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	0.71	CHEMBL4895	Homo sapiens	Inhibition	%	0.71
	8205774	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-1.13	CHEMBL4895	Homo sapiens	Inhibition	%	-1.13
	8205998	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	-3.14	CHEMBL4895	Homo sapiens	Inhibition	%	-3.14
	8206130	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	1.82	CHEMBL4895	Homo sapiens	Inhibition	%	1.82
	8206406	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-5.02	CHEMBL4895	Homo sapiens	Inhibition	%	-5.02
	8206549	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.81	CHEMBL4895	Homo sapiens	Inhibition	%	0.81
	8206773	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	2.96	CHEMBL4895	Homo sapiens	Inhibition	%	2.96
	8206953	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	-7.29	CHEMBL4895	Homo sapiens	Inhibition	%	-7.29
	8207303	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	-6.08	CHEMBL4895	Homo sapiens	Inhibition	%	-6.08
	8207433	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	-6.3	CHEMBL4895	Homo sapiens	Inhibition	%	-6.3
	8207789	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	1.26	CHEMBL4895	Homo sapiens	Inhibition	%	1.26
	8207934	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-7.99	CHEMBL4895	Homo sapiens	Inhibition	%	-7.99
	8208158	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-4.37	CHEMBL4895	Homo sapiens	Inhibition	%	-4.37
	8208290	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	-6.83	CHEMBL4895	Homo sapiens	Inhibition	%	-6.83
	8208680	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	-2.62	CHEMBL4895	Homo sapiens	Inhibition	%	-2.62
	8208813	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	-6.05	CHEMBL4895	Homo sapiens	Inhibition	%	-6.05
	8209142	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.9	CHEMBL4895	Homo sapiens	Inhibition	%	0.9
	8209482	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	-2.51	CHEMBL4895	Homo sapiens	Inhibition	%	-2.51
	8209632	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	-5.65	CHEMBL4895	Homo sapiens	Inhibition	%	-5.65
	8209856	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	-4.27	CHEMBL4895	Homo sapiens	Inhibition	%	-4.27
	8209992	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	-0.05	CHEMBL4895	Homo sapiens	Inhibition	%	-0.05
	8210357	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	-1.55	CHEMBL4895	Homo sapiens	Inhibition	%	-1.55
	8210493	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	1.67	CHEMBL4895	Homo sapiens	Inhibition	%	1.67
	8210752	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-5.93	CHEMBL4895	Homo sapiens	Inhibition	%	-5.93
	8211120	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	-8.88	CHEMBL4895	Homo sapiens	Inhibition	%	-8.88
	8211290	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	-8.31	CHEMBL4895	Homo sapiens	Inhibition	%	-8.31
	8211637	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	-8.66	CHEMBL4895	Homo sapiens	Inhibition	%	-8.66
	8211766	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	-7.6	CHEMBL4895	Homo sapiens	Inhibition	%	-7.6
	8211990	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	-7.01	CHEMBL4895	Homo sapiens	Inhibition	%	-7.01
	8212122	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	-7.61	CHEMBL4895	Homo sapiens	Inhibition	%	-7.61
	8212487	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	-5.44	CHEMBL4895	Homo sapiens	Inhibition	%	-5.44
	8212620	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	-5.64	CHEMBL4895	Homo sapiens	Inhibition	%	-5.64
	8212844	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	-9.15	CHEMBL4895	Homo sapiens	Inhibition	%	-9.15
	8213014	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	-3.18	CHEMBL4895	Homo sapiens	Inhibition	%	-3.18
	8213143	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-7.63	CHEMBL4895	Homo sapiens	Inhibition	%	-7.63
	8213367	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.16	CHEMBL4895	Homo sapiens	Inhibition	%	0.16
	8213471	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	2.28	CHEMBL4895	Homo sapiens	Inhibition	%	2.28
	8213808	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	-4.26	CHEMBL4895	Homo sapiens	Inhibition	%	-4.26
	8214179	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	-2.63	CHEMBL4895	Homo sapiens	Inhibition	%	-2.63
	8214316	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	-0.27	CHEMBL4895	Homo sapiens	Inhibition	%	-0.27
	8214674	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-5.49	CHEMBL4895	Homo sapiens	Inhibition	%	-5.49
	8214826	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	2.24	CHEMBL4895	Homo sapiens	Inhibition	%	2.24
	8215077	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-7.1	CHEMBL4895	Homo sapiens	Inhibition	%	-7.1
	8215301	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	-5.59	CHEMBL4895	Homo sapiens	Inhibition	%	-5.59
	8215454	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	-2.03	CHEMBL4895	Homo sapiens	Inhibition	%	-2.03
	8215618	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	-7.4	CHEMBL4895	Homo sapiens	Inhibition	%	-7.4
	8215842	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	-5.54	CHEMBL4895	Homo sapiens	Inhibition	%	-5.54
	8215961	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-4.74	CHEMBL4895	Homo sapiens	Inhibition	%	-4.74
	8216304	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-8.18	CHEMBL4895	Homo sapiens	Inhibition	%	-8.18
	8216440	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	-7.14	CHEMBL4895	Homo sapiens	Inhibition	%	-7.14
	8216664	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	-8.77	CHEMBL4895	Homo sapiens	Inhibition	%	-8.77
	8216802	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	-2.92	CHEMBL4895	Homo sapiens	Inhibition	%	-2.92
	8217160	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	-8.4	CHEMBL4895	Homo sapiens	Inhibition	%	-8.4
	8217334	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-1.17	CHEMBL4895	Homo sapiens	Inhibition	%	-1.17
	8217689	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC	Outside typical range	CHEMBL373751	=	Inhibition	%	-31.78	CHEMBL4895	Homo sapiens	Inhibition	%	-31.78
	8217790	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	2.69	CHEMBL4895	Homo sapiens	Inhibition	%	2.69
	8218014	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	7.43	CHEMBL4895	Homo sapiens	Inhibition	%	7.43
	8218129	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	-2.86	CHEMBL4895	Homo sapiens	Inhibition	%	-2.86
	8218480	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	3.3	CHEMBL4895	Homo sapiens	Inhibition	%	3.3
	8218623	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	8.37	CHEMBL4895	Homo sapiens	Inhibition	%	8.37
	8218847	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	21.34	CHEMBL4895	Homo sapiens	Inhibition	%	21.34
	8218978	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	0.42	CHEMBL4895	Homo sapiens	Inhibition	%	0.42
	8219138	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	8.29	CHEMBL4895	Homo sapiens	Inhibition	%	8.29
	8219362	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	10.83	CHEMBL4895	Homo sapiens	Inhibition	%	10.83
	8219612	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1	Outside typical range	CHEMBL274863	=	Inhibition	%	-45.6	CHEMBL4895	Homo sapiens	Inhibition	%	-45.6
	8219773	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	-5.99	CHEMBL4895	Homo sapiens	Inhibition	%	-5.99
	8220166	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	-6.53	CHEMBL4895	Homo sapiens	Inhibition	%	-6.53
	8220295	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	7.75	CHEMBL4895	Homo sapiens	Inhibition	%	7.75
	8220633	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-3.8	CHEMBL4895	Homo sapiens	Inhibition	%	-3.8
	8220995	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	1.9	CHEMBL4895	Homo sapiens	Inhibition	%	1.9
	8221131	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-3.39	CHEMBL4895	Homo sapiens	Inhibition	%	-3.39
	8221488	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.71	CHEMBL4895	Homo sapiens	Inhibition	%	2.71
	8221653	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-0.31	CHEMBL4895	Homo sapiens	Inhibition	%	-0.31
	8222008	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	43.51	CHEMBL4895	Homo sapiens	Inhibition	%	43.51
	8222330	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	-3.14	CHEMBL4895	Homo sapiens	Inhibition	%	-3.14
	8222464	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	-4.92	CHEMBL4895	Homo sapiens	Inhibition	%	-4.92
	8222688	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	-5.59	CHEMBL4895	Homo sapiens	Inhibition	%	-5.59
	8222806	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	40.91	CHEMBL4895	Homo sapiens	Inhibition	%	40.91
	8223174	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	82.14	CHEMBL4895	Homo sapiens	Inhibition	%	82.14
	8223303	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	-3.01	CHEMBL4895	Homo sapiens	Inhibition	%	-3.01
	8223688	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	4.25	CHEMBL4895	Homo sapiens	Inhibition	%	4.25
	8223938	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	-5.68	CHEMBL4895	Homo sapiens	Inhibition	%	-5.68
	8224100	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	-2.11	CHEMBL4895	Homo sapiens	Inhibition	%	-2.11
	8224324	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-7.11	CHEMBL4895	Homo sapiens	Inhibition	%	-7.11
	8224494	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	-2.34	CHEMBL4895	Homo sapiens	Inhibition	%	-2.34
	8224629	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	-7.35	CHEMBL4895	Homo sapiens	Inhibition	%	-7.35
	8224853	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	-9.25	CHEMBL4895	Homo sapiens	Inhibition	%	-9.25
	8224967	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	-4.79	CHEMBL4895	Homo sapiens	Inhibition	%	-4.79
	8225325	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1	Outside typical range	CHEMBL103104	=	Inhibition	%	-10.26	CHEMBL4895	Homo sapiens	Inhibition	%	-10.26
	8225463	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-1.32	CHEMBL4895	Homo sapiens	Inhibition	%	-1.32
	8225687	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-1.96	CHEMBL4895	Homo sapiens	Inhibition	%	-1.96
	8225822	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	37.3	CHEMBL4895	Homo sapiens	Inhibition	%	37.3
	8225980	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.09	CHEMBL4895	Homo sapiens	Inhibition	%	1.09
	8226204	CHEMBL1962245	GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.45	CHEMBL4895	Homo sapiens	Inhibition	%	1.45
	8226329	CHEMBL1962244	GSK_PKIS: AXL mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	-7.36	CHEMBL4895	Homo sapiens	Inhibition	%	-7.36
inactive	9523666	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523667	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	31.62	CHEMBL4895	Homo sapiens	pKi		7.5
inactive	9523668	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523669	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	19.95	CHEMBL4895	Homo sapiens	pKi		7.7
active	9523670	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	199.53	CHEMBL4895	Homo sapiens	pKi		6.7
active	9523671	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	3.981	CHEMBL4895	Homo sapiens	pKi		8.4
active	9523672	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	10.0	CHEMBL4895	Homo sapiens	pKi		8.0
active	9523673	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	7.943	CHEMBL4895	Homo sapiens	pKi		8.1
active	9523674	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	Ki	nM	19.95	CHEMBL4895	Homo sapiens	pKi		7.7
inactive	9523675	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523676	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	19.95	CHEMBL4895	Homo sapiens	pKi		7.7
inactive	9523677	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523678	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523679	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523680	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523681	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	=	Ki	nM	316.23	CHEMBL4895	Homo sapiens	pKi		6.5
inactive	9523682	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523683	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	=	Ki	nM	100.0	CHEMBL4895	Homo sapiens	pKi		7.0
active	9523684	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	=	Ki	nM	794.33	CHEMBL4895	Homo sapiens	pKi		6.1
inactive	9523685	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523686	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523687	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	398.11	CHEMBL4895	Homo sapiens	pKi		6.4
inactive	9523688	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Ki	nM	1258.93	CHEMBL4895	Homo sapiens	pKi		5.9
inactive	9523689	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523690	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	=	Ki	nM	1584.89	CHEMBL4895	Homo sapiens	pKi		5.8
inactive	9523691	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523692	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523693	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523694	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523695	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	15.85	CHEMBL4895	Homo sapiens	pKi		7.8
inactive	9523696	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523697	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523698	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523699	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523700	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	39.81	CHEMBL4895	Homo sapiens	pKi		7.4
inactive	9523701	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523702	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	794.33	CHEMBL4895	Homo sapiens	pKi		6.1
inactive	9523703	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523704	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	3.981	CHEMBL4895	Homo sapiens	pKi		8.4
inactive	9523705	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523706	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	=	Ki	nM	251.19	CHEMBL4895	Homo sapiens	pKi		6.6
inactive	9523707	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523708	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523709	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523710	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523711	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523712	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523713	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523714	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	=	Ki	nM	1.995	CHEMBL4895	Homo sapiens	pKi		8.7
inactive	9523715	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523716	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523717	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	125.89	CHEMBL4895	Homo sapiens	pKi		6.9
active	9523718	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	398.11	CHEMBL4895	Homo sapiens	pKi		6.4
inactive	9523719	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523720	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523721	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523722	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523723	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523724	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523725	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523726	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523727	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523728	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523729	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523730	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	630.96	CHEMBL4895	Homo sapiens	pKi		6.2
inactive	9523731	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523732	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	158.49	CHEMBL4895	Homo sapiens	pKi		6.8
inactive	9523733	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523734	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	1258.93	CHEMBL4895	Homo sapiens	pKi		5.9
inactive	9523735	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523736	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	1.259	CHEMBL4895	Homo sapiens	pKi		8.9
inactive	9523737	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523738	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	50.12	CHEMBL4895	Homo sapiens	pKi		7.3
active	9523739	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	158.49	CHEMBL4895	Homo sapiens	pKi		6.8
active	9523740	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	19.95	CHEMBL4895	Homo sapiens	pKi		7.7
inactive	9523741	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523742	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	=	Ki	nM	316.23	CHEMBL4895	Homo sapiens	pKi		6.5
inactive	9523743	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523744	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523745	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523746	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	199.53	CHEMBL4895	Homo sapiens	pKi		6.7
inactive	9523747	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523748	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523749	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	=	Ki	nM	79.43	CHEMBL4895	Homo sapiens	pKi		7.1
active	9523750	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	=	Ki	nM	3.162	CHEMBL4895	Homo sapiens	pKi		8.5
active	9523751	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	50.12	CHEMBL4895	Homo sapiens	pKi		7.3
inactive	9523752	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523753	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	=	Ki	nM	39.81	CHEMBL4895	Homo sapiens	pKi		7.4
active	9523754	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	19.95	CHEMBL4895	Homo sapiens	pKi		7.7
active	9523755	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	630.96	CHEMBL4895	Homo sapiens	pKi		6.2
inactive	9523756	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523757	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523758	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	1.259	CHEMBL4895	Homo sapiens	pKi		8.9
inactive	9523759	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523760	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	=	Ki	nM	794.33	CHEMBL4895	Homo sapiens	pKi		6.1
inactive	9523761	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523762	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523763	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523764	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	<	Ki	nM	1258.93	CHEMBL4895	Homo sapiens	pKi		5.9
active	9523765	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	=	Ki	nM	630.96	CHEMBL4895	Homo sapiens	pKi		6.2
inactive	9523766	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523767	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	=	Ki	nM	125.89	CHEMBL4895	Homo sapiens	pKi		6.9
active	9523768	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	12.59	CHEMBL4895	Homo sapiens	pKi		7.9
active	9523769	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	=	Ki	nM	2.512	CHEMBL4895	Homo sapiens	pKi		8.6
active	9523770	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	316.23	CHEMBL4895	Homo sapiens	pKi		6.5
active	9523771	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	1584.89	CHEMBL4895	Homo sapiens	pKi		5.8
active	9523772	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	63.1	CHEMBL4895	Homo sapiens	pKi		7.2
inactive	9523773	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523774	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523775	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523776	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523777	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523778	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523779	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	63.1	CHEMBL4895	Homo sapiens	pKi		7.2
inactive	9523780	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523781	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523782	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523783	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523784	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	1.995	CHEMBL4895	Homo sapiens	pKi		8.7
inactive	9523785	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523786	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523787	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	1.259	CHEMBL4895	Homo sapiens	pKi		8.9
inactive	9523788	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523789	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	=	Ki	nM	63.1	CHEMBL4895	Homo sapiens	pKi		7.2
active	9523790	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	1584.89	CHEMBL4895	Homo sapiens	pKi		5.8
active	9523791	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Ki	nM	251.19	CHEMBL4895	Homo sapiens	pKi		6.6
active	9523792	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	5.012	CHEMBL4895	Homo sapiens	pKi		8.3
inactive	9523793	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523794	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523795	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523796	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523797	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523798	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	63.1	CHEMBL4895	Homo sapiens	pKi		7.2
active	9523799	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	10.0	CHEMBL4895	Homo sapiens	pKi		8.0
inactive	9523800	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523801	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	=	Ki	nM	1000.0	CHEMBL4895	Homo sapiens	pKi		6.0
inactive	9523802	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523803	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	251.19	CHEMBL4895	Homo sapiens	pKi		6.6
inactive	9523804	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523805	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523806	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523807	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	501.19	CHEMBL4895	Homo sapiens	pKi		6.3
inactive	9523808	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523809	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523810	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	251.19	CHEMBL4895	Homo sapiens	pKi		6.6
inactive	9523811	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523812	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523813	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523814	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	6.31	CHEMBL4895	Homo sapiens	pKi		8.2
inactive	9523815	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523816	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523817	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523818	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523819	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523820	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	158.49	CHEMBL4895	Homo sapiens	pKi		6.8
active	9523821	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	39.81	CHEMBL4895	Homo sapiens	pKi		7.4
inactive	9523822	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523823	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	630.96	CHEMBL4895	Homo sapiens	pKi		6.2
inactive	9523824	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523825	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	794.33	CHEMBL4895	Homo sapiens	pKi		6.1
active	9523826	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1n[nH]c2c1C(c1ccccc1Br)C(C#N)=C(N)O2		CHEMBL2005214	=	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523827	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	316.23	CHEMBL4895	Homo sapiens	pKi		6.5
inactive	9523828	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523829	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523830	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523831	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523832	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523833	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	=	Ki	nM	1258.93	CHEMBL4895	Homo sapiens	pKi		5.9
inactive	9523834	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523835	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523836	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523837	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	=	Ki	nM	1584.89	CHEMBL4895	Homo sapiens	pKi		5.8
inactive	9523838	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523839	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9523840	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9523841	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	=	Ki	nM	1000.0	CHEMBL4895	Homo sapiens	pKi		6.0
active	9527754	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	10.0	CHEMBL4895	Homo sapiens	pKi		8.0
active	9527755	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	3.162	CHEMBL4895	Homo sapiens	pKi		8.5
active	9527756	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	3.162	CHEMBL4895	Homo sapiens	pKi		8.5
inactive	9527757	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527758	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	=	Ki	nM	15.85	CHEMBL4895	Homo sapiens	pKi		7.8
inactive	9527759	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527760	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527761	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	=	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527762	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	1258.93	CHEMBL4895	Homo sapiens	pKi		5.9
inactive	9527763	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527764	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527765	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527766	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527767	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527768	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	=	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527769	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527770	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Ki	nM	158.49	CHEMBL4895	Homo sapiens	pKi		6.8
inactive	9527771	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527772	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	=	Ki	nM	1000.0	CHEMBL4895	Homo sapiens	pKi		6.0
active	9527773	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	25.12	CHEMBL4895	Homo sapiens	pKi		7.6
inactive	9527774	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527775	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527776	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527777	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	251.19	CHEMBL4895	Homo sapiens	pKi		6.6
inactive	9527778	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527779	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527780	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527781	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527782	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	251.19	CHEMBL4895	Homo sapiens	pKi		6.6
inactive	9527783	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527784	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	3.162	CHEMBL4895	Homo sapiens	pKi		8.5
inactive	9527785	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527786	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	6.31	CHEMBL4895	Homo sapiens	pKi		8.2
inactive	9527787	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527788	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	=	Ki	nM	15.85	CHEMBL4895	Homo sapiens	pKi		7.8
inactive	9527789	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527790	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	15.85	CHEMBL4895	Homo sapiens	pKi		7.8
inactive	9527791	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527792	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527793	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	=	Ki	nM	1000.0	CHEMBL4895	Homo sapiens	pKi		6.0
inactive	9527794	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527795	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	100.0	CHEMBL4895	Homo sapiens	pKi		7.0
inactive	9527796	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527797	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527798	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527799	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527800	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	=	Ki	nM	794.33	CHEMBL4895	Homo sapiens	pKi		6.1
inactive	9527801	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527802	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	630.96	CHEMBL4895	Homo sapiens	pKi		6.2
active	9527803	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	=	Ki	nM	1584.89	CHEMBL4895	Homo sapiens	pKi		5.8
inactive	9527804	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527805	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527806	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527807	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527808	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527809	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	=	Ki	nM	1258.93	CHEMBL4895	Homo sapiens	pKi		5.9
inactive	9527810	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527811	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	=	Ki	nM	50.12	CHEMBL4895	Homo sapiens	pKi		7.3
inactive	9527812	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527813	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527814	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527815	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527816	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527817	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	63.1	CHEMBL4895	Homo sapiens	pKi		7.2
inactive	9527818	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527819	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527820	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	50.12	CHEMBL4895	Homo sapiens	pKi		7.3
inactive	9527821	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527822	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	Ki	nM	1584.89	CHEMBL4895	Homo sapiens	pKi		5.8
inactive	9527823	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527824	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527825	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527826	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527827	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	=	Ki	nM	316.23	CHEMBL4895	Homo sapiens	pKi		6.5
active	9527828	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	63.1	CHEMBL4895	Homo sapiens	pKi		7.2
active	9527829	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	251.19	CHEMBL4895	Homo sapiens	pKi		6.6
inactive	9527830	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527831	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527832	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527833	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527834	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527835	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	63.1	CHEMBL4895	Homo sapiens	pKi		7.2
inactive	9527836	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527837	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527838	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527839	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527840	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	158.49	CHEMBL4895	Homo sapiens	pKi		6.8
inactive	9527841	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527842	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527843	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527844	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	7.943	CHEMBL4895	Homo sapiens	pKi		8.1
active	9527845	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	1584.89	CHEMBL4895	Homo sapiens	pKi		5.8
active	9527846	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	=	Ki	nM	630.96	CHEMBL4895	Homo sapiens	pKi		6.2
inactive	9527847	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527848	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	251.19	CHEMBL4895	Homo sapiens	pKi		6.6
inactive	9527849	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527850	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	1000.0	CHEMBL4895	Homo sapiens	pKi		6.0
active	9527851	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	199.53	CHEMBL4895	Homo sapiens	pKi		6.7
inactive	9527852	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527853	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527854	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527855	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527856	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527857	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	100.0	CHEMBL4895	Homo sapiens	pKi		7.0
inactive	9527858	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527859	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	=	Ki	nM	25.12	CHEMBL4895	Homo sapiens	pKi		7.6
inactive	9527860	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527861	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527862	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527863	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527864	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	=	Ki	nM	398.11	CHEMBL4895	Homo sapiens	pKi		6.4
active	9527865	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	=	Ki	nM	398.11	CHEMBL4895	Homo sapiens	pKi		6.4
active	9527866	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	15.85	CHEMBL4895	Homo sapiens	pKi		7.8
inactive	9527867	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527868	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	=	Ki	nM	1584.89	CHEMBL4895	Homo sapiens	pKi		5.8
inactive	9527869	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527870	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527871	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527872	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527873	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	15.85	CHEMBL4895	Homo sapiens	pKi		7.8
inactive	9527874	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527875	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	39.81	CHEMBL4895	Homo sapiens	pKi		7.4
active	9527876	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	=	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527877	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	=	Ki	nM	6.31	CHEMBL4895	Homo sapiens	pKi		8.2
inactive	9527878	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527879	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	398.11	CHEMBL4895	Homo sapiens	pKi		6.4
inactive	9527880	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527881	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527882	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	15.85	CHEMBL4895	Homo sapiens	pKi		7.8
active	9527883	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	=	Ki	nM	1000.0	CHEMBL4895	Homo sapiens	pKi		6.0
active	9527884	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	7.943	CHEMBL4895	Homo sapiens	pKi		8.1
inactive	9527885	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527886	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C1CC(c2ccc(Cl)cc2)Cc2[nH]c3cc(Cl)ccc3c(=O)c21		CHEMBL1990432	=	Ki	nM	1584.89	CHEMBL4895	Homo sapiens	pKi		5.8
active	9527887	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	3.162	CHEMBL4895	Homo sapiens	pKi		8.5
inactive	9527888	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527889	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	1000.0	CHEMBL4895	Homo sapiens	pKi		6.0
inactive	9527890	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527891	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	=	Ki	nM	398.11	CHEMBL4895	Homo sapiens	pKi		6.4
inactive	9527892	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527893	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	251.19	CHEMBL4895	Homo sapiens	pKi		6.6
inactive	9527894	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527895	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527896	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	10.0	CHEMBL4895	Homo sapiens	pKi		8.0
inactive	9527897	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527898	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	199.53	CHEMBL4895	Homo sapiens	pKi		6.7
inactive	9527899	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527900	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527901	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	199.53	CHEMBL4895	Homo sapiens	pKi		6.7
inactive	9527902	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527903	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527904	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527905	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	50.12	CHEMBL4895	Homo sapiens	pKi		7.3
inactive	9527906	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527907	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	501.19	CHEMBL4895	Homo sapiens	pKi		6.3
inactive	9527908	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527909	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527910	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527911	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527912	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527913	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	794.33	CHEMBL4895	Homo sapiens	pKi		6.1
active	9527914	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	=	Ki	nM	15.85	CHEMBL4895	Homo sapiens	pKi		7.8
active	9527915	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	=	Ki	nM	1000.0	CHEMBL4895	Homo sapiens	pKi		6.0
inactive	9527916	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527917	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	251.19	CHEMBL4895	Homo sapiens	pKi		6.6
active	9527918	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	630.96	CHEMBL4895	Homo sapiens	pKi		6.2
active	9527919	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	10.0	CHEMBL4895	Homo sapiens	pKi		8.0
inactive	9527920	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527921	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	39.81	CHEMBL4895	Homo sapiens	pKi		7.4
inactive	9527922	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527923	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	251.19	CHEMBL4895	Homo sapiens	pKi		6.6
inactive	9527924	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527925	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	=	Ki	nM	794.33	CHEMBL4895	Homo sapiens	pKi		6.1
inactive	9527926	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527927	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527928	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527929	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527930	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527931	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527932	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527933	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527934	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527935	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527936	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527937	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527938	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527939	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527940	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527941	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	=	Ki	nM	199.53	CHEMBL4895	Homo sapiens	pKi		6.7
active	9527942	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	=	Ki	nM	794.33	CHEMBL4895	Homo sapiens	pKi		6.1
active	9527943	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	1584.89	CHEMBL4895	Homo sapiens	pKi		5.8
inactive	9527944	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527945	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527946	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527947	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527948	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527949	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	=	Ki	nM	1584.89	CHEMBL4895	Homo sapiens	pKi		5.8
active	9527950	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	251.19	CHEMBL4895	Homo sapiens	pKi		6.6
inactive	9527951	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527952	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	39.81	CHEMBL4895	Homo sapiens	pKi		7.4
inactive	9527953	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527954	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	15.85	CHEMBL4895	Homo sapiens	pKi		7.8
active	9527955	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	=	Ki	nM	398.11	CHEMBL4895	Homo sapiens	pKi		6.4
active	9527956	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	794.33	CHEMBL4895	Homo sapiens	pKi		6.1
inactive	9527957	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527958	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527959	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527960	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527961	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527962	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527963	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527964	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527965	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	1000.0	CHEMBL4895	Homo sapiens	pKi		6.0
active	9527966	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	39.81	CHEMBL4895	Homo sapiens	pKi		7.4
inactive	9527967	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527968	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527969	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527970	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527971	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527972	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	=	Ki	nM	100.0	CHEMBL4895	Homo sapiens	pKi		7.0
inactive	9527973	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527974	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527975	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527976	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	251.19	CHEMBL4895	Homo sapiens	pKi		6.6
active	9527977	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	501.19	CHEMBL4895	Homo sapiens	pKi		6.3
active	9527978	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	15.85	CHEMBL4895	Homo sapiens	pKi		7.8
inactive	9527979	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527980	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527981	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	=	Ki	nM	10.0	CHEMBL4895	Homo sapiens	pKi		8.0
inactive	9527982	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527983	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527984	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9527985	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9527986	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	=	Ki	nM	630.96	CHEMBL4895	Homo sapiens	pKi		6.2
active	9527987	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Ki	nM	251.19	CHEMBL4895	Homo sapiens	pKi		6.6
inactive	9527988	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9531897	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9531898	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	=	Ki	nM	251.19	CHEMBL4895	Homo sapiens	pKi		6.6
inactive	9531899	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9531900	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9531901	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	5.012	CHEMBL4895	Homo sapiens	pKi		8.3
active	9531902	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	=	Ki	nM	158.49	CHEMBL4895	Homo sapiens	pKi		6.8
active	9531903	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	7.943	CHEMBL4895	Homo sapiens	pKi		8.1
active	9531904	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	12.59	CHEMBL4895	Homo sapiens	pKi		7.9
active	9531905	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	199.53	CHEMBL4895	Homo sapiens	pKi		6.7
inactive	9531906	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9531907	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	125.89	CHEMBL4895	Homo sapiens	pKi		6.9
inactive	9531908	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9531909	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9531910	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9531911	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9531912	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9531913	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	19.95	CHEMBL4895	Homo sapiens	pKi		7.7
active	9531914	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	=	Ki	nM	501.19	CHEMBL4895	Homo sapiens	pKi		6.3
active	9531915	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	=	Ki	nM	316.23	CHEMBL4895	Homo sapiens	pKi		6.5
active	9531916	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	=	Ki	nM	1000.0	CHEMBL4895	Homo sapiens	pKi		6.0
active	9531917	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	63.1	CHEMBL4895	Homo sapiens	pKi		7.2
active	9531918	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	1.585	CHEMBL4895	Homo sapiens	pKi		8.8
inactive	9531919	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9531920	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9531921	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9531922	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	6.31	CHEMBL4895	Homo sapiens	pKi		8.2
active	9531923	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	=	Ki	nM	1258.93	CHEMBL4895	Homo sapiens	pKi		5.9
active	9531924	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	398.11	CHEMBL4895	Homo sapiens	pKi		6.4
active	9531925	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	=	Ki	nM	630.96	CHEMBL4895	Homo sapiens	pKi		6.2
inactive	9531926	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
inactive	9531927	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	1995.26	CHEMBL4895	Homo sapiens	pKi		5.7
active	9531928	CHEMBL1964114	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: AXL	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	12.59	CHEMBL4895	Homo sapiens	pKi		7.9
	10838141	CHEMBL2015888	Inhibition of AXL	B	C[C@H]1C/C=C/[C@@H](O)[C@@H](O)CC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL1173442	=	Kd	nM	1000.0	CHEMBL4895	Homo sapiens	Kd	uM	1.0
	10838143	CHEMBL2015887	Inhibition of AXL assessed as enzyme activity at 10 uM relative to control	B	C[C@H]1C/C=C/[C@@H](O)[C@@H](O)CC/C=C/c2cc(O)cc(O)c2C(=O)O1		CHEMBL1173442	=	Activity	%	4.7	CHEMBL4895	Homo sapiens	Activity	%	4.7
	10838552	CHEMBL2014125	Inhibition of AXL at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	34.0	CHEMBL4895	Homo sapiens	INH	%	34.0
	10850672	CHEMBL2019792	Inhibition of human Axl at 1 uM	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	>	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	10867512	CHEMBL2027269	Inhibition of Axl at 2 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Inhibition	%	0.0	CHEMBL4895	Homo sapiens	INH	%	0.0
	10870000	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	Cc1cnc(Nc2ccc(N3CCN(C)CC3)c(F)c2)nc1-c1ccc(F)c(Cl)c1		CHEMBL2022573	=	IC50	nM	2800.0	CHEMBL4895	Homo sapiens	IC50	uM	2.8
	10870001	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	Cc1cnc(Nc2ccc(N3CCN(C)CC3)c(F)c2)nc1-c1ccc(F)cc1		CHEMBL2022574	=	IC50	nM	6100.0	CHEMBL4895	Homo sapiens	IC50	uM	6.1
	10870002	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	Cc1cnc(Nc2ccc(CN3CCN(C)CC3)cc2)nc1-c1ccc(F)c(Cl)c1		CHEMBL2022575	=	IC50	nM	730.0	CHEMBL4895	Homo sapiens	IC50	uM	0.73
	10870003	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	Cc1cnc(Nc2ccc(OCCN3CCCCC3)cc2)nc1-c1ccc(F)c(Cl)c1		CHEMBL2022961	=	IC50	nM	1630.0	CHEMBL4895	Homo sapiens	IC50	uM	1.63
	10870004	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	Cc1cnc(Nc2ccc(N(C)C3CCN(C)CC3)cc2)nc1-c1ccc(F)c(Cl)c1		CHEMBL2022962	=	IC50	nM	420.0	CHEMBL4895	Homo sapiens	IC50	uM	0.42
	10870005	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	Cc1cnc(Nc2ccc(CN3CCN(C)CC3)cc2)nc1-c1cccc(Cl)c1		CHEMBL2022963	=	IC50	nM	440.0	CHEMBL4895	Homo sapiens	IC50	uM	0.44
	10870006	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	Cc1cnc(Nc2ccc(CN3CCN(C)CC3)cc2)nc1-c1ccc(C(C)(C)C#N)cc1		CHEMBL2022964	=	IC50	nM	290.0	CHEMBL4895	Homo sapiens	IC50	uM	0.29
	10870007	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	Cc1cnc(Nc2ccc(CN3CCN(C)CC3)cc2)nc1Oc1ccc(F)c(Cl)c1		CHEMBL2022965	=	IC50	nM	1400.0	CHEMBL4895	Homo sapiens	IC50	uM	1.4
	10870008	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	Cc1cnc(Nc2ccc(CN3CCN(C)CC3)cc2)nc1Nc1ccc(F)c(Cl)c1		CHEMBL2022966	=	IC50	nM	62700.0	CHEMBL4895	Homo sapiens	IC50	uM	62.7
	10870009	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	CN1CCN(Cc2ccc(Nc3ncc(C4CC4)c(-c4ccc(F)c(Cl)c4)n3)cc2)CC1		CHEMBL2022967	=	IC50	nM	3400.0	CHEMBL4895	Homo sapiens	IC50	uM	3.4
	10870010	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1		CHEMBL2022968	=	IC50	nM	27.0	CHEMBL4895	Homo sapiens	IC50	uM	0.027
	10870011	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)N(C)C)n3)cc2)CC1		CHEMBL2022969	=	IC50	nM	88.0	CHEMBL4895	Homo sapiens	IC50	uM	0.088
	10870012	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	Cc1cnc(Nc2ccc(CN3CCN(C)CC3)cc2)nc1-c1ccc(F)cc1S(=O)(=O)N1CCCC1		CHEMBL2022970	=	IC50	nM	2930.0	CHEMBL4895	Homo sapiens	IC50	uM	2.93
	10870013	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	CN1CCN(Cc2ccc(Nc3ncc(F)c(-c4ccc(F)cc4S(=O)(=O)N4CCCC4)n3)cc2)CC1		CHEMBL2022971	=	IC50	nM	1150.0	CHEMBL4895	Homo sapiens	IC50	uM	1.15
	10870014	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	CN1CCN(Cc2ccc(Nc3ncc(C(F)(F)F)c(Nc4ccccc4C(=O)N(C)C)n3)cc2)CC1		CHEMBL2022972	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	10870015	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)N4CCCC4)n3)cc2)CC1		CHEMBL2022973	=	IC50	nM	61.0	CHEMBL4895	Homo sapiens	IC50	uM	0.061
	10870016	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC4CC4)n3)cc2)CC1		CHEMBL2022974	=	IC50	nM	32.0	CHEMBL4895	Homo sapiens	IC50	uM	0.032
	10870017	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N4CCCC4)n3)cc2)CC1		CHEMBL2022975	=	IC50	nM	19.0	CHEMBL4895	Homo sapiens	IC50	uM	0.019
	10870018	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccc(F)cc4S(=O)(=O)N4CCOCC4)n3)cc2)CC1		CHEMBL2022976	=	IC50	nM	240.0	CHEMBL4895	Homo sapiens	IC50	uM	0.24
	10870019	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccc(F)cc4S(=O)(=O)N4CCCC4)n3)cc2)CC1		CHEMBL2022977	=	IC50	nM	37.0	CHEMBL4895	Homo sapiens	IC50	uM	0.037
	10870020	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccc(Cl)cc4S(=O)(=O)N4CCCC4)n3)cc2)CC1		CHEMBL2022978	=	IC50	nM	1080.0	CHEMBL4895	Homo sapiens	IC50	uM	1.08
	10870021	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccc(O)cc4S(=O)(=O)N4CCCC4)n3)cc2)CC1		CHEMBL2023343	=	IC50	nM	1320.0	CHEMBL4895	Homo sapiens	IC50	uM	1.32
	10870022	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(N(C)c4ccc(F)cc4S(=O)(=O)N4CCCC4)n3)cc2)CC1		CHEMBL2023344	=	IC50	nM	3910.0	CHEMBL4895	Homo sapiens	IC50	uM	3.91
	10870023	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(-c4ccc(F)cc4S(=O)(=O)N(C)C)n3)cc2)CC1		CHEMBL2023345	=	IC50	nM	82.0	CHEMBL4895	Homo sapiens	IC50	uM	0.082
	10870024	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(-c4ccc(F)cc4S(=O)(=O)N4CCCC4)n3)cc2)CC1		CHEMBL2023346	=	IC50	nM	91.0	CHEMBL4895	Homo sapiens	IC50	uM	0.091
	10870025	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	CN1CCC(N(C)c2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1		CHEMBL2023347	=	IC50	nM	56.0	CHEMBL4895	Homo sapiens	IC50	uM	0.056
	10870026	CHEMBL2027231	Inhibition of human recombinant His-tagged AXL kinase using fluorescein-labelled poly-GT as substrate after 60 mins by TR-FRET analysis	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1		CHEMBL2023348	=	IC50	nM	1730.0	CHEMBL4895	Homo sapiens	IC50	uM	1.73
	10870027	CHEMBL2027232	Inhibition of AXL kinase	B	Nc1nc(Nc2ccc3c(c2)CCC(N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2		CHEMBL2023349	=	IC50	nM	14.0	CHEMBL4895	Homo sapiens	IC50	nM	14.0
	10870028	CHEMBL2027232	Inhibition of AXL kinase	B	Cc1nn(C2CCN(C)CC2)cc1-c1cnc(N)c(-c2nc3ccccc3o2)c1		CHEMBL2023350	=	IC50	nM	30.0	CHEMBL4895	Homo sapiens	IC50	nM	30.0
	10870029	CHEMBL2027232	Inhibition of AXL kinase	B	COc1cc2c(Oc3cc(NS(=O)(=O)c4cc(F)ccc4F)ccc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL2023351	=	IC50	nM	16.0	CHEMBL4895	Homo sapiens	IC50	nM	16.0
	10870030	CHEMBL2027232	Inhibition of AXL kinase	B	Cc1c[nH]c2nc(Nc3ccc(N4CCN(CCO)CC4)cc3)nc(-c3cccc(CC#N)c3)c12		CHEMBL2023352	=	IC50	nM	100.0	CHEMBL4895	Homo sapiens	IC50	nM	100.0
	10870031	CHEMBL2027232	Inhibition of AXL kinase	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	300.0	CHEMBL4895	Homo sapiens	IC50	uM	0.3
	10870032	CHEMBL2027232	Inhibition of AXL kinase	B	CC1CCN(c2cc(N3CCN(C)CC3)ccc2NC(=O)c2cc(C#N)c[nH]2)CC1		CHEMBL254702	=	IC50	nM	6.4	CHEMBL4895	Homo sapiens	IC50	nM	6.4
Dose-dependent effect	10870052	CHEMBL2027235	Inhibition of AXL in human PSN1 cells assessed as decrease in GAS6-induced phospho-AXL level after 2 hrs by EILSA	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1		CHEMBL2022968		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Dose-dependent effect	10870053	CHEMBL2027236	Inhibition of AXL-mediated AKT Ser473 phosphorylation in human PSN1 cells assessed as decrease in GAS6-induced phospho-AKT level after 2 hrs by ELISA	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1		CHEMBL2022968		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	10870054	CHEMBL2027235	Inhibition of AXL in human PSN1 cells assessed as decrease in GAS6-induced phospho-AXL level after 2 hrs by EILSA	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1		CHEMBL2022968	=	EC50	nM	222.0	CHEMBL4895	Homo sapiens	EC50	nM	222.0
	10870055	CHEMBL2027236	Inhibition of AXL-mediated AKT Ser473 phosphorylation in human PSN1 cells assessed as decrease in GAS6-induced phospho-AKT level after 2 hrs by ELISA	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1		CHEMBL2022968	=	EC50	nM	305.0	CHEMBL4895	Homo sapiens	EC50	nM	305.0
	10870056	CHEMBL2027237	Inhibition of AXL at 200 nM	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1		CHEMBL2022968	>	Inhibition	%	80.0	CHEMBL4895	Homo sapiens	INH	%	80.0
	10870074	CHEMBL2027232	Inhibition of AXL kinase	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	IC50	nM	1.1	CHEMBL4895	Homo sapiens	IC50	nM	1.1
	10870075	CHEMBL2027232	Inhibition of AXL kinase	B	CN1CCN(c2ccc(Nc3nc(-c4ccc(F)c(Cl)c4)cc(-c4ccc[nH]4)n3)cc2F)CC1	Non standard unit for type	CHEMBL2023353	=	INH	uM	33.0	CHEMBL4895	Homo sapiens	INH	uM	33.0
	10870076	CHEMBL2027232	Inhibition of AXL kinase	B	CN1CCN(c2ccc(Nc3nc(-c4ccc(F)c(Cl)c4)cc(-c4ccc(F)c(Cl)c4)n3)cc2F)CC1	Non standard unit for type	CHEMBL2023354	=	INH	uM	47.0	CHEMBL4895	Homo sapiens	INH	uM	47.0
	10903437	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CNc1ncc2c(C(C)C)nn(C[C@H]3CC[C@H](O)CC3)c2n1		CHEMBL2036621	=	IC50	nM	2400.0	CHEMBL4895	Homo sapiens	IC50	uM	2.4
	10903438	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CNc1ncc2c(C(C)C)nn(C[C@@H]3CCCN3)c2n1		CHEMBL2036622	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	uM	30.0
	10903439	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CNc1ncc2c(C(C)C)nn(CC3CCCNC3)c2n1		CHEMBL2036623	=	IC50	nM	4600.0	CHEMBL4895	Homo sapiens	IC50	uM	4.6
	10903440	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CNc1ncc2c(C(C)C)nn(CC3CCNCC3)c2n1		CHEMBL2036624	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	uM	30.0
	10903441	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	C=C(C)c1nn(C[C@H]2CC[C@H](O)CC2)c2nc(NC)ncc12		CHEMBL2036625	=	IC50	nM	380.0	CHEMBL4895	Homo sapiens	IC50	uM	0.38
	10903442	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CNc1ncc2c(-c3ccccc3)nn(C[C@H]3CC[C@H](O)CC3)c2n1		CHEMBL2036626	=	IC50	nM	83.0	CHEMBL4895	Homo sapiens	IC50	uM	0.083
	10903443	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CNc1ncc2c(-c3ccccc3)nn(C[C@H]3CC[C@@H](O)CC3)c2n1		CHEMBL2036627	=	IC50	nM	190.0	CHEMBL4895	Homo sapiens	IC50	uM	0.19
	10903444	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CNc1ncc2c(-c3ccccc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1		CHEMBL2036628	=	IC50	nM	81.0	CHEMBL4895	Homo sapiens	IC50	uM	0.081
	10903445	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CNc1ncc2c(-c3ccccc3)nn(C[C@H]3CC[C@@H](N)CC3)c2n1		CHEMBL2036629	=	IC50	nM	370.0	CHEMBL4895	Homo sapiens	IC50	uM	0.37
	10903446	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CNc1ncc2c(-c3ccc(OC)cc3)nn(CC3CCC(N)CC3)c2n1		CHEMBL2036630	=	IC50	nM	36.0	CHEMBL4895	Homo sapiens	IC50	uM	0.036
	10903447	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CNc1ncc2c(-c3cccc(OC)c3)nn(CC3CCC(N)CC3)c2n1		CHEMBL2036631	=	IC50	nM	150.0	CHEMBL4895	Homo sapiens	IC50	uM	0.15
	10903448	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CNc1ncc2c(-c3ccccc3OC)nn(CC3CCC(N)CC3)c2n1		CHEMBL2036632	=	IC50	nM	690.0	CHEMBL4895	Homo sapiens	IC50	uM	0.69
	10903449	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CNc1ncc2c(-c3ccc(C(F)(F)F)cc3)nn(CC3CCC(N)CC3)c2n1		CHEMBL2036633	=	IC50	nM	220.0	CHEMBL4895	Homo sapiens	IC50	uM	0.22
	10903450	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CNc1ncc2c(-c3ccc(-c4ccccc4)cc3)nn(CC3CCC(N)CC3)c2n1		CHEMBL2036788	=	IC50	nM	50.0	CHEMBL4895	Homo sapiens	IC50	uM	0.05
	10903451	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CNc1ncc2c(-c3cccnc3)nn(CC3CCC(N)CC3)c2n1		CHEMBL2036789	=	IC50	nM	750.0	CHEMBL4895	Homo sapiens	IC50	uM	0.75
	10903452	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CNc1ncc2c(-c3ccc(F)nc3)nn(CC3CCC(N)CC3)c2n1		CHEMBL2036790	=	IC50	nM	610.0	CHEMBL4895	Homo sapiens	IC50	uM	0.61
	10903453	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(CC3CCC(N)CC3)c2n1		CHEMBL2036791	=	IC50	nM	57.0	CHEMBL4895	Homo sapiens	IC50	uM	0.057
	10903454	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(CC3CCC(N)CC3)c2n1		CHEMBL2036792	=	IC50	nM	140.0	CHEMBL4895	Homo sapiens	IC50	uM	0.14
	10903455	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CN(C)c1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1		CHEMBL2036793	=	IC50	nM	22000.0	CHEMBL4895	Homo sapiens	IC50	uM	22.0
	10903456	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CCCNc1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1		CHEMBL2036794	=	IC50	nM	180.0	CHEMBL4895	Homo sapiens	IC50	uM	0.18
	10903457	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CCCCNc1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1		CHEMBL2036795	=	IC50	nM	100.0	CHEMBL4895	Homo sapiens	IC50	uM	0.1
	10903458	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CCCCCNc1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1		CHEMBL2036796	=	IC50	nM	47.0	CHEMBL4895	Homo sapiens	IC50	uM	0.047
	10903459	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CC(C)Nc1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1		CHEMBL2036797	=	IC50	nM	1400.0	CHEMBL4895	Homo sapiens	IC50	uM	1.4
	10903460	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	NC1CCC(Cn2nc(-c3ccccc3)c3cnc(NC4CCC4)nc32)CC1		CHEMBL2036798	=	IC50	nM	360.0	CHEMBL4895	Homo sapiens	IC50	uM	0.36
	10903461	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	COCCNc1ncc2c(-c3ccccc3)nn(CC3CCC(N)CC3)c2n1		CHEMBL2036799	=	IC50	nM	660.0	CHEMBL4895	Homo sapiens	IC50	uM	0.66
	10903462	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	NC1CCC(Cn2nc(-c3ccccc3)c3cnc(NCCCN4CCOCC4)nc32)CC1		CHEMBL2036800	=	IC50	nM	17000.0	CHEMBL4895	Homo sapiens	IC50	uM	17.0
	10903463	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	NC1CCC(Cn2nc(-c3ccccc3)c3cnc(NCc4ccccc4)nc32)CC1		CHEMBL2036801	=	IC50	nM	38.0	CHEMBL4895	Homo sapiens	IC50	uM	0.038
	10903464	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	COc1ccc(CNc2ncc3c(-c4ccccc4)nn(CC4CCC(N)CC4)c3n2)cc1		CHEMBL2036802	=	IC50	nM	59.0	CHEMBL4895	Homo sapiens	IC50	uM	0.059
	10903465	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	NC1CCC(Cn2nc(-c3ccccc3)c3cnc(NCCc4ccccc4)nc32)CC1		CHEMBL2036803	=	IC50	nM	41.0	CHEMBL4895	Homo sapiens	IC50	uM	0.041
	10903466	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	NC1CCC(Cn2nc(-c3ccccc3)c3cnc(NCCCc4ccccc4)nc32)CC1		CHEMBL2036787	=	IC50	nM	38.0	CHEMBL4895	Homo sapiens	IC50	uM	0.038
	10903467	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CCCCNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1		CHEMBL2036804	=	IC50	nM	12.0	CHEMBL4895	Homo sapiens	IC50	nM	12.0
	10903468	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	N[C@H]1CC[C@H](Cn2nc(-c3ccc(N4CCNCC4)nc3)c3cnc(NCCCc4ccccc4)nc32)CC1		CHEMBL2036805	=	IC50	nM	3.7	CHEMBL4895	Homo sapiens	IC50	nM	3.7
	10903469	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CCCCNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1		CHEMBL2036806	=	IC50	nM	4.0	CHEMBL4895	Homo sapiens	IC50	nM	4.0
	10903470	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	N[C@H]1CC[C@H](Cn2nc(-c3ccc(N4CCNCC4)cc3)c3cnc(NCCCc4ccccc4)nc32)CC1		CHEMBL2036807	=	IC50	nM	1.4	CHEMBL4895	Homo sapiens	IC50	nM	1.4
	10903471	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	CCCCNc1ncc2c(-c3ccc(F)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1		CHEMBL2036808	=	IC50	nM	37.0	CHEMBL4895	Homo sapiens	IC50	nM	37.0
	10903472	CHEMBL2037931	Inhibition of Axl using KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluid capillary electrophoresis assay	B	N[C@H]1CC[C@H](Cn2nc(-c3ccc(F)cc3)c3cnc(NCCCc4ccccc4)nc32)CC1		CHEMBL2036809	=	IC50	nM	16.0	CHEMBL4895	Homo sapiens	IC50	nM	16.0
Not Active	10912560	CHEMBL2038043	Inhibition of recombinant AXL at <10 uM by radiometric kinase assay	B	Cn1c(=O)c2ccc(-c3nc4ccccc4n3C)nc2n(C)c1=O		CHEMBL2036871		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	10913470	CHEMBL2038043	Inhibition of recombinant AXL at <10 uM by radiometric kinase assay	B	Cn1c(-c2ccnc(Nc3ccccc3)n2)nc2ccccc21		CHEMBL2036725		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	10913486	CHEMBL2038043	Inhibition of recombinant AXL at <10 uM by radiometric kinase assay	B	Cc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036726		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	10913502	CHEMBL2038043	Inhibition of recombinant AXL at <10 uM by radiometric kinase assay	B	Cn1c(-c2ccnc(Nc3ccc(Cl)cc3)n2)nc2ccccc21		CHEMBL2036727		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	10913518	CHEMBL2038043	Inhibition of recombinant AXL at <10 uM by radiometric kinase assay	B	Cn1c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)nc2ccccc21		CHEMBL2036728		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	10913534	CHEMBL2038043	Inhibition of recombinant AXL at <10 uM by radiometric kinase assay	B	CCOc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036867		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	10913550	CHEMBL2038043	Inhibition of recombinant AXL at <10 uM by radiometric kinase assay	B	COc1ccc(Nc2nccc(-c3nc4ccccc4n3C)n2)cc1		CHEMBL2036868		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	10983095	CHEMBL2072598	Inhibition of Axl	B	C[C@H](NC(=O)c1cc(-c2cnn(C3CCOCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2071457	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	10984736	CHEMBL2072032	Inhibition of human Axl at 1 uM	B	Nc1cc(Nc2cnccn2)nc(-c2ccnc(N3CCNCC3)c2)c1		CHEMBL2069349	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	10993510	CHEMBL2073243	Inhibition of Axl at 10 uM	B	ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL411043	=	Inhibition	%	8.0	CHEMBL4895	Homo sapiens	INH	%	8.0
	11004740	CHEMBL2089900	Inhibition of Axl	B	N#Cc1ccc(Nc2cc(Cl)c([N+](=O)[O-])cc2[N+](=O)[O-])cc1		CHEMBL2088175	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	11004741	CHEMBL2089900	Inhibition of Axl	B	N#Cc1ccc(Oc2cc(Cl)c([N+](=O)[O-])cc2[N+](=O)[O-])cc1		CHEMBL2088176	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	uM	30.0
	11004742	CHEMBL2089900	Inhibition of Axl	B	COc1ccc(Oc2nc(Cl)ccc2[N+](=O)[O-])cc1		CHEMBL2088178	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	11018493	CHEMBL2091522	Inhibition of Axl at 10 uM	B	Nc1n[nH]c2nc(Nc3cccc(NC(=O)Nc4ccc(F)c(Cl)c4)c3)ncc12		CHEMBL2089212	=	Inhibition	%	46.0	CHEMBL4895	Homo sapiens	INH	%	46.0
	12046244	CHEMBL2156626	Inhibition of Axl at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	3.2	CHEMBL4895	Homo sapiens	INH	%	3.2
Not Active	12047554	CHEMBL2155708	Inhibition of AXL at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3Cl)cc1CC2		CHEMBL2152781		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048345	CHEMBL2155708	Inhibition of AXL at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccccc3C(F)(F)F)cc1CC2		CHEMBL2152782		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048360	CHEMBL2155708	Inhibition of AXL at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3Cl)cc1CC2		CHEMBL2152785		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048375	CHEMBL2155708	Inhibition of AXL at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)cc3C)cc1CC2		CHEMBL2152786		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048390	CHEMBL2155708	Inhibition of AXL at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(C(F)(F)F)cc3N)cc1CC2		CHEMBL2152787		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048405	CHEMBL2155708	Inhibition of AXL at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3ccc(F)c(C)c3)cc1CC2		CHEMBL2152788		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048420	CHEMBL2155708	Inhibition of AXL at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(Nc3cc(F)cc(F)c3F)cc1CC2		CHEMBL2152789		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048435	CHEMBL2155708	Inhibition of AXL at 10 uM	B	COc1ccc2c(c1)C(=O)c1ccc(-c3ccccc3)cc1CC2		CHEMBL2152791		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048450	CHEMBL2155708	Inhibition of AXL at 10 uM	B	COc1ccc2ccc3cc(Nc4ccc(F)cc4F)ccc3c(=O)c2c1		CHEMBL2152792		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048465	CHEMBL2155708	Inhibition of AXL at 10 uM	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccccc4N)cc2CC3)O1		CHEMBL2152798		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048480	CHEMBL2155708	Inhibition of AXL at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)CCc1ccc(OC[C@H](O)CO)cc1C2=O		CHEMBL2152936		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048495	CHEMBL2155708	Inhibition of AXL at 10 uM	B	Nc1ccccc1Nc1ccc2c(=O)c3cc(OCCN4CCOCC4)ccc3ccc2c1		CHEMBL2152939		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048510	CHEMBL2155708	Inhibition of AXL at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCO)cc21		CHEMBL2152940		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048525	CHEMBL2155708	Inhibition of AXL at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCCO)cc21		CHEMBL2152941		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048540	CHEMBL2155708	Inhibition of AXL at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC3CCOCC3)cc21		CHEMBL2152942		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048555	CHEMBL2155708	Inhibition of AXL at 10 uM	B	CC1(C)OC[C@H](COc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)O1		CHEMBL2152943		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048570	CHEMBL2155708	Inhibition of AXL at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@@H](O)CO)cc21		CHEMBL2152946		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048585	CHEMBL2155708	Inhibition of AXL at 10 uM	B	CC1(C)OC[C@@H](CCOc2ccc3c(c2)C(=O)c2ccc(Nc4ccc(F)cc4F)cc2CC3)O1		CHEMBL2152947		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048600	CHEMBL2155708	Inhibition of AXL at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OCCCN3CCOCC3)cc21		CHEMBL2152950		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048615	CHEMBL2155708	Inhibition of AXL at 10 uM	B	CC1(C)OC[C@H](COc2ccc3c(c2)CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152957		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048630	CHEMBL2155708	Inhibition of AXL at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OC[C@H](O)CO)ccc21		CHEMBL2152958		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048645	CHEMBL2155708	Inhibition of AXL at 10 uM	B	CC1(C)OC[C@@H](COc2ccc3c(c2)CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152959		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048660	CHEMBL2155708	Inhibition of AXL at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2cc(OC[C@@H](O)CO)ccc21		CHEMBL2152960		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12048675	CHEMBL2155708	Inhibition of AXL at 10 uM	B	COc1cccc2c1CCc1cc(Nc3ccc(F)cc3F)ccc1C2=O		CHEMBL2152965		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12049619	CHEMBL2155708	Inhibition of AXL at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(O)cccc21		CHEMBL2152966		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12049634	CHEMBL2155708	Inhibition of AXL at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c1cccc2C1CCOCC1		CHEMBL2152967		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12049649	CHEMBL2155708	Inhibition of AXL at 10 uM	B	CC1(C)OC[C@H](COc2cccc3c2CCc2cc(Nc4ccc(F)cc4F)ccc2C3=O)O1		CHEMBL2152968		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12049664	CHEMBL2155708	Inhibition of AXL at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(OC[C@H](O)CO)cccc21		CHEMBL2152969		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12049679	CHEMBL2155708	Inhibition of AXL at 10 uM	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2c(OCCN3CCOCC3)cccc21		CHEMBL2152970		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12049694	CHEMBL2155708	Inhibition of AXL at 10 uM	B	COc1cccc2c1CCc1cc(Nc3ccccc3N)ccc1C2=O		CHEMBL2152971		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12049709	CHEMBL2155708	Inhibition of AXL at 10 uM	B	CC1(C)OC[C@H](COc2cccc3c2CCc2cc(Nc4ccccc4N)ccc2C3=O)O1		CHEMBL2152972		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	12049724	CHEMBL2155708	Inhibition of AXL at 10 uM	B	Nc1ccccc1Nc1ccc2c(c1)CCc1c(OC[C@H](O)CO)cccc1C2=O		CHEMBL2152973		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	12074591	CHEMBL2160988	Inhibition of AXL at 0.1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	>	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	12074718	CHEMBL2161434	Inhibition of AXL	B	CS(=O)(=O)CCN1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL2158227	=	IC50	nM	16.0	CHEMBL4895	Homo sapiens	IC50	nM	16.0
	12074719	CHEMBL2161434	Inhibition of AXL	B	N#Cc1cnc(C(=O)Nc2ccc(C3CCN(CCN4CCOCC4)CC3)cc2C2=CCCCC2)[nH]1		CHEMBL2158230	=	IC50	nM	6.0	CHEMBL4895	Homo sapiens	IC50	nM	6.0
	12074720	CHEMBL2161434	Inhibition of AXL	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	=	IC50	nM	12.0	CHEMBL4895	Homo sapiens	IC50	nM	12.0
Not Determined	12074754	CHEMBL2161446	Inhibition of AXL overexpressed in human HEK cells assessed as inhibition of GAS6-induced autophosphorylation by immunoblot assay	B	CS(=O)(=O)CCN1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL2158227		IC50			CHEMBL4895	Homo sapiens	IC50		
Not Determined	12074755	CHEMBL2161446	Inhibition of AXL overexpressed in human HEK cells assessed as inhibition of GAS6-induced autophosphorylation by immunoblot assay	B	N#Cc1cnc(C(=O)Nc2ccc(C3CCN(CCN4CCOCC4)CC3)cc2C2=CCCCC2)[nH]1		CHEMBL2158230		IC50			CHEMBL4895	Homo sapiens	IC50		
	12074756	CHEMBL2161446	Inhibition of AXL overexpressed in human HEK cells assessed as inhibition of GAS6-induced autophosphorylation by immunoblot assay	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	=	IC50	nM	2600.0	CHEMBL4895	Homo sapiens	IC50	nM	2600.0
	12105211	CHEMBL2175676	Inhibition of human AXL assessed as residual enzyme activity at 1 uM by Ambit kinome assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cc(F)cc(F)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172315	=	Activity	%	82.0	CHEMBL4895	Homo sapiens	Activity	%	82.0
	12105212	CHEMBL2175676	Inhibition of human AXL assessed as residual enzyme activity at 1 uM by Ambit kinome assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172308	=	Activity	%	0.75	CHEMBL4895	Homo sapiens	Activity	%	0.75
	12105259	CHEMBL2176255	Binding affinity to human AXL by Ambit titration assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cc(F)cc(F)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172315	=	Kd	nM	1600.0	CHEMBL4895	Homo sapiens	Kd	nM	1600.0
	12105260	CHEMBL2176255	Binding affinity to human AXL by Ambit titration assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172308	=	Kd	nM	29.0	CHEMBL4895	Homo sapiens	Kd	nM	29.0
	12116226	CHEMBL2174227	Inhibition of AXL	B	Cn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(C(F)(F)F)c2)c2c(N)ncnc21		CHEMBL2171124	=	IC50	nM	2705.0	CHEMBL4895	Homo sapiens	IC50	nM	2705.0
	12173730	CHEMBL2212068	Inhibition of AXL assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	46.0	CHEMBL4895	Homo sapiens	Activity	%	46.0
	12219412	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	108.0	CHEMBL4895	Homo sapiens	Residual Activity	%	108.0
	12219413	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	86.0	CHEMBL4895	Homo sapiens	Residual Activity	%	86.0
	12219414	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	102.0	CHEMBL4895	Homo sapiens	Residual Activity	%	102.0
	12219415	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	98.0	CHEMBL4895	Homo sapiens	Residual Activity	%	98.0
	12219416	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	75.0	CHEMBL4895	Homo sapiens	Residual Activity	%	75.0
	12219417	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	104.0	CHEMBL4895	Homo sapiens	Residual Activity	%	104.0
	12219418	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	13.0	CHEMBL4895	Homo sapiens	Residual Activity	%	13.0
	12219419	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	102.0	CHEMBL4895	Homo sapiens	Residual Activity	%	102.0
	12219420	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	87.0	CHEMBL4895	Homo sapiens	Residual Activity	%	87.0
	12219421	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	77.0	CHEMBL4895	Homo sapiens	Residual Activity	%	77.0
	12219422	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	82.0	CHEMBL4895	Homo sapiens	Residual Activity	%	82.0
	12219423	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	75.0	CHEMBL4895	Homo sapiens	Residual Activity	%	75.0
	12219424	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	83.0	CHEMBL4895	Homo sapiens	Residual Activity	%	83.0
	12219425	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	80.0	CHEMBL4895	Homo sapiens	Residual Activity	%	80.0
	12219426	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	74.0	CHEMBL4895	Homo sapiens	Residual Activity	%	74.0
	12219427	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	84.0	CHEMBL4895	Homo sapiens	Residual Activity	%	84.0
	12219428	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	134.0	CHEMBL4895	Homo sapiens	Residual Activity	%	134.0
	12219429	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	93.0	CHEMBL4895	Homo sapiens	Residual Activity	%	93.0
	12219430	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	76.0	CHEMBL4895	Homo sapiens	Residual Activity	%	76.0
	12219431	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	40.0	CHEMBL4895	Homo sapiens	Residual Activity	%	40.0
	12219432	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	81.0	CHEMBL4895	Homo sapiens	Residual Activity	%	81.0
	12219433	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	94.0	CHEMBL4895	Homo sapiens	Residual Activity	%	94.0
	12219434	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	69.0	CHEMBL4895	Homo sapiens	Residual Activity	%	69.0
	12219435	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	86.0	CHEMBL4895	Homo sapiens	Residual Activity	%	86.0
	12219436	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	90.0	CHEMBL4895	Homo sapiens	Residual Activity	%	90.0
	12219437	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	66.0	CHEMBL4895	Homo sapiens	Residual Activity	%	66.0
	12219438	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	50.0	CHEMBL4895	Homo sapiens	Residual Activity	%	50.0
	12219439	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	36.0	CHEMBL4895	Homo sapiens	Residual Activity	%	36.0
	12219440	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	71.0	CHEMBL4895	Homo sapiens	Residual Activity	%	71.0
	12219441	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	86.0	CHEMBL4895	Homo sapiens	Residual Activity	%	86.0
	12219442	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	65.0	CHEMBL4895	Homo sapiens	Residual Activity	%	65.0
	12219443	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	12.0	CHEMBL4895	Homo sapiens	Residual Activity	%	12.0
	12219444	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	77.0	CHEMBL4895	Homo sapiens	Residual Activity	%	77.0
	12219445	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	82.0	CHEMBL4895	Homo sapiens	Residual Activity	%	82.0
	12219446	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	80.0	CHEMBL4895	Homo sapiens	Residual Activity	%	80.0
	12219447	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	69.0	CHEMBL4895	Homo sapiens	Residual Activity	%	69.0
	12219448	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	71.0	CHEMBL4895	Homo sapiens	Residual Activity	%	71.0
	12219449	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	89.0	CHEMBL4895	Homo sapiens	Residual Activity	%	89.0
	12219450	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	87.0	CHEMBL4895	Homo sapiens	Residual Activity	%	87.0
	12219451	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	72.0	CHEMBL4895	Homo sapiens	Residual Activity	%	72.0
	12219452	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	88.0	CHEMBL4895	Homo sapiens	Residual Activity	%	88.0
	12219453	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	110.0	CHEMBL4895	Homo sapiens	Residual Activity	%	110.0
	12219454	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	53.0	CHEMBL4895	Homo sapiens	Residual Activity	%	53.0
	12219455	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	8.0	CHEMBL4895	Homo sapiens	Residual Activity	%	8.0
	12219456	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	11.0	CHEMBL4895	Homo sapiens	Residual Activity	%	11.0
	12219457	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	81.0	CHEMBL4895	Homo sapiens	Residual Activity	%	81.0
	12219458	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	91.0	CHEMBL4895	Homo sapiens	Residual Activity	%	91.0
	12219459	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	31.0	CHEMBL4895	Homo sapiens	Residual Activity	%	31.0
	12219460	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	81.0	CHEMBL4895	Homo sapiens	Residual Activity	%	81.0
	12219461	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	111.0	CHEMBL4895	Homo sapiens	Residual Activity	%	111.0
	12219462	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	88.0	CHEMBL4895	Homo sapiens	Residual Activity	%	88.0
	12219463	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	58.0	CHEMBL4895	Homo sapiens	Residual Activity	%	58.0
	12219464	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	26.0	CHEMBL4895	Homo sapiens	Residual Activity	%	26.0
	12219465	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	88.0	CHEMBL4895	Homo sapiens	Residual Activity	%	88.0
	12219466	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	95.0	CHEMBL4895	Homo sapiens	Residual Activity	%	95.0
	12219467	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	94.0	CHEMBL4895	Homo sapiens	Residual Activity	%	94.0
	12221842	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	99.0	CHEMBL4895	Homo sapiens	Residual Activity	%	99.0
	12221843	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	103.0	CHEMBL4895	Homo sapiens	Residual Activity	%	103.0
	12221844	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	81.0	CHEMBL4895	Homo sapiens	Residual Activity	%	81.0
	12221845	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	80.0	CHEMBL4895	Homo sapiens	Residual Activity	%	80.0
	12221846	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	71.0	CHEMBL4895	Homo sapiens	Residual Activity	%	71.0
	12221847	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	14.0	CHEMBL4895	Homo sapiens	Residual Activity	%	14.0
	12221848	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	92.0	CHEMBL4895	Homo sapiens	Residual Activity	%	92.0
	12221849	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	86.0	CHEMBL4895	Homo sapiens	Residual Activity	%	86.0
	12221850	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	89.0	CHEMBL4895	Homo sapiens	Residual Activity	%	89.0
	12221851	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	78.0	CHEMBL4895	Homo sapiens	Residual Activity	%	78.0
	12221852	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	104.0	CHEMBL4895	Homo sapiens	Residual Activity	%	104.0
	12221853	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	80.0	CHEMBL4895	Homo sapiens	Residual Activity	%	80.0
	12221854	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	75.0	CHEMBL4895	Homo sapiens	Residual Activity	%	75.0
	12221855	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	54.0	CHEMBL4895	Homo sapiens	Residual Activity	%	54.0
	12221856	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	100.0	CHEMBL4895	Homo sapiens	Residual Activity	%	100.0
	12221857	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	79.0	CHEMBL4895	Homo sapiens	Residual Activity	%	79.0
	12221858	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	70.0	CHEMBL4895	Homo sapiens	Residual Activity	%	70.0
	12221859	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	63.0	CHEMBL4895	Homo sapiens	Residual Activity	%	63.0
	12221860	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	90.0	CHEMBL4895	Homo sapiens	Residual Activity	%	90.0
	12221861	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	13.0	CHEMBL4895	Homo sapiens	Residual Activity	%	13.0
	12221862	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	98.0	CHEMBL4895	Homo sapiens	Residual Activity	%	98.0
	12221863	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	9.0	CHEMBL4895	Homo sapiens	Residual Activity	%	9.0
	12221864	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	96.0	CHEMBL4895	Homo sapiens	Residual Activity	%	96.0
	12221865	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-2.0	CHEMBL4895	Homo sapiens	Residual Activity	%	-2.0
	12221866	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	111.0	CHEMBL4895	Homo sapiens	Residual Activity	%	111.0
	12221867	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	56.0	CHEMBL4895	Homo sapiens	Residual Activity	%	56.0
	12221868	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	94.0	CHEMBL4895	Homo sapiens	Residual Activity	%	94.0
	12221869	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	102.0	CHEMBL4895	Homo sapiens	Residual Activity	%	102.0
	12221870	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	51.0	CHEMBL4895	Homo sapiens	Residual Activity	%	51.0
	12221871	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	105.0	CHEMBL4895	Homo sapiens	Residual Activity	%	105.0
	12221872	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	101.0	CHEMBL4895	Homo sapiens	Residual Activity	%	101.0
	12221873	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	122.0	CHEMBL4895	Homo sapiens	Residual Activity	%	122.0
	12221874	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	102.0	CHEMBL4895	Homo sapiens	Residual Activity	%	102.0
	12221875	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	17.0	CHEMBL4895	Homo sapiens	Residual Activity	%	17.0
	12221876	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	96.0	CHEMBL4895	Homo sapiens	Residual Activity	%	96.0
	12221877	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	98.0	CHEMBL4895	Homo sapiens	Residual Activity	%	98.0
	12221878	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	33.0	CHEMBL4895	Homo sapiens	Residual Activity	%	33.0
	12221879	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	96.0	CHEMBL4895	Homo sapiens	Residual Activity	%	96.0
	12221880	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	118.0	CHEMBL4895	Homo sapiens	Residual Activity	%	118.0
	12221881	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	108.0	CHEMBL4895	Homo sapiens	Residual Activity	%	108.0
	12221882	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	109.0	CHEMBL4895	Homo sapiens	Residual Activity	%	109.0
	12221883	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	107.0	CHEMBL4895	Homo sapiens	Residual Activity	%	107.0
	12221884	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	103.0	CHEMBL4895	Homo sapiens	Residual Activity	%	103.0
	12221885	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	118.0	CHEMBL4895	Homo sapiens	Residual Activity	%	118.0
	12221886	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	86.0	CHEMBL4895	Homo sapiens	Residual Activity	%	86.0
	12221887	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	4.0	CHEMBL4895	Homo sapiens	Residual Activity	%	4.0
	12221888	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	119.0	CHEMBL4895	Homo sapiens	Residual Activity	%	119.0
	12221889	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	91.0	CHEMBL4895	Homo sapiens	Residual Activity	%	91.0
	12221890	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	91.0	CHEMBL4895	Homo sapiens	Residual Activity	%	91.0
	12221891	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	105.0	CHEMBL4895	Homo sapiens	Residual Activity	%	105.0
	12221892	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	77.0	CHEMBL4895	Homo sapiens	Residual Activity	%	77.0
	12221893	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	73.0	CHEMBL4895	Homo sapiens	Residual Activity	%	73.0
	12221894	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	98.0	CHEMBL4895	Homo sapiens	Residual Activity	%	98.0
	12221895	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	85.0	CHEMBL4895	Homo sapiens	Residual Activity	%	85.0
	12221896	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	120.0	CHEMBL4895	Homo sapiens	Residual Activity	%	120.0
	12221897	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	112.0	CHEMBL4895	Homo sapiens	Residual Activity	%	112.0
	12221898	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	57.0	CHEMBL4895	Homo sapiens	Residual Activity	%	57.0
	12221899	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	111.0	CHEMBL4895	Homo sapiens	Residual Activity	%	111.0
	12221900	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	107.0	CHEMBL4895	Homo sapiens	Residual Activity	%	107.0
	12221901	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	96.0	CHEMBL4895	Homo sapiens	Residual Activity	%	96.0
	12221902	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	77.0	CHEMBL4895	Homo sapiens	Residual Activity	%	77.0
	12221903	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	107.0	CHEMBL4895	Homo sapiens	Residual Activity	%	107.0
	12221904	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	94.0	CHEMBL4895	Homo sapiens	Residual Activity	%	94.0
	12221905	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	109.0	CHEMBL4895	Homo sapiens	Residual Activity	%	109.0
	12221906	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	92.0	CHEMBL4895	Homo sapiens	Residual Activity	%	92.0
	12221907	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	78.0	CHEMBL4895	Homo sapiens	Residual Activity	%	78.0
	12221908	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	94.0	CHEMBL4895	Homo sapiens	Residual Activity	%	94.0
	12221909	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	74.0	CHEMBL4895	Homo sapiens	Residual Activity	%	74.0
	12221910	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	12.0	CHEMBL4895	Homo sapiens	Residual Activity	%	12.0
	12221911	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	100.0	CHEMBL4895	Homo sapiens	Residual Activity	%	100.0
	12221912	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	90.0	CHEMBL4895	Homo sapiens	Residual Activity	%	90.0
	12221913	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	114.0	CHEMBL4895	Homo sapiens	Residual Activity	%	114.0
	12221914	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	77.0	CHEMBL4895	Homo sapiens	Residual Activity	%	77.0
	12221915	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	3.0	CHEMBL4895	Homo sapiens	Residual Activity	%	3.0
	12221916	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	92.0	CHEMBL4895	Homo sapiens	Residual Activity	%	92.0
	12221917	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	93.0	CHEMBL4895	Homo sapiens	Residual Activity	%	93.0
	12221918	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	50.0	CHEMBL4895	Homo sapiens	Residual Activity	%	50.0
	12221919	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	104.0	CHEMBL4895	Homo sapiens	Residual Activity	%	104.0
	12221920	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	101.0	CHEMBL4895	Homo sapiens	Residual Activity	%	101.0
	12221921	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	80.0	CHEMBL4895	Homo sapiens	Residual Activity	%	80.0
	12221922	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	94.0	CHEMBL4895	Homo sapiens	Residual Activity	%	94.0
	12221923	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	27.0	CHEMBL4895	Homo sapiens	Residual Activity	%	27.0
	12221924	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	52.0	CHEMBL4895	Homo sapiens	Residual Activity	%	52.0
	12221925	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	90.0	CHEMBL4895	Homo sapiens	Residual Activity	%	90.0
	12221926	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	96.0	CHEMBL4895	Homo sapiens	Residual Activity	%	96.0
	12221927	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	108.0	CHEMBL4895	Homo sapiens	Residual Activity	%	108.0
	12221928	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	61.0	CHEMBL4895	Homo sapiens	Residual Activity	%	61.0
	12221929	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	76.0	CHEMBL4895	Homo sapiens	Residual Activity	%	76.0
	12221930	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	77.0	CHEMBL4895	Homo sapiens	Residual Activity	%	77.0
	12221931	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	90.0	CHEMBL4895	Homo sapiens	Residual Activity	%	90.0
	12221932	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	77.0	CHEMBL4895	Homo sapiens	Residual Activity	%	77.0
	12221933	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	73.0	CHEMBL4895	Homo sapiens	Residual Activity	%	73.0
	12221934	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	90.0	CHEMBL4895	Homo sapiens	Residual Activity	%	90.0
	12221935	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	121.0	CHEMBL4895	Homo sapiens	Residual Activity	%	121.0
	12221936	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	83.0	CHEMBL4895	Homo sapiens	Residual Activity	%	83.0
	12221937	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	91.0	CHEMBL4895	Homo sapiens	Residual Activity	%	91.0
	12221938	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	94.0	CHEMBL4895	Homo sapiens	Residual Activity	%	94.0
	12221939	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	61.0	CHEMBL4895	Homo sapiens	Residual Activity	%	61.0
	12221940	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	96.0	CHEMBL4895	Homo sapiens	Residual Activity	%	96.0
	12221941	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	72.0	CHEMBL4895	Homo sapiens	Residual Activity	%	72.0
	12221942	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	121.0	CHEMBL4895	Homo sapiens	Residual Activity	%	121.0
	12221943	CHEMBL2218954	Millipore: Percentage of residual kinase activity of AXL at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	19.0	CHEMBL4895	Homo sapiens	Residual Activity	%	19.0
	12221944	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	95.0	CHEMBL4895	Homo sapiens	Residual Activity	%	95.0
	12221945	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	56.0	CHEMBL4895	Homo sapiens	Residual Activity	%	56.0
	12221946	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	83.0	CHEMBL4895	Homo sapiens	Residual Activity	%	83.0
	12221947	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	88.0	CHEMBL4895	Homo sapiens	Residual Activity	%	88.0
	12221948	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	69.0	CHEMBL4895	Homo sapiens	Residual Activity	%	69.0
	12221949	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	81.0	CHEMBL4895	Homo sapiens	Residual Activity	%	81.0
	12221950	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	27.0	CHEMBL4895	Homo sapiens	Residual Activity	%	27.0
	12221951	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	51.0	CHEMBL4895	Homo sapiens	Residual Activity	%	51.0
	12221952	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	68.0	CHEMBL4895	Homo sapiens	Residual Activity	%	68.0
	12221953	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	57.0	CHEMBL4895	Homo sapiens	Residual Activity	%	57.0
	12221954	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	74.0	CHEMBL4895	Homo sapiens	Residual Activity	%	74.0
	12221955	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	78.0	CHEMBL4895	Homo sapiens	Residual Activity	%	78.0
	12221956	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	80.0	CHEMBL4895	Homo sapiens	Residual Activity	%	80.0
	12221957	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	72.0	CHEMBL4895	Homo sapiens	Residual Activity	%	72.0
	12221958	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	58.0	CHEMBL4895	Homo sapiens	Residual Activity	%	58.0
	12221959	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	81.0	CHEMBL4895	Homo sapiens	Residual Activity	%	81.0
	12221960	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	58.0	CHEMBL4895	Homo sapiens	Residual Activity	%	58.0
	12221961	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	44.0	CHEMBL4895	Homo sapiens	Residual Activity	%	44.0
	12221962	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	76.0	CHEMBL4895	Homo sapiens	Residual Activity	%	76.0
	12221963	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	59.0	CHEMBL4895	Homo sapiens	Residual Activity	%	59.0
	12221964	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	80.0	CHEMBL4895	Homo sapiens	Residual Activity	%	80.0
	12221965	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	81.0	CHEMBL4895	Homo sapiens	Residual Activity	%	81.0
	12221966	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	81.0	CHEMBL4895	Homo sapiens	Residual Activity	%	81.0
	12221967	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	82.0	CHEMBL4895	Homo sapiens	Residual Activity	%	82.0
	12221968	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	80.0	CHEMBL4895	Homo sapiens	Residual Activity	%	80.0
	12221969	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	31.0	CHEMBL4895	Homo sapiens	Residual Activity	%	31.0
	12221970	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	15.0	CHEMBL4895	Homo sapiens	Residual Activity	%	15.0
	12221971	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	17.0	CHEMBL4895	Homo sapiens	Residual Activity	%	17.0
	12221972	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	60.0	CHEMBL4895	Homo sapiens	Residual Activity	%	60.0
	12221973	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	66.0	CHEMBL4895	Homo sapiens	Residual Activity	%	66.0
	12221974	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	80.0	CHEMBL4895	Homo sapiens	Residual Activity	%	80.0
	12221975	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	10.0	CHEMBL4895	Homo sapiens	Residual Activity	%	10.0
	12221976	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	64.0	CHEMBL4895	Homo sapiens	Residual Activity	%	64.0
	12221977	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	78.0	CHEMBL4895	Homo sapiens	Residual Activity	%	78.0
	12221978	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	74.0	CHEMBL4895	Homo sapiens	Residual Activity	%	74.0
	12221979	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	74.0	CHEMBL4895	Homo sapiens	Residual Activity	%	74.0
	12221980	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	50.0	CHEMBL4895	Homo sapiens	Residual Activity	%	50.0
	12221981	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	84.0	CHEMBL4895	Homo sapiens	Residual Activity	%	84.0
	12221982	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	81.0	CHEMBL4895	Homo sapiens	Residual Activity	%	81.0
	12221983	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	62.0	CHEMBL4895	Homo sapiens	Residual Activity	%	62.0
	12221984	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	83.0	CHEMBL4895	Homo sapiens	Residual Activity	%	83.0
	12221985	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	85.0	CHEMBL4895	Homo sapiens	Residual Activity	%	85.0
	12221986	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	32.0	CHEMBL4895	Homo sapiens	Residual Activity	%	32.0
	12221987	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	-1.0	CHEMBL4895	Homo sapiens	Residual Activity	%	-1.0
	12221988	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	8.0	CHEMBL4895	Homo sapiens	Residual Activity	%	8.0
	12221989	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	75.0	CHEMBL4895	Homo sapiens	Residual Activity	%	75.0
	12221990	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	92.0	CHEMBL4895	Homo sapiens	Residual Activity	%	92.0
	12221991	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	21.0	CHEMBL4895	Homo sapiens	Residual Activity	%	21.0
	12221992	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	42.0	CHEMBL4895	Homo sapiens	Residual Activity	%	42.0
	12221993	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	86.0	CHEMBL4895	Homo sapiens	Residual Activity	%	86.0
	12221994	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	40.0	CHEMBL4895	Homo sapiens	Residual Activity	%	40.0
	12221995	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	21.0	CHEMBL4895	Homo sapiens	Residual Activity	%	21.0
	12221996	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	8.0	CHEMBL4895	Homo sapiens	Residual Activity	%	8.0
	12221997	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	74.0	CHEMBL4895	Homo sapiens	Residual Activity	%	74.0
	12221998	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	77.0	CHEMBL4895	Homo sapiens	Residual Activity	%	77.0
	12221999	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	95.0	CHEMBL4895	Homo sapiens	Residual Activity	%	95.0
	12222000	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	40.0	CHEMBL4895	Homo sapiens	Residual Activity	%	40.0
	12222001	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	89.0	CHEMBL4895	Homo sapiens	Residual Activity	%	89.0
	12222002	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	73.0	CHEMBL4895	Homo sapiens	Residual Activity	%	73.0
	12222003	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	82.0	CHEMBL4895	Homo sapiens	Residual Activity	%	82.0
	12222004	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	46.0	CHEMBL4895	Homo sapiens	Residual Activity	%	46.0
	12222005	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	9.0	CHEMBL4895	Homo sapiens	Residual Activity	%	9.0
	12222006	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	87.0	CHEMBL4895	Homo sapiens	Residual Activity	%	87.0
	12222007	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	72.0	CHEMBL4895	Homo sapiens	Residual Activity	%	72.0
	12222008	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	76.0	CHEMBL4895	Homo sapiens	Residual Activity	%	76.0
	12222009	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	49.0	CHEMBL4895	Homo sapiens	Residual Activity	%	49.0
	12222010	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	77.0	CHEMBL4895	Homo sapiens	Residual Activity	%	77.0
	12222011	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	76.0	CHEMBL4895	Homo sapiens	Residual Activity	%	76.0
	12222012	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	54.0	CHEMBL4895	Homo sapiens	Residual Activity	%	54.0
	12222013	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	25.0	CHEMBL4895	Homo sapiens	Residual Activity	%	25.0
	12222014	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	88.0	CHEMBL4895	Homo sapiens	Residual Activity	%	88.0
	12222015	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	81.0	CHEMBL4895	Homo sapiens	Residual Activity	%	81.0
	12222016	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	39.0	CHEMBL4895	Homo sapiens	Residual Activity	%	39.0
	12222017	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	48.0	CHEMBL4895	Homo sapiens	Residual Activity	%	48.0
	12222018	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	40.0	CHEMBL4895	Homo sapiens	Residual Activity	%	40.0
	12222019	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	11.0	CHEMBL4895	Homo sapiens	Residual Activity	%	11.0
	12222020	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	84.0	CHEMBL4895	Homo sapiens	Residual Activity	%	84.0
	12222021	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	1.0	CHEMBL4895	Homo sapiens	Residual Activity	%	1.0
	12222022	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	84.0	CHEMBL4895	Homo sapiens	Residual Activity	%	84.0
	12222023	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL4895	Homo sapiens	Residual Activity	%	0.0
	12222024	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	100.0	CHEMBL4895	Homo sapiens	Residual Activity	%	100.0
	12222025	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	13.0	CHEMBL4895	Homo sapiens	Residual Activity	%	13.0
	12222026	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	80.0	CHEMBL4895	Homo sapiens	Residual Activity	%	80.0
	12222027	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	103.0	CHEMBL4895	Homo sapiens	Residual Activity	%	103.0
	12222028	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	36.0	CHEMBL4895	Homo sapiens	Residual Activity	%	36.0
	12222029	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	100.0	CHEMBL4895	Homo sapiens	Residual Activity	%	100.0
	12222030	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	85.0	CHEMBL4895	Homo sapiens	Residual Activity	%	85.0
	12222031	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	119.0	CHEMBL4895	Homo sapiens	Residual Activity	%	119.0
	12222032	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	86.0	CHEMBL4895	Homo sapiens	Residual Activity	%	86.0
	12222033	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	8.0	CHEMBL4895	Homo sapiens	Residual Activity	%	8.0
	12222034	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	83.0	CHEMBL4895	Homo sapiens	Residual Activity	%	83.0
	12222035	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	84.0	CHEMBL4895	Homo sapiens	Residual Activity	%	84.0
	12222036	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	3.0	CHEMBL4895	Homo sapiens	Residual Activity	%	3.0
	12222037	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	110.0	CHEMBL4895	Homo sapiens	Residual Activity	%	110.0
	12222038	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	115.0	CHEMBL4895	Homo sapiens	Residual Activity	%	115.0
	12222039	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	98.0	CHEMBL4895	Homo sapiens	Residual Activity	%	98.0
	12222040	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	91.0	CHEMBL4895	Homo sapiens	Residual Activity	%	91.0
	12222041	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	94.0	CHEMBL4895	Homo sapiens	Residual Activity	%	94.0
	12222042	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	112.0	CHEMBL4895	Homo sapiens	Residual Activity	%	112.0
	12222043	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	104.0	CHEMBL4895	Homo sapiens	Residual Activity	%	104.0
	12222044	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	71.0	CHEMBL4895	Homo sapiens	Residual Activity	%	71.0
	12222045	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	-3.0	CHEMBL4895	Homo sapiens	Residual Activity	%	-3.0
	12222046	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	111.0	CHEMBL4895	Homo sapiens	Residual Activity	%	111.0
	12222047	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	87.0	CHEMBL4895	Homo sapiens	Residual Activity	%	87.0
	12222048	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	58.0	CHEMBL4895	Homo sapiens	Residual Activity	%	58.0
	12222049	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	75.0	CHEMBL4895	Homo sapiens	Residual Activity	%	75.0
	12222050	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	75.0	CHEMBL4895	Homo sapiens	Residual Activity	%	75.0
	12222051	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	62.0	CHEMBL4895	Homo sapiens	Residual Activity	%	62.0
	12222052	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	71.0	CHEMBL4895	Homo sapiens	Residual Activity	%	71.0
	12222053	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	60.0	CHEMBL4895	Homo sapiens	Residual Activity	%	60.0
	12222054	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	106.0	CHEMBL4895	Homo sapiens	Residual Activity	%	106.0
	12222055	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	79.0	CHEMBL4895	Homo sapiens	Residual Activity	%	79.0
	12222056	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	35.0	CHEMBL4895	Homo sapiens	Residual Activity	%	35.0
	12222057	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	58.0	CHEMBL4895	Homo sapiens	Residual Activity	%	58.0
	12222058	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	70.0	CHEMBL4895	Homo sapiens	Residual Activity	%	70.0
	12222059	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	66.0	CHEMBL4895	Homo sapiens	Residual Activity	%	66.0
	12222060	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	24.0	CHEMBL4895	Homo sapiens	Residual Activity	%	24.0
	12222061	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	82.0	CHEMBL4895	Homo sapiens	Residual Activity	%	82.0
	12222062	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	64.0	CHEMBL4895	Homo sapiens	Residual Activity	%	64.0
	12222063	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	86.0	CHEMBL4895	Homo sapiens	Residual Activity	%	86.0
	12222064	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	75.0	CHEMBL4895	Homo sapiens	Residual Activity	%	75.0
	12222065	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	21.0	CHEMBL4895	Homo sapiens	Residual Activity	%	21.0
	12222066	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	44.0	CHEMBL4895	Homo sapiens	Residual Activity	%	44.0
	12222067	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	60.0	CHEMBL4895	Homo sapiens	Residual Activity	%	60.0
	12222068	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	5.0	CHEMBL4895	Homo sapiens	Residual Activity	%	5.0
	12222069	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	77.0	CHEMBL4895	Homo sapiens	Residual Activity	%	77.0
	12222070	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	31.0	CHEMBL4895	Homo sapiens	Residual Activity	%	31.0
	12222071	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	80.0	CHEMBL4895	Homo sapiens	Residual Activity	%	80.0
	12222072	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	96.0	CHEMBL4895	Homo sapiens	Residual Activity	%	96.0
	12222073	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	2.0	CHEMBL4895	Homo sapiens	Residual Activity	%	2.0
	12222074	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	75.0	CHEMBL4895	Homo sapiens	Residual Activity	%	75.0
	12222075	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	75.0	CHEMBL4895	Homo sapiens	Residual Activity	%	75.0
	12222076	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	17.0	CHEMBL4895	Homo sapiens	Residual Activity	%	17.0
	12222077	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	80.0	CHEMBL4895	Homo sapiens	Residual Activity	%	80.0
	12222078	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	39.0	CHEMBL4895	Homo sapiens	Residual Activity	%	39.0
	12222079	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	20.0	CHEMBL4895	Homo sapiens	Residual Activity	%	20.0
	12222080	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	96.0	CHEMBL4895	Homo sapiens	Residual Activity	%	96.0
	12222081	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	7.0	CHEMBL4895	Homo sapiens	Residual Activity	%	7.0
	12224447	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	39.0	CHEMBL4895	Homo sapiens	Residual Activity	%	39.0
	12224448	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	63.0	CHEMBL4895	Homo sapiens	Residual Activity	%	63.0
	12224449	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	73.0	CHEMBL4895	Homo sapiens	Residual Activity	%	73.0
	12224450	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	93.0	CHEMBL4895	Homo sapiens	Residual Activity	%	93.0
	12224451	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	35.0	CHEMBL4895	Homo sapiens	Residual Activity	%	35.0
	12224452	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	24.0	CHEMBL4895	Homo sapiens	Residual Activity	%	24.0
	12224453	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	85.0	CHEMBL4895	Homo sapiens	Residual Activity	%	85.0
	12224454	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	87.0	CHEMBL4895	Homo sapiens	Residual Activity	%	87.0
	12224455	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	44.0	CHEMBL4895	Homo sapiens	Residual Activity	%	44.0
	12224456	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	65.0	CHEMBL4895	Homo sapiens	Residual Activity	%	65.0
	12224457	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	57.0	CHEMBL4895	Homo sapiens	Residual Activity	%	57.0
	12224458	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	90.0	CHEMBL4895	Homo sapiens	Residual Activity	%	90.0
	12224459	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	29.0	CHEMBL4895	Homo sapiens	Residual Activity	%	29.0
	12224460	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	51.0	CHEMBL4895	Homo sapiens	Residual Activity	%	51.0
	12224461	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	93.0	CHEMBL4895	Homo sapiens	Residual Activity	%	93.0
	12224462	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	59.0	CHEMBL4895	Homo sapiens	Residual Activity	%	59.0
	12224463	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	79.0	CHEMBL4895	Homo sapiens	Residual Activity	%	79.0
	12224464	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	33.0	CHEMBL4895	Homo sapiens	Residual Activity	%	33.0
	12224465	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	83.0	CHEMBL4895	Homo sapiens	Residual Activity	%	83.0
	12224466	CHEMBL2218955	Millipore: Percentage of residual kinase activity of AXL at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	22.0	CHEMBL4895	Homo sapiens	Residual Activity	%	22.0
	12626692	CHEMBL2317140	Inhibition of AXL (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>=	Inhibition	%	80.0	CHEMBL4895	Homo sapiens	INH	%	80.0
	12627674	CHEMBL2317037	Inhibition of Axl (unknown origin)	B	O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312304	=	IC50	nM	3990.0	CHEMBL4895	Homo sapiens	IC50	uM	3.99
	12627675	CHEMBL2317037	Inhibition of Axl (unknown origin)	B	O=C(NCCCN1CCCC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312303	=	IC50	nM	3200.0	CHEMBL4895	Homo sapiens	IC50	uM	3.2
	12627676	CHEMBL2317037	Inhibition of Axl (unknown origin)	B	COc1ccccc1CNc1ncc(C(=O)NCCCN2CCCC2=O)c(NC2CCCC2)n1		CHEMBL2312301	=	IC50	nM	5700.0	CHEMBL4895	Homo sapiens	IC50	uM	5.7
	12627677	CHEMBL2317037	Inhibition of Axl (unknown origin)	B	COc1ccc(CCNc2ncc(C(=O)NCCCN3CCCC3=O)c(NC3CCCC3)n2)cc1OC		CHEMBL2312290	=	IC50	nM	61.0	CHEMBL4895	Homo sapiens	IC50	uM	0.061
	12693254	CHEMBL2343939	Inhibition of AXL (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	nM	10000.0
	12725820	CHEMBL2353695	Binding affinity to AXL (unknown origin) after 1 hr	B	O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O		CHEMBL2348264	=	Kd	nM	170.0	CHEMBL4895	Homo sapiens	Kd	nM	170.0
	12725821	CHEMBL2353695	Binding affinity to AXL (unknown origin) after 1 hr	B	O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL2346680	=	Kd	nM	39.0	CHEMBL4895	Homo sapiens	Kd	nM	39.0
	12725822	CHEMBL2353695	Binding affinity to AXL (unknown origin) after 1 hr	B	O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(F)c2)c1=O		CHEMBL2348263	=	Kd	nM	210.0	CHEMBL4895	Homo sapiens	Kd	nM	210.0
	12727282	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Activity	%	99.0	CHEMBL4895	Homo sapiens	Activity	%	99.0
	12727283	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Activity	%	100.0	CHEMBL4895	Homo sapiens	Activity	%	100.0
	12727284	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1		CHEMBL2347986	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727285	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1)c1ccccc1F		CHEMBL2347985	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727286	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1		CHEMBL2347984	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727287	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5ccc(F)cc5)ncnc4[nH]3)c2)ccc1Br		CHEMBL2347983	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727288	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(F)c4)ncnc3[nH]2)c1		CHEMBL2347982	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727289	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(F)c4)ncnc3[nH]2)c1		CHEMBL2347981	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727290	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5cccc(F)c5)ncnc4[nH]3)c2)ccc1Br		CHEMBL2347980	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727291	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1		CHEMBL2347979	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727292	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1)c1ccccc1F		CHEMBL2347978	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727293	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1		CHEMBL2347977	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727294	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5cccc(C(F)(F)F)c5)ncnc4[nH]3)c2)ccc1Br		CHEMBL2347976	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727295	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1		CHEMBL2347975	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727296	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1)c1ccccc1F		CHEMBL2348261	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727297	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1		CHEMBL2348260	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727298	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O		CHEMBL2348259	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727299	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O		CHEMBL2348258	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727300	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL2348257	=	Activity	%	13.0	CHEMBL4895	Homo sapiens	Activity	%	13.0
	12727301	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2cccc(F)c2)c1=O		CHEMBL2348256	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727302	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	COc1ncccc1C(=O)Nc1cccc(-c2ncnc3[nH]cnc23)c1		CHEMBL2348255	=	Activity	%	60.0	CHEMBL4895	Homo sapiens	Activity	%	60.0
	12727303	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccnc1F		CHEMBL2348254	=	Activity	%	69.0	CHEMBL4895	Homo sapiens	Activity	%	69.0
	12727304	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1ccccc1F		CHEMBL2348253	=	Activity	%	64.0	CHEMBL4895	Homo sapiens	Activity	%	64.0
	12727305	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	Cc1cc(C(=O)Nc2cccc(-c3ncnc4[nH]cnc34)c2)ccc1Br		CHEMBL2348252	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727306	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	COc1ccccc1C(=O)Nc1cccc(-c2ncnc3[nH]cnc23)c1		CHEMBL2348251	=	Activity	%	81.0	CHEMBL4895	Homo sapiens	Activity	%	81.0
	12727307	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O		CHEMBL2348250	=	Activity	%	61.0	CHEMBL4895	Homo sapiens	Activity	%	61.0
	12727308	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O		CHEMBL2348249	=	Activity	%	88.0	CHEMBL4895	Homo sapiens	Activity	%	88.0
	12727309	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL2348248	=	Activity	%	57.0	CHEMBL4895	Homo sapiens	Activity	%	57.0
	12727310	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(F)c2)c1=O		CHEMBL2348247	=	Activity	%	90.0	CHEMBL4895	Homo sapiens	Activity	%	90.0
	12727311	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	COc1ncccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1		CHEMBL2348246	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727312	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccnc1F		CHEMBL2347573	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727313	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1ccccc1F		CHEMBL2347572	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727314	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	Cc1cc(C(=O)Nc2ccc(Nc3ncnc4[nH]cnc34)c(F)c2)ccc1Br		CHEMBL2347571	=	Activity	%	31.0	CHEMBL4895	Homo sapiens	Activity	%	31.0
	12727315	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	COc1ccccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1		CHEMBL2346674	=	Activity	%	10.0	CHEMBL4895	Homo sapiens	Activity	%	10.0
	12727316	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O		CHEMBL2347570	=	Activity	%	2.0	CHEMBL4895	Homo sapiens	Activity	%	2.0
	12727317	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccn(-c2cccc(F)c2)c1=O		CHEMBL2347569	=	Activity	%	32.0	CHEMBL4895	Homo sapiens	Activity	%	32.0
	12727318	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	COc1ncccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)cc1		CHEMBL2347568	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727319	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccnc1F		CHEMBL2348266	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727320	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1ccccc1F		CHEMBL2348265	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727321	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O		CHEMBL2348264	=	Activity	%	99.0	CHEMBL4895	Homo sapiens	Activity	%	99.0
	12727322	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL2346680	=	Activity	%	99.0	CHEMBL4895	Homo sapiens	Activity	%	99.0
	12727323	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(F)c2)c1=O		CHEMBL2348263	=	Activity	%	99.0	CHEMBL4895	Homo sapiens	Activity	%	99.0
	12727324	CHEMBL2351815	Binding affinity to AXL (unknown origin) at 75 uM after 1 hr relative to control	B	O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1ccccc1F		CHEMBL2348262	=	Activity	%	4.0	CHEMBL4895	Homo sapiens	Activity	%	4.0
	12727325	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Activity	%	82.0	CHEMBL4895	Homo sapiens	Activity	%	82.0
	12727326	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Activity	%	99.9	CHEMBL4895	Homo sapiens	Activity	%	99.9
	12727327	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1		CHEMBL2347986	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727328	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1)c1ccccc1F		CHEMBL2347985	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727329	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccc(F)cc4)ncnc3[nH]2)c1		CHEMBL2347984	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727330	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5ccc(F)cc5)ncnc4[nH]3)c2)ccc1Br		CHEMBL2347983	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727331	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(F)c4)ncnc3[nH]2)c1		CHEMBL2347982	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727332	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(F)c4)ncnc3[nH]2)c1		CHEMBL2347981	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727333	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5cccc(F)c5)ncnc4[nH]3)c2)ccc1Br		CHEMBL2347980	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727334	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1		CHEMBL2347979	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727335	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1)c1ccccc1F		CHEMBL2347978	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727336	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4cccc(C(F)(F)F)c4)ncnc3[nH]2)c1		CHEMBL2347977	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727337	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	Cc1cc(C(=O)Nc2cccc(-c3nc4c(Nc5cccc(C(F)(F)F)c5)ncnc4[nH]3)c2)ccc1Br		CHEMBL2347976	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727338	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	COc1ncccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1		CHEMBL2347975	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727339	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1)c1ccccc1F		CHEMBL2348261	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727340	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	COc1ccccc1C(=O)Nc1cccc(-c2nc3c(Nc4ccccc4)ncnc3[nH]2)c1		CHEMBL2348260	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727341	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O		CHEMBL2348259	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727342	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O		CHEMBL2348258	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727343	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL2348257	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727344	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccn(-c2cccc(F)c2)c1=O		CHEMBL2348256	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727345	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	COc1ncccc1C(=O)Nc1cccc(-c2ncnc3[nH]cnc23)c1		CHEMBL2348255	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727346	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1cccnc1F		CHEMBL2348254	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727347	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1cccc(-c2ncnc3[nH]cnc23)c1)c1ccccc1F		CHEMBL2348253	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727348	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	Cc1cc(C(=O)Nc2cccc(-c3ncnc4[nH]cnc34)c2)ccc1Br		CHEMBL2348252	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727349	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	COc1ccccc1C(=O)Nc1cccc(-c2ncnc3[nH]cnc23)c1		CHEMBL2348251	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727350	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O		CHEMBL2348250	=	Activity	%	34.0	CHEMBL4895	Homo sapiens	Activity	%	34.0
	12727351	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O		CHEMBL2348249	=	Activity	%	45.0	CHEMBL4895	Homo sapiens	Activity	%	45.0
	12727352	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL2348248	=	Activity	%	45.0	CHEMBL4895	Homo sapiens	Activity	%	45.0
	12727353	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(F)c2)c1=O		CHEMBL2348247	=	Activity	%	81.0	CHEMBL4895	Homo sapiens	Activity	%	81.0
	12727354	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	COc1ncccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1		CHEMBL2348246	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727355	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1cccnc1F		CHEMBL2347573	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727356	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1)c1ccccc1F		CHEMBL2347572	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727357	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	Cc1cc(C(=O)Nc2ccc(Nc3ncnc4[nH]cnc34)c(F)c2)ccc1Br		CHEMBL2347571	=	Activity	%	10.0	CHEMBL4895	Homo sapiens	Activity	%	10.0
	12727358	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	COc1ccccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)c(F)c1		CHEMBL2346674	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727359	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccn(-c2cccc(C(F)(F)F)c2)c1=O		CHEMBL2347570	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727360	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccn(-c2cccc(F)c2)c1=O		CHEMBL2347569	=	Activity	%	4.0	CHEMBL4895	Homo sapiens	Activity	%	4.0
	12727361	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	COc1ncccc1C(=O)Nc1ccc(Nc2ncnc3[nH]cnc23)cc1		CHEMBL2347568	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727362	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1cccnc1F		CHEMBL2348266	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12727363	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1ccc(Nc2ncnc3[nH]cnc23)cc1)c1ccccc1F		CHEMBL2348265	=	Activity	%	9.0	CHEMBL4895	Homo sapiens	Activity	%	9.0
	12727364	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(C(F)(F)F)cc2)c1=O		CHEMBL2348264	=	Activity	%	88.0	CHEMBL4895	Homo sapiens	Activity	%	88.0
	12727365	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL2346680	=	Activity	%	99.0	CHEMBL4895	Homo sapiens	Activity	%	99.0
	12727366	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2cccc(F)c2)c1=O		CHEMBL2348263	=	Activity	%	93.0	CHEMBL4895	Homo sapiens	Activity	%	93.0
	12727367	CHEMBL2351816	Binding affinity to AXL (unknown origin) at 1 uM after 1 hr relative to control	B	O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1ccccc1F		CHEMBL2348262	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	12728570	CHEMBL2352090	Inhibition of AXL (unknown origin) phosphorylation expressed in mouse NIH/3T3 cells after 2 hrs by immunoprecipitation assay	B	CC(C)[S+]([O-])c1ccccc1Nc1nc(Nc2ccc(CN3CCN(C)CC3)cc2)ncc1Cl		CHEMBL2347987	=	IC50	nM	27.0	CHEMBL4895	Homo sapiens	IC50	nM	27.0
	12728575	CHEMBL2352093	Inhibition of AXL (unknown origin)	B	CCCCNc1ncc2c(-c3ccc(F)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1		CHEMBL2036808	=	IC50	nM	37.0	CHEMBL4895	Homo sapiens	IC50	nM	37.0
Not Determined	12728576	CHEMBL2352093	Inhibition of AXL (unknown origin)	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228		IC50			CHEMBL4895	Homo sapiens	IC50		
	12728579	CHEMBL2352097	Binding affinity to AXL (unknown origin)	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	250.0	CHEMBL4895	Homo sapiens	Kd	nM	250.0
	12728893	CHEMBL2349975	Inhibition of AXL (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	87.0	CHEMBL4895	Homo sapiens	Activity	%	87.0
	12730035	CHEMBL2353910	Inhibition of AXL (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	101.0	CHEMBL4895	Homo sapiens	Activity	%	101.0
	12730929	CHEMBL2350102	Inhibition of AXL (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	89.0	CHEMBL4895	Homo sapiens	Activity	%	89.0
	12731172	CHEMBL2349975	Inhibition of AXL (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	102.0	CHEMBL4895	Homo sapiens	Activity	%	102.0
Active	13294874	CHEMBL2379175	Inhibition of AXL phosphorylation in growth factor-stimulated HUVEC at 3 uM after 24 hrs	B	O=C(O)C(O)C(O)C(=O)O.O=c1[nH]c(CN2CCCCC2)nc2cc(-c3cn(Cc4ccccc4)c4ccccc34)sc12		CHEMBL2377454		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	13336004	CHEMBL2394052	Inhibition of AXL (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs	B	Cc1ccc(-n2cnc3cc(Nc4nnc(C)c5ccccc45)ccc32)cc1		CHEMBL2390986		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	13336005	CHEMBL2394052	Inhibition of AXL (unknown origin) transfected in mouse Ba/F3 cells at 5 uM after 24 hrs	B	Fc1ccc(-c2n[nH]cc2-c2ccncc2)cc1Cl		CHEMBL2390985		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	13336074	CHEMBL2394076	Inhibition of AXL (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	Cc1cccc(C(=O)Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL2390984		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	13336075	CHEMBL2394076	Inhibition of AXL (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	Cc1ccc(-c2cc(NC(=O)c3ccc(F)cc3)[nH]n2)cc1		CHEMBL2390983		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	13336076	CHEMBL2394076	Inhibition of AXL (unknown origin) transfected in mouse Ba/F3 cells at 1 uM after 24 hrs	B	COc1ccc(C(=O)Nc2cc(-c3ccccc3)[nH]n2)cc1		CHEMBL167454		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	13371348	CHEMBL2403995	Inhibition of AXL (unknown origin) at 10 uM by Z'-LYTE kinase assay	B	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1		CHEMBL1483261	=	Inhibition	%	2.58	CHEMBL4895	Homo sapiens	INH	%	2.58
	13375941	CHEMBL2405953	Inhibition of AXL (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	1.0	CHEMBL4895	Homo sapiens	INH	%	1.0
	13439894	CHEMBL2428323	Competitive binding affinity to AXL (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	13445402	CHEMBL2428323	Competitive binding affinity to AXL (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	100.0	CHEMBL4895	Homo sapiens	INH	%	100.0
	13448459	CHEMBL2428323	Competitive binding affinity to AXL (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	93.0	CHEMBL4895	Homo sapiens	INH	%	93.0
	13451714	CHEMBL2428323	Competitive binding affinity to AXL (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	13476403	CHEMBL2439126	Inhibition of human wild type AXL at 1 uM by qPCR analysis relative to control	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978	>	Inhibition	%	90.0	CHEMBL4895	Homo sapiens	INH	%	90.0
	13499591	CHEMBL2447156	Inhibition of AXL (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Sc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2442124	=	IC50	nM	446.5	CHEMBL4895	Homo sapiens	IC50	nM	446.5
	13836299	CHEMBL3090907	Inhibition of AXL (unknown origin) after 90 mins by TR-FRET/IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(Cl)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3086065	>	IC50	nM	50000.0	CHEMBL4895	Homo sapiens	IC50	uM	50.0
	13840850	CHEMBL3096632	Inhibition of Axl (unknown origin) at 75 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2)ncn1		CHEMBL3091590	=	Inhibition	%	100.0	CHEMBL4895	Homo sapiens	INH	%	100.0
	13840851	CHEMBL3096633	Inhibition of Axl (unknown origin) at 1 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2)ncn1		CHEMBL3091590	=	Inhibition	%	95.0	CHEMBL4895	Homo sapiens	INH	%	95.0
	13840852	CHEMBL3096634	Inhibition of Axl (unknown origin) at 0.5 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2)ncn1		CHEMBL3091590	=	Inhibition	%	85.0	CHEMBL4895	Homo sapiens	INH	%	85.0
	13840877	CHEMBL3096632	Inhibition of Axl (unknown origin) at 75 uM relative to control	B	Nc1nccc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)n1		CHEMBL3091589	=	Inhibition	%	100.0	CHEMBL4895	Homo sapiens	INH	%	100.0
	13840878	CHEMBL3096633	Inhibition of Axl (unknown origin) at 1 uM relative to control	B	Nc1nccc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)n1		CHEMBL3091589	=	Inhibition	%	100.0	CHEMBL4895	Homo sapiens	INH	%	100.0
	13840879	CHEMBL3096634	Inhibition of Axl (unknown origin) at 0.5 uM relative to control	B	Nc1nccc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)n1		CHEMBL3091589	=	Inhibition	%	96.0	CHEMBL4895	Homo sapiens	INH	%	96.0
	13840904	CHEMBL3096632	Inhibition of Axl (unknown origin) at 75 uM relative to control	B	O=C(Nc1ccc(Oc2cc(NCCN3CCOCC3)ncn2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL3091588	=	Inhibition	%	100.0	CHEMBL4895	Homo sapiens	INH	%	100.0
	13840905	CHEMBL3096633	Inhibition of Axl (unknown origin) at 1 uM relative to control	B	O=C(Nc1ccc(Oc2cc(NCCN3CCOCC3)ncn2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL3091588	=	Inhibition	%	99.0	CHEMBL4895	Homo sapiens	INH	%	99.0
	13840906	CHEMBL3096634	Inhibition of Axl (unknown origin) at 0.5 uM relative to control	B	O=C(Nc1ccc(Oc2cc(NCCN3CCOCC3)ncn2)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL3091588	=	Inhibition	%	95.0	CHEMBL4895	Homo sapiens	INH	%	95.0
	13840931	CHEMBL3096632	Inhibition of Axl (unknown origin) at 75 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)ncn1		CHEMBL3091587	=	Inhibition	%	100.0	CHEMBL4895	Homo sapiens	INH	%	100.0
	13840932	CHEMBL3096633	Inhibition of Axl (unknown origin) at 1 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)ncn1		CHEMBL3091587	=	Inhibition	%	100.0	CHEMBL4895	Homo sapiens	INH	%	100.0
	13840933	CHEMBL3096634	Inhibition of Axl (unknown origin) at 0.5 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4)c3=O)cc2F)ncn1		CHEMBL3091587	=	Inhibition	%	97.0	CHEMBL4895	Homo sapiens	INH	%	97.0
	13840958	CHEMBL3096632	Inhibition of Axl (unknown origin) at 75 uM relative to control	B	Cc1cc(F)ccc1-n1cccc(C(=O)Nc2ccc(Oc3cc(N)ncn3)c(F)c2)c1=O		CHEMBL3091603	=	Inhibition	%	100.0	CHEMBL4895	Homo sapiens	INH	%	100.0
	13840959	CHEMBL3096633	Inhibition of Axl (unknown origin) at 1 uM relative to control	B	Cc1cc(F)ccc1-n1cccc(C(=O)Nc2ccc(Oc3cc(N)ncn3)c(F)c2)c1=O		CHEMBL3091603	=	Inhibition	%	98.0	CHEMBL4895	Homo sapiens	INH	%	98.0
	13840960	CHEMBL3096634	Inhibition of Axl (unknown origin) at 0.5 uM relative to control	B	Cc1cc(F)ccc1-n1cccc(C(=O)Nc2ccc(Oc3cc(N)ncn3)c(F)c2)c1=O		CHEMBL3091603	=	Inhibition	%	93.0	CHEMBL4895	Homo sapiens	INH	%	93.0
	13840985	CHEMBL3096632	Inhibition of Axl (unknown origin) at 75 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4F)c3=O)cc2F)ncn1		CHEMBL3091602	=	Inhibition	%	100.0	CHEMBL4895	Homo sapiens	INH	%	100.0
	13840986	CHEMBL3096633	Inhibition of Axl (unknown origin) at 1 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4F)c3=O)cc2F)ncn1		CHEMBL3091602	=	Inhibition	%	93.0	CHEMBL4895	Homo sapiens	INH	%	93.0
	13840987	CHEMBL3096634	Inhibition of Axl (unknown origin) at 0.5 uM relative to control	B	Nc1cc(Oc2ccc(NC(=O)c3cccn(-c4ccc(F)cc4F)c3=O)cc2F)ncn1		CHEMBL3091602	=	Inhibition	%	74.0	CHEMBL4895	Homo sapiens	INH	%	74.0
	13841012	CHEMBL3096632	Inhibition of Axl (unknown origin) at 75 uM relative to control	B	O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL2346680	=	Inhibition	%	98.0	CHEMBL4895	Homo sapiens	INH	%	98.0
	13841013	CHEMBL3096633	Inhibition of Axl (unknown origin) at 1 uM relative to control	B	O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL2346680	=	Inhibition	%	100.0	CHEMBL4895	Homo sapiens	INH	%	100.0
	13841014	CHEMBL3096634	Inhibition of Axl (unknown origin) at 0.5 uM relative to control	B	O=C(Nc1ccc(Oc2ncnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL2346680	=	Inhibition	%	98.0	CHEMBL4895	Homo sapiens	INH	%	98.0
	13841910	CHEMBL3096632	Inhibition of Axl (unknown origin) at 75 uM relative to control	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Inhibition	%	99.0	CHEMBL4895	Homo sapiens	INH	%	99.0
	13841911	CHEMBL3096633	Inhibition of Axl (unknown origin) at 1 uM relative to control	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Inhibition	%	99.0	CHEMBL4895	Homo sapiens	INH	%	99.0
	13841912	CHEMBL3096634	Inhibition of Axl (unknown origin) at 0.5 uM relative to control	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Inhibition	%	99.0	CHEMBL4895	Homo sapiens	INH	%	99.0
	13847950	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(N2CCOCC2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3093624	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	uM	30.0
	13847951	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CN(C)c1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093634	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	uM	30.0
	13847952	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NCc2ccc(F)cc2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3093633	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	uM	30.0
	13847953	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NC2CCOCC2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3093632	=	IC50	nM	7400.0	CHEMBL4895	Homo sapiens	IC50	uM	7.4
	13847954	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NC2CCCCC2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3093631	=	IC50	nM	9000.0	CHEMBL4895	Homo sapiens	IC50	uM	9.0
	13847955	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CC(C)Nc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093630	=	IC50	nM	1900.0	CHEMBL4895	Homo sapiens	IC50	uM	1.9
	13847956	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NCCCO)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3093629	=	IC50	nM	4300.0	CHEMBL4895	Homo sapiens	IC50	uM	4.3
	13847957	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NCCCC(F)(F)F)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3093628	=	IC50	nM	5700.0	CHEMBL4895	Homo sapiens	IC50	uM	5.7
	13847958	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cnc(NCCC2CC2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3093627	=	IC50	nM	300.0	CHEMBL4895	Homo sapiens	IC50	uM	0.3
	13847959	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093626	=	IC50	nM	1100.0	CHEMBL4895	Homo sapiens	IC50	uM	1.1
	13847960	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093625	=	IC50	nM	610.0	CHEMBL4895	Homo sapiens	IC50	uM	0.61
	13847961	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093647	=	IC50	nM	780.0	CHEMBL4895	Homo sapiens	IC50	uM	0.78
	13847962	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093646	=	IC50	nM	1200.0	CHEMBL4895	Homo sapiens	IC50	uM	1.2
	13847963	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	Nc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093645	=	IC50	nM	16600.0	CHEMBL4895	Homo sapiens	IC50	uM	16.6
	13847964	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N2CCOCC2)n1		CHEMBL3093644	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	uM	30.0
	13847965	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NC2CCOCC2)n1		CHEMBL3093643	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	uM	30.0
	13847966	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NCc2ccncc2)n1		CHEMBL3093642	=	IC50	nM	21000.0	CHEMBL4895	Homo sapiens	IC50	uM	21.0
	13847967	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CCNC2)n1		CHEMBL3093641	=	IC50	nM	12600.0	CHEMBL4895	Homo sapiens	IC50	uM	12.6
	13847968	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@@H]2CCNC2)n1		CHEMBL3093640	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	uM	30.0
	13847969	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NC2CCNCC2)n1		CHEMBL3093639	=	IC50	nM	10700.0	CHEMBL4895	Homo sapiens	IC50	uM	10.7
	13847970	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NC[C@@H]2CCCNC2)n1		CHEMBL3093638	=	IC50	nM	14000.0	CHEMBL4895	Homo sapiens	IC50	uM	14.0
	13847971	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NCC2CCNCC2)n1		CHEMBL3093637	=	IC50	nM	4700.0	CHEMBL4895	Homo sapiens	IC50	uM	4.7
	13847972	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(NC2CCCCC2)n1		CHEMBL3093636	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	uM	30.0
	13847973	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](N)CC2)n1		CHEMBL3093635	=	IC50	nM	400.0	CHEMBL4895	Homo sapiens	IC50	uM	0.4
	13847974	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)NCc2ccc(-n3ccnc3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093756	=	IC50	nM	360.0	CHEMBL4895	Homo sapiens	IC50	uM	0.36
	13847975	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093755	=	IC50	nM	260.0	CHEMBL4895	Homo sapiens	IC50	uM	0.26
	13847976	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)NCc2ccc(F)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093754	=	IC50	nM	790.0	CHEMBL4895	Homo sapiens	IC50	uM	0.79
	13847977	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093753	=	IC50	nM	530.0	CHEMBL4895	Homo sapiens	IC50	uM	0.53
	13847978	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccc(CN3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093752	=	IC50	nM	370.0	CHEMBL4895	Homo sapiens	IC50	uM	0.37
	13847979	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccc(N3CCOCC3)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093751	=	IC50	nM	570.0	CHEMBL4895	Homo sapiens	IC50	uM	0.57
	13847980	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccccc2OC)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093750	=	IC50	nM	3800.0	CHEMBL4895	Homo sapiens	IC50	uM	3.8
	13847981	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2cccc(OC)c2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093749	=	IC50	nM	1700.0	CHEMBL4895	Homo sapiens	IC50	uM	1.7
	13847982	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccc(OC)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093748	=	IC50	nM	880.0	CHEMBL4895	Homo sapiens	IC50	uM	0.88
	13847983	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccc(C(F)(F)F)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093747	=	IC50	nM	16600.0	CHEMBL4895	Homo sapiens	IC50	uM	16.6
	13847984	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)NC2CCCCC2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093746	=	IC50	nM	370.0	CHEMBL4895	Homo sapiens	IC50	uM	0.37
	13847985	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)NC2CCOCC2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093649	=	IC50	nM	580.0	CHEMBL4895	Homo sapiens	IC50	uM	0.58
	13847986	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)NC2CCN(c3ncccn3)CC2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093648	=	IC50	nM	560.0	CHEMBL4895	Homo sapiens	IC50	uM	0.56
	13847987	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)NC2CCN(C(C)C)CC2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093763	=	IC50	nM	430.0	CHEMBL4895	Homo sapiens	IC50	uM	0.43
	13847988	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)N2CCC(N)CC2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093762	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	uM	30.0
	13847989	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)NC2CCNCC2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093761	=	IC50	nM	480.0	CHEMBL4895	Homo sapiens	IC50	uM	0.48
	13847990	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)N(C)CCCC)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093760	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	uM	30.0
	13847991	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNC(=O)c1cnc(NCCCC)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3093759	=	IC50	nM	3000.0	CHEMBL4895	Homo sapiens	IC50	uM	3.0
	13847992	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(NC(=O)c2ccc(F)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093758	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	uM	30.0
	13847993	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccc(F)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3093757	=	IC50	nM	1700.0	CHEMBL4895	Homo sapiens	IC50	uM	1.7
	13847994	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(NC(=O)c2ccc(F)cc2)c(NC[C@H]2CC[C@H](N)CC2)n1		CHEMBL3093765	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	uM	30.0
	13847995	CHEMBL3094775	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(C(=O)Nc2ccc(F)cc2)c(NC[C@H]2CC[C@H](N)CC2)n1		CHEMBL3093764	=	IC50	nM	2000.0	CHEMBL4895	Homo sapiens	IC50	uM	2.0
	13848538	CHEMBL3095076	Inhibition of full-length AXL (unknown origin) phosphorylation expressed in MEF after 90 mins by Sandwich-ELISA	B	C[C@@H](Oc1cc(-c2ccc3c(c2)NC(=O)C32CCN(C)CC2)cnc1N)c1c(Cl)ccc(F)c1Cl	Outside typical range	CHEMBL3091723	=	IC50	nM	300000.0	CHEMBL4895	Homo sapiens	IC50	uM	300.0
	13848541	CHEMBL3095079	Inhibition of human AXL (unknown origin) using EAIYAAPFAKKK peptide as substrate by nanoliter kinase assay	B	C[C@@H](Oc1cc(-c2ccc3c(c2)NC(=O)C32CCN(C)CC2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL3091723	=	IC50	nM	28.9	CHEMBL4895	Homo sapiens	IC50	nM	28.9
	13848544	CHEMBL3095082	Binding affinity to human AXL at 100 nM by scanEDGE assay	B	C[C@@H](Oc1cc(-c2ccc3c(c2)NC(=O)C32CCN(C)CC2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL3091723	<	Activity	%	10.0	CHEMBL4895	Homo sapiens	Activity	%	10.0
	13848555	CHEMBL3095079	Inhibition of human AXL (unknown origin) using EAIYAAPFAKKK peptide as substrate by nanoliter kinase assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O		CHEMBL14249	=	Km	nM	100000.0	CHEMBL4895	Homo sapiens	Km	uM	100.0
	13855588	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccccn2)c(NC[C@H]2CC[C@H](N)CC2)n1		CHEMBL3092787	=	IC50	nM	680.0	CHEMBL4895	Homo sapiens	IC50	nM	680.0
	13856565	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	OCCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092784	=	IC50	nM	3460.0	CHEMBL4895	Homo sapiens	IC50	nM	3460.0
	13856566	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	OCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092783	=	IC50	nM	15000.0	CHEMBL4895	Homo sapiens	IC50	nM	15000.0
	13856567	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	OCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092782	=	IC50	nM	18500.0	CHEMBL4895	Homo sapiens	IC50	nM	18500.0
	13856568	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	O[C@H]1CC[C@H](Nc2nc(NCCc3ccccc3)ncc2-c2ccccn2)CC1		CHEMBL3092781	=	IC50	nM	430.0	CHEMBL4895	Homo sapiens	IC50	nM	430.0
	13856569	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	O[C@H]1CC[C@H](Nc2nc(NCc3ccccc3)ncc2-c2ccccn2)CC1		CHEMBL3092780	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	nM	30000.0
	13856570	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	O[C@H]1CC[C@H](Nc2nc(NC3CCCCC3)ncc2-c2ccccn2)CC1		CHEMBL3092779	=	IC50	nM	20300.0	CHEMBL4895	Homo sapiens	IC50	nM	20300.0
	13856571	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	O[C@H]1CC[C@H](Nc2nc(N3CCCCC3)ncc2-c2ccccn2)CC1		CHEMBL3092778	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	nM	30000.0
	13856572	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCN(C)c1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092777	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	nM	30000.0
	13856573	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCC(C)Nc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092776	=	IC50	nM	8040.0	CHEMBL4895	Homo sapiens	IC50	nM	8040.0
	13856574	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092775	=	IC50	nM	650.0	CHEMBL4895	Homo sapiens	IC50	nM	650.0
	13856575	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092774	=	IC50	nM	6180.0	CHEMBL4895	Homo sapiens	IC50	nM	6180.0
	13856576	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092773	=	IC50	nM	3530.0	CHEMBL4895	Homo sapiens	IC50	nM	3530.0
	13856577	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092772	=	IC50	nM	3920.0	CHEMBL4895	Homo sapiens	IC50	nM	3920.0
	13856578	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CSc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092771	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	nM	30000.0
	13856579	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccccn2)c(N2CCNCC2)n1		CHEMBL3092770	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	nM	30000.0
	13856580	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccccn2)c(NCCCCO)n1		CHEMBL3092769	=	IC50	nM	20800.0	CHEMBL4895	Homo sapiens	IC50	nM	20800.0
	13856581	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccccn2)c(NCCCO)n1		CHEMBL3092768	=	IC50	nM	9890.0	CHEMBL4895	Homo sapiens	IC50	nM	9890.0
	13856582	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccccn2)c(N[C@H]2C[C@H](O)C2)n1		CHEMBL3092767	=	IC50	nM	2790.0	CHEMBL4895	Homo sapiens	IC50	nM	2790.0
	13856583	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccccn2)c(N[C@@H]2CC[C@@H](O)C2)n1		CHEMBL3092766	=	IC50	nM	3700.0	CHEMBL4895	Homo sapiens	IC50	nM	3700.0
	13856584	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccccn2)c(NCC2CCNCC2)n1		CHEMBL3092765	=	IC50	nM	1280.0	CHEMBL4895	Homo sapiens	IC50	nM	1280.0
	13856585	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccccn2)c(NC2CCNCC2)n1		CHEMBL3092809	=	IC50	nM	1580.0	CHEMBL4895	Homo sapiens	IC50	nM	1580.0
	13856586	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccccn2)c(Nc2ccc(N)cc2)n1		CHEMBL3092801	=	IC50	nM	830.0	CHEMBL4895	Homo sapiens	IC50	nM	830.0
	13856587	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](CN)CC2)n1		CHEMBL3092800	=	IC50	nM	180.0	CHEMBL4895	Homo sapiens	IC50	nM	180.0
	13856588	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](N)CC2)n1		CHEMBL3092799	=	IC50	nM	550.0	CHEMBL4895	Homo sapiens	IC50	nM	550.0
	13856589	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccccn2)c(NC2CCCCC2)n1		CHEMBL3092798	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	nM	30000.0
	13856590	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccc(CNCCO)cn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092797	=	IC50	nM	70.0	CHEMBL4895	Homo sapiens	IC50	nM	70.0
	13856591	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccc(CNC3CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092796	=	IC50	nM	84.0	CHEMBL4895	Homo sapiens	IC50	nM	84.0
	13856592	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccc(CNC3CCCCC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092795	=	IC50	nM	38.0	CHEMBL4895	Homo sapiens	IC50	nM	38.0
	13856593	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccc(NC(=O)C3CCN(C)CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092794	=	IC50	nM	170.0	CHEMBL4895	Homo sapiens	IC50	nM	170.0
	13856594	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccc(C(=O)NC3CCN(C)CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092793	=	IC50	nM	61.0	CHEMBL4895	Homo sapiens	IC50	nM	61.0
	13856595	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccc(S(=O)(=O)N3CCOCC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092792	=	IC50	nM	72.0	CHEMBL4895	Homo sapiens	IC50	nM	72.0
	13856596	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccc(CN(C)C)cn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092791	=	IC50	nM	63.0	CHEMBL4895	Homo sapiens	IC50	nM	63.0
	13856597	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccc(CN3CCC(F)(F)CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092790	=	IC50	nM	130.0	CHEMBL4895	Homo sapiens	IC50	nM	130.0
	13856598	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2cc(CN3CCOCC3)ccn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092788	=	IC50	nM	930.0	CHEMBL4895	Homo sapiens	IC50	nM	930.0
	13856599	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ncccc2CN2CCOCC2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092808	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	nM	30000.0
	13856600	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccc(CN3CCOCC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092807	=	IC50	nM	270.0	CHEMBL4895	Homo sapiens	IC50	nM	270.0
	13856601	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccc(CN3CCN(C)CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092806	=	IC50	nM	260.0	CHEMBL4895	Homo sapiens	IC50	nM	260.0
	13856602	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccc(N3CCN(C)CC3)cn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092805	=	IC50	nM	180.0	CHEMBL4895	Homo sapiens	IC50	nM	180.0
	13856603	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccc(F)cn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092804	=	IC50	nM	460.0	CHEMBL4895	Homo sapiens	IC50	nM	460.0
	13856604	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1nccc(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092803	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	nM	30000.0
	13856605	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccc(F)cc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092802	=	IC50	nM	29000.0	CHEMBL4895	Homo sapiens	IC50	nM	29000.0
	13856606	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2cccnc2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092786	=	IC50	nM	16200.0	CHEMBL4895	Homo sapiens	IC50	nM	16200.0
	13856607	CHEMBL3097237	Inhibition of Axl kinase (unknown origin) using 5-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay	B	CCCCNc1ncc(-c2ccccn2)c(N[C@H]2CC[C@H](O)CC2)n1		CHEMBL3092785	=	IC50	nM	1130.0	CHEMBL4895	Homo sapiens	IC50	nM	1130.0
	13872204	CHEMBL3102391	Inhibition of human Axl assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	92.0	CHEMBL4895	Homo sapiens	Activity	%	92.0
	13878421	CHEMBL3108327	Inhibition of AXL (unknown origin)	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	IC50	nM	960.0	CHEMBL4895	Homo sapiens	IC50	uM	0.96
	13878422	CHEMBL3108327	Inhibition of AXL (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	40.0	CHEMBL4895	Homo sapiens	IC50	uM	0.04
	13878423	CHEMBL3108327	Inhibition of AXL (unknown origin)	B	Cc1c(O)c(O)c(O)c(C=O)c1-c1cc2c(C=O)c(C)c(O)c(O)c2o1		CHEMBL3104855	=	IC50	nM	220.0	CHEMBL4895	Homo sapiens	IC50	uM	0.22
	13878424	CHEMBL3108327	Inhibition of AXL (unknown origin)	B	Cc1c(O)c(O)c(O)c2c1COC2=O		CHEMBL3104854	=	IC50	nM	2460.0	CHEMBL4895	Homo sapiens	IC50	uM	2.46
	13878425	CHEMBL3108327	Inhibition of AXL (unknown origin)	B	COCc1c(C)c(O)c(O)c(O)c1C=O		CHEMBL3104853	=	IC50	nM	11000.0	CHEMBL4895	Homo sapiens	IC50	uM	11.0
	13878426	CHEMBL3108327	Inhibition of AXL (unknown origin)	B	COC1OC(=O)c2c(O)c(O)c(O)c(C)c21		CHEMBL3104852	=	IC50	nM	6390.0	CHEMBL4895	Homo sapiens	IC50	uM	6.39
	13878427	CHEMBL3108327	Inhibition of AXL (unknown origin)	B	Cc1c(O)c(O)c2c(c1C=O)[C@@H]1O[C@H](O2)c2c(C)c(O)c(O)c(O)c2C1=O		CHEMBL3104851	=	IC50	nM	160.0	CHEMBL4895	Homo sapiens	IC50	uM	0.16
	13897466	CHEMBL3111645	Inhibition of recombinant AXL (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	COC(=O)c1cc(O)c(O)c(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)c1		CHEMBL3109404	=	IC50	nM	13100.0	CHEMBL4895	Homo sapiens	IC50	uM	13.1
	13897467	CHEMBL3111645	Inhibition of recombinant AXL (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	COc1cc2nc(C)oc2c(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)c1O		CHEMBL3109402	=	IC50	nM	14700.0	CHEMBL4895	Homo sapiens	IC50	uM	14.7
	13897468	CHEMBL3111645	Inhibition of recombinant AXL (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)CC1=C(O)C(=O)C=C(NCCC(C)C)C1=O		CHEMBL3109401	>	IC50	nM	100000.0	CHEMBL4895	Homo sapiens	IC50	uM	100.0
	13953272	CHEMBL3132652	Inhibition of human AXL assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	98.0	CHEMBL4895	Homo sapiens	Activity	%	98.0
	13954634	CHEMBL3132652	Inhibition of human AXL assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	103.0	CHEMBL4895	Homo sapiens	Activity	%	103.0
	13954683	CHEMBL3132652	Inhibition of human AXL assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	98.0	CHEMBL4895	Homo sapiens	Activity	%	98.0
	14582440	CHEMBL3240223	Inhibition of human Axl assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	93.0	CHEMBL4895	Homo sapiens	Activity	%	93.0
	14653545	CHEMBL3267432	Inhibition of recombinant AXL (unknown origin) at 1 uM	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cccc(-c5ccsc5)c4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL3263964	>	Inhibition	%	70.0	CHEMBL4895	Homo sapiens	INH	%	70.0
	14659339	CHEMBL3267558	Inhibition of AXL (unknown origin) at 1 uM	B	CCOP(=O)(CC)Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1		CHEMBL3264107	=	Inhibition	%	21.0	CHEMBL4895	Homo sapiens	INH	%	21.0
	14659340	CHEMBL3267558	Inhibition of AXL (unknown origin) at 1 uM	B	CCCP(=O)(Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1)OCC		CHEMBL3264108	=	Inhibition	%	7.0	CHEMBL4895	Homo sapiens	INH	%	7.0
	14713696	CHEMBL3296762	Binding affinity to AXL (unknown origin)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Ki	nM	63.0	CHEMBL4895	Homo sapiens	Ki	uM	0.063
	14713746	CHEMBL3296851	Inhibition of AXL (unknown origin) at 1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Inhibition	%	95.0	CHEMBL4895	Homo sapiens	INH	%	95.0
Not Determined	14713755	CHEMBL3296762	Binding affinity to AXL (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Ki			CHEMBL4895	Homo sapiens	Ki		
	14992054	CHEMBL3374150	Inhibition of AXL (unknown origin) at 1 uM by ELISA method	B	O=C(Nc1ccc(F)cc1)C1(C(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c(F)c2)CC1		CHEMBL3360678	=	Inhibition	%	41.6	CHEMBL4895	Homo sapiens	INH	%	41.6
	14992119	CHEMBL3374165	Inhibition of AXL (unknown origin) at 0.1 uM by ELISA method	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	Inhibition	%	100.0	CHEMBL4895	Homo sapiens	INH	%	100.0
	15005097	CHEMBL3366505	Inhibition of AXL (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN)c2)ncc1Cl		CHEMBL3357439	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	uM	1.0
	15014105	CHEMBL3361860	Inhibition of AXL (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	-0.8	CHEMBL4895	Homo sapiens	INH	%	-0.8
	15056460	CHEMBL3363356	Inhibition of Axl (unknown origin) by Off-chip Mobility Shift Assay	B	CCCCNc1ncc2c(-c3ccc(S(=O)(=O)N4CCOCC4)cc3)nn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL3326002	=	IC50	nM	85.0	CHEMBL4895	Homo sapiens	IC50	nM	85.0
	15056461	CHEMBL3363356	Inhibition of Axl (unknown origin) by Off-chip Mobility Shift Assay	B	CCCCNc1ncc2c(-c3ccc(S(=O)(=O)N4CCN(C)CC4)c(F)c3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL3326004	=	IC50	nM	22.0	CHEMBL4895	Homo sapiens	IC50	nM	22.0
	15056462	CHEMBL3363356	Inhibition of Axl (unknown origin) by Off-chip Mobility Shift Assay	B	CN1CCN(S(=O)(=O)c2ccc(-c3cn([C@H]4CC[C@H](O)CC4)c4nc(NCCC5CC5)ncc34)c(F)c2)CC1		CHEMBL3326005	=	IC50	nM	32.0	CHEMBL4895	Homo sapiens	IC50	nM	32.0
	15056463	CHEMBL3363356	Inhibition of Axl (unknown origin) by Off-chip Mobility Shift Assay	B	CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL3326006	=	IC50	nM	14.0	CHEMBL4895	Homo sapiens	IC50	nM	14.0
	15056464	CHEMBL3363356	Inhibition of Axl (unknown origin) by Off-chip Mobility Shift Assay	B	CN1CCN(Cc2ccc(-c3cn([C@H]4CC[C@H](O)CC4)c4nc(NCCC5CC5)ncc34)cc2)CC1		CHEMBL3326007	=	IC50	nM	15.0	CHEMBL4895	Homo sapiens	IC50	nM	15.0
	15056487	CHEMBL3363375	Inhibition of EGFR extracellular/transmembrane domain-tagged Axl intracellular domain (unknown origin) expressed in 32D cells assessed as inhibition EGF-stimulated of phosphorylation pretreated for 1 hr prior to EGF stimulation by Western blot analysis	B	CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL3326006	=	IC50	nM	122.0	CHEMBL4895	Homo sapiens	IC50	nM	122.0
Active	15073670	CHEMBL3387724	Inhibition of AXL in human PANC1 cells assessed as reduction in VEGF level at 1.5 to 3 uM after 24 hrs by Western blot analysis	B	COc1cc(/C=C/C(=O)N2C(=O)C=CCC2/C=C/c2ccccc2)cc(OC)c1OC		CHEMBL3344329		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Active	15073671	CHEMBL3387723	Inhibition of AXL in human PANC1 cells assessed as reduction in HIF-1alpha expression at 1.5 to 3 uM after 24 hrs by Western blot analysis	B	COc1cc(/C=C/C(=O)N2C(=O)C=CCC2/C=C/c2ccccc2)cc(OC)c1OC		CHEMBL3344329		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Active	15073680	CHEMBL3387159	Effect on AXL in human PANC1 cells assessed as increase in p-ERK at Thr202/Tyr 204 protein level at 30 to 60 uM after 24 hrs by Western blot analysis	B	O=C1C=CC[C@H](/C=C/c2ccccc2)O1		CHEMBL464443		Activity			CHEMBL4895	Homo sapiens	Activity		
Active	15073681	CHEMBL3387158	Inhibition of AXL in human PANC1 cells assessed as inhibition of ERK phosphorylation at Thr202/Tyr 204 at 1.5 to 3 uM after 24 hrs by Western blot analysis	B	COc1cc(/C=C/C(=O)N2C(=O)C=CCC2/C=C/c2ccccc2)cc(OC)c1OC		CHEMBL3344329		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	15223344	CHEMBL3420300	Inhibition of AXL (unknown origin)	B	O=c1ccc(-n2ccc3ccc(F)cc32)nn1CCOc1ccnc2cc(OCCCN3CCOCC3)ccc12		CHEMBL3417489	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	nM	1000.0
	15223968	CHEMBL3419150	Competitive binding affinity to human AXL	B	NC(=O)c1nnc(N[C@@H]2CCCC[C@@H]2N)nc1Nc1cccc2cc[nH]c12		CHEMBL3416026	=	Kd	nM	71.0	CHEMBL4895	Homo sapiens	Kd	nM	71.0
	15249271	CHEMBL3428301	Inhibition of human AXL using EAIYAAPFAKKK peptide substrate at 1 uM by 33P Hotspot assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(NC[C@H]4CCCO4)n3)cc2)CC1		CHEMBL3426891	=	Inhibition	%	75.9	CHEMBL4895	Homo sapiens	INH	%	75.9
	15253810	CHEMBL3429884	Inhibition of human Axl	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21		CHEMBL3426225	=	IC50	nM	578.0	CHEMBL4895	Homo sapiens	IC50	uM	0.578
	15614577	CHEMBL3583345	Inhibition of Axl (unknown origin) using polu (Glu,Tyr)4:1 substrate after 30 mins incubation by multi-well spectrophotometry	B	CNC(=O)c1ccc(-c2cc(F)c3ncc(Cc4ccc5ncccc5c4)n3c2)cc1F		CHEMBL3582294	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	15650186	CHEMBL3595506	Inhibition of human AXL at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1	Outside typical range	CHEMBL3593290	=	Inhibition	%	-16.0	CHEMBL4895	Homo sapiens	INH	%	-16.0
	15736625	CHEMBL3625826	Inhibition of human recombinant Axl	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	15755842	CHEMBL3630634	Inhibition of AXL (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	26.0	CHEMBL4895	Homo sapiens	Activity	%	26.0
	15756103	CHEMBL3632163	Inhibition of AXL (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	82.1	CHEMBL4895	Homo sapiens	INH	%	82.1
	15757698	CHEMBL3632163	Inhibition of AXL (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	86.57	CHEMBL4895	Homo sapiens	INH	%	86.57
	15757996	CHEMBL3632163	Inhibition of AXL (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	7.68	CHEMBL4895	Homo sapiens	INH	%	7.68
	16417070	CHEMBL3751443	Inhibition of AXL (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21		CHEMBL3747699	=	Inhibition	%	8.0	CHEMBL4895	Homo sapiens	INH	%	8.0
	16417071	CHEMBL3751443	Inhibition of AXL (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCC(O)CC4)cc3)nc21		CHEMBL3746959	=	Inhibition	%	9.0	CHEMBL4895	Homo sapiens	INH	%	9.0
	16417072	CHEMBL3751443	Inhibition of AXL (unknown origin) at 10 uM	B	CN1CCN(CCCNc2ncc3cc(Oc4ccc(F)cc4F)c(=O)n(C)c3n2)CC1		CHEMBL3746022	=	Inhibition	%	4.0	CHEMBL4895	Homo sapiens	INH	%	4.0
	16417073	CHEMBL3751443	Inhibition of AXL (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5ccc(F)cc5F)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3745734	=	Inhibition	%	9.0	CHEMBL4895	Homo sapiens	INH	%	9.0
	16417074	CHEMBL3751443	Inhibition of AXL (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2c(Cl)cccc2Cl)cc2cnc(NC3CCOCC3)nc21		CHEMBL3747351	=	Inhibition	%	0.0	CHEMBL4895	Homo sapiens	INH	%	0.0
	16417075	CHEMBL3751443	Inhibition of AXL (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3747023	=	Inhibition	%	0.0	CHEMBL4895	Homo sapiens	INH	%	0.0
	16417076	CHEMBL3751443	Inhibition of AXL (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NCCc3ccccn3)nc21		CHEMBL3746951	=	Inhibition	%	0.0	CHEMBL4895	Homo sapiens	INH	%	0.0
	16417077	CHEMBL3751443	Inhibition of AXL (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCCCC4)cc3)nc21		CHEMBL3746973	=	Inhibition	%	6.0	CHEMBL4895	Homo sapiens	INH	%	6.0
	16417078	CHEMBL3751443	Inhibition of AXL (unknown origin) at 10 uM	B	CN(C)CCNc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL3745857	=	Inhibition	%	0.0	CHEMBL4895	Homo sapiens	INH	%	0.0
	16426141	CHEMBL3750468	Inhibition of Axl (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1	Outside typical range	CHEMBL3746293	=	Inhibition	%	-22.4	CHEMBL4895	Homo sapiens	INH	%	-22.4
	16429045	CHEMBL3750783	Inhibition of AXL (unknown origin) at 1 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(N)(=O)=O)CC3)nc21		CHEMBL3747489	=	Inhibition	%	16.0	CHEMBL4895	Homo sapiens	INH	%	16.0
	16431736	CHEMBL3748628	Inhibition of human AXL using [EAIYAAPFAKKK] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	16450767	CHEMBL3762153	Inhibition of AXL (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-2.2	CHEMBL4895	Homo sapiens	INH	%	-2.2
	16461592	CHEMBL3762052	Inhibition of recombinant human Axl using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	Cn1cc(-c2cnc(Nc3cccc(Cn4nc(-c5cnn(C)c5)ccc4=O)c3)nc2)cn1		CHEMBL3759079	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	nM	1000.0
	16461593	CHEMBL3762052	Inhibition of recombinant human Axl using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	100.0	CHEMBL4895	Homo sapiens	IC50	nM	100.0
	16465577	CHEMBL3766485	Inhibition of human AXL using poly(Glu, Tyr) as substrate	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	7.0	CHEMBL4895	Homo sapiens	IC50	nM	7.0
	16465581	CHEMBL3766489	Inhibition of AXL phosphorylation in human MDA-MB-231 cells incubated for 1 to 3 hrs	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	5000.0	CHEMBL4895	Homo sapiens	IC50	uM	5.0
	16466193	CHEMBL3767452	Inhibition of Axl (unknown origin)	B	Nc1nccc(Oc2ccc(NC(=O)c3c[nH]cc(-c4ccc(F)cc4)c3=O)cc2F)c1Cl		CHEMBL2143592	<	IC50	nM	3.0	CHEMBL4895	Homo sapiens	IC50	nM	3.0
	16485702	CHEMBL3773983	Inhibition of human recombinant AXL assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL4895	Homo sapiens	Activity	%	100.0
	16495339	CHEMBL3776886	Inhibition of N-terminal His6-tagged recombinant human AXL expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	0.0	CHEMBL4895	Homo sapiens	Activity	%	0.0
	16508108	CHEMBL3776886	Inhibition of N-terminal His6-tagged recombinant human AXL expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-6.0	CHEMBL4895	Homo sapiens	Activity	%	-6.0
	16509085	CHEMBL3776886	Inhibition of N-terminal His6-tagged recombinant human AXL expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-12.0	CHEMBL4895	Homo sapiens	Activity	%	-12.0
Not Active	16514101	CHEMBL3782149	Inhibition of partial length human AXL expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	16534410	CHEMBL3789290	Inhibition of human AXL at 1 uM after 30 mins by fluorescence assay in presence of ATP	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(N)C2(C)C		CHEMBL3786892	=	Inhibition	%	97.0	CHEMBL4895	Homo sapiens	INH	%	97.0
	16540726	CHEMBL3789971	Inhibition of AXL (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	16540727	CHEMBL3789971	Inhibition of AXL (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	16540728	CHEMBL3789971	Inhibition of AXL (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	16574780	CHEMBL3802634	Inhibition of recombinant AXL (unknown origin) using poly (Glu, Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1		CHEMBL3797579	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	uM	1.0
	16574821	CHEMBL3801250	Inhibition of recombinant AXL (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 1000 nM incubated for 60 mins by ELISA relative to control	B	Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1		CHEMBL3797579	=	Inhibition	%	36.0	CHEMBL4895	Homo sapiens	INH	%	36.0
	16593475	CHEMBL3812159	Inhibition of full length His-tagged human recombinant AXL expressed in insect expression system using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL4895	Homo sapiens	INH	%	40.0
	16594913	CHEMBL3812226	Inhibition of human AXL (497 to 821 amino acid residues) assessed as enzyme activity at 10 uM by KINOMEScan assay expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	100.0	CHEMBL4895	Homo sapiens	Activity	%	100.0
	16595568	CHEMBL3811327	Inhibition of AXL (unknown origin) by cell based assay	B	Cc1c[nH]c2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc(-c3cccc(CC#N)c3)c12		CHEMBL3809908	<	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	uM	1.0
	16595569	CHEMBL3811327	Inhibition of AXL (unknown origin) by cell based assay	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	340.0	CHEMBL4895	Homo sapiens	IC50	uM	0.34
	16595570	CHEMBL3811327	Inhibition of AXL (unknown origin) by cell based assay	B	Cc1c(C(=O)Nc2ccc(Oc3ccnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)n1C		CHEMBL3810063	<	IC50	nM	500.0	CHEMBL4895	Homo sapiens	IC50	uM	0.5
	16595571	CHEMBL3811326	Inhibition of human recombinant AXL expressed in Escherichia coli BL21 infected with T7 phage by qPCR method	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	9.0	CHEMBL4895	Homo sapiens	IC50	nM	9.0
	16595572	CHEMBL3811326	Inhibition of human recombinant AXL expressed in Escherichia coli BL21 infected with T7 phage by qPCR method	B	Cc1c(C(=O)Nc2ccc(Oc3ccnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)n1C		CHEMBL3810063	=	IC50	nM	10.0	CHEMBL4895	Homo sapiens	IC50	nM	10.0
	16595573	CHEMBL3811325	Inhibition of human full length AXL after 4 hrs followed by stimulation with human recombinant Gas6 for 15 minutes by cell based assay	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	=	IC50	nM	2.0	CHEMBL4895	Homo sapiens	IC50	nM	2.0
	16595574	CHEMBL3811324	Inhibition of human full length AXL by scintillation counting method in presence of 33P-gammaATP	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	=	IC50	nM	11.0	CHEMBL4895	Homo sapiens	IC50	nM	11.0
	16595575	CHEMBL3811323	Inhibition of AXL in human MDA-MB-231 cells assessed as receptor phosphorylation after 1 to 3 hrs	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c2cc1OC		CHEMBL489326	=	IC50	nM	42.0	CHEMBL4895	Homo sapiens	IC50	nM	42.0
	16595576	CHEMBL3811322	Inhibition of human recombinant full length AXL using poly (Glu,Tyr) as substrate by AlphaScreen assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c2cc1OC		CHEMBL489326	=	IC50	nM	7.0	CHEMBL4895	Homo sapiens	IC50	nM	7.0
	16595577	CHEMBL3811321	Inhibition of AXL in lapatinib-sensitive human BT474 cells	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	<	IC50	nM	100.0	CHEMBL4895	Homo sapiens	IC50	nM	100.0
	16595578	CHEMBL3811320	Inhibition of AXL (unknown origin)	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	<	IC50	nM	1.0	CHEMBL4895	Homo sapiens	IC50	nM	1.0
	16595579	CHEMBL3811320	Inhibition of AXL (unknown origin)	B	Cc1c[nH]c2nc(Nc3ccc(N4CCN(C)CC4)c(F)c3)nc(-c3cccc(CC#N)c3)c12		CHEMBL3809908	=	IC50	nM	58.0	CHEMBL4895	Homo sapiens	IC50	nM	58.0
	16595599	CHEMBL3811320	Inhibition of AXL (unknown origin)	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	11.0	CHEMBL4895	Homo sapiens	IC50	nM	11.0
	16595604	CHEMBL3811334	Inhibition of recombinant AXL in human HeLa cells after 1 hr by ELISA	B	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2		CHEMBL3809489	<	IC50	nM	30.0	CHEMBL4895	Homo sapiens	IC50	nM	30.0
	16595605	CHEMBL3811333	Inhibition of human recombinant AXL by fluorescence polarization assay	B	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2		CHEMBL3809489	=	IC50	nM	14.0	CHEMBL4895	Homo sapiens	IC50	nM	14.0
	16595606	CHEMBL3811332	Inhibition of human AXL expressed in MEF cells by ELISA	B	O=C1Nc2ccc(CN3C(=O)CSC3=O)cc2/C1=C/c1cc(CN2CCOCC2)c[nH]1		CHEMBL3808948	=	IC50	nM	56.0	CHEMBL4895	Homo sapiens	IC50	nM	56.0
	16595607	CHEMBL3811331	Inhibition of human AXL by radiometric assay	B	O=C1Nc2ccc(CN3C(=O)CSC3=O)cc2/C1=C/c1cc(CN2CCOCC2)c[nH]1		CHEMBL3808948	=	IC50	nM	7.0	CHEMBL4895	Homo sapiens	IC50	nM	7.0
	16595608	CHEMBL3811330	Inhibition of AXL in human GIST cells	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	<	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	uM	1.0
	16595609	CHEMBL3811329	Inhibition of human AXL by scintillation counting method in presence of [gamma-32P]ATP	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	560.0	CHEMBL4895	Homo sapiens	IC50	uM	0.56
	16595610	CHEMBL3811328	Inhibition of AXL in human Hs578t cells by homogeneous time-resolved fluorescence assay	B	CCOc1cn(-c2ccc(F)cc2C)nc1C(=O)Nc1ccc(Oc2ccnc3cc(OC)c(OC)cc23)c(F)c1		CHEMBL3808844	=	IC50	nM	19.0	CHEMBL4895	Homo sapiens	IC50	nM	19.0
	16613775	CHEMBL3817211	Inhibition of human AXL at 1 uM using [EAIYAAPFAKKK] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	6.0	CHEMBL4895	Homo sapiens	INH	%	6.0
	16618276	CHEMBL3816174	Inhibition of recombinant human His-tagged cytoplasmic AXL (473 nd residues) expressed in insect cells at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	16621479	CHEMBL3820472	Inhibition of AXL (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	=	IC50	nM	8690.0	CHEMBL4895	Homo sapiens	IC50	nM	8690.0
	16622194	CHEMBL3820472	Inhibition of AXL (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.0	CHEMBL4895	Homo sapiens	IC50	nM	3.0
	16655113	CHEMBL3830311	Inhibition of recombinant human AXL using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	=	IC50	nM	170.0	CHEMBL4895	Homo sapiens	IC50	nM	170.0
	16737929	CHEMBL3856647	Inhibition of recombinant human AXL expressed in insect Sf21 cells assessed as remaining activity at 10 uM preincubated for 15 mins followed by poly(Glu:Tyr) substrate addition for 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	44.0	CHEMBL4895	Homo sapiens	Activity	%	44.0
	16742594	CHEMBL3857916	Inhibition of AXL (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	7.0	CHEMBL4895	Homo sapiens	IC50	nM	7.0
	16780210	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCNC(=O)CCC4)cc2)CC1		CHEMBL3947503	=	IC50	nM	1300.0	CHEMBL4895	Homo sapiens	IC50	nM	1300.0
	16780211	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	OC1CCCCCCCNc2ncc3c(C4CCOCC4)cn(c3n2)CCCC1		CHEMBL3923652	=	IC50	nM	640.0	CHEMBL4895	Homo sapiens	IC50	nM	640.0
	16780212	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	OC1CCCCCCCNc2ncc3c(-c4ccncc4)cn(c3n2)CCCC1		CHEMBL3973830	=	IC50	nM	120.0	CHEMBL4895	Homo sapiens	IC50	nM	120.0
	16780213	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	OC1CCCCCCCNc2ncc3c(-c4cccnc4)cn(c3n2)CCCC1		CHEMBL3932605	=	IC50	nM	180.0	CHEMBL4895	Homo sapiens	IC50	nM	180.0
	16780214	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	OC1CCCCCCCNc2ncc3c(-c4ccccn4)cn(c3n2)CCCC1		CHEMBL3898397	=	IC50	nM	390.0	CHEMBL4895	Homo sapiens	IC50	nM	390.0
	16780215	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	OC1CCCCCCCNc2ncc3c(-c4ccc(N5CCOCC5)cc4)cn(c3n2)CCCC1		CHEMBL3969591	=	IC50	nM	180.0	CHEMBL4895	Homo sapiens	IC50	nM	180.0
	16780216	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	O=C(Nc1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1)N1CCOCC1		CHEMBL3925379	=	IC50	nM	180.0	CHEMBL4895	Homo sapiens	IC50	nM	180.0
	16780217	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	O=S(=O)(c1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1)N1CCOCC1		CHEMBL3963528	=	IC50	nM	110.0	CHEMBL4895	Homo sapiens	IC50	nM	110.0
	16780218	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	O=C(c1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1)N1CCOCC1		CHEMBL3916387	=	IC50	nM	65.0	CHEMBL4895	Homo sapiens	IC50	nM	65.0
	16780219	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	OC1CCCCCCCNc2ncc3c(-c4ccc(CN5CCOCC5)cc4)cn(c3n2)CCCC1		CHEMBL3986139	=	IC50	nM	93.0	CHEMBL4895	Homo sapiens	IC50	nM	93.0
	16780220	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	COc1ccccc1-c1cn2c3nc(ncc13)NCCCCCCCC(O)CCCC2		CHEMBL3943243	=	IC50	nM	910.0	CHEMBL4895	Homo sapiens	IC50	nM	910.0
	16780221	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	COc1cccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)c1		CHEMBL3915275	=	IC50	nM	920.0	CHEMBL4895	Homo sapiens	IC50	nM	920.0
	16780222	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	COc1ccc(-c2cn3c4nc(ncc24)NCCCCCCCC(O)CCCC3)cc1		CHEMBL3934278	=	IC50	nM	340.0	CHEMBL4895	Homo sapiens	IC50	nM	340.0
	16780223	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	OC1CCCCCCCNc2ncc3c(-c4ccc(F)cc4)cn(c3n2)CCCC1		CHEMBL3906299	=	IC50	nM	620.0	CHEMBL4895	Homo sapiens	IC50	nM	620.0
	16780224	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	OC1CCCCCCCNc2ncc3c(-c4ccccc4)cn(c3n2)CCCC1		CHEMBL3955697	=	IC50	nM	810.0	CHEMBL4895	Homo sapiens	IC50	nM	810.0
	16780225	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCC(O)CCCCC4)cc2)CC1		CHEMBL3984314	=	IC50	nM	17.0	CHEMBL4895	Homo sapiens	IC50	nM	17.0
	16780226	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCC(O)CCCCC4)cc2)CC1		CHEMBL3946971	=	IC50	nM	18.0	CHEMBL4895	Homo sapiens	IC50	nM	18.0
	16780227	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCC(O)CCCCC4)cc2)CC1		CHEMBL3976261	=	IC50	nM	25.0	CHEMBL4895	Homo sapiens	IC50	nM	25.0
	16780228	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCC(O)CCCCC4)cc2)CC1		CHEMBL3938180	=	IC50	nM	28.0	CHEMBL4895	Homo sapiens	IC50	nM	28.0
	16780229	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCC(O)CCCC4)cc2)CC1		CHEMBL3932614	=	IC50	nM	17.0	CHEMBL4895	Homo sapiens	IC50	nM	17.0
	16780230	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCC(O)CCCC4)cc2)CC1		CHEMBL3967759	=	IC50	nM	9.3	CHEMBL4895	Homo sapiens	IC50	nM	9.3
	16780231	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCC(O)CCCC4)cc2)CC1		CHEMBL3956694	=	IC50	nM	36.0	CHEMBL4895	Homo sapiens	IC50	nM	36.0
	16780232	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCC(O)CCCC4)cc2)CC1		CHEMBL3920231	=	IC50	nM	120.0	CHEMBL4895	Homo sapiens	IC50	nM	120.0
	16780233	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCC(O)CCC4)cc2)CC1		CHEMBL3948030	=	IC50	nM	26.0	CHEMBL4895	Homo sapiens	IC50	nM	26.0
	16780234	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCC(O)CCC4)cc2)CC1		CHEMBL3910520	=	IC50	nM	14.0	CHEMBL4895	Homo sapiens	IC50	nM	14.0
	16780235	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCC(O)CCC4)cc2)CC1		CHEMBL3961597	=	IC50	nM	50.0	CHEMBL4895	Homo sapiens	IC50	nM	50.0
	16780236	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCC(O)CCC4)cc2)CC1		CHEMBL3951096	=	IC50	nM	40.0	CHEMBL4895	Homo sapiens	IC50	nM	40.0
	16780237	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCNC(=O)[C@@H](N)CCCC4)cc2)CC1		CHEMBL3964573	=	IC50	nM	4.2	CHEMBL4895	Homo sapiens	IC50	nM	4.2
	16780238	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCNC(=O)[C@@H](N)CCCC4)cc2)CC1		CHEMBL3892515	=	IC50	nM	11.0	CHEMBL4895	Homo sapiens	IC50	nM	11.0
	16780239	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCNC(=O)[C@@H](N)CCCC4)cc2)CC1		CHEMBL3961508	=	IC50	nM	150.0	CHEMBL4895	Homo sapiens	IC50	nM	150.0
	16780240	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCCCNC(=O)[C@@H](N)CCC4)cc2)CC1		CHEMBL3962587	=	IC50	nM	170.0	CHEMBL4895	Homo sapiens	IC50	nM	170.0
	16780241	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCCCNC(=O)[C@@H](N)CCC4)cc2)CC1		CHEMBL3935102	=	IC50	nM	300.0	CHEMBL4895	Homo sapiens	IC50	nM	300.0
	16780242	CHEMBL3865273	Inhibition of Axl (unknown origin) by microfluidic capillary electrophoresis assay	B	CN1CCN(Cc2ccc(-c3cn4c5nc(ncc35)NCCCCNC(=O)[C@@H](N)CCC4)cc2)CC1		CHEMBL3973561	=	IC50	nM	33.0	CHEMBL4895	Homo sapiens	IC50	nM	33.0
294890	17676246	CHEMBL3705826	Binding Assay: The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of the tracer to the kinase is detected using an EU-labeled anti-tag antibody. Simultaneous binding of both the tracer and antibody to the kinase gives rise to a FRET-signal. Binding of an inhibitor to the kinase competes for binding with the tracer, resulting in a loss of FRET-signal. At first a compound according to formula (I) was diluted in 20 mM Hepes pH 8.0, 1 mM DTT, 10 mM MgCl2 and 0.01% Brij35. Next Axl kinase (5 nM final concentration; Proqinase), kinase tracer (15 nM final concentration; Invitrogen) and LanthaScreen Eu-Anti-GST antibody (2 nM final concentration; Invitrogen) was mixed with suitable compound dilutions and incubated for 1 hour. FRET-signal was quantified employing an EnVision Multilabelreader 2104 (Perkin Elmer).	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnn(-c5ccccc5)c4C(F)(F)F)cc3F)c2cc1OC		CHEMBL1087984	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	nM	10000.0
294891	17676247	CHEMBL3705826	Binding Assay: The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of the tracer to the kinase is detected using an EU-labeled anti-tag antibody. Simultaneous binding of both the tracer and antibody to the kinase gives rise to a FRET-signal. Binding of an inhibitor to the kinase competes for binding with the tracer, resulting in a loss of FRET-signal. At first a compound according to formula (I) was diluted in 20 mM Hepes pH 8.0, 1 mM DTT, 10 mM MgCl2 and 0.01% Brij35. Next Axl kinase (5 nM final concentration; Proqinase), kinase tracer (15 nM final concentration; Invitrogen) and LanthaScreen Eu-Anti-GST antibody (2 nM final concentration; Invitrogen) was mixed with suitable compound dilutions and incubated for 1 hour. FRET-signal was quantified employing an EnVision Multilabelreader 2104 (Perkin Elmer).	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cc(-c5ccccc5)on4)cc3F)c2cc1OC		CHEMBL3667494	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	nM	10000.0
294892	17676248	CHEMBL3705826	Binding Assay: The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of the tracer to the kinase is detected using an EU-labeled anti-tag antibody. Simultaneous binding of both the tracer and antibody to the kinase gives rise to a FRET-signal. Binding of an inhibitor to the kinase competes for binding with the tracer, resulting in a loss of FRET-signal. At first a compound according to formula (I) was diluted in 20 mM Hepes pH 8.0, 1 mM DTT, 10 mM MgCl2 and 0.01% Brij35. Next Axl kinase (5 nM final concentration; Proqinase), kinase tracer (15 nM final concentration; Invitrogen) and LanthaScreen Eu-Anti-GST antibody (2 nM final concentration; Invitrogen) was mixed with suitable compound dilutions and incubated for 1 hour. FRET-signal was quantified employing an EnVision Multilabelreader 2104 (Perkin Elmer).	B	COc1cc2nccc(Oc3ccc(NC(=O)c4ccco4)cc3)c2cc1OC		CHEMBL3667495	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	nM	10000.0
294893	17676249	CHEMBL3705826	Binding Assay: The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of the tracer to the kinase is detected using an EU-labeled anti-tag antibody. Simultaneous binding of both the tracer and antibody to the kinase gives rise to a FRET-signal. Binding of an inhibitor to the kinase competes for binding with the tracer, resulting in a loss of FRET-signal. At first a compound according to formula (I) was diluted in 20 mM Hepes pH 8.0, 1 mM DTT, 10 mM MgCl2 and 0.01% Brij35. Next Axl kinase (5 nM final concentration; Proqinase), kinase tracer (15 nM final concentration; Invitrogen) and LanthaScreen Eu-Anti-GST antibody (2 nM final concentration; Invitrogen) was mixed with suitable compound dilutions and incubated for 1 hour. FRET-signal was quantified employing an EnVision Multilabelreader 2104 (Perkin Elmer).	B	COc1cc2nccc(Oc3ccc(NC(=O)c4ccsc4)cc3)c2cc1OC		CHEMBL3667496	=	IC50	nM	7042.0	CHEMBL4895	Homo sapiens	IC50	nM	7042.0
294894	17676250	CHEMBL3705826	Binding Assay: The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of the tracer to the kinase is detected using an EU-labeled anti-tag antibody. Simultaneous binding of both the tracer and antibody to the kinase gives rise to a FRET-signal. Binding of an inhibitor to the kinase competes for binding with the tracer, resulting in a loss of FRET-signal. At first a compound according to formula (I) was diluted in 20 mM Hepes pH 8.0, 1 mM DTT, 10 mM MgCl2 and 0.01% Brij35. Next Axl kinase (5 nM final concentration; Proqinase), kinase tracer (15 nM final concentration; Invitrogen) and LanthaScreen Eu-Anti-GST antibody (2 nM final concentration; Invitrogen) was mixed with suitable compound dilutions and incubated for 1 hour. FRET-signal was quantified employing an EnVision Multilabelreader 2104 (Perkin Elmer).	B	COc1cc2nccc(Oc3ccc(NC(=O)c4ccncc4)cc3)c2cc1OC		CHEMBL3667497	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	nM	10000.0
294895	17676251	CHEMBL3705826	Binding Assay: The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of the tracer to the kinase is detected using an EU-labeled anti-tag antibody. Simultaneous binding of both the tracer and antibody to the kinase gives rise to a FRET-signal. Binding of an inhibitor to the kinase competes for binding with the tracer, resulting in a loss of FRET-signal. At first a compound according to formula (I) was diluted in 20 mM Hepes pH 8.0, 1 mM DTT, 10 mM MgCl2 and 0.01% Brij35. Next Axl kinase (5 nM final concentration; Proqinase), kinase tracer (15 nM final concentration; Invitrogen) and LanthaScreen Eu-Anti-GST antibody (2 nM final concentration; Invitrogen) was mixed with suitable compound dilutions and incubated for 1 hour. FRET-signal was quantified employing an EnVision Multilabelreader 2104 (Perkin Elmer).	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cccs4)cc3)c2cc1OC		CHEMBL3667498	=	IC50	nM	8293.0	CHEMBL4895	Homo sapiens	IC50	nM	8293.0
294896	17676252	CHEMBL3705826	Binding Assay: The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of the tracer to the kinase is detected using an EU-labeled anti-tag antibody. Simultaneous binding of both the tracer and antibody to the kinase gives rise to a FRET-signal. Binding of an inhibitor to the kinase competes for binding with the tracer, resulting in a loss of FRET-signal. At first a compound according to formula (I) was diluted in 20 mM Hepes pH 8.0, 1 mM DTT, 10 mM MgCl2 and 0.01% Brij35. Next Axl kinase (5 nM final concentration; Proqinase), kinase tracer (15 nM final concentration; Invitrogen) and LanthaScreen Eu-Anti-GST antibody (2 nM final concentration; Invitrogen) was mixed with suitable compound dilutions and incubated for 1 hour. FRET-signal was quantified employing an EnVision Multilabelreader 2104 (Perkin Elmer).	B	COc1cc2nccc(Oc3ccc(NC(=O)c4ccccn4)cc3)c2cc1OC		CHEMBL3667499	=	IC50	nM	9302.0	CHEMBL4895	Homo sapiens	IC50	nM	9302.0
294897	17676253	CHEMBL3705826	Binding Assay: The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of the tracer to the kinase is detected using an EU-labeled anti-tag antibody. Simultaneous binding of both the tracer and antibody to the kinase gives rise to a FRET-signal. Binding of an inhibitor to the kinase competes for binding with the tracer, resulting in a loss of FRET-signal. At first a compound according to formula (I) was diluted in 20 mM Hepes pH 8.0, 1 mM DTT, 10 mM MgCl2 and 0.01% Brij35. Next Axl kinase (5 nM final concentration; Proqinase), kinase tracer (15 nM final concentration; Invitrogen) and LanthaScreen Eu-Anti-GST antibody (2 nM final concentration; Invitrogen) was mixed with suitable compound dilutions and incubated for 1 hour. FRET-signal was quantified employing an EnVision Multilabelreader 2104 (Perkin Elmer).	B	COc1cc2nccc(Oc3ccc(N)cc3F)c2cc1OC		CHEMBL3667500	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	nM	10000.0
294898	17676254	CHEMBL3705826	Binding Assay: The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of the tracer to the kinase is detected using an EU-labeled anti-tag antibody. Simultaneous binding of both the tracer and antibody to the kinase gives rise to a FRET-signal. Binding of an inhibitor to the kinase competes for binding with the tracer, resulting in a loss of FRET-signal. At first a compound according to formula (I) was diluted in 20 mM Hepes pH 8.0, 1 mM DTT, 10 mM MgCl2 and 0.01% Brij35. Next Axl kinase (5 nM final concentration; Proqinase), kinase tracer (15 nM final concentration; Invitrogen) and LanthaScreen Eu-Anti-GST antibody (2 nM final concentration; Invitrogen) was mixed with suitable compound dilutions and incubated for 1 hour. FRET-signal was quantified employing an EnVision Multilabelreader 2104 (Perkin Elmer).	B	COc1cc2nccc(Oc3ccc(N)cc3)c2cc1OC		CHEMBL3667501	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	nM	10000.0
294899	17676255	CHEMBL3705826	Binding Assay: The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of the tracer to the kinase is detected using an EU-labeled anti-tag antibody. Simultaneous binding of both the tracer and antibody to the kinase gives rise to a FRET-signal. Binding of an inhibitor to the kinase competes for binding with the tracer, resulting in a loss of FRET-signal. At first a compound according to formula (I) was diluted in 20 mM Hepes pH 8.0, 1 mM DTT, 10 mM MgCl2 and 0.01% Brij35. Next Axl kinase (5 nM final concentration; Proqinase), kinase tracer (15 nM final concentration; Invitrogen) and LanthaScreen Eu-Anti-GST antibody (2 nM final concentration; Invitrogen) was mixed with suitable compound dilutions and incubated for 1 hour. FRET-signal was quantified employing an EnVision Multilabelreader 2104 (Perkin Elmer).	B	COc1cc2nccc(Oc3ccc(N)cc3C)c2cc1OC		CHEMBL3667502	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	nM	10000.0
294900	17676256	CHEMBL3705826	Binding Assay: The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of the tracer to the kinase is detected using an EU-labeled anti-tag antibody. Simultaneous binding of both the tracer and antibody to the kinase gives rise to a FRET-signal. Binding of an inhibitor to the kinase competes for binding with the tracer, resulting in a loss of FRET-signal. At first a compound according to formula (I) was diluted in 20 mM Hepes pH 8.0, 1 mM DTT, 10 mM MgCl2 and 0.01% Brij35. Next Axl kinase (5 nM final concentration; Proqinase), kinase tracer (15 nM final concentration; Invitrogen) and LanthaScreen Eu-Anti-GST antibody (2 nM final concentration; Invitrogen) was mixed with suitable compound dilutions and incubated for 1 hour. FRET-signal was quantified employing an EnVision Multilabelreader 2104 (Perkin Elmer).	B	COc1cc2nccc(Oc3ccc(N)cc3Cl)c2cc1OC		CHEMBL3667503	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	nM	10000.0
294901	17676257	CHEMBL3705826	Binding Assay: The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of the tracer to the kinase is detected using an EU-labeled anti-tag antibody. Simultaneous binding of both the tracer and antibody to the kinase gives rise to a FRET-signal. Binding of an inhibitor to the kinase competes for binding with the tracer, resulting in a loss of FRET-signal. At first a compound according to formula (I) was diluted in 20 mM Hepes pH 8.0, 1 mM DTT, 10 mM MgCl2 and 0.01% Brij35. Next Axl kinase (5 nM final concentration; Proqinase), kinase tracer (15 nM final concentration; Invitrogen) and LanthaScreen Eu-Anti-GST antibody (2 nM final concentration; Invitrogen) was mixed with suitable compound dilutions and incubated for 1 hour. FRET-signal was quantified employing an EnVision Multilabelreader 2104 (Perkin Elmer).	B	COc1cc2nccc(Oc3ccc(N)nc3)c2cc1OC		CHEMBL509608	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	nM	10000.0
294902	17676258	CHEMBL3705826	Binding Assay: The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of the tracer to the kinase is detected using an EU-labeled anti-tag antibody. Simultaneous binding of both the tracer and antibody to the kinase gives rise to a FRET-signal. Binding of an inhibitor to the kinase competes for binding with the tracer, resulting in a loss of FRET-signal. At first a compound according to formula (I) was diluted in 20 mM Hepes pH 8.0, 1 mM DTT, 10 mM MgCl2 and 0.01% Brij35. Next Axl kinase (5 nM final concentration; Proqinase), kinase tracer (15 nM final concentration; Invitrogen) and LanthaScreen Eu-Anti-GST antibody (2 nM final concentration; Invitrogen) was mixed with suitable compound dilutions and incubated for 1 hour. FRET-signal was quantified employing an EnVision Multilabelreader 2104 (Perkin Elmer).	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1N		CHEMBL3667504	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	nM	10000.0
294903	17676259	CHEMBL3705826	Binding Assay: The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of the tracer to the kinase is detected using an EU-labeled anti-tag antibody. Simultaneous binding of both the tracer and antibody to the kinase gives rise to a FRET-signal. Binding of an inhibitor to the kinase competes for binding with the tracer, resulting in a loss of FRET-signal. At first a compound according to formula (I) was diluted in 20 mM Hepes pH 8.0, 1 mM DTT, 10 mM MgCl2 and 0.01% Brij35. Next Axl kinase (5 nM final concentration; Proqinase), kinase tracer (15 nM final concentration; Invitrogen) and LanthaScreen Eu-Anti-GST antibody (2 nM final concentration; Invitrogen) was mixed with suitable compound dilutions and incubated for 1 hour. FRET-signal was quantified employing an EnVision Multilabelreader 2104 (Perkin Elmer).	B	COc1cc2nccc(Oc3ccc(N)c(C)c3)c2cc1OC		CHEMBL3667505	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	nM	10000.0
294904	17676260	CHEMBL3705826	Binding Assay: The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of the tracer to the kinase is detected using an EU-labeled anti-tag antibody. Simultaneous binding of both the tracer and antibody to the kinase gives rise to a FRET-signal. Binding of an inhibitor to the kinase competes for binding with the tracer, resulting in a loss of FRET-signal. At first a compound according to formula (I) was diluted in 20 mM Hepes pH 8.0, 1 mM DTT, 10 mM MgCl2 and 0.01% Brij35. Next Axl kinase (5 nM final concentration; Proqinase), kinase tracer (15 nM final concentration; Invitrogen) and LanthaScreen Eu-Anti-GST antibody (2 nM final concentration; Invitrogen) was mixed with suitable compound dilutions and incubated for 1 hour. FRET-signal was quantified employing an EnVision Multilabelreader 2104 (Perkin Elmer).	B	COc1cc2c(Oc3ccc(N)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL3667506	=	IC50	nM	8503.0	CHEMBL4895	Homo sapiens	IC50	nM	8503.0
294905	17676261	CHEMBL3705826	Binding Assay: The principle behind this assay is based upon the binding and displacement of an Alexa Fluor 647-labeled tracer to the kinase of interest. Binding of the tracer to the kinase is detected using an EU-labeled anti-tag antibody. Simultaneous binding of both the tracer and antibody to the kinase gives rise to a FRET-signal. Binding of an inhibitor to the kinase competes for binding with the tracer, resulting in a loss of FRET-signal. At first a compound according to formula (I) was diluted in 20 mM Hepes pH 8.0, 1 mM DTT, 10 mM MgCl2 and 0.01% Brij35. Next Axl kinase (5 nM final concentration; Proqinase), kinase tracer (15 nM final concentration; Invitrogen) and LanthaScreen Eu-Anti-GST antibody (2 nM final concentration; Invitrogen) was mixed with suitable compound dilutions and incubated for 1 hour. FRET-signal was quantified employing an EnVision Multilabelreader 2104 (Perkin Elmer).	B	COc1cc2c(Oc3ccc(N)cc3F)ccnc2cc1OCC1CCN(C(=O)OC(C)(C)C)CC1		CHEMBL3667507	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	nM	10000.0
326860	17705587	CHEMBL3887258	Kinase Assay: Axl (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 μM KKSRGDYMTMQIG, 10 mM MgAcetate and [γ-33P-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 3% phosphoric acid solution. 10 μL of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	Cc1c(C(=O)Nc2ccc(Oc3ccnc4cc(OCC(C)(C)O)ccc34)c(F)c2)c(=O)n(-c2ccccc2)n1C		CHEMBL3984441	=	IC50	nM	11.0	CHEMBL4895	Homo sapiens	IC50	nM	11.0
326861	17705588	CHEMBL3887258	Kinase Assay: Axl (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 μM KKSRGDYMTMQIG, 10 mM MgAcetate and [γ-33P-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 3% phosphoric acid solution. 10 μL of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	COc1cc2c(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)ccnc2cc1OCC(C)(C)O		CHEMBL3919169	=	IC50	nM	17.0	CHEMBL4895	Homo sapiens	IC50	nM	17.0
326862	17705589	CHEMBL3887258	Kinase Assay: Axl (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 250 μM KKSRGDYMTMQIG, 10 mM MgAcetate and [γ-33P-ATP] (specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 3% phosphoric acid solution. 10 μL of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	Cc1c(C(=O)Nc2ccc(Oc3ccnc4cc(OCC(C)(C)O)ccc34)cc2)c(=O)n(-c2ccccc2)n1C		CHEMBL3920222	=	IC50	nM	5.0	CHEMBL4895	Homo sapiens	IC50	nM	5.0
342798	17720189	CHEMBL3887554	Kinase Inhibition Assay: This example shows that the inhibitory activity of the compound, N1'-[3-fluoro-4-[[7-[4-(hydroxyamino)-4-oxobutoxy]-6-methoxy-4-quinolyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide prepared in Example 9 in cells against kinases including ALK, AXL, FLT3, VEGFR2, c-KIT, c-MET, PDGFR-beta, RET and SRC (tested by Advanced Cellular Dynamics, 3550 General Atomics Court, Building 2, Room 639, San Diego, CA 92121. www.advancedcelldynamics.com and Carna Biosciences, Inc.(www.carnabio.com)) measured according to the method described in the literature (Reference: Daley, G. Q.; Baltimore, D. Proc. Natl. Acd. Sci. USA 1988, 85(23), 9312). Specific steps were as follows: The compound of the present invention was dissolved in dimethyl sulfoxide (DMSO) to make a stock solution of 2 mM, then the stock solution was diluted with DMSO following a 7 half-log series to concentrations ranging from 2 uM to 600 pM.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCC(=O)NO		CHEMBL3981567	=	IC50	nM	19.0	CHEMBL4895	Homo sapiens	IC50	nM	19.0
412006	17776721	CHEMBL3888650	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 μM at maximum. Firstly, a 50-fold concentration (i.e. 500 μM) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 μM, 100 μM, 20 μM, 4 μM, and 0.8 μM). After diluting with 1-fold kinase buffer by 10 folds, 5 μl of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 μl of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 μl/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 Î¼l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 μl/well. The plate was incubated at 28° C. for a certain period. 25 μl termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	=	IC50	nM	2138.0	CHEMBL4895	Homo sapiens	IC50	nM	2138.0
	17964876	CHEMBL3994985	Inhibition of human AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	30.0	CHEMBL4895	Homo sapiens	Activity	%	30.0
	17999500	CHEMBL4001907	Inhibition of Axl (unknown origin)	B	CS(=O)(=O)N1CCC[C@H](c2csc(-c3ccccc3NC(=O)c3ncc[nH]3)n2)C1		CHEMBL4069884	=	IC50	nM	33.0	CHEMBL4895	Homo sapiens	IC50	nM	33.0
	17999501	CHEMBL4001907	Inhibition of Axl (unknown origin)	B	Cc1c[nH]c(C(=O)Nc2ccccc2-c2nc([C@H]3CCCN(S(C)(=O)=O)C3)cs2)n1		CHEMBL4104797	=	IC50	nM	200.0	CHEMBL4895	Homo sapiens	IC50	nM	200.0
	17999502	CHEMBL4001907	Inhibition of Axl (unknown origin)	B	CS(=O)(=O)N1CCC[C@H](c2csc(-c3ccccc3NC(=O)c3nc(C#N)c[nH]3)n2)C1		CHEMBL4080569	=	IC50	nM	43.0	CHEMBL4895	Homo sapiens	IC50	nM	43.0
	17999503	CHEMBL4001907	Inhibition of Axl (unknown origin)	B	CS(=O)(=O)N1CCC[C@H](c2csc(-c3ccccc3NC(=O)c3nc(Cl)c[nH]3)n2)C1		CHEMBL4101465	=	IC50	nM	130.0	CHEMBL4895	Homo sapiens	IC50	nM	130.0
	17999504	CHEMBL4001907	Inhibition of Axl (unknown origin)	B	CS(=O)(=O)N1CCC[C@H](c2csc(-c3ccccc3NC(=O)c3nc4ccccc4[nH]3)n2)C1		CHEMBL4074783	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	nM	1000.0
	17999505	CHEMBL4001907	Inhibition of Axl (unknown origin)	B	CS(=O)(=O)N1CCC[C@H](c2csc(-c3ccccc3NC(=O)c3cnc[nH]3)n2)C1		CHEMBL4080983	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	nM	1000.0
	17999506	CHEMBL4001907	Inhibition of Axl (unknown origin)	B	CCS(=O)(=O)N1CCC[C@H](c2csc(-c3ccccc3NC(=O)c3ncc[nH]3)n2)C1		CHEMBL4105225	>	IC50	nM	630.0	CHEMBL4895	Homo sapiens	IC50	nM	630.0
	17999507	CHEMBL4001907	Inhibition of Axl (unknown origin)	B	NS(=O)(=O)N1CCC[C@H](c2csc(-c3ccccc3NC(=O)c3ncc[nH]3)n2)C1		CHEMBL4088862	=	IC50	nM	89.0	CHEMBL4895	Homo sapiens	IC50	nM	89.0
	17999508	CHEMBL4001907	Inhibition of Axl (unknown origin)	B	CNC(=O)N1CCC[C@H](c2csc(-c3ccccc3NC(=O)c3ncc[nH]3)n2)C1		CHEMBL4067646	=	IC50	nM	620.0	CHEMBL4895	Homo sapiens	IC50	nM	620.0
	17999509	CHEMBL4001907	Inhibition of Axl (unknown origin)	B	CC(=O)N1CCC[C@H](c2csc(-c3ccccc3NC(=O)c3ncc[nH]3)n2)C1		CHEMBL4096558	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	nM	1000.0
	17999510	CHEMBL4001907	Inhibition of Axl (unknown origin)	B	COC(=O)N1CCC[C@H](c2csc(-c3ccccc3NC(=O)c3ncc[nH]3)n2)C1		CHEMBL4078534	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	nM	1000.0
	17999511	CHEMBL4001907	Inhibition of Axl (unknown origin)	B	CS(=O)(=O)N1CCC[C@@H](c2csc(-c3ccccc3NC(=O)c3ncc[nH]3)n2)C1		CHEMBL4104287	=	IC50	nM	210.0	CHEMBL4895	Homo sapiens	IC50	nM	210.0
	17999512	CHEMBL4001907	Inhibition of Axl (unknown origin)	B	CS(=O)(=O)N1CCO[C@H](c2csc(-c3ccccc3NC(=O)c3ncc[nH]3)n2)C1		CHEMBL4086393	=	IC50	nM	25.0	CHEMBL4895	Homo sapiens	IC50	nM	25.0
	17999513	CHEMBL4001907	Inhibition of Axl (unknown origin)	B	CS(=O)(=O)N1CCC[C@H](c2csc(-c3cc(N4CCOCC4)ccc3NC(=O)c3ncc[nH]3)n2)C1		CHEMBL4066616	=	IC50	nM	3.4	CHEMBL4895	Homo sapiens	IC50	nM	3.4
	17999514	CHEMBL4001907	Inhibition of Axl (unknown origin)	B	CS(=O)(=O)N1CCO[C@H](c2csc(-c3cc(N4CCOCC4)ccc3NC(=O)c3ncc[nH]3)n2)C1		CHEMBL4094158	=	IC50	nM	2.2	CHEMBL4895	Homo sapiens	IC50	nM	2.2
	17999515	CHEMBL4001907	Inhibition of Axl (unknown origin)	B	CS(=O)(=O)N1CCC[C@H](c2csc(-c3cc(N4CCNCC4)ccc3NC(=O)c3ncc[nH]3)n2)C1		CHEMBL4062894	=	IC50	nM	1.0	CHEMBL4895	Homo sapiens	IC50	nM	1.0
	17999516	CHEMBL4001907	Inhibition of Axl (unknown origin)	B	CN(C)CCOc1ccc(NC(=O)c2ncc[nH]2)c(-c2nc([C@H]3CCCN(S(C)(=O)=O)C3)cs2)c1		CHEMBL4090103	=	IC50	nM	1.8	CHEMBL4895	Homo sapiens	IC50	nM	1.8
	17999517	CHEMBL4001908	Inhibition of Axl (unknown origin) phosphorylation expressed in HEK293 cells by ELISA	B	CS(=O)(=O)N1CCC[C@H](c2csc(-c3ccccc3NC(=O)c3ncc[nH]3)n2)C1		CHEMBL4069884	=	EC50	nM	3600.0	CHEMBL4895	Homo sapiens	EC50	nM	3600.0
	17999518	CHEMBL4001908	Inhibition of Axl (unknown origin) phosphorylation expressed in HEK293 cells by ELISA	B	CS(=O)(=O)N1CCO[C@H](c2csc(-c3ccccc3NC(=O)c3ncc[nH]3)n2)C1		CHEMBL4086393	=	EC50	nM	4700.0	CHEMBL4895	Homo sapiens	EC50	nM	4700.0
	17999519	CHEMBL4001908	Inhibition of Axl (unknown origin) phosphorylation expressed in HEK293 cells by ELISA	B	CS(=O)(=O)N1CCC[C@H](c2csc(-c3cc(N4CCOCC4)ccc3NC(=O)c3ncc[nH]3)n2)C1		CHEMBL4066616	=	EC50	nM	15.0	CHEMBL4895	Homo sapiens	EC50	nM	15.0
	17999520	CHEMBL4001908	Inhibition of Axl (unknown origin) phosphorylation expressed in HEK293 cells by ELISA	B	CS(=O)(=O)N1CCO[C@H](c2csc(-c3cc(N4CCOCC4)ccc3NC(=O)c3ncc[nH]3)n2)C1		CHEMBL4094158	=	EC50	nM	83.0	CHEMBL4895	Homo sapiens	EC50	nM	83.0
	17999521	CHEMBL4001908	Inhibition of Axl (unknown origin) phosphorylation expressed in HEK293 cells by ELISA	B	CS(=O)(=O)N1CCC[C@H](c2csc(-c3cc(N4CCNCC4)ccc3NC(=O)c3ncc[nH]3)n2)C1		CHEMBL4062894	=	EC50	nM	167.0	CHEMBL4895	Homo sapiens	EC50	nM	167.0
	17999522	CHEMBL4001908	Inhibition of Axl (unknown origin) phosphorylation expressed in HEK293 cells by ELISA	B	CN(C)CCOc1ccc(NC(=O)c2ncc[nH]2)c(-c2nc([C@H]3CCCN(S(C)(=O)=O)C3)cs2)c1		CHEMBL4090103	=	EC50	nM	50.0	CHEMBL4895	Homo sapiens	EC50	nM	50.0
	17999523	CHEMBL4001909	Ratio of EC50 for Axl (unknown origin) phosphorylation expressed in HEK293 cells to IC50 for Axl (unknown origin)	B	CS(=O)(=O)N1CCC[C@H](c2csc(-c3ccccc3NC(=O)c3ncc[nH]3)n2)C1		CHEMBL4069884	=	Ratio		100.0	CHEMBL4895	Homo sapiens	Ratio		100.0
	17999787	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	COC(=O)c1cc2cccnc2[nH]1		CHEMBL4097745	=	Inhibition	%	10.0	CHEMBL4895	Homo sapiens	INH	%	10.0
	17999788	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	COC(=O)c1c[nH]c2ncccc12		CHEMBL2391621	=	Inhibition	%	3.0	CHEMBL4895	Homo sapiens	INH	%	3.0
	17999789	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	O=C(Nc1cccnc1)c1c[nH]c2ncccc12		CHEMBL4090019	=	Inhibition	%	5.0	CHEMBL4895	Homo sapiens	INH	%	5.0
	17999790	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	O=C(Nc1cc[nH]n1)c1c[nH]c2ncccc12		CHEMBL4061976	=	Inhibition	%	15.0	CHEMBL4895	Homo sapiens	INH	%	15.0
	17999791	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	c1ccc(-c2cnc3[nH]ccc3c2)cc1		CHEMBL4091294	=	Inhibition	%	46.0	CHEMBL4895	Homo sapiens	INH	%	46.0
	17999792	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	COC(=O)c1cc2cc(-c3ccncc3)cnc2[nH]1		CHEMBL4100172	=	Inhibition	%	35.0	CHEMBL4895	Homo sapiens	INH	%	35.0
	17999793	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	COC(=O)c1c[nH]c2ncc(-c3ccccc3)cc12		CHEMBL4079544	=	Inhibition	%	70.0	CHEMBL4895	Homo sapiens	INH	%	70.0
	17999794	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	COC(=O)c1c[nH]c2ncc(-c3ccncc3)cc12		CHEMBL4103803	=	Inhibition	%	97.0	CHEMBL4895	Homo sapiens	INH	%	97.0
	17999795	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	COC(=O)c1c[nH]c2ncc(-c3ccccn3)cc12		CHEMBL4068740	=	Inhibition	%	60.0	CHEMBL4895	Homo sapiens	INH	%	60.0
	17999796	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	COC(=O)c1c[nH]c2ncc(-c3ccsc3)cc12		CHEMBL4096050	=	Inhibition	%	79.0	CHEMBL4895	Homo sapiens	INH	%	79.0
	17999797	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	COC(=O)c1c[nH]c2ncc(-c3ccco3)cc12		CHEMBL4095116	=	Inhibition	%	59.0	CHEMBL4895	Homo sapiens	INH	%	59.0
	17999798	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	c1ccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL3102859	=	Inhibition	%	55.0	CHEMBL4895	Homo sapiens	INH	%	55.0
	17999799	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	O=C(Nc1ccccc1)c1c[nH]c2ncc(-c3ccccc3)cc12		CHEMBL4087427	=	Inhibition	%	18.0	CHEMBL4895	Homo sapiens	INH	%	18.0
	17999800	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	c1ccc(-c2cnc3[nH]cc(CNc4cccnc4)c3c2)cc1		CHEMBL4066045	=	Inhibition	%	30.0	CHEMBL4895	Homo sapiens	INH	%	30.0
	17999801	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	COC(=O)c1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1		CHEMBL4064994	=	Inhibition	%	49.0	CHEMBL4895	Homo sapiens	INH	%	49.0
	17999802	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	O=Cc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1		CHEMBL4092680	=	Inhibition	%	70.0	CHEMBL4895	Homo sapiens	INH	%	70.0
	17999803	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	O=C(O)c1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1		CHEMBL4102305	=	Inhibition	%	94.0	CHEMBL4895	Homo sapiens	INH	%	94.0
	17999804	CHEMBL4001929	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 10 uM after 60 mins by Z'-LYTE assay relative to control	B	O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1		CHEMBL550795	=	Inhibition	%	77.0	CHEMBL4895	Homo sapiens	INH	%	77.0
	17999805	CHEMBL4001931	Inhibition of recombinant human His-tagged AXL expressed in insect cells at 1 uM after 60 mins by Z'-LYTE assay relative to control	B	c1ccc(-c2cnc3[nH]cc(-c4ccc(-c5nnn[nH]5)cc4)c3c2)cc1		CHEMBL564697	=	Inhibition	%	75.0	CHEMBL4895	Homo sapiens	INH	%	75.0
	17999806	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	COC(=O)c1cc2cccnc2[nH]1		CHEMBL4097745	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	17999807	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	COC(=O)c1c[nH]c2ncccc12		CHEMBL2391621	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	17999808	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	O=C(Nc1cccnc1)c1c[nH]c2ncccc12		CHEMBL4090019	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	17999809	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	O=C(Nc1cc[nH]n1)c1c[nH]c2ncccc12		CHEMBL4061976	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	17999810	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	c1ccc(-c2cnc3[nH]ccc3c2)cc1		CHEMBL4091294	=	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	17999811	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	COC(=O)c1cc2cc(-c3ccncc3)cnc2[nH]1		CHEMBL4100172	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	17999812	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	COC(=O)c1c[nH]c2ncc(-c3ccccc3)cc12		CHEMBL4079544	=	IC50	nM	1100.0	CHEMBL4895	Homo sapiens	IC50	uM	1.1
	17999813	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	COC(=O)c1c[nH]c2ncc(-c3ccncc3)cc12		CHEMBL4103803	=	IC50	nM	1800.0	CHEMBL4895	Homo sapiens	IC50	uM	1.8
	17999814	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	COC(=O)c1c[nH]c2ncc(-c3ccccn3)cc12		CHEMBL4068740	=	IC50	nM	2400.0	CHEMBL4895	Homo sapiens	IC50	uM	2.4
	17999815	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	COC(=O)c1c[nH]c2ncc(-c3ccsc3)cc12		CHEMBL4096050	=	IC50	nM	2200.0	CHEMBL4895	Homo sapiens	IC50	uM	2.2
	17999816	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	COC(=O)c1c[nH]c2ncc(-c3ccco3)cc12		CHEMBL4095116	=	IC50	nM	6500.0	CHEMBL4895	Homo sapiens	IC50	uM	6.5
	17999817	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	c1ccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL3102859	=	IC50	nM	4060.0	CHEMBL4895	Homo sapiens	IC50	nM	4060.0
	17999818	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccccc1)c1c[nH]c2ncc(-c3ccccc3)cc12		CHEMBL4087427	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	17999819	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	c1ccc(-c2cnc3[nH]cc(CNc4cccnc4)c3c2)cc1		CHEMBL4066045	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	17999820	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	COC(=O)c1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1		CHEMBL4064994	=	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	nM	10000.0
	17999821	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	O=Cc1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1		CHEMBL4092680	=	IC50	nM	3450.0	CHEMBL4895	Homo sapiens	IC50	nM	3450.0
	17999822	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	O=C(O)c1cccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1		CHEMBL4102305	=	IC50	nM	896.0	CHEMBL4895	Homo sapiens	IC50	nM	896.0
	17999823	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1		CHEMBL550795	=	IC50	nM	182.0	CHEMBL4895	Homo sapiens	IC50	nM	182.0
	17999824	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	c1ccc(-c2cnc3[nH]cc(-c4ccc(-c5nnn[nH]5)cc4)c3c2)cc1		CHEMBL564697	=	IC50	nM	524.0	CHEMBL4895	Homo sapiens	IC50	nM	524.0
	17999825	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	O=C(O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL4085916	=	IC50	nM	10200.0	CHEMBL4895	Homo sapiens	IC50	nM	10200.0
	17999826	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	O=C(O)c1ccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL4072966	=	IC50	nM	1940.0	CHEMBL4895	Homo sapiens	IC50	nM	1940.0
	17999827	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c(F)c1		CHEMBL4093667	=	IC50	nM	111.0	CHEMBL4895	Homo sapiens	IC50	nM	111.0
	17999828	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1F		CHEMBL4083405	=	IC50	nM	118.0	CHEMBL4895	Homo sapiens	IC50	nM	118.0
	17999829	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	O=C(O)c1cc(F)cc(-c2c[nH]c3ncc(-c4ccccc4)cc23)c1		CHEMBL4101393	=	IC50	nM	340.0	CHEMBL4895	Homo sapiens	IC50	nM	340.0
	17999830	CHEMBL4001930	Inhibition of recombinant human His-tagged AXL expressed in insect cells after 60 mins by Z'-LYTE assay	B	O=C(O)c1cc(-c2c[nH]c3ncc(-c4ccccc4)cc23)ccc1F		CHEMBL4102893	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	nM	1000.0
	18012388	CHEMBL4004208	Inhibition of recombinant human N-terminal GST-tagged AXL cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12		CHEMBL3822972	>	IC50	nM	50000.0	CHEMBL4895	Homo sapiens	IC50	uM	50.0
	18033108	CHEMBL4007924	Inhibition of human AXL at 0.1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)[C@H]1CCCN1.Cl		CHEMBL4093614	=	Inhibition	%	44.0	CHEMBL4895	Homo sapiens	INH	%	44.0
	18086025	CHEMBL4018651	Inhibition of recombinant AXL (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4105329	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	nM	1000.0
	18086026	CHEMBL4018651	Inhibition of recombinant AXL (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3cnccc3c2)c1)c1ccccc1		CHEMBL4067871	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	nM	1000.0
	18086027	CHEMBL4018651	Inhibition of recombinant AXL (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	nM	1000.0
	18086028	CHEMBL4018651	Inhibition of recombinant AXL (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccc(F)cc3O)cc12		CHEMBL4075917	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	nM	1000.0
	18096333	CHEMBL4021220	Inhibition of Axl (unknown origin) using FAM-labeled peptide as substrate preincubated for 5 to 10 mins followed by substrate/ATP addition measured after 30 to 60 mins by mobility shift assay	B	CC(c1cc2cc(-c3cnn(C)c3)cnc2cc1F)n1nnc2ncc(-c3cnn(CCO)c3)nc21		CHEMBL4074262	=	IC50	nM	1075.0	CHEMBL4895	Homo sapiens	IC50	nM	1075.0
	18114473	CHEMBL4025021	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	86.0	CHEMBL4895	Homo sapiens	Activity	%	86.0
	18203411	CHEMBL4043832	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	92.0	CHEMBL4895	Homo sapiens	Activity	%	92.0
	18250465	CHEMBL4054282	Inhibition of AXL (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 100 uM after 1 hr by ELISA relative to control	B	CCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4081419	=	Inhibition	%	33.8	CHEMBL4895	Homo sapiens	INH	%	33.8
	18250466	CHEMBL4054283	Inhibition of AXL (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	3.4	CHEMBL4895	Homo sapiens	IC50	nM	3.4
	18253584	CHEMBL4055076	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	90.0	CHEMBL4895	Homo sapiens	Activity	%	90.0
	18253585	CHEMBL4055076	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	96.0	CHEMBL4895	Homo sapiens	Activity	%	96.0
	18265925	CHEMBL4057375	Inhibition of AXL (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	0.3	CHEMBL4895	Homo sapiens	INH	%	0.3
	18266130	CHEMBL4057580	Inhibition of AXL (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-0.3	CHEMBL4895	Homo sapiens	INH	%	-0.3
	18266658	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Nc1nc(Nc2ccc(OCCN3CCCC3)c(F)c2)nn1C(=O)c1ccc(N2CCOCC2)cc1		CHEMBL4095081	=	EC50	nM	47.0	CHEMBL4895	Homo sapiens	EC50	nM	47.0
	18266659	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Nc1nc(Nc2ccc(OCCN3CCCC3)c(F)c2)nn1-c1ccccn1		CHEMBL4067670	=	EC50	nM	334.0	CHEMBL4895	Homo sapiens	EC50	nM	334.0
	18266660	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Nc1nc(Nc2ccc(OCCN3CCCC3)cc2)nn1-c1ncnc2ccc(Cl)cc12		CHEMBL4087395	=	EC50	nM	4.0	CHEMBL4895	Homo sapiens	EC50	uM	0.004
	18266661	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Cc1csc2c(-n3nc(Nc4ccc(OCCN5CCCC5)cc4)nc3N)nc(Cl)nc12		CHEMBL4105249	=	EC50	nM	12.0	CHEMBL4895	Homo sapiens	EC50	uM	0.012
	18266662	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Nc1nc(Nc2ccc(OCCN3CCCC3)cc2)nn1-c1ncnc2ccc(F)cc12		CHEMBL4064955	=	EC50	nM	22.0	CHEMBL4895	Homo sapiens	EC50	uM	0.022
	18266663	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Nc1nc(Nc2ccc(OCCN3CCCC3)cc2)nn1-c1ncnc2c1CCC2		CHEMBL4086420	=	EC50	nM	23.0	CHEMBL4895	Homo sapiens	EC50	uM	0.023
	18266664	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Nc1nc(Nc2ccc(OCCN3CCCC3)cc2)nn1-c1nc(Cl)nc2ccccc12		CHEMBL4102842	=	EC50	nM	27.0	CHEMBL4895	Homo sapiens	EC50	uM	0.027
	18266665	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Nc1nc(Nc2ccc(OCCN3CCCC3)cc2)nn1-c1ncnc2c1sc1ccccc12		CHEMBL4078564	=	EC50	nM	28.0	CHEMBL4895	Homo sapiens	EC50	uM	0.028
	18266666	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Cc1nc(-n2nc(Nc3ccc(OCCN4CCCC4)cc3)nc2N)c2ccccc2n1		CHEMBL4060051	=	EC50	nM	52.0	CHEMBL4895	Homo sapiens	EC50	uM	0.052
	18266667	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	COc1cc2ncnc(-n3nc(Nc4ccc(OCCN5CCCC5)c(Cl)c4)nc3N)c2cc1OC		CHEMBL4081956	=	EC50	nM	62.0	CHEMBL4895	Homo sapiens	EC50	uM	0.062
	18266668	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	COc1cc2ncnc(-n3nc(Nc4ccc(C5CCN(C)CC5)cc4)nc3N)c2cc1OC		CHEMBL4090507	=	EC50	nM	16.0	CHEMBL4895	Homo sapiens	EC50	uM	0.016
	18266669	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	COc1cc2ncnc(-n3nc(Nc4ccc(N5CCN(C)CC5)cc4)nc3N)c2cc1OC		CHEMBL4069483	=	EC50	nM	39.0	CHEMBL4895	Homo sapiens	EC50	uM	0.039
	18266670	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	COc1cc2ncnc(-n3nc(Nc4ccc(OC5CCCN(C)C5)cc4)nc3N)c2cc1OC		CHEMBL4098219	=	EC50	nM	52.0	CHEMBL4895	Homo sapiens	EC50	uM	0.052
	18266671	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	COc1cc2ncnc(-n3nc(Nc4ccc(N5CCN(C6CCCCC6)CC5)c(F)c4)nc3N)c2cc1OC		CHEMBL4080190	=	EC50	nM	55.0	CHEMBL4895	Homo sapiens	EC50	uM	0.055
	18266672	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	COc1cc2ncnc(-n3nc(Nc4ccc(N5CCN(C6CC7CCC6C7)CC5)c(Cl)c4)nc3N)c2cc1OC		CHEMBL4059790	=	EC50	nM	68.0	CHEMBL4895	Homo sapiens	EC50	uM	0.068
	18266673	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	COc1cc2ncnc(-n3nc(Nc4ccc(N5CC[C@H](N(C)C)C5)cc4)nc3N)c2cc1OC		CHEMBL4088067	=	EC50	nM	193.0	CHEMBL4895	Homo sapiens	EC50	uM	0.193
	18266674	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Cc1csc2c(-n3nc(Nc4ccc(N5CCN(C6CC7CCC6C7)CC5)cc4)nc3N)nc(Cl)nc12		CHEMBL4068447	=	EC50	nM	170.0	CHEMBL4895	Homo sapiens	EC50	uM	0.17
	18266675	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Nc1nc(Nc2ccc(N3CCN(C4CC5CCC4C5)CC3)cc2)nn1-c1ncnc2ccc(F)cc12		CHEMBL4095789	=	EC50	nM	253.0	CHEMBL4895	Homo sapiens	EC50	uM	0.253
	18266676	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Nc1nc(Nc2ccc(N3CCN(C4CC5CCC4C5)CC3)cc2)nn1-c1nccc2ccccc12		CHEMBL4101639	=	EC50	nM	350.0	CHEMBL4895	Homo sapiens	EC50	uM	0.35
	18266677	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Cc1nc(-n2nc(Nc3ccc(N4CCN(C5CC6CCC5C6)CC4)cc3)nc2N)c2ccccc2n1		CHEMBL4083641	=	EC50	nM	397.0	CHEMBL4895	Homo sapiens	EC50	uM	0.397
	18266678	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Nc1nc(Nc2ccc(N3CCN(C4CC5CCC4C5)CC3)cc2)nn1-c1ncnc2ccc(Cl)cc12		CHEMBL4090562	=	EC50	nM	485.0	CHEMBL4895	Homo sapiens	EC50	uM	0.485
	18266679	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Nc1nc(Nc2ccc(N3CCN(C4CC5CCC4C5)CC3)c(F)c2)nn1-c1ncnc2ccsc12		CHEMBL4062594	=	EC50	nM	20.0	CHEMBL4895	Homo sapiens	EC50	uM	0.02
	18266680	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Nc1nc(Nc2ccc(N3CCN(C4CC5CCC4C5)CC3)cc2)nn1-c1ncnc2ccsc12		CHEMBL4098293	=	EC50	nM	21.0	CHEMBL4895	Homo sapiens	EC50	uM	0.021
	18266681	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Nc1nc(Nc2ccc(N3CCN(C4CC5CCC4C5)CC3)cc2)nn1-c1ncnc2c1sc1ncccc12		CHEMBL4071242	=	EC50	nM	52.0	CHEMBL4895	Homo sapiens	EC50	uM	0.052
	18266682	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Cc1csc2c(-n3nc(Nc4ccc(N5CCN(C6CC7CCC6C7)CC5)c(F)c4)nc3N)ncnc12		CHEMBL4067869	=	EC50	nM	62.0	CHEMBL4895	Homo sapiens	EC50	uM	0.062
	18266683	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	CC(C)(C)c1cc2ncnc(-n3nc(Nc4ccc(N5CCN(C6CC7CCC6C7)CC5)c(Cl)c4)nc3N)c2s1		CHEMBL4093021	=	EC50	nM	84.0	CHEMBL4895	Homo sapiens	EC50	uM	0.084
	18266684	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Nc1nc(Nc2ccc(N3CCN(C4CC5CCC4C5)CC3)c(Cl)c2)nn1-c1ncnc2sccc12		CHEMBL4082743	=	EC50	nM	85.0	CHEMBL4895	Homo sapiens	EC50	uM	0.085
	18266685	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Cc1csc2c(-n3nc(Nc4ccc(N5CCN([C@H]6C[C@@H]7CC[C@H]6C7)CC5)c(Cl)c4)nc3N)nc(Cl)nc12		CHEMBL4100738	=	EC50	nM	136.0	CHEMBL4895	Homo sapiens	EC50	nM	136.0
	18266686	CHEMBL4057775	Inhibition of Axl in human HeLa cells assessed as reduction in AKT phosphorylation at Ser 473 residues pre-incubated for 1 hr before preclustered anti-Axl antibody stimulation by Western blot analysis	B	Cc1csc2c(-n3nc(Nc4ccc(N5CCN([C@@H]6C[C@H]7CC[C@@H]6C7)CC5)c(Cl)c4)nc3N)nc(Cl)nc12		CHEMBL4071540	=	EC50	nM	216.0	CHEMBL4895	Homo sapiens	EC50	nM	216.0
	18266719	CHEMBL4057778	Inhibition of N-terminal GST-tagged human Axl (464 to 885 end residues) cytoplasmic domain expressed in baculovirus expression system using HS1 peptide as substrate after 40 mins in presence of ATP by fluorescence polarization assay	B	Nc1nc(Nc2ccc(OCCN3CCCC3)cc2)nn1-c1ncnc2ccc(Cl)cc12		CHEMBL4087395	=	IC50	nM	3.0	CHEMBL4895	Homo sapiens	IC50	uM	0.003
	18266720	CHEMBL4057778	Inhibition of N-terminal GST-tagged human Axl (464 to 885 end residues) cytoplasmic domain expressed in baculovirus expression system using HS1 peptide as substrate after 40 mins in presence of ATP by fluorescence polarization assay	B	Cc1csc2c(-n3nc(Nc4ccc(OCCN5CCCC5)cc4)nc3N)nc(Cl)nc12		CHEMBL4105249	=	IC50	nM	2.0	CHEMBL4895	Homo sapiens	IC50	uM	0.002
	18266721	CHEMBL4057778	Inhibition of N-terminal GST-tagged human Axl (464 to 885 end residues) cytoplasmic domain expressed in baculovirus expression system using HS1 peptide as substrate after 40 mins in presence of ATP by fluorescence polarization assay	B	Nc1nc(Nc2ccc(OCCN3CCCC3)cc2)nn1-c1ncnc2ccc(F)cc12		CHEMBL4064955	=	IC50	nM	3.0	CHEMBL4895	Homo sapiens	IC50	uM	0.003
	18266722	CHEMBL4057778	Inhibition of N-terminal GST-tagged human Axl (464 to 885 end residues) cytoplasmic domain expressed in baculovirus expression system using HS1 peptide as substrate after 40 mins in presence of ATP by fluorescence polarization assay	B	Nc1nc(Nc2ccc(OCCN3CCCC3)cc2)nn1-c1ncnc2c1CCC2		CHEMBL4086420	=	IC50	nM	14.0	CHEMBL4895	Homo sapiens	IC50	uM	0.014
	18266723	CHEMBL4057778	Inhibition of N-terminal GST-tagged human Axl (464 to 885 end residues) cytoplasmic domain expressed in baculovirus expression system using HS1 peptide as substrate after 40 mins in presence of ATP by fluorescence polarization assay	B	Nc1nc(Nc2ccc(OCCN3CCCC3)cc2)nn1-c1nc(Cl)nc2ccccc12		CHEMBL4102842	=	IC50	nM	7.0	CHEMBL4895	Homo sapiens	IC50	uM	0.007
	18266724	CHEMBL4057778	Inhibition of N-terminal GST-tagged human Axl (464 to 885 end residues) cytoplasmic domain expressed in baculovirus expression system using HS1 peptide as substrate after 40 mins in presence of ATP by fluorescence polarization assay	B	Nc1nc(Nc2ccc(OCCN3CCCC3)cc2)nn1-c1ncnc2c1sc1ccccc12		CHEMBL4078564	=	IC50	nM	4.0	CHEMBL4895	Homo sapiens	IC50	uM	0.004
	18266725	CHEMBL4057778	Inhibition of N-terminal GST-tagged human Axl (464 to 885 end residues) cytoplasmic domain expressed in baculovirus expression system using HS1 peptide as substrate after 40 mins in presence of ATP by fluorescence polarization assay	B	Cc1nc(-n2nc(Nc3ccc(OCCN4CCCC4)cc3)nc2N)c2ccccc2n1		CHEMBL4060051	=	IC50	nM	32.0	CHEMBL4895	Homo sapiens	IC50	uM	0.032
	18266726	CHEMBL4057778	Inhibition of N-terminal GST-tagged human Axl (464 to 885 end residues) cytoplasmic domain expressed in baculovirus expression system using HS1 peptide as substrate after 40 mins in presence of ATP by fluorescence polarization assay	B	COc1cc2ncnc(-n3nc(Nc4ccc(OCCN5CCCC5)c(Cl)c4)nc3N)c2cc1OC		CHEMBL4081956	=	IC50	nM	16.0	CHEMBL4895	Homo sapiens	IC50	uM	0.016
	18266727	CHEMBL4057778	Inhibition of N-terminal GST-tagged human Axl (464 to 885 end residues) cytoplasmic domain expressed in baculovirus expression system using HS1 peptide as substrate after 40 mins in presence of ATP by fluorescence polarization assay	B	COc1cc2ncnc(-n3nc(Nc4ccc(N5CCN(C6CC7CCC6C7)CC5)c(Cl)c4)nc3N)c2cc1OC		CHEMBL4059790	=	IC50	nM	9.0	CHEMBL4895	Homo sapiens	IC50	uM	0.009
	18266728	CHEMBL4057778	Inhibition of N-terminal GST-tagged human Axl (464 to 885 end residues) cytoplasmic domain expressed in baculovirus expression system using HS1 peptide as substrate after 40 mins in presence of ATP by fluorescence polarization assay	B	Cc1csc2c(-n3nc(Nc4ccc(N5CCN(C6CC7CCC6C7)CC5)cc4)nc3N)nc(Cl)nc12		CHEMBL4068447	=	IC50	nM	9.0	CHEMBL4895	Homo sapiens	IC50	uM	0.009
	18266729	CHEMBL4057778	Inhibition of N-terminal GST-tagged human Axl (464 to 885 end residues) cytoplasmic domain expressed in baculovirus expression system using HS1 peptide as substrate after 40 mins in presence of ATP by fluorescence polarization assay	B	Nc1nc(Nc2ccc(N3CCN(C4CC5CCC4C5)CC3)cc2)nn1-c1ncnc2ccc(F)cc12		CHEMBL4095789	=	IC50	nM	10.0	CHEMBL4895	Homo sapiens	IC50	uM	0.01
	18266730	CHEMBL4057778	Inhibition of N-terminal GST-tagged human Axl (464 to 885 end residues) cytoplasmic domain expressed in baculovirus expression system using HS1 peptide as substrate after 40 mins in presence of ATP by fluorescence polarization assay	B	Nc1nc(Nc2ccc(N3CCN(C4CC5CCC4C5)CC3)cc2)nn1-c1nccc2ccccc12		CHEMBL4101639	=	IC50	nM	15.0	CHEMBL4895	Homo sapiens	IC50	uM	0.015
	18266731	CHEMBL4057778	Inhibition of N-terminal GST-tagged human Axl (464 to 885 end residues) cytoplasmic domain expressed in baculovirus expression system using HS1 peptide as substrate after 40 mins in presence of ATP by fluorescence polarization assay	B	Cc1nc(-n2nc(Nc3ccc(N4CCN(C5CC6CCC5C6)CC4)cc3)nc2N)c2ccccc2n1		CHEMBL4083641	=	IC50	nM	32.0	CHEMBL4895	Homo sapiens	IC50	uM	0.032
	18266732	CHEMBL4057778	Inhibition of N-terminal GST-tagged human Axl (464 to 885 end residues) cytoplasmic domain expressed in baculovirus expression system using HS1 peptide as substrate after 40 mins in presence of ATP by fluorescence polarization assay	B	Nc1nc(Nc2ccc(N3CCN(C4CC5CCC4C5)CC3)cc2)nn1-c1ncnc2ccc(Cl)cc12		CHEMBL4090562	=	IC50	nM	3.0	CHEMBL4895	Homo sapiens	IC50	uM	0.003
	18266764	CHEMBL4057792	Inhibition of Axl (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	9.0	CHEMBL4895	Homo sapiens	IC50	nM	9.0
	18274773	CHEMBL4118303	Inhibition of AXL in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled NCMLNENMSVCVADFGLSKK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	27.2	CHEMBL4895	Homo sapiens	INH	%	27.2
	18274774	CHEMBL4118303	Inhibition of AXL in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled NCMLNENMSVCVADFGLSKK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-59.7	CHEMBL4895	Homo sapiens	INH	%	-59.7
	18274775	CHEMBL4118303	Inhibition of AXL in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled NCMLNENMSVCVADFGLSKK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-33.2	CHEMBL4895	Homo sapiens	INH	%	-33.2
	18282046	CHEMBL4120001	Inhibition of recombinant His-tagged human AXL (473 to end residues) cytoplasmic domain expressed in insect cells at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	40.7	CHEMBL4895	Homo sapiens	INH	%	40.7
	18282365	CHEMBL4120001	Inhibition of recombinant His-tagged human AXL (473 to end residues) cytoplasmic domain expressed in insect cells at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	57.4	CHEMBL4895	Homo sapiens	INH	%	57.4
	18282543	CHEMBL4120181	Inhibition of recombinant His-tagged human AXL (473 to end residues) cytoplasmic domain expressed in insect cells by FRET assay	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	IC50	nM	448.0	CHEMBL4895	Homo sapiens	IC50	uM	0.448
	18282767	CHEMBL4120352	Inhibition of AXL (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	0.3	CHEMBL4895	Homo sapiens	INH	%	0.3
	18282936	CHEMBL4120521	Inhibition of AXL (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-2.3	CHEMBL4895	Homo sapiens	INH	%	-2.3
	18283160	CHEMBL4120745	Inhibition of AXL (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	4.0	CHEMBL4895	Homo sapiens	INH	%	4.0
	18309587	CHEMBL4131859	Inhibition of recombinant human full length AXL using poly (Glu, Tyr) as substrate by alpha screen assay	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	7.0	CHEMBL4895	Homo sapiens	IC50	nM	7.0
	18390493	CHEMBL4147641	Inhibition of AXL (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	9.5	CHEMBL4895	Homo sapiens	IC50	umol/L	0.0095
	18390494	CHEMBL4147641	Inhibition of AXL (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)c(F)c3)ccnc2cc1OCCCN1CCCC1		CHEMBL4171115	=	IC50	nM	62.0	CHEMBL4895	Homo sapiens	IC50	umol/L	0.062
	18440087	CHEMBL4156911	Binding affinity to wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	94.0	CHEMBL4895	Homo sapiens	Activity	%	94.0
	18463719	CHEMBL4181135	Inhibition of recombinant human N-terminal His6-tagged AXL (473 to end residues) expressed in Sf21 cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	24.0	CHEMBL4895	Homo sapiens	INH	%	24.0
	18464426	CHEMBL4181425	Inhibition of GST-tagged human AXL (473 end residues) at 100 nM relative to control	B	CCOP(=O)(CCCOc1ccc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(=O)NC)n2)cc1)N1CCOCC1		CHEMBL4216755	=	Inhibition	%	60.0	CHEMBL4895	Homo sapiens	INH	%	60.0
	18484527	CHEMBL4185690	Binding affinity to wild-type human partial length AXL (R497 to Y821 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	87.0	CHEMBL4895	Homo sapiens	Activity	%	87.0
	18485094	CHEMBL4185690	Binding affinity to wild-type human partial length AXL (R497 to Y821 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	95.0	CHEMBL4895	Homo sapiens	Activity	%	95.0
	18489491	CHEMBL4187232	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	82.0	CHEMBL4895	Homo sapiens	Activity	%	82.0
	18499340	CHEMBL4189000	Inhibition of AXL (unknown origin)	B	CCCCNc1ncc2c(-c3ccc(F)cc3)nn(C[C@H]3CC[C@H](N)CC3)c2n1		CHEMBL2036808	=	IC50	nM	37.0	CHEMBL4895	Homo sapiens	IC50	nM	37.0
	18499341	CHEMBL4189000	Inhibition of AXL (unknown origin)	B	CNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(CC3CCC(N)CC3)c2n1		CHEMBL2036792	=	IC50	nM	14.0	CHEMBL4895	Homo sapiens	IC50	nM	14.0
	18499506	CHEMBL4188972	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C(=O)C(C)(C)C)CC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4204515	=	IC50	nM	7200.0	CHEMBL4895	Homo sapiens	IC50	uM	7.2
	18499507	CHEMBL4188972	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CCN1CCN(c2ccc(-c3nn(CC4CCCC4)c4nc(NC)ncc34)cn2)CC1		CHEMBL4213775	=	IC50	nM	260.0	CHEMBL4895	Homo sapiens	IC50	uM	0.26
	18499508	CHEMBL4188972	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4208852	=	IC50	nM	70.0	CHEMBL4895	Homo sapiens	IC50	uM	0.07
	18499509	CHEMBL4188972	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)nn(CC3CCCC3)c2n1		CHEMBL4218175	=	IC50	nM	13.0	CHEMBL4895	Homo sapiens	IC50	uM	0.013
	18499510	CHEMBL4188972	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2		CHEMBL3809489	=	IC50	nM	0.7	CHEMBL4895	Homo sapiens	IC50	uM	0.0007
	18499511	CHEMBL4188972	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C(=O)C(C)(C)C)CC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1		CHEMBL4207004	=	IC50	nM	760.0	CHEMBL4895	Homo sapiens	IC50	uM	0.76
	18499512	CHEMBL4188972	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CCN1CCN(c2ccc(-c3nn(Cc4cn(Cc5ccccc5)nn4)c4nc(NC)ncc34)cn2)CC1		CHEMBL4217649	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	18499513	CHEMBL4188972	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1		CHEMBL4218369	=	IC50	nM	380.0	CHEMBL4895	Homo sapiens	IC50	uM	0.38
	18499514	CHEMBL4188972	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1		CHEMBL4211308	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	18499515	CHEMBL4188972	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(Cc3cn(-c4ccsc4C(=O)OC)nn3)c2n1		CHEMBL4205191	=	IC50	nM	780.0	CHEMBL4895	Homo sapiens	IC50	uM	0.78
	18499516	CHEMBL4188972	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1		CHEMBL4210084	=	IC50	nM	400.0	CHEMBL4895	Homo sapiens	IC50	uM	0.4
	18499517	CHEMBL4188972	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(OC)cc3)nn(CC3OCCO3)c2n1		CHEMBL4209569	=	IC50	nM	1300.0	CHEMBL4895	Homo sapiens	IC50	uM	1.3
	18499518	CHEMBL4188972	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(CC3OCCO3)c2n1		CHEMBL4214476	=	IC50	nM	530.0	CHEMBL4895	Homo sapiens	IC50	uM	0.53
	18499519	CHEMBL4188972	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4213003	=	IC50	nM	120.0	CHEMBL4895	Homo sapiens	IC50	uM	0.12
	18507890	CHEMBL4190877	Inhibition of recombinant human Axl (473 to end residues) at 1 uM using KKSRGDYMTMQIG as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	9.0	CHEMBL4895	Homo sapiens	INH	%	9.0
	18653757	CHEMBL4230025	Inhibition of AXL (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	12.0	CHEMBL4895	Homo sapiens	INH	%	12.0
	18653758	CHEMBL4230025	Inhibition of AXL (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	2.0	CHEMBL4895	Homo sapiens	INH	%	2.0
	18655630	CHEMBL4230590	Binding affinity to wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	95.0	CHEMBL4895	Homo sapiens	Activity	%	95.0
	18658979	CHEMBL4231722	Inhibition of GST-tagged human AXL at 5 uM preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by Hot-Spot kinase assay	B	COc1ccc2c(OCc3nnc4sc(-c5cnn(C)c5)nn34)ccnc2c1		CHEMBL4249147	=	Inhibition	%	11.11	CHEMBL4895	Homo sapiens	INH	%	11.11
	18663898	CHEMBL4232870	Inhibition of human AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	100.0	CHEMBL4895	Homo sapiens	Activity	%	100.0
	18663983	CHEMBL4232967	Binding affinity to human AXL (R497 to Y821 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL4895	Homo sapiens	Kd	uM	5.0
	18693966	CHEMBL4253419	Inhibition of recombinant human N-terminal GST tagged AXL (473-end residues) expressed in baculovirus infected Sf9 cells at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	-1.0	CHEMBL4895	Homo sapiens	INH	%	-1.0
	18694048	CHEMBL4253501	Inhibition of recombinant human N-terminal GST tagged AXL (473-end residues) expressed in baculovirus infected Sf9 cells at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	26.0	CHEMBL4895	Homo sapiens	INH	%	26.0
	18697612	CHEMBL4254285	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	99.0	CHEMBL4895	Homo sapiens	Activity	%	99.0
	18725370	CHEMBL4259067	Inhibition of AXL (unknown origin)	B	CC(=O)n1nc(C)c(-c2ccc(Cl)c(Cl)c2)c1N		CHEMBL4276946	>	IC50	nM	100000.0	CHEMBL4895	Homo sapiens	IC50	uM	100.0
	18737837	CHEMBL4261402	Inhibition of recombinant human Axl Q764R mutant (473 to end residues) using KKSRGDYMTMQIG as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	35.0	CHEMBL4895	Homo sapiens	IC50	nM	35.0
	18751066	CHEMBL4263739	Inhibition of AXL (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	34.0	CHEMBL4895	Homo sapiens	INH	%	34.0
	18751724	CHEMBL4264179	Binding affinity to wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	91.0	CHEMBL4895	Homo sapiens	Activity	%	91.0
	18753756	CHEMBL4264825	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 5 mins in presence of ADP by fluorescence analysis	B	O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4285809	=	IC50	nM	2000.0	CHEMBL4895	Homo sapiens	IC50	nM	2000.0
	18753757	CHEMBL4264825	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 5 mins in presence of ADP by fluorescence analysis	B	O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4277499	=	IC50	nM	0.77	CHEMBL4895	Homo sapiens	IC50	nM	0.77
	18753758	CHEMBL4264825	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 5 mins in presence of ADP by fluorescence analysis	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1		CHEMBL4285448	=	IC50	nM	70.0	CHEMBL4895	Homo sapiens	IC50	nM	70.0
	18753759	CHEMBL4264825	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 5 mins in presence of ADP by fluorescence analysis	B	Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F		CHEMBL4293688	>	IC50	nM	100000.0	CHEMBL4895	Homo sapiens	IC50	uM	100.0
Not Active	18753778	CHEMBL4264828	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA	B	O=C(Nc1ccc(Oc2c(-c3ccccc3)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4279970		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	18753779	CHEMBL4264828	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA	B	O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4285809		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Active	18753780	CHEMBL4264828	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA	B	O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4277499		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	18753781	CHEMBL4264828	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA	B	CCc1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccc(N(C)C)cc3)cnc2[nH]1		CHEMBL4291263		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	18753782	CHEMBL4264828	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA	B	CCc1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccoc3)cnc2[nH]1		CHEMBL4280621		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	18753783	CHEMBL4264828	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA	B	CCc1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccncc3)cnc2[nH]1		CHEMBL4294675		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	18753784	CHEMBL4264828	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA	B	CCc1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3cccnc3)cnc2[nH]1		CHEMBL4284078		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	18753785	CHEMBL4264828	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccc(N(C)C)cc3)cnc2[nH]1		CHEMBL4279522		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	18753786	CHEMBL4264828	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccoc3)cnc2[nH]1		CHEMBL4287444		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	18753787	CHEMBL4264828	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccncc3)cnc2[nH]1		CHEMBL4282995		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	18753788	CHEMBL4264828	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3cccnc3)cnc2[nH]1		CHEMBL4290862		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	18753789	CHEMBL4264828	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA	B	Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F		CHEMBL4293688		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	18753790	CHEMBL4264828	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA	B	CCc1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccc(O)cc3)cnc2[nH]1		CHEMBL4277630		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Active	18753791	CHEMBL4264828	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)c(-c3ccc(O)cc3)cnc2[nH]1		CHEMBL4285573		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	18753914	CHEMBL4264857	Binding affinity to human AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4285809	=	Activity	%	4.0	CHEMBL4895	Homo sapiens	Activity	%	4.0
	18753915	CHEMBL4264857	Binding affinity to human AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4277499	=	Activity	%	78.0	CHEMBL4895	Homo sapiens	Activity	%	78.0
	18753916	CHEMBL4264857	Binding affinity to human AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1		CHEMBL4285448	=	Activity	%	61.0	CHEMBL4895	Homo sapiens	Activity	%	61.0
	18753917	CHEMBL4264857	Binding affinity to human AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F		CHEMBL4293688	=	Activity	%	22.0	CHEMBL4895	Homo sapiens	Activity	%	22.0
	18753918	CHEMBL4264858	Binding affinity to human AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4285809	=	Activity	%	52.0	CHEMBL4895	Homo sapiens	Activity	%	52.0
	18753919	CHEMBL4264858	Binding affinity to human AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4277499	=	Activity	%	90.7	CHEMBL4895	Homo sapiens	Activity	%	90.7
	18753920	CHEMBL4264858	Binding affinity to human AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1		CHEMBL4285448	=	Activity	%	90.0	CHEMBL4895	Homo sapiens	Activity	%	90.0
	18753921	CHEMBL4264858	Binding affinity to human AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F		CHEMBL4293688	=	Activity	%	67.0	CHEMBL4895	Homo sapiens	Activity	%	67.0
	18753922	CHEMBL4264859	Binding affinity to human AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4285809	=	Activity	%	90.4	CHEMBL4895	Homo sapiens	Activity	%	90.4
	18753923	CHEMBL4264859	Binding affinity to human AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4277499	=	Activity	%	93.3	CHEMBL4895	Homo sapiens	Activity	%	93.3
	18753924	CHEMBL4264859	Binding affinity to human AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1		CHEMBL4285448	=	Activity	%	89.0	CHEMBL4895	Homo sapiens	Activity	%	89.0
	18753925	CHEMBL4264859	Binding affinity to human AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F		CHEMBL4293688	=	Activity	%	90.1	CHEMBL4895	Homo sapiens	Activity	%	90.1
Not Active	18753961	CHEMBL4264828	Inhibition of recombinant His-tagged human Axl (473 to end residues) cytoplasmic domain expressed in insect system using poly (Glu-Ala-Tyr) peptide as substrate after 1.5 hrs by ELISA	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1		CHEMBL4285448		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	18761496	CHEMBL4266527	Inhibition of recombinant human N-terminal His6-tagged Axl (473 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	65.0	CHEMBL4895	Homo sapiens	INH	%	65.0
	18761746	CHEMBL4266527	Inhibition of recombinant human N-terminal His6-tagged Axl (473 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	8.0	CHEMBL4895	Homo sapiens	INH	%	8.0
	18761909	CHEMBL4266527	Inhibition of recombinant human N-terminal His6-tagged Axl (473 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	4.0	CHEMBL4895	Homo sapiens	INH	%	4.0
	18763059	CHEMBL4266856	Inhibition of AXL (unknown origin) at 1 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)N(C)C)cc2c1C(N)=O		CHEMBL4290876	=	Inhibition	%	37.21	CHEMBL4895	Homo sapiens	INH	%	37.21
	18763090	CHEMBL4266887	Inhibition of AXL (unknown origin) at 10 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cccs3)cc2c1C(N)=O		CHEMBL4288081	=	Inhibition	%	112.17	CHEMBL4895	Homo sapiens	INH	%	112.17
	18763721	CHEMBL4266992	Inhibition of AXL (unknown origin)	B	CN1CCN(c2ccc(-c3c(-c4cc(F)c(O)c(F)c4)cnc4[nH]ccc34)cc2)CC1		CHEMBL4292020	<	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	uM	1.0
	18812584	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(NC4CCCCC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4287802	=	IC50	nM	7356.0	CHEMBL4895	Homo sapiens	IC50	nM	7356.0
	18812593	CHEMBL4276367	Inhibition of AXL in human A549 cells assessed as reduction in phosphorylated AXL level preincubated for 1 hr followed by pervanadate phopshatase inhibitor addition and measured after 3 mins by immunoblot analysis	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4283353	=	IC50	nM	859.0	CHEMBL4895	Homo sapiens	IC50	nM	859.0
	18812600	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CC[C@H](N(C)C)C4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4294601	=	IC50	nM	152.0	CHEMBL4895	Homo sapiens	IC50	nM	152.0
	18812604	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4C5CCC4CC5)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4286701	=	IC50	nM	84.0	CHEMBL4895	Homo sapiens	IC50	nM	84.0
	18812613	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(S(=O)(=O)N4CCN(C)CC4)cc3F)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4284392	=	IC50	nM	191.0	CHEMBL4895	Homo sapiens	IC50	nM	191.0
	18812622	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(NC4CCNCC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4295042	=	IC50	nM	206.0	CHEMBL4895	Homo sapiens	IC50	nM	206.0
	18812627	CHEMBL4276355	Inhibition of N-terminal GST-tagged human AXL cytoplasmic domain (464 to 885 end residues) expressed in baculovirus expression system using fluorecence-labeled substrate by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4283353	=	IC50	nM	12.1	CHEMBL4895	Homo sapiens	IC50	nM	12.1
	18812649	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4283353	=	Ki	nM	40.22	CHEMBL4895	Homo sapiens	Ki	nM	40.22
	18812650	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4283353	=	IC50	nM	80.0	CHEMBL4895	Homo sapiens	IC50	nM	80.0
	18812660	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCOCC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4291202	=	IC50	nM	218.0	CHEMBL4895	Homo sapiens	IC50	nM	218.0
	18812664	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCCC[C@H](CO)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4277366	=	IC50	nM	3015.0	CHEMBL4895	Homo sapiens	IC50	nM	3015.0
	18812668	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCCCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4288009	=	IC50	nM	81.0	CHEMBL4895	Homo sapiens	IC50	nM	81.0
	18812672	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4280761	=	IC50	nM	64.0	CHEMBL4895	Homo sapiens	IC50	nM	64.0
	18812677	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1)C(F)(F)F		CHEMBL4291409	=	IC50	nM	11037.0	CHEMBL4895	Homo sapiens	IC50	nM	11037.0
	18812682	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@@H](Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1)C(F)(F)F		CHEMBL4284201	=	IC50	nM	2543.0	CHEMBL4895	Homo sapiens	IC50	nM	2543.0
	18812686	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@@H](C)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4294819	=	IC50	nM	560.0	CHEMBL4895	Homo sapiens	IC50	nM	560.0
	18812690	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4287582	=	IC50	nM	118.0	CHEMBL4895	Homo sapiens	IC50	nM	118.0
	18812694	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCCCNc1ncc2c(-c3ccc(Oc4ccccc4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4279673	=	IC50	nM	1690.0	CHEMBL4895	Homo sapiens	IC50	nM	1690.0
	18812698	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCCCNc1ncc2c(-c3ccc(NC4CCNCC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4291006	=	IC50	nM	42.0	CHEMBL4895	Homo sapiens	IC50	nM	42.0
	18812702	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCCCNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4283152	=	IC50	nM	26.0	CHEMBL4895	Homo sapiens	IC50	nM	26.0
	18812706	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCCCNc1ncc2c(-c3ccc(C4(N5CCN(C)CC5)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4284541	=	IC50	nM	15.0	CHEMBL4895	Homo sapiens	IC50	nM	15.0
	18812711	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CN1CCN(Cc2ccc(-c3cn([C@H]4CC[C@H](O)CC4)c4nc(NC5CCCCC5)ncc34)cc2)CC1		CHEMBL4292435	=	IC50	nM	340.0	CHEMBL4895	Homo sapiens	IC50	nM	340.0
	18812717	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC(CC)CNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4279154	=	IC50	nM	206.0	CHEMBL4895	Homo sapiens	IC50	nM	206.0
	18812722	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC(C)CNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4287078	=	IC50	nM	100.0	CHEMBL4895	Homo sapiens	IC50	nM	100.0
	18812727	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCCC(C)Nc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4282624	=	IC50	nM	125.0	CHEMBL4895	Homo sapiens	IC50	nM	125.0
	18812731	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	N[C@H]1CCCCNc2nc(ncc2C(=O)NCc2ccc(F)cc2)NCCCCCCNC1=O		CHEMBL4290493	=	IC50	nM	120.0	CHEMBL4895	Homo sapiens	IC50	nM	120.0
	18812742	CHEMBL4276355	Inhibition of N-terminal GST-tagged human AXL cytoplasmic domain (464 to 885 end residues) expressed in baculovirus expression system using fluorecence-labeled substrate by MCE assay	B	CCCCNc1ncc2c(-c3ccc(CN4CCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL3326006	=	IC50	nM	1.65	CHEMBL4895	Homo sapiens	IC50	nM	1.65
	18812749	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(C4CCOCC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4277445	=	IC50	nM	3291.0	CHEMBL4895	Homo sapiens	IC50	nM	3291.0
	18812753	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(CNCCN(CC)CC)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4277564	=	IC50	nM	80.0	CHEMBL4895	Homo sapiens	IC50	nM	80.0
	18812762	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3cccc(CN4CCN(C)CC4)c3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4288213	=	IC50	nM	213.0	CHEMBL4895	Homo sapiens	IC50	nM	213.0
	18812767	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3cccc(N4CCN(C)CC4)c3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4281432	=	IC50	nM	230.0	CHEMBL4895	Homo sapiens	IC50	nM	230.0
	18812772	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3ccnc(N4CCNCC4)c3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4289301	=	IC50	nM	79.0	CHEMBL4895	Homo sapiens	IC50	nM	79.0
	18812782	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3ccnc(C(=O)OC)c3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4284846	=	IC50	nM	416.0	CHEMBL4895	Homo sapiens	IC50	nM	416.0
	18812787	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3cnc(C4CC4)nc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4292717	=	IC50	nM	1084.0	CHEMBL4895	Homo sapiens	IC50	nM	1084.0
	18812792	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3cnn(C4CCNCC4)c3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4293116	=	IC50	nM	161.0	CHEMBL4895	Homo sapiens	IC50	nM	161.0
	18812802	CHEMBL4276333	Inhibition of AXL (unknown origin) using 5'-FAM-KKKKEEIYFFF-CONH2 as substrate after 180 mins by MCE assay	B	CCC[C@H](C)Nc1ncc2c(-c3ccc4nc(C)oc4c3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4282510	=	IC50	nM	3295.0	CHEMBL4895	Homo sapiens	IC50	nM	3295.0
Not Active	18847341	CHEMBL4304879	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	18857850	CHEMBL4307696	Binding affinity to wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	99.0	CHEMBL4895	Homo sapiens	Activity	%	99.0
	18892758	CHEMBL4314654	Inhibition of recombinant human AXL Q764R mutant (473 to end residues) assessed as residual activity at 10 uM using KKSRGDYMTMQIG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	107.0	CHEMBL4895	Homo sapiens	Activity	%	107.0
	18919414	CHEMBL4322773	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged AXL (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	313.0	CHEMBL4895	Homo sapiens	Kd	nM	313.0
	18919602	CHEMBL4322773	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged AXL (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	559.0	CHEMBL4895	Homo sapiens	Kd	nM	559.0
	18933916	CHEMBL4326586	Inhibition of human recombinant His-tagged AXL (473 to end residues) expressed in insect expression system	B	CC(C)(C)NS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(OCCN3CCCC3)cc2)ncc1Cl		CHEMBL4465517	=	Kd	nM	6300.0	CHEMBL4895	Homo sapiens	Kd	uM	6.3
	18933918	CHEMBL4326588	Inhibition AXL (unknown origin)	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	12.0	CHEMBL4895	Homo sapiens	Kd	uM	0.012
	18933921	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	COc1cc(Nc2ncc(C(F)(F)F)c(N3Cc4cccc(N(C)S(C)(=O)=O)c4C3)n2)cc(OC)c1		CHEMBL4457670	=	IC50	nM	80.0	CHEMBL4895	Homo sapiens	IC50	uM	0.08
	18933922	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	COc1cc(Nc2ncc(C(F)(F)F)c(N3Cc4cccc(N(C)S(C)(=O)=O)c4C3)n2)c(OC)cc1Cl		CHEMBL4531245	>	IC50	nM	20000.0	CHEMBL4895	Homo sapiens	IC50	uM	20.0
	18933923	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	COc1ccc(C(F)(F)F)cc1Nc1ncc(C(F)(F)F)c(N2Cc3cccc(N(C)S(C)(=O)=O)c3C2)n1		CHEMBL4475794	>	IC50	nM	20000.0	CHEMBL4895	Homo sapiens	IC50	uM	20.0
	18933924	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	COc1cc(Nc2ncc(C(F)(F)F)c(N3Cc4cccc(N(C)S(C)(=O)=O)c4C3)n2)cc(C(F)(F)F)c1		CHEMBL4441802	=	IC50	nM	890.0	CHEMBL4895	Homo sapiens	IC50	uM	0.89
	18933925	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	COc1ccc(Nc2ncc(C(F)(F)F)c(N3Cc4cccc(N(C)S(C)(=O)=O)c4C3)n2)cc1C(F)(F)F		CHEMBL4553509	>	IC50	nM	20000.0	CHEMBL4895	Homo sapiens	IC50	uM	20.0
	18933926	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	Cc1ccc(Nc2ncc(C(F)(F)F)c(N3Cc4cccc(N(C)S(C)(=O)=O)c4C3)n2)c(C)c1		CHEMBL4460249	=	IC50	nM	2900.0	CHEMBL4895	Homo sapiens	IC50	uM	2.9
	18933927	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	Cc1cc(C)cc(Nc2ncc(C(F)(F)F)c(N3Cc4cccc(N(C)S(C)(=O)=O)c4C3)n2)c1		CHEMBL4546644	>	IC50	nM	20000.0	CHEMBL4895	Homo sapiens	IC50	uM	20.0
	18933928	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	Cc1ccc(Nc2ncc(C(F)(F)F)c(N3Cc4cccc(N(C)S(C)(=O)=O)c4C3)n2)cc1C		CHEMBL4520283	>	IC50	nM	20000.0	CHEMBL4895	Homo sapiens	IC50	uM	20.0
	18933929	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	Cc1cc(Cl)ccc1Nc1ncc(C(F)(F)F)c(N2Cc3cccc(N(C)S(C)(=O)=O)c3C2)n1		CHEMBL4461185	>	IC50	nM	20000.0	CHEMBL4895	Homo sapiens	IC50	uM	20.0
	18933930	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	Cc1cc(F)ccc1Nc1ncc(C(F)(F)F)c(N2Cc3cccc(N(C)S(C)(=O)=O)c3C2)n1		CHEMBL4448090	=	IC50	nM	9100.0	CHEMBL4895	Homo sapiens	IC50	uM	9.1
	18933931	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	Cc1ccc(Nc2ncc(C(F)(F)F)c(N3Cc4cccc(N(C)S(C)(=O)=O)c4C3)n2)c(Cl)c1		CHEMBL4553517	>	IC50	nM	20000.0	CHEMBL4895	Homo sapiens	IC50	uM	20.0
	18933932	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	CN(c1cccc2c1CN(c1nc(Nc3cccc(C(F)(F)F)c3)ncc1C(F)(F)F)C2)S(C)(=O)=O		CHEMBL4558560	=	IC50	nM	1500.0	CHEMBL4895	Homo sapiens	IC50	uM	1.5
	18933933	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	CN(c1cccc2c1CN(c1nc(Nc3ccc(C(F)(F)F)cc3)ncc1C(F)(F)F)C2)S(C)(=O)=O		CHEMBL4545017	>	IC50	nM	20000.0	CHEMBL4895	Homo sapiens	IC50	uM	20.0
	18933934	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	CN(c1cccc2c1CN(c1nc(Nc3cc(C(F)(F)F)cc(C(F)(F)F)c3)ncc1C(F)(F)F)C2)S(C)(=O)=O		CHEMBL4435161	>	IC50	nM	20000.0	CHEMBL4895	Homo sapiens	IC50	uM	20.0
	18933935	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	CN(c1cccc2c1CN(c1nc(Nc3cc(Cl)cc(C(F)(F)F)c3)ncc1C(F)(F)F)C2)S(C)(=O)=O		CHEMBL4550527	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	uM	30.0
	18933936	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	CN(c1cccc2c1CN(c1nc(Nc3ccc(Cl)c(C(F)(F)F)c3)ncc1C(F)(F)F)C2)S(C)(=O)=O		CHEMBL4444917	>	IC50	nM	20000.0	CHEMBL4895	Homo sapiens	IC50	uM	20.0
	18933937	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	CN(c1cccc2c1CN(c1nc(Nc3ccc(Nc4ccccc4)cc3)ncc1C(F)(F)F)C2)S(C)(=O)=O		CHEMBL4543540	>	IC50	nM	20000.0	CHEMBL4895	Homo sapiens	IC50	uM	20.0
	18933938	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	CN(c1cccc2c1CN(c1nc(Nc3cccc(Oc4ccccc4)c3)ncc1C(F)(F)F)C2)S(C)(=O)=O		CHEMBL4473075	=	IC50	nM	2600.0	CHEMBL4895	Homo sapiens	IC50	uM	2.6
	18933939	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	CN(c1cccc2c1CN(c1nc(Nc3ccccc3N3CCOCC3)ncc1C(F)(F)F)C2)S(C)(=O)=O		CHEMBL4463698	>	IC50	nM	20000.0	CHEMBL4895	Homo sapiens	IC50	uM	20.0
	18933940	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	CN(c1cccc2c1CN(c1nc(Nc3ccc(N4CCOCC4)cc3)ncc1C(F)(F)F)C2)S(C)(=O)=O		CHEMBL4445940	=	IC50	nM	0.94	CHEMBL4895	Homo sapiens	IC50	uM	0.00094
	18933941	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1		CHEMBL4476226	<	IC50	nM	0.5	CHEMBL4895	Homo sapiens	IC50	uM	0.0005
	18933942	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(C(F)(F)F)c(N2Cc3cccc(N(C)S(C)(=O)=O)c3C2)n1		CHEMBL4546231	=	IC50	nM	790.0	CHEMBL4895	Homo sapiens	IC50	uM	0.79
	18933943	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	CN(c1cccc2c1CN(c1nc(Nc3ccc4c(c3)OCO4)ncc1C(F)(F)F)C2)S(C)(=O)=O		CHEMBL4445646	=	IC50	nM	4.5	CHEMBL4895	Homo sapiens	IC50	uM	0.0045
	18933944	CHEMBL4326591	Inhibition of N-terminal His-tagged recombinant human AXL (473 to end amino acids) expressed by baculovirus in Sf9 cells using axltide substrate and ATP by ADP-Glo luminescence assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.9	CHEMBL4895	Homo sapiens	IC50	uM	0.0039
	18934070	CHEMBL4326602	Inhibition of human AXL at 10 uM using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assay relative to control	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1		CHEMBL4476226	=	Inhibition	%	92.1	CHEMBL4895	Homo sapiens	INH	%	92.1
	18934116	CHEMBL4326648	Inhibition of human AXL using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assay	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1		CHEMBL4476226	<	IC50	nM	0.5	CHEMBL4895	Homo sapiens	IC50	uM	0.0005
	18937723	CHEMBL4327591	Inhibition of human AXL assessed as residual activity at 1 uM using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	95.66	CHEMBL4895	Homo sapiens	Activity	%	95.66
	18937724	CHEMBL4327591	Inhibition of human AXL assessed as residual activity at 1 uM using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	94.79	CHEMBL4895	Homo sapiens	Activity	%	94.79
	18938432	CHEMBL4327952	Inhibition of human AXL assessed as residual activity at 100 uM using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4895	Homo sapiens	Activity	%	65.0
	18938804	CHEMBL4328316	Inhibition of human AXL using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	7.65	CHEMBL4895	Homo sapiens	IC50	10'-9M	7.65
	18946682	CHEMBL4330204	Inhibition of AXL (unknown origin)	B	COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)cc4F)c3s2)nc1		CHEMBL3989926	=	IC50	nM	1.5	CHEMBL4895	Homo sapiens	IC50	uM	0.0015
	18948042	CHEMBL4330454	Inhibition of AXL (unknown origin) using FAM-labelled peptide and ATP incubated for 10 mins by mobility shift assay	B	CCN1CCN(CCCOc2cc3nccc(Oc4c(F)cc(NC(=O)NN5C(=O)CSC5c5c(F)cccc5F)cc4F)c3cc2OC)CC1		CHEMBL4587222	=	IC50	nM	53.0	CHEMBL4895	Homo sapiens	IC50	uM	0.053
	18958675	CHEMBL4333288	Binding affinity to wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	89.0	CHEMBL4895	Homo sapiens	Activity	%	89.0
	18964080	CHEMBL4334974	Inhibition of recombinant human Axl Q764R mutant (473 to end residues) assessed as residual activity at 1 uM using KKSRGDYMTMQIG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	98.0	CHEMBL4895	Homo sapiens	Activity	%	98.0
	18964081	CHEMBL4334974	Inhibition of recombinant human Axl Q764R mutant (473 to end residues) assessed as residual activity at 1 uM using KKSRGDYMTMQIG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	101.0	CHEMBL4895	Homo sapiens	Activity	%	101.0
	18971792	CHEMBL4336802	Inhibition of recombinant human Axl Q764R mutant (473 to end residues) assessed as residual activity at 10 uM using KKSRGDYMTMQIG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	64.0	CHEMBL4895	Homo sapiens	Activity	%	64.0
	18985711	CHEMBL4340010	Inhibition of AXL (unknown origin)	B	COC[C@@H](C)Nc1cc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4475216	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	nM	10000.0
	19021456	CHEMBL4347679	Inhibition of recombinant human AXL at 20 nM using Ulight-TK peptide as substrate measured after 180 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO	Outside typical range	CHEMBL4526274	=	Inhibition	%	-14.0	CHEMBL4895	Homo sapiens	INH	%	-14.0
	19021457	CHEMBL4347680	Inhibition of recombinant human AXL at 200 nM using Ulight-TK peptide as substrate measured after 180 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	32.0	CHEMBL4895	Homo sapiens	INH	%	32.0
Not Active	19039890	CHEMBL4351751	Inhibition of recombinant human AXL Q764R mutant (473 to end residues) at 10 uM using KKSRGDYMTMQIG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Active	19041017	CHEMBL4352278	Inhibition of human AXL at 10 uM using EAIYAAPFAKKK as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	19043738	CHEMBL4353208	Inhibition of human AXL using EAIYAAPFAKKK as substrate at 0.1 uM in presence of 33P-gamma ATP by hotspot kinase assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4ccc5c(c4)OCO5)n[nH]3)cc2)CC1		CHEMBL4456471	=	Inhibition	%	107.05	CHEMBL4895	Homo sapiens	INH	%	107.05
	19059467	CHEMBL4357768	Binding affinity to wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL4895	Homo sapiens	Activity	%	100.0
	19067271	CHEMBL4360650	Inhibition of N-terminal GST-tagged human AXL (464 to 885 residues) cytoplasmic domain expressed in baculovirus expression system by ELISA	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	IC50	nM	0.73	CHEMBL4895	Homo sapiens	IC50	nM	0.73
	19090040	CHEMBL4365614	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	29.0	CHEMBL4895	Homo sapiens	Activity	%	29.0
	19091820	CHEMBL4366294	Inhibition of human AXL at 100 nM using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	25.4	CHEMBL4895	Homo sapiens	INH	%	25.4
	19092265	CHEMBL4366685	Inhibition of AXL (unknown origin) at 1 uM relative to control	B	Nc1nccc(Oc2ccc(Nc3nccc4ccn(-c5ccc(F)cc5)c(=O)c34)cc2F)c1Cl		CHEMBL4474232	=	Inhibition	%	97.0	CHEMBL4895	Homo sapiens	INH	%	97.0
	19114516	CHEMBL4371404	Binding affinity to AXL in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Kd	nM	15.0	CHEMBL4895	Homo sapiens	Kd(free)	uM	0.015
	19114533	CHEMBL4371351	Inhibition of AXL (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Efficacy	%	83.0	CHEMBL4895	Homo sapiens	Efficacy	%	83.0
	19114534	CHEMBL4371350	Inhibition of AXL (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Efficacy	%	83.0	CHEMBL4895	Homo sapiens	Efficacy	%	83.0
	19114535	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	IC50	nM	27.0	CHEMBL4895	Homo sapiens	IC50	uM	0.027
	19114536	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccc(F)cc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4458253	=	IC50	nM	380.0	CHEMBL4895	Homo sapiens	IC50	uM	0.38
	19114537	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4464365	=	IC50	nM	121.0	CHEMBL4895	Homo sapiens	IC50	uM	0.121
	19114545	CHEMBL4371476	Inhibition of AXL (unknown origin)	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4OC(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4470236	=	IC50	nM	51.0	CHEMBL4895	Homo sapiens	IC50	uM	0.051
	19114546	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4OC(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4470236	=	IC50	nM	51.0	CHEMBL4895	Homo sapiens	IC50	uM	0.051
	19114547	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4OC)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4456208	=	IC50	nM	1434.0	CHEMBL4895	Homo sapiens	IC50	uM	1.434
	19114548	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cccc(C(F)(F)F)c4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4442793	=	IC50	nM	354.0	CHEMBL4895	Homo sapiens	IC50	uM	0.354
	19114549	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4555354	=	IC50	nM	430.0	CHEMBL4895	Homo sapiens	IC50	uM	0.43
	19114550	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4591609	=	IC50	nM	218.0	CHEMBL4895	Homo sapiens	IC50	uM	0.218
	19114558	CHEMBL4371476	Inhibition of AXL (unknown origin)	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811	=	IC50	nM	21.0	CHEMBL4895	Homo sapiens	IC50	uM	0.021
	19114597	CHEMBL4371351	Inhibition of AXL (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811	=	Efficacy	%	83.0	CHEMBL4895	Homo sapiens	Efficacy	%	83.0
	19114598	CHEMBL4371350	Inhibition of AXL (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811	=	Efficacy	%	83.0	CHEMBL4895	Homo sapiens	Efficacy	%	83.0
	19114599	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811	=	IC50	nM	21.0	CHEMBL4895	Homo sapiens	IC50	uM	0.021
	19114600	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)c2cc1OCCCN1CCN(C)CC1		CHEMBL4520339	=	IC50	nM	101.0	CHEMBL4895	Homo sapiens	IC50	uM	0.101
	19114601	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	CN1CCN(CCCOc2ccc3c(Oc4ccc(NS(=O)(=O)c5ccccc5C(F)(F)F)cc4F)ccnc3c2)CC1		CHEMBL4462011	=	IC50	nM	93.0	CHEMBL4895	Homo sapiens	IC50	uM	0.093
	19114602	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	CN1CCN(CCCOc2ccc3nccc(Oc4ccc(NS(=O)(=O)c5ccccc5C(F)(F)F)cc4F)c3c2)CC1		CHEMBL4584711	=	IC50	nM	910.0	CHEMBL4895	Homo sapiens	IC50	uM	0.91
	19114603	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)c2cc1OC		CHEMBL4458636	=	IC50	nM	77.0	CHEMBL4895	Homo sapiens	IC50	uM	0.077
	19114604	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3OC)c2cc1OC		CHEMBL4452919	=	IC50	nM	1960.0	CHEMBL4895	Homo sapiens	IC50	uM	1.96
	19114605	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NS(=O)(=O)c1ccccc1C(F)(F)F		CHEMBL4522053	=	IC50	nM	289.0	CHEMBL4895	Homo sapiens	IC50	uM	0.289
	19114606	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3C)c2cc1OC		CHEMBL4451342	=	IC50	nM	2250.0	CHEMBL4895	Homo sapiens	IC50	uM	2.25
	19114607	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)c(C)c3)c2cc1OC		CHEMBL4579638	>	IC50	nM	3000.0	CHEMBL4895	Homo sapiens	IC50	uM	3.0
	19114608	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3)c2cc1OC		CHEMBL4451421	=	IC50	nM	350.0	CHEMBL4895	Homo sapiens	IC50	uM	0.35
	19114609	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4ccc(F)c(Cl)c4)c(F)c3)c2cc1OC		CHEMBL4570884	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	uM	1.0
	19114610	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4c(Cl)cccc4Cl)c(F)c3)c2cc1OC		CHEMBL4535274	=	IC50	nM	1770.0	CHEMBL4895	Homo sapiens	IC50	uM	1.77
	19114611	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4cc(Cl)ccc4Cl)c(F)c3)c2cc1OC		CHEMBL4513518	=	IC50	nM	1610.0	CHEMBL4895	Homo sapiens	IC50	uM	1.61
	19114612	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4ccccc4Cl)c(F)c3)c2cc1OC		CHEMBL4483717	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	uM	1.0
	19114613	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4cccc(F)c4)c(F)c3)c2cc1OC		CHEMBL4588339	=	IC50	nM	3010.0	CHEMBL4895	Homo sapiens	IC50	uM	3.01
	19114614	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)c(F)c3)c2cc1OC		CHEMBL4566970	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	uM	1.0
	19114615	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)c(F)c3)c2cc1OC		CHEMBL4517444	=	IC50	nM	840.0	CHEMBL4895	Homo sapiens	IC50	uM	0.84
	19114616	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4ccc(F)cc4F)c(F)c3)c2cc1OC		CHEMBL4446117	=	IC50	nM	6400.0	CHEMBL4895	Homo sapiens	IC50	uM	6.4
	19114617	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4ccccc4F)c(F)c3)c2cc1OC		CHEMBL4552903	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	uM	1.0
	19114618	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4ccccc4OC(F)(F)F)c(F)c3)c2cc1OC		CHEMBL4473808	=	IC50	nM	300.0	CHEMBL4895	Homo sapiens	IC50	uM	0.3
	19114619	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4ccccc4OC)c(F)c3)c2cc1OC		CHEMBL4556804	>	IC50	nM	3000.0	CHEMBL4895	Homo sapiens	IC50	uM	3.0
	19114620	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4cccc(C(F)(F)F)c4)c(F)c3)c2cc1OC		CHEMBL4527928	=	IC50	nM	6000.0	CHEMBL4895	Homo sapiens	IC50	uM	6.0
	19114621	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)c(F)c3)c2cc1OC		CHEMBL4545343	=	IC50	nM	360.0	CHEMBL4895	Homo sapiens	IC50	uM	0.36
	19114622	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4ccccc4C)c(F)c3)c2cc1OC		CHEMBL4539431	=	IC50	nM	2350.0	CHEMBL4895	Homo sapiens	IC50	uM	2.35
	19114623	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2nccc(Oc3ccc(NS(=O)(=O)c4ccccc4)c(F)c3)c2cc1OC		CHEMBL4450650	=	IC50	nM	2600.0	CHEMBL4895	Homo sapiens	IC50	uM	2.6
Dose-dependent effect	19114624	CHEMBL4371476	Inhibition of AXL (unknown origin)	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	19114628	CHEMBL4371476	Inhibition of AXL (unknown origin)	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	IC50	nM	27.0	CHEMBL4895	Homo sapiens	IC50	uM	0.027
	19114658	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	IC50	nM	35.0	CHEMBL4895	Homo sapiens	IC50	uM	0.035
	19114659	CHEMBL4371350	Inhibition of AXL (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Efficacy	%	83.0	CHEMBL4895	Homo sapiens	Efficacy	%	83.0
	19114660	CHEMBL4371351	Inhibition of AXL (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Efficacy	%	83.0	CHEMBL4895	Homo sapiens	Efficacy	%	83.0
	19114677	CHEMBL4371404	Binding affinity to AXL in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	6.0	CHEMBL4895	Homo sapiens	Kd(free)	uM	0.006
	19114739	CHEMBL4371476	Inhibition of AXL (unknown origin)	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	IC50	nM	35.0	CHEMBL4895	Homo sapiens	IC50	uM	0.035
	19114747	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cccc(F)c4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4556669	=	IC50	nM	388.0	CHEMBL4895	Homo sapiens	IC50	uM	0.388
	19114748	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4Cl)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4476648	=	IC50	nM	184.0	CHEMBL4895	Homo sapiens	IC50	uM	0.184
	19114749	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(Cl)ccc4Cl)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4441242	=	IC50	nM	201.0	CHEMBL4895	Homo sapiens	IC50	uM	0.201
	19114750	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(Cl)cccc4Cl)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4437340	=	IC50	nM	68.0	CHEMBL4895	Homo sapiens	IC50	uM	0.068
	19114751	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccc(F)c(Cl)c4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4460286	=	IC50	nM	202.0	CHEMBL4895	Homo sapiens	IC50	uM	0.202
	19114752	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCN1CCOCC1		CHEMBL4445932	=	IC50	nM	54.0	CHEMBL4895	Homo sapiens	IC50	uM	0.054
	19114753	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL4536115	=	IC50	nM	21.0	CHEMBL4895	Homo sapiens	IC50	uM	0.021
Active	19114754	CHEMBL4371389	Binding affinity to wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual binding level at 5 umol/L by Kinomescan method	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL4536115		Activity			CHEMBL4895	Homo sapiens	Activity		
	19114769	CHEMBL4371476	Inhibition of AXL (unknown origin)	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL4536115	=	IC50	nM	21.0	CHEMBL4895	Homo sapiens	IC50	uM	0.021
	19114774	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCCN1CCOCC1		CHEMBL4440766	=	IC50	nM	21.0	CHEMBL4895	Homo sapiens	IC50	uM	0.021
	19114775	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCCC1		CHEMBL4439964	=	IC50	nM	18.0	CHEMBL4895	Homo sapiens	IC50	uM	0.018
	19114776	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCCC1C		CHEMBL4537492	=	IC50	nM	70.0	CHEMBL4895	Homo sapiens	IC50	uM	0.07
	19114777	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCCC(C)C1		CHEMBL4581109	=	IC50	nM	31.0	CHEMBL4895	Homo sapiens	IC50	uM	0.031
	19114778	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4447225	=	IC50	nM	46.0	CHEMBL4895	Homo sapiens	IC50	uM	0.046
Active	19114779	CHEMBL4371389	Binding affinity to wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual binding level at 5 umol/L by Kinomescan method	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4447225		Activity			CHEMBL4895	Homo sapiens	Activity		
	19114794	CHEMBL4371476	Inhibition of AXL (unknown origin)	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4447225	=	IC50	nM	27.0	CHEMBL4895	Homo sapiens	IC50	uM	0.027
	19114799	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCCOC(C)=O		CHEMBL4519394	=	IC50	nM	46.0	CHEMBL4895	Homo sapiens	IC50	uM	0.046
	19114800	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCC(=O)N(C)C		CHEMBL4565101	=	IC50	nM	796.0	CHEMBL4895	Homo sapiens	IC50	uM	0.796
	19114801	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN(C)C		CHEMBL4439173	=	IC50	nM	27.0	CHEMBL4895	Homo sapiens	IC50	uM	0.027
	19114802	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCNC(=O)OC(C)(C)C		CHEMBL4578900	=	IC50	nM	170.0	CHEMBL4895	Homo sapiens	IC50	uM	0.17
	19114803	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN.Cl		CHEMBL4547776	=	IC50	nM	238.0	CHEMBL4895	Homo sapiens	IC50	uM	0.238
	19114804	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCN1CCOCC1		CHEMBL4575854	=	IC50	nM	52.0	CHEMBL4895	Homo sapiens	IC50	uM	0.052
	19114805	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL4521196	=	IC50	nM	35.0	CHEMBL4895	Homo sapiens	IC50	uM	0.035
	19114806	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCCN1CCOCC1		CHEMBL4563652	=	IC50	nM	27.0	CHEMBL4895	Homo sapiens	IC50	uM	0.027
	19114807	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCCCC1		CHEMBL4473577	=	IC50	nM	72.0	CHEMBL4895	Homo sapiens	IC50	uM	0.072
	19114808	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCCCC1C		CHEMBL4458062	=	IC50	nM	50.0	CHEMBL4895	Homo sapiens	IC50	uM	0.05
	19114809	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCCC(C)C1		CHEMBL4457733	=	IC50	nM	28.0	CHEMBL4895	Homo sapiens	IC50	uM	0.028
	19114810	CHEMBL4371350	Inhibition of AXL (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCCC(C)C1		CHEMBL4457733	=	Efficacy	%	83.0	CHEMBL4895	Homo sapiens	Efficacy	%	83.0
	19114811	CHEMBL4371351	Inhibition of AXL (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCCC(C)C1		CHEMBL4457733	=	Efficacy	%	83.0	CHEMBL4895	Homo sapiens	Efficacy	%	83.0
	19114828	CHEMBL4371476	Inhibition of AXL (unknown origin)	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCCC(C)C1		CHEMBL4457733	=	IC50	nM	28.0	CHEMBL4895	Homo sapiens	IC50	uM	0.028
	19114859	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4589698	=	IC50	nM	16.0	CHEMBL4895	Homo sapiens	IC50	uM	0.016
	19114860	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCCOC(C)=O		CHEMBL4528959	=	IC50	nM	91.0	CHEMBL4895	Homo sapiens	IC50	uM	0.091
	19114861	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCC(=O)N(C)C		CHEMBL4449680	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	uM	1.0
	19114862	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN(C)C		CHEMBL4471160	=	IC50	nM	36.0	CHEMBL4895	Homo sapiens	IC50	uM	0.036
	19114863	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCNC(=O)OC(C)(C)C		CHEMBL4475420	=	IC50	nM	120.0	CHEMBL4895	Homo sapiens	IC50	uM	0.12
	19114864	CHEMBL4371349	Inhibition of AXL (unknown origin) phosphorylation after 1 hr by ELISA	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN.Cl		CHEMBL4460986	=	IC50	nM	636.0	CHEMBL4895	Homo sapiens	IC50	uM	0.636
	19114869	CHEMBL4371476	Inhibition of AXL (unknown origin)	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	560.0	CHEMBL4895	Homo sapiens	IC50	uM	0.56
	19118519	CHEMBL4372363	Inhibition of recombinant human N-terminal His6-tagged Axl (473 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM using Axltide as substrate in presence of [gamma-33P]-ATP or [gamma-32P]-ATP relative to control	B	Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1		CHEMBL4483816	=	Inhibition	%	12.0	CHEMBL4895	Homo sapiens	INH	%	12.0
	19140686	CHEMBL4376515	Inhibition of recombinant full length human N-terminal GST-tagged AXL (473 to end residues) expressed in baculovirus infected Sf21 insect cells using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	=	IC50	nM	8.2	CHEMBL4895	Homo sapiens	IC50	nM	8.2
	19140791	CHEMBL4376555	Inhibition of recombinant full length human N-terminal GST-tagged AXL (473 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	>	Inhibition	%	80.0	CHEMBL4895	Homo sapiens	INH	%	80.0
	19144621	CHEMBL4377637	Inhibition of recombinant human AXL Q764R mutant (473 to end residues) at 1 uM using KKSRGDYMTMQIG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	71.0	CHEMBL4895	Homo sapiens	INH	%	71.0
	19148113	CHEMBL4379508	Inhibition of human recombinant Axl Q764R mutant (473 to end residues) using KKSRGDYMTMQIG as substrate measured after 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	19159295	CHEMBL4382399	Binding affinity to wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	10.0	CHEMBL4895	Homo sapiens	Activity	%	10.0
	19180964	CHEMBL4387174	Inhibition of recombinant full length human GST-tagged AXL expressed in insect expression system at 0.1 uM using tyrosine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	15.0	CHEMBL4895	Homo sapiens	INH	%	15.0
	19181190	CHEMBL4387174	Inhibition of recombinant full length human GST-tagged AXL expressed in insect expression system at 0.1 uM using tyrosine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	11.5	CHEMBL4895	Homo sapiens	INH	%	11.5
	19191230	CHEMBL4389595	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	23.0	CHEMBL4895	Homo sapiens	INH	%	23.0
	19191712	CHEMBL4389118	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	16.0	CHEMBL4895	Homo sapiens	INH	%	16.0
	19200001	CHEMBL4391221	Binding affinity to wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	5.5	CHEMBL4895	Homo sapiens	Activity	%	5.5
	19236733	CHEMBL4398806	Inhibition of AXL (unknown origin) at 100 nM relative to control	B	COc1cc2c(Nc3ccc(NC(=O)C(c4cc(F)ccc4F)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL4443483	=	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	19250396	CHEMBL4401419	Inhibition of full length human N-terminal 6His-tagged AXL expressed in baculovirus expression system at 100 nM relative to control	B	C=CS(=O)(=O)Nc1ccc2c(c1)/C(=C/c1[nH]c(C)c(C(=O)NCCN(CC)CC)c1C)C(=O)N2		CHEMBL4553725	=	Inhibition	%	81.0	CHEMBL4895	Homo sapiens	INH	%	81.0
	19266317	CHEMBL4405267	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	19275936	CHEMBL4407939	Inhibition of recombinant human AXL (473 to end residues) at 1 uM using KKSRGDYMTMQIG as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	65.0	CHEMBL4895	Homo sapiens	INH	%	65.0
	19295857	CHEMBL4412334	Inhibition of AXL (unknown origin) at 1000 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	99.8	CHEMBL4895	Homo sapiens	INH	%	99.8
	19295887	CHEMBL4412364	Inhibition of AXL (unknown origin) at 100 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	72.6	CHEMBL4895	Homo sapiens	INH	%	72.6
	19295917	CHEMBL4412394	Inhibition of AXL (unknown origin) at 10 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	42.0	CHEMBL4895	Homo sapiens	INH	%	42.0
	19367691	CHEMBL4424132	Inhibition of AXL (unknown origin) using poly (Glu, Tyr) as substrate after 60 mins by ELISA	B	CCc1nc(C(N)=O)c(Nc2ccc3c(c2)C(=O)N2CCNCC2CO3)nc1NC1CCOCC1		CHEMBL4462288	=	IC50	nM	126.0	CHEMBL4895	Homo sapiens	IC50	nM	126.0
	19367692	CHEMBL4424132	Inhibition of AXL (unknown origin) using poly (Glu, Tyr) as substrate after 60 mins by ELISA	B	CCc1nc(C(N)=O)c(Nc2ccc3c(c2)C(=O)N2CCN(C)CC2CO3)nc1NC1CCOCC1		CHEMBL4592943	=	IC50	nM	356.0	CHEMBL4895	Homo sapiens	IC50	nM	356.0
	19367693	CHEMBL4424132	Inhibition of AXL (unknown origin) using poly (Glu, Tyr) as substrate after 60 mins by ELISA	B	CCc1nc(C(N)=O)c(Nc2ccc3c(c2)C(=O)N2CCN(C(C)C)CC2CO3)nc1NC1CCOCC1		CHEMBL4475960	=	IC50	nM	216.0	CHEMBL4895	Homo sapiens	IC50	nM	216.0
	19367694	CHEMBL4424132	Inhibition of AXL (unknown origin) using poly (Glu, Tyr) as substrate after 60 mins by ELISA	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	IC50	nM	11.3	CHEMBL4895	Homo sapiens	IC50	nM	11.3
	19367695	CHEMBL4424132	Inhibition of AXL (unknown origin) using poly (Glu, Tyr) as substrate after 60 mins by ELISA	B	CCc1nc(C(N)=O)c(Nc2ccc3c(c2)CCC(N2CCCC2)CC3)nc1NC1CCOCC1		CHEMBL4576727	=	IC50	nM	1.6	CHEMBL4895	Homo sapiens	IC50	nM	1.6
	19367696	CHEMBL4424132	Inhibition of AXL (unknown origin) using poly (Glu, Tyr) as substrate after 60 mins by ELISA	B	CCc1nc(C(N)=O)c(Nc2ccc3c(c2)CCC(N2CC4CNCC4C2)CC3)nc1NC1CCOCC1		CHEMBL4578043	=	IC50	nM	2.5	CHEMBL4895	Homo sapiens	IC50	nM	2.5
	19367697	CHEMBL4424132	Inhibition of AXL (unknown origin) using poly (Glu, Tyr) as substrate after 60 mins by ELISA	B	CCc1nc(C(N)=O)c(Nc2ccc3c(c2)CCN(C2CCCC2)CC3)nc1NC1CCOCC1		CHEMBL4524568	=	IC50	nM	1.2	CHEMBL4895	Homo sapiens	IC50	nM	1.2
	19367698	CHEMBL4424132	Inhibition of AXL (unknown origin) using poly (Glu, Tyr) as substrate after 60 mins by ELISA	B	CCc1nc(C(N)=O)c(Nc2ccc3c(c2)CCN(C2CC2)CC3)nc1NC1CCOCC1		CHEMBL4581972	=	IC50	nM	8.3	CHEMBL4895	Homo sapiens	IC50	nM	8.3
	19367699	CHEMBL4424132	Inhibition of AXL (unknown origin) using poly (Glu, Tyr) as substrate after 60 mins by ELISA	B	CCc1nc(C(N)=O)c(Nc2ccc3c(c2)CCN(C2CCC(CC)C2)CC3)nc1NC1CCOCC1		CHEMBL4516515	=	IC50	nM	0.7	CHEMBL4895	Homo sapiens	IC50	nM	0.7
	19367700	CHEMBL4424132	Inhibition of AXL (unknown origin) using poly (Glu, Tyr) as substrate after 60 mins by ELISA	B	CCc1nc(C(N)=O)c(Nc2ccc3c(c2)CCN(C2CCN(C)CC2)CC3)nc1NC1CCOCC1		CHEMBL4519811	=	IC50	nM	4.5	CHEMBL4895	Homo sapiens	IC50	nM	4.5
	19367701	CHEMBL4424132	Inhibition of AXL (unknown origin) using poly (Glu, Tyr) as substrate after 60 mins by ELISA	B	CCc1nc(C(N)=O)c(Nc2ccc3c(c2)CCN(C(=O)C2(N)CC2)CC3)nc1NC1CCOCC1		CHEMBL4529955	=	IC50	nM	10.3	CHEMBL4895	Homo sapiens	IC50	nM	10.3
Dose-dependent effect	19407697	CHEMBL4426916	Inhibition of Axl in human MDA-MB-231 cells assessed as reduction in Akt phosphorylation phosphorylation level after 6 hrs by Western blot method	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(F)c1)c(C)n2C		CHEMBL4571241		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Dose-dependent effect	19407698	CHEMBL4426916	Inhibition of Axl in human MDA-MB-231 cells assessed as reduction in Akt phosphorylation phosphorylation level after 6 hrs by Western blot method	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c1)c(C)n2C		CHEMBL4513513		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Active	19407699	CHEMBL4426916	Inhibition of Axl in human MDA-MB-231 cells assessed as reduction in Akt phosphorylation phosphorylation level after 6 hrs by Western blot method	B	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2		CHEMBL3809489		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Dose-dependent effect	19407700	CHEMBL4426915	Inhibition of Axl in human MDA-MB-231 cells assessed as reduction in pAxl Tyr 702 phosphorylation level after 6 hrs by Western blot method	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(F)c1)c(C)n2C		CHEMBL4571241		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Dose-dependent effect	19407701	CHEMBL4426915	Inhibition of Axl in human MDA-MB-231 cells assessed as reduction in pAxl Tyr 702 phosphorylation level after 6 hrs by Western blot method	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c1)c(C)n2C		CHEMBL4513513		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Active	19407702	CHEMBL4426915	Inhibition of Axl in human MDA-MB-231 cells assessed as reduction in pAxl Tyr 702 phosphorylation level after 6 hrs by Western blot method	B	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2		CHEMBL3809489		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	19407722	CHEMBL4426895	Binding affinity to human AXL	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(F)c1)c(C)n2C		CHEMBL4571241	=	Kd	nM	2.7	CHEMBL4895	Homo sapiens	Kd	nM	2.7
	19407724	CHEMBL4426893	Binding affinity to human AXL by active site dependent completion binding assay	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(F)c1)c(C)n2C		CHEMBL4571241	=	Kd	nM	2.7	CHEMBL4895	Homo sapiens	Kd	nM	2.7
	19407725	CHEMBL4426893	Binding affinity to human AXL by active site dependent completion binding assay	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c1)c(C)n2C		CHEMBL4513513	=	Kd	nM	1.2	CHEMBL4895	Homo sapiens	Kd	nM	1.2
	19407726	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(F)c1)c(C)n2C		CHEMBL4571241	=	IC50	nM	4.0	CHEMBL4895	Homo sapiens	IC50	uM	0.004
	19407727	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ccnc(C(N)=O)c3Cl)c(F)c1)c(C)n2C		CHEMBL4472633	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	19407728	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ccnc(N)c3Cl)c(F)c1)c(C)n2C		CHEMBL4456472	=	IC50	nM	72.0	CHEMBL4895	Homo sapiens	IC50	uM	0.072
	19407729	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ccnc(C(N)=O)c3)c(F)c1)c(C)n2C		CHEMBL4470051	=	IC50	nM	4377.0	CHEMBL4895	Homo sapiens	IC50	uM	4.377
	19407730	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ccnc(N)c3)c(F)c1)c(C)n2C		CHEMBL4444198	=	IC50	nM	888.0	CHEMBL4895	Homo sapiens	IC50	uM	0.888
	19407731	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ccnc(Cl)c3)c(F)c1)c(C)n2C		CHEMBL4454283	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	19407732	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3cccc4occ(-c5ccccc5)c34)c(F)c1)c(C)n2C		CHEMBL4464266	=	IC50	nM	192.0	CHEMBL4895	Homo sapiens	IC50	uM	0.192
	19407733	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ccnc4[nH]cc(-c5ccccc5)c34)c(F)c1)c(C)n2C		CHEMBL4449055	=	IC50	nM	30.0	CHEMBL4895	Homo sapiens	IC50	uM	0.03
	19407734	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4[nH]cc(-c5cnn(C)c5)c34)c(F)c1)c(C)n2C		CHEMBL4468711	=	IC50	nM	34.0	CHEMBL4895	Homo sapiens	IC50	uM	0.034
	19407735	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4[nH]ccc34)c(F)c1)c(C)n2C		CHEMBL4583626	=	IC50	nM	157.0	CHEMBL4895	Homo sapiens	IC50	uM	0.157
	19407736	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	IC50	nM	6.0	CHEMBL4895	Homo sapiens	IC50	uM	0.006
	19407737	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(C)c1)c(C)n2C		CHEMBL4445294	=	IC50	nM	1120.0	CHEMBL4895	Homo sapiens	IC50	uM	1.12
	19407738	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)cc1)c(C)n2C		CHEMBL4541303	=	IC50	nM	105.0	CHEMBL4895	Homo sapiens	IC50	uM	0.105
	19407739	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)cc1F)c(C)n2C		CHEMBL4550377	=	IC50	nM	30.0	CHEMBL4895	Homo sapiens	IC50	uM	0.03
	19407740	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c1)c(-c1ccccc1)n2C		CHEMBL4588522	=	IC50	nM	78.0	CHEMBL4895	Homo sapiens	IC50	uM	0.078
	19407741	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCc1c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2cc(C)ccc2n1C		CHEMBL4445218	=	IC50	nM	78.0	CHEMBL4895	Homo sapiens	IC50	uM	0.078
	19407742	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c1)cn2C		CHEMBL4565473	=	IC50	nM	150.0	CHEMBL4895	Homo sapiens	IC50	uM	0.15
	19407743	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c1)c(C)n2-c1ccccc1		CHEMBL4437303	=	IC50	nM	620.0	CHEMBL4895	Homo sapiens	IC50	uM	0.62
	19407744	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCCCn1c(C)c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2cc(C)ccc21		CHEMBL4578200	=	IC50	nM	480.0	CHEMBL4895	Homo sapiens	IC50	uM	0.48
	19407745	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCCn1c(C)c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2cc(C)ccc21		CHEMBL4458751	=	IC50	nM	530.0	CHEMBL4895	Homo sapiens	IC50	uM	0.53
	19407746	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCn1c(C)c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2cc(C)ccc21		CHEMBL4516966	=	IC50	nM	150.0	CHEMBL4895	Homo sapiens	IC50	uM	0.15
	19407747	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1ccc2[nH]c(C)c(C(=O)Nc3ccc(Oc4ncnc5[nH]cc(-c6ccccc6)c45)c(F)c3)c(=O)c2c1		CHEMBL4459999	=	IC50	nM	560.0	CHEMBL4895	Homo sapiens	IC50	uM	0.56
	19407748	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	COC(=O)c1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c1)c(C)n2C		CHEMBL4474599	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	19407749	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2cc(OC(F)(F)F)ccc2n1C		CHEMBL4549099	=	IC50	nM	74.0	CHEMBL4895	Homo sapiens	IC50	uM	0.074
	19407750	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	COc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c1)c(C)n2C		CHEMBL4593206	=	IC50	nM	99.0	CHEMBL4895	Homo sapiens	IC50	uM	0.099
	19407751	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2cc3ccccc3cc2n1C		CHEMBL4558343	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	19407752	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2cc(-c3ccccc3)ccc2n1C		CHEMBL4445176	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	19407753	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2cc(C3=CCCC3)ccc2n1C		CHEMBL4548071	=	IC50	nM	3320.0	CHEMBL4895	Homo sapiens	IC50	uM	3.32
	19407754	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2cc(C3CCCC3)ccc2n1C		CHEMBL4566072	=	IC50	nM	200.0	CHEMBL4895	Homo sapiens	IC50	uM	0.2
	19407755	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2cc(C(C)(C)C)ccc2n1C		CHEMBL4473545	=	IC50	nM	42.0	CHEMBL4895	Homo sapiens	IC50	uM	0.042
	19407756	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c1)c(C)n2C		CHEMBL4517938	=	IC50	nM	61.0	CHEMBL4895	Homo sapiens	IC50	uM	0.061
	19407757	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	C=C(C)c1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c1)c(C)n2C		CHEMBL4515742	=	IC50	nM	170.0	CHEMBL4895	Homo sapiens	IC50	uM	0.17
	19407758	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2cc(C(C)C)ccc2n1C		CHEMBL4449888	=	IC50	nM	26.0	CHEMBL4895	Homo sapiens	IC50	uM	0.026
	19407759	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2cc(C3CC3)ccc2n1C		CHEMBL4470280	=	IC50	nM	230.0	CHEMBL4895	Homo sapiens	IC50	uM	0.23
	19407760	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c1)c(C)n2C		CHEMBL4513513	=	IC50	nM	6.0	CHEMBL4895	Homo sapiens	IC50	uM	0.006
	19407761	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c1)c(C)n2C		CHEMBL4469879	=	IC50	nM	100.0	CHEMBL4895	Homo sapiens	IC50	uM	0.1
	19407762	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2cc(C(F)(F)F)ccc2n1C		CHEMBL4471186	=	IC50	nM	150.0	CHEMBL4895	Homo sapiens	IC50	uM	0.15
	19407763	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2cc(Br)ccc2n1C		CHEMBL4458533	=	IC50	nM	3120.0	CHEMBL4895	Homo sapiens	IC50	uM	3.12
	19407764	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2cc(F)ccc2n1C		CHEMBL4454276	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	19407765	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2ccc(Cl)cc2n1C		CHEMBL4470872	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	19407766	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2cc(Cl)ccc2n1C		CHEMBL4558601	=	IC50	nM	1890.0	CHEMBL4895	Homo sapiens	IC50	uM	1.89
	19407767	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2c(Cl)cccc2n1C		CHEMBL4452895	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	19407768	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Cc1c(C(=O)Nc2ccc(Oc3ncnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)c2ccccc2n1C		CHEMBL4453884	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	19407769	CHEMBL4426892	Inhibition of human recombinant AXL incubated for 1 to 1.5 hrs by FRET based Z'-Lyte kinase assay	B	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2		CHEMBL3809489	=	IC50	nM	5.0	CHEMBL4895	Homo sapiens	IC50	uM	0.005
	19407770	CHEMBL4426890	Inhibition of Axl (unknown origin)	B	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2		CHEMBL3809489	=	IC50	nM	14.0	CHEMBL4895	Homo sapiens	IC50	nM	14.0
	19407772	CHEMBL4426890	Inhibition of Axl (unknown origin)	B	Cc1c(C(=O)Nc2ccc(Oc3ccnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)n1C		CHEMBL3810063	=	IC50	nM	10.3	CHEMBL4895	Homo sapiens	IC50	nM	10.3
Dose-dependent effect	19407782	CHEMBL4426937	Inhibition of TGFbeta1-induced AXL activation in human MDA-MB-231 cells by Western blot method	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(F)c1)c(C)n2C		CHEMBL4571241		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	19475347	CHEMBL4479442	Inhibition of human AXL	B	C[C@@H](c1cc2cccnc2cc1F)n1cnc2ncc(-c3cnn(C)c3)nc21		CHEMBL4068255	>	IC50	nM	30000.0	CHEMBL4895	Homo sapiens	IC50	nM	30000.0
	20600467	CHEMBL4603282	Inhibition of recombinant full length human GST-tagged AXL expressed in insect expression system using tyrosine-6 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL4895	Homo sapiens	IC50	uM	100.0
	20683590	CHEMBL4623612	Inhibition of AXL (unknown origin) at 10 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl		CHEMBL4644985	=	Inhibition	%	17.0	CHEMBL4895	Homo sapiens	INH	%	17.0
	20683634	CHEMBL4623613	Inhibition of AXL (unknown origin) at 100 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl		CHEMBL4644985	=	Inhibition	%	75.0	CHEMBL4895	Homo sapiens	INH	%	75.0
	22391803	CHEMBL4667007	Inhibition of recombinant human GST-tagged full length AXL expressed in insect expression system using Tyr 06 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12	Outside typical range	CHEMBL4744172	=	Inhibition	%	-12.0	CHEMBL4895	Homo sapiens	INH	%	-12.0
	22391804	CHEMBL4667007	Inhibition of recombinant human GST-tagged full length AXL expressed in insect expression system using Tyr 06 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	5.0	CHEMBL4895	Homo sapiens	INH	%	5.0
	22391805	CHEMBL4667007	Inhibition of recombinant human GST-tagged full length AXL expressed in insect expression system using Tyr 06 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	0.0	CHEMBL4895	Homo sapiens	INH	%	0.0
	22391927	CHEMBL4667078	Inhibition of recombinant human GST-tagged full length AXL expressed in insect expression system using Tyr 06 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	6.5	CHEMBL4895	Homo sapiens	INH	%	6.5
	22421708	CHEMBL4673682	Inhibition of human AXL using poly [Glu, Tyr] 4:1 as substrate in presence of [gamma33P]-ATP by radioisotope-based assay	B	c1cc2cc(c1)Cn1cc(nn1)Cn1nc(-c3ccc(N4CCNCC4)nc3)c3cnc(nc31)NCc1cn(nn1)C2		CHEMBL4761353	=	IC50	nM	13000.0	CHEMBL4895	Homo sapiens	IC50	uM	13.0
	22423120	CHEMBL4674133	Inhibition of human AXL using EAIYAAPFAKKK as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL4895	Homo sapiens	INH	%	80.0
	22423817	CHEMBL4674484	Inhibition of human AXL using EAIYAAPFAKKK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	18.53	CHEMBL4895	Homo sapiens	Activity	%	18.53
	22423818	CHEMBL4674484	Inhibition of human AXL using EAIYAAPFAKKK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	19.54	CHEMBL4895	Homo sapiens	Activity	%	19.54
	22458712	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4nnc(-c5ccc(F)cc5)o4)cc3)c2cc1OC		CHEMBL4800154	=	Inhibition	%	-2.0	CHEMBL4895	Homo sapiens	INH	%	-2.0
	22458713	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4ncc(-c5ccc(F)cc5)o4)cc3)c2cc1OC		CHEMBL4788023	=	Inhibition	%	21.5	CHEMBL4895	Homo sapiens	INH	%	21.5
	22458714	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4nc(-c5ccc(F)cc5)no4)cc3)c2cc1OC		CHEMBL4743290	=	Inhibition	%	-4.5	CHEMBL4895	Homo sapiens	INH	%	-4.5
	22458715	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cc(-c5ccc(F)cc5)on4)cc3)c2cc1OC		CHEMBL4764683	=	Inhibition	%	-2.2	CHEMBL4895	Homo sapiens	INH	%	-2.2
	22458716	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)c4nnc(-c5ccc(F)cc5)o4)cc3)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4782585	=	Inhibition	%	73.2	CHEMBL4895	Homo sapiens	INH	%	73.2
	22458717	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)c4ncc(-c5ccc(F)cc5)o4)cc3)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4743013	=	Inhibition	%	80.9	CHEMBL4895	Homo sapiens	INH	%	80.9
	22458718	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)c4nc(-c5ccc(F)cc5)no4)cc3)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4800644	=	Inhibition	%	36.6	CHEMBL4895	Homo sapiens	INH	%	36.6
	22458719	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)c4cc(-c5ccc(F)cc5)on4)cc3)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4799751	=	Inhibition	%	11.0	CHEMBL4895	Homo sapiens	INH	%	11.0
	22458720	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	Inhibition	%	93.0	CHEMBL4895	Homo sapiens	INH	%	93.0
Not Determined	22458721	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	22458722	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)Cc4nc(-c5ccc(F)cc5)no4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4762896	=	Inhibition	%	68.0	CHEMBL4895	Homo sapiens	INH	%	68.0
	22458723	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)Cc4ncc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4791910	=	Inhibition	%	83.1	CHEMBL4895	Homo sapiens	INH	%	83.1
	22458724	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)Cc4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4785680	=	Inhibition	%	88.1	CHEMBL4895	Homo sapiens	INH	%	88.1
	22458725	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)Cc4ncc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL4764400	=	Inhibition	%	24.0	CHEMBL4895	Homo sapiens	INH	%	24.0
	22458726	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)Cc4ncc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4757797	=	Inhibition	%	55.5	CHEMBL4895	Homo sapiens	INH	%	55.5
	22458727	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)Cc4ncc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCCC1		CHEMBL4780245	=	Inhibition	%	49.0	CHEMBL4895	Homo sapiens	INH	%	49.0
	22458728	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)Cc4ncc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCCCC1		CHEMBL4747674	=	Inhibition	%	37.0	CHEMBL4895	Homo sapiens	INH	%	37.0
	22458729	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)Cc4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL4751800	=	Inhibition	%	27.5	CHEMBL4895	Homo sapiens	INH	%	27.5
	22458730	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)Cc4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4755347	=	Inhibition	%	66.0	CHEMBL4895	Homo sapiens	INH	%	66.0
	22458731	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)Cc4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCCC1		CHEMBL4756808	=	Inhibition	%	61.5	CHEMBL4895	Homo sapiens	INH	%	61.5
	22458732	CHEMBL4682575	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 1 uM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)Cc4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCCCC1		CHEMBL4795187	=	Inhibition	%	58.5	CHEMBL4895	Homo sapiens	INH	%	58.5
	22458761	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Inhibition	%	88.0	CHEMBL4895	Homo sapiens	INH	%	88.0
Not Determined	22458762	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)Cc4nnc(-c5ccc(Br)cc5)o4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4748369		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Determined	22458763	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)Cc4nnc(-c5ccc(Cl)cc5)o4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4740310		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Determined	22458764	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)Cc4nnc(-c5ccccc5)o4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4792326		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Not Determined	22458765	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1ccc(-c2nnc(CC(=O)Nc3ccc(Oc4ccnc5cc(OCCCN6CCC(C)CC6)c(OC)cc45)c(F)c3)o2)cc1		CHEMBL4758666		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	22458766	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C(C)c4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4776125	=	Inhibition	%	83.2	CHEMBL4895	Homo sapiens	INH	%	83.2
	22458767	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C(C)c4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL4760831	=	Inhibition	%	47.9	CHEMBL4895	Homo sapiens	INH	%	47.9
	22458768	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C(C)c4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4792655	=	Inhibition	%	80.0	CHEMBL4895	Homo sapiens	INH	%	80.0
	22458769	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C(C)c4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCCC1		CHEMBL4779007	=	Inhibition	%	79.3	CHEMBL4895	Homo sapiens	INH	%	79.3
	22458770	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C(C)c4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCCCC1		CHEMBL4740711	=	Inhibition	%	69.7	CHEMBL4895	Homo sapiens	INH	%	69.7
	22458771	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	CCC(C(=O)Nc1ccc(Oc2ccnc3cc(OCCCN4CCC(C)CC4)c(OC)cc23)c(F)c1)c1nnc(-c2ccc(F)cc2)o1		CHEMBL4762473	=	Inhibition	%	78.7	CHEMBL4895	Homo sapiens	INH	%	78.7
	22458772	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	CCC(C(=O)Nc1ccc(Oc2ccnc3cc(OCCCN4CCOCC4)c(OC)cc23)c(F)c1)c1nnc(-c2ccc(F)cc2)o1		CHEMBL4796611	=	Inhibition	%	48.9	CHEMBL4895	Homo sapiens	INH	%	48.9
	22458773	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	CCC(C(=O)Nc1ccc(Oc2ccnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(F)c1)c1nnc(-c2ccc(F)cc2)o1		CHEMBL4794218	=	Inhibition	%	76.0	CHEMBL4895	Homo sapiens	INH	%	76.0
	22458774	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	CCC(C(=O)Nc1ccc(Oc2ccnc3cc(OCCCN4CCCC4)c(OC)cc23)c(F)c1)c1nnc(-c2ccc(F)cc2)o1		CHEMBL4758043	=	Inhibition	%	75.3	CHEMBL4895	Homo sapiens	INH	%	75.3
	22458775	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	CCC(C(=O)Nc1ccc(Oc2ccnc3cc(OCCCN4CCCCC4)c(OC)cc23)c(F)c1)c1nnc(-c2ccc(F)cc2)o1		CHEMBL4786978	=	Inhibition	%	80.1	CHEMBL4895	Homo sapiens	INH	%	80.1
	22458776	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C(C)(C)c4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4760214	=	Inhibition	%	69.9	CHEMBL4895	Homo sapiens	INH	%	69.9
	22458777	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C(C)(C)c4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL4740248	=	Inhibition	%	42.7	CHEMBL4895	Homo sapiens	INH	%	42.7
	22458778	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C(C)(C)c4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4753965	=	Inhibition	%	76.3	CHEMBL4895	Homo sapiens	INH	%	76.3
	22458779	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C(C)(C)c4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCCC1		CHEMBL4778116	=	Inhibition	%	70.3	CHEMBL4895	Homo sapiens	INH	%	70.3
	22458780	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C(C)(C)c4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCCCC1		CHEMBL4758972	=	Inhibition	%	73.7	CHEMBL4895	Homo sapiens	INH	%	73.7
	22458781	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C4(c5nnc(-c6ccc(F)cc6)o5)CC4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4749425	=	Inhibition	%	87.9	CHEMBL4895	Homo sapiens	INH	%	87.9
	22458782	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C4(c5nnc(-c6ccc(F)cc6)o5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL4800423	=	Inhibition	%	42.7	CHEMBL4895	Homo sapiens	INH	%	42.7
	22458783	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C4(c5nnc(-c6ccc(F)cc6)o5)CC4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4796782	=	Inhibition	%	82.3	CHEMBL4895	Homo sapiens	INH	%	82.3
	22458784	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C4(c5nnc(-c6ccc(F)cc6)o5)CC4)cc3F)ccnc2cc1OCCCN1CCCC1		CHEMBL4792266	=	Inhibition	%	79.3	CHEMBL4895	Homo sapiens	INH	%	79.3
	22458785	CHEMBL4682580	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system at 100 nM using CSKtide as substrate measured after 1 hr by mobility shift assay relative to control	B	COc1cc2c(Oc3ccc(NC(=O)C4(c5nnc(-c6ccc(F)cc6)o5)CC4)cc3F)ccnc2cc1OCCCN1CCCCC1		CHEMBL4764463	=	Inhibition	%	93.7	CHEMBL4895	Homo sapiens	INH	%	93.7
	22458799	CHEMBL4682586	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system using CSKtide as substrate measured after 1 hr by mobility shift assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	14.0	CHEMBL4895	Homo sapiens	IC50	uM	0.013999999999999999
	22458800	CHEMBL4682586	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system using CSKtide as substrate measured after 1 hr by mobility shift assay	B	COc1cc2c(Oc3ccc(NC(=O)C(C)c4nnc(-c5ccc(F)cc5)o4)cc3F)ccnc2cc1OCCCN1CCC(C)CC1		CHEMBL4776125	=	IC50	nM	36.0	CHEMBL4895	Homo sapiens	IC50	uM	0.036000000000000004
	22458801	CHEMBL4682586	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system using CSKtide as substrate measured after 1 hr by mobility shift assay	B	CCC(C(=O)Nc1ccc(Oc2ccnc3cc(OCCCN4CCC(C)CC4)c(OC)cc23)c(F)c1)c1nnc(-c2ccc(F)cc2)o1		CHEMBL4762473	=	IC50	nM	77.0	CHEMBL4895	Homo sapiens	IC50	uM	0.077
	22458802	CHEMBL4682586	Inhibition of human N-terminal GST-fused Axl cytoplasmic domain (464 to 885 residues) expressed in baculovirus expression system using CSKtide as substrate measured after 1 hr by mobility shift assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(c5nnc(-c6ccc(F)cc6)o5)CC4)cc3F)ccnc2cc1OCCCN1CCCCC1		CHEMBL4764463	=	IC50	nM	10.0	CHEMBL4895	Homo sapiens	IC50	uM	0.01
	22472876	CHEMBL4685516	Inhibition of AXL (unknown origin) at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins by HTRF assay relative to control	B	CC(C)(O)COc1ccc2c(Oc3ccc(Nc4nccc5[nH]cc(-c6ccccc6)c(=O)c45)cc3F)ccnc2c1		CHEMBL4747900	>	Inhibition	%	80.0	CHEMBL4895	Homo sapiens	INH	%	80.0
	22472882	CHEMBL4685522	Inhibition of AXL (unknown origin) using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins by HTRF assay	B	CC(C)(O)COc1ccc2c(Oc3ccc(Nc4nccc5[nH]cc(-c6ccccc6)c(=O)c45)cc3F)ccnc2c1		CHEMBL4747900	=	IC50	nM	32.3	CHEMBL4895	Homo sapiens	IC50	nM	32.3
	22478018	CHEMBL4686591	Inhibition of Axl (unknown origin)	B	COc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL4753082	=	IC50	nM	1.1	CHEMBL4895	Homo sapiens	IC50	nM	1.1
	22788905	CHEMBL4709111	Inhibition of AXL (unknown origin) using FAM-labelled peptide and ATP incubated for 10 mins by mobility shift assay	B	COc1cc2c(Oc3ccc(NC(=O)NN4C(=O)CSC4c4c(F)cccc4F)cc3)ccnc2cc1OC1CCN(C(=O)NC(C)C)CC1		CHEMBL4781937	=	IC50	nM	632.0	CHEMBL4895	Homo sapiens	IC50	uM	0.632
	22790971	CHEMBL4709476	Inhibition of AXL (unknown origin) assessed as residual activity at 0.1 uM preincubated for 20 min followed by [gamma33P]ATP addition and measured after 120 mins by Hotspot assay relative to control	B	Cc1cccn(-c2ccc(-c3ccc4c(C(=O)NCc5ccncc5)n[nH]c4c3)c(Cl)c2)c1=O		CHEMBL4758500	=	Activity	%	88.41	CHEMBL4895	Homo sapiens	Activity	%	88.41
	22810004	CHEMBL4713441	Inhibition of AXL (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	7.0	CHEMBL4895	Homo sapiens	IC50	nM	7.0
	22818093	CHEMBL4715316	Inhibition of recombinant N-terminal His6-tagged human AXL (473 to end residues) expressed in Sf21 insect cells at 2 uM using Axl-tide as substrate relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL4895	Homo sapiens	INH	%	50.0
	22820434	CHEMBL4716219	Inhibition of recombinant human AXL assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	106.0	CHEMBL4895	Homo sapiens	Activity	%	106.0
	22820435	CHEMBL4716219	Inhibition of recombinant human AXL assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	9.0	CHEMBL4895	Homo sapiens	Activity	%	9.0
	22837414	CHEMBL4719088	Inhibition of recombinant His-tagged human AXL (473 to end residues) expressed in insect cells at 10 uM by TR-FRET assay relative to control	B	C/C1=C\[C@H](OC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C[C@](C)(O)/C=C/[C@H](C(C)C)CC/C(C)=C/CC1		CHEMBL4756514	=	Inhibition	%	11.0	CHEMBL4895	Homo sapiens	INH	%	11.0
	22843493	CHEMBL4720490	Inhibition of human AXL assessed as residual activity using EAIYAAPFAKKK as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	95.77	CHEMBL4895	Homo sapiens	Activity	%	95.77
	22843842	CHEMBL4720828	Inhibition of human AXL using EAIYAAPFAKKK as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	11.0	CHEMBL4895	Homo sapiens	IC50	10^-8M	1.1
	22844627	CHEMBL4721302	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	93.93	CHEMBL4895	Homo sapiens	Activity	%	93.93
Not Active	22889487	CHEMBL4729006	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	22934075	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	Cc1c(C(=O)Nc2ccc(Oc3ccnc4[nH]cc(-c5ccccc5)c34)c(F)c2)c(=O)n(-c2ccc(F)cc2)n1C		CHEMBL3810063	=	IC50	nM	3.162	CHEMBL4895	Homo sapiens	pIC50		8.5
	22934076	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	COc1cc2ncnc(Nc3cnc(OCCC4CC4)nc3)c2cc1OCC1CCNCC1		CHEMBL4749779	=	IC50	nM	3162.28	CHEMBL4895	Homo sapiens	pIC50		5.5
	22934077	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	COc1cc2c(Nc3cnc(OCCCC4CCCC4)nc3)ncnc2cc1OCCCN1CCCCC1		CHEMBL4777640	=	IC50	nM	10.0	CHEMBL4895	Homo sapiens	pIC50		8.0
	22934078	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	C[C@@H]1CN(c2cnc(Nc3cc(F)c(OCC4CC4)c(F)c3)nc2NC2CCOCC2)CCN1		CHEMBL4756823	=	IC50	nM	1584.89	CHEMBL4895	Homo sapiens	pIC50		5.8
	22934079	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	O=S(=O)(c1ccc(Nc2ncc(N3CCOCC3)c(Nc3ccccc3)n2)cc1)N1CCCCC1		CHEMBL4750302	=	IC50	nM	199.53	CHEMBL4895	Homo sapiens	pIC50		6.7
	22934080	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	CS(=O)(=O)c1cnc(Nc2ccc(O)cc2)nc1NCc1ccccc1		CHEMBL4759323	=	IC50	nM	1584.89	CHEMBL4895	Homo sapiens	pIC50		5.8
	22934081	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	CNc1nc(OCC2CCC2)nc2c1ncn2Cc1c(F)cccc1F		CHEMBL4786113	=	IC50	nM	1584.89	CHEMBL4895	Homo sapiens	pIC50		5.8
	22934082	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	O=C(Nc1ccc(Oc2cc(NC(=O)C3CC3)ncn2)cc1)Nc1ccc(CN2CCn3ccnc3C2)c(C(F)(F)F)c1		CHEMBL4746916	=	IC50	nM	398.11	CHEMBL4895	Homo sapiens	pIC50		6.4
	22934083	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	CNC(=O)c1sc(N2CC3CC2(CNC(=O)c2c[nH]c4ncc(Cl)cc24)C3)nc1C(F)(F)F		CHEMBL4744243	=	IC50	nM	10.0	CHEMBL4895	Homo sapiens	pIC50		8.0
	22934084	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	CNC(=O)C[C@@H](NC(=O)[C@@H](CCc1ccccc1)NC(=O)c1c(C)noc1-c1snnc1C)c1ccc(C(F)(F)F)cc1		CHEMBL4746146	=	IC50	nM	15.85	CHEMBL4895	Homo sapiens	pIC50		7.8
	22934085	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(-c3ccccc3Cl)cc2)o1		CHEMBL4754609	=	IC50	nM	398.11	CHEMBL4895	Homo sapiens	pIC50		6.4
	22934086	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	CNC(=O)c1sc(N2CC3CC2(CNC(=O)c2c[nH]c4ncc(C)cc24)C3)nc1C(F)(F)F		CHEMBL4782810	=	IC50	nM	3.981	CHEMBL4895	Homo sapiens	pIC50		8.4
	22934087	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	CNC(=O)c1sc(N2CC3CC2(CNC(=O)c2c[nH]c4ncc(C(F)(F)F)cc24)C3)nc1C(F)(F)F		CHEMBL4747462	=	IC50	nM	25.12	CHEMBL4895	Homo sapiens	pIC50		7.6
	22934088	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	CNC(=O)c1sc(N2CC3CC2(CNC(=O)c2c[nH]c4ncccc24)C3)nc1C(F)(F)F		CHEMBL4740965	=	IC50	nM	10.0	CHEMBL4895	Homo sapiens	pIC50		8.0
	22934089	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	CN(Cc1ccc2c(c1)CCCO2)c1nnc(-c2ccc(-c3ccccc3Cl)cc2)o1		CHEMBL4751490	=	IC50	nM	398.11	CHEMBL4895	Homo sapiens	pIC50		6.4
	22934090	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(-c3ccccc3Cl)nc2)o1		CHEMBL4755626	=	IC50	nM	3162.28	CHEMBL4895	Homo sapiens	pIC50		5.5
	22934091	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(OC3CCCC3)cc2)o1		CHEMBL4799967	=	IC50	nM	3981.07	CHEMBL4895	Homo sapiens	pIC50		5.4
	22934092	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	CN(Cc1ccc2nccn2c1)c1nnc(-c2ncc(C(F)(F)F)cc2Cl)o1		CHEMBL4797582	<	IC50	nM	100000.0	CHEMBL4895	Homo sapiens	pIC50		4.0
	22934093	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	Cc1cc(N(C)C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4783293	=	IC50	nM	15848.93	CHEMBL4895	Homo sapiens	pIC50		4.8
	22934094	CHEMBL4739197	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis	B	CCn1c(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)nc2ccccc21		CHEMBL4786015	=	IC50	nM	39810.72	CHEMBL4895	Homo sapiens	pIC50		4.4
	22934253	CHEMBL4739205	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 40 mins by ADP-Glo Reagent based method	B	COc1cc2c(Nc3cnc(NC(=O)c4cccn4C)nc3)ncnc2cc1OCCCNC1CCCC1		CHEMBL4751475	=	IC50	nM	125.89	CHEMBL4895	Homo sapiens	pIC50		6.9
	22934254	CHEMBL4739205	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 40 mins by ADP-Glo Reagent based method	B	CNC(=O)c1cnc(Nc2ccc(OC)cc2C)nc1NC1CCCC1		CHEMBL4788254	=	IC50	nM	31622.78	CHEMBL4895	Homo sapiens	pIC50		4.5
	22934255	CHEMBL4739205	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 40 mins by ADP-Glo Reagent based method	B	CNc1nc(OC2CCCC2)nc2c1ncn2Cc1c(F)cccc1F		CHEMBL4758206	=	IC50	nM	794.33	CHEMBL4895	Homo sapiens	pIC50		6.1
	22934260	CHEMBL4739208	Inhibition of GST-tagged AXL (unknown origin) (464 to 485 residues) at 1 uM using Axltide (CKKSRGDYMTMQJG-acid) peptide as substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration measured after 180 mins by RapidFire LC-MS analysis relative to control	B	CNC(=O)c1sc(N2CC3CC2(CNC(=O)c2c[nH]c4ncc(Cl)cc24)C3)nc1C(F)(F)F		CHEMBL4744243	>	Inhibition	%	75.0	CHEMBL4895	Homo sapiens	INH	%	75.0
	22952760	CHEMBL4766697	Inhibition of recombinant human Axl (473 to end residues) assessed as residual activity at 10 uM using KKSRGDYMTMQIG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	6.0	CHEMBL4895	Homo sapiens	Activity	%	6.0
	22953083	CHEMBL4767020	Inhibition of recombinant human Axl (473 to end residues) using KKSRGDYMTMQIG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	708.0	CHEMBL4895	Homo sapiens	IC50	uM	0.708
	22987251	CHEMBL4774503	Inhibition of Axl (unknown origin)	B	COc1cc2ncnc(Oc3ccc(Nc4nccc5[nH]cc(-c6ccc(F)cc6)c(=O)c45)cc3F)c2cc1OC		CHEMBL4794496	=	IC50	nM	11.0	CHEMBL4895	Homo sapiens	IC50	nM	11.0
	23122453	CHEMBL4804804	Inhibition of human AXL assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	95.0	CHEMBL4895	Homo sapiens	Activity	%	95.0
	23123148	CHEMBL4805392	Inhibition of human AXL assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	94.0	CHEMBL4895	Homo sapiens	Activity	%	94.0
	23123738	CHEMBL4805982	Inhibition of DNA-tagged human AXL assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	90.0	CHEMBL4895	Homo sapiens	Activity	%	90.0
	23124251	CHEMBL4806324	Inhibition of AXL (unknown origin) at 10 uM relative to control	B	Cn1cc(-n2cnc3c(NCc4nc5cc(Cl)c(Cl)cc5[nH]4)nc(N4CCOCC4)nc32)cn1		CHEMBL4877117	=	Inhibition	%	7.0	CHEMBL4895	Homo sapiens	INH	%	7.0
	23124386	CHEMBL4806409	Inhibition of human AXL assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	99.0	CHEMBL4895	Homo sapiens	Activity	%	99.0
	23124387	CHEMBL4806409	Inhibition of human AXL assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	96.0	CHEMBL4895	Homo sapiens	Activity	%	96.0
	23127831	CHEMBL4807752	Inhibition of AXL (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL4895	Homo sapiens	Activity	%	75.0
	23127832	CHEMBL4807752	Inhibition of AXL (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	50.0	CHEMBL4895	Homo sapiens	Activity	%	50.0
	23127833	CHEMBL4807752	Inhibition of AXL (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL4895	Homo sapiens	Activity	%	75.0
	23128797	CHEMBL4808064	Inhibition of AXL (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)[nH]c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4874174	=	Inhibition	%	91.0	CHEMBL4895	Homo sapiens	INH	%	91.0
	23128798	CHEMBL4808064	Inhibition of AXL (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(S(C)(=O)=O)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4850066	=	Inhibition	%	83.0	CHEMBL4895	Homo sapiens	INH	%	83.0
	23128799	CHEMBL4808064	Inhibition of AXL (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(C(F)(F)F)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4870763	=	Inhibition	%	52.0	CHEMBL4895	Homo sapiens	INH	%	52.0
	23128800	CHEMBL4808064	Inhibition of AXL (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)n(CCN(C)C)c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4847460	=	Inhibition	%	64.0	CHEMBL4895	Homo sapiens	INH	%	64.0
	23208877	CHEMBL4822240	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	CCc1cc(NC(=O)[C@H](O)c2cc(F)cc(F)c2)ccc1-c1cnc(N)c(C(=O)NC(C)C)c1		CHEMBL4857782	=	Activity	%	70.0	CHEMBL4895	Homo sapiens	Activity	%	70.0
	23208878	CHEMBL4822240	Inhibition of wild-type human partial length AXL (R497 to Y821 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Cc1cccc(CC(=O)N2CCc3c2ccc(-c2cn(C)c4ncnc(N)c24)c3F)n1		CHEMBL2441340	=	Activity	%	8.2	CHEMBL4895	Homo sapiens	Activity	%	8.2
	23209547	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)CN(C)C)c3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4873958	=	IC50	nM	11.0	CHEMBL4895	Homo sapiens	IC50	nM	11.0
	23209548	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)CC4CCN(C)CC4)c3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4865592	=	IC50	nM	0.65	CHEMBL4895	Homo sapiens	IC50	nM	0.65
	23209549	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)CC4CCN(C)CC4)c3)cc2F)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4848604	=	IC50	nM	0.81	CHEMBL4895	Homo sapiens	IC50	nM	0.81
	23209550	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CN1CCC(CC(=O)Nc2cc(Oc3ccc(NC(=O)c4cn(C5CC5)c(=O)n(-c5ccc(F)cc5)c4=O)cc3F)ccn2)CC1		CHEMBL4865438	=	IC50	nM	2.5	CHEMBL4895	Homo sapiens	IC50	nM	2.5
	23209551	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CN1CCC(CC(=O)Nc2cc(Oc3ccc(NC(=O)c4cn(C5CCCC5)c(=O)n(-c5ccc(F)cc5)c4=O)cc3F)ccn2)CC1		CHEMBL4867696	=	IC50	nM	1.1	CHEMBL4895	Homo sapiens	IC50	nM	1.1
	23209552	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CN1CCC(CC(=O)Nc2cc(Oc3ccc(NC(=O)c4cc5c(n(-c6ccccc6)c4=O)CCCC5=O)cc3)ccn2)CC1		CHEMBL4867578	=	IC50	nM	6.8	CHEMBL4895	Homo sapiens	IC50	nM	6.8
	23209553	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CN1CCC(CC(=O)Nc2cc(Oc3ccc(NC(=O)c4cc5c(n(-c6ccccc6)c4=O)CCCC5=O)cc3F)ccn2)CC1		CHEMBL4869320	=	IC50	nM	6.9	CHEMBL4895	Homo sapiens	IC50	nM	6.9
	23209554	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CN1CCC(CC(=O)Nc2cc(Oc3ccc(NC(=O)c4cc5c(n(-c6ccccc6)c4=O)CCCC5=O)c(F)c3)ccn2)CC1		CHEMBL4862542	=	IC50	nM	4.2	CHEMBL4895	Homo sapiens	IC50	nM	4.2
	23209555	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CN1CCC(CC(=O)Nc2cc(Oc3cc(F)c(NC(=O)c4cc5c(n(-c6ccccc6)c4=O)CCCC5=O)cc3F)ccn2)CC1		CHEMBL4864389	=	IC50	nM	2.3	CHEMBL4895	Homo sapiens	IC50	nM	2.3
	23209556	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CC(C)n1cc(C(=O)Nc2cc(F)c(Oc3ccnc(NC(=O)N4CCC(N5CCN(C)CC5)CC4)c3)cc2F)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4852684	=	IC50	nM	0.76	CHEMBL4895	Homo sapiens	IC50	nM	0.76
	23209557	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4cc(F)c(NC(=O)c5cc6c(n(-c7ccccc7)c5=O)CCCC6=O)cc4F)ccn3)CC2)CC1		CHEMBL4849679	=	IC50	nM	1.3	CHEMBL4895	Homo sapiens	IC50	nM	1.3
	23209558	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3cc(NC(=O)C4CC4)ncn3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4845957	=	IC50	nM	0.85	CHEMBL4895	Homo sapiens	IC50	nM	0.85
	23209559	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3cc(NC(=O)N4CCC4)ncn3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4867664	=	IC50	nM	2.0	CHEMBL4895	Homo sapiens	IC50	nM	2.0
	23209560	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3cc(NC(=O)N4CCCC4)ncn3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4849099	=	IC50	nM	2.1	CHEMBL4895	Homo sapiens	IC50	nM	2.1
	23209561	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3cc(NC(=O)N4CC(O)C4)ncn3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4864028	=	IC50	nM	3.5	CHEMBL4895	Homo sapiens	IC50	nM	3.5
	23209562	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CNC1CN(C(=O)Nc2cc(Oc3ccc(NC(=O)c4cn(C(C)C)c(=O)n(-c5ccc(F)cc5)c4=O)cc3)ncn2)C1		CHEMBL4868163	=	IC50	nM	6.4	CHEMBL4895	Homo sapiens	IC50	nM	6.4
	23209563	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3cc(NC(=O)N4CC(N5CCCC5)C4)ncn3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4861060	=	IC50	nM	5.6	CHEMBL4895	Homo sapiens	IC50	nM	5.6
	23209564	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3cc(NC(=O)N4CCC(N5CCN(C)CC5)CC4)ncn3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4846932	=	IC50	nM	2.0	CHEMBL4895	Homo sapiens	IC50	nM	2.0
	23209565	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)c5cn(C)c(=O)n(-c6ccc(F)cc6)c5=O)cc4)ncn3)CC2)CC1		CHEMBL4867209	=	IC50	nM	32.0	CHEMBL4895	Homo sapiens	IC50	nM	32.0
	23209566	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)c5cn(C6CC6)c(=O)n(-c6ccc(F)cc6)c5=O)cc4)ncn3)CC2)CC1		CHEMBL4873739	=	IC50	nM	7.1	CHEMBL4895	Homo sapiens	IC50	nM	7.1
	23209567	CHEMBL4822425	Inhibition of recombinant human GST-tagged Axl incubated for 1 hr by ADP-glo based luminometry analysis	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)c5cn(C6CCCC6)c(=O)n(-c6ccc(F)cc6)c5=O)cc4)ncn3)CC2)CC1		CHEMBL4853815	=	IC50	nM	1.5	CHEMBL4895	Homo sapiens	IC50	nM	1.5
	23209589	CHEMBL4822427	Inhibition of recombinant human Axl expressed in mouse BaF3 cells assessed as reduction in cell viability incubated for 2 days by cell titer glo assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)CN(C)C)c3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4873958	=	IC50	nM	90.0	CHEMBL4895	Homo sapiens	IC50	nM	90.0
	23209590	CHEMBL4822427	Inhibition of recombinant human Axl expressed in mouse BaF3 cells assessed as reduction in cell viability incubated for 2 days by cell titer glo assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)CC4CCN(C)CC4)c3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4865592	=	IC50	nM	5.9	CHEMBL4895	Homo sapiens	IC50	nM	5.9
	23209591	CHEMBL4822427	Inhibition of recombinant human Axl expressed in mouse BaF3 cells assessed as reduction in cell viability incubated for 2 days by cell titer glo assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)CC4CCN(C)CC4)c3)cc2F)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4848604	=	IC50	nM	7.6	CHEMBL4895	Homo sapiens	IC50	nM	7.6
	23209592	CHEMBL4822427	Inhibition of recombinant human Axl expressed in mouse BaF3 cells assessed as reduction in cell viability incubated for 2 days by cell titer glo assay	B	CN1CCC(CC(=O)Nc2cc(Oc3ccc(NC(=O)c4cn(C5CC5)c(=O)n(-c5ccc(F)cc5)c4=O)cc3F)ccn2)CC1		CHEMBL4865438	=	IC50	nM	23.0	CHEMBL4895	Homo sapiens	IC50	nM	23.0
	23209593	CHEMBL4822427	Inhibition of recombinant human Axl expressed in mouse BaF3 cells assessed as reduction in cell viability incubated for 2 days by cell titer glo assay	B	CN1CCC(CC(=O)Nc2cc(Oc3ccc(NC(=O)c4cn(C5CCCC5)c(=O)n(-c5ccc(F)cc5)c4=O)cc3F)ccn2)CC1		CHEMBL4867696	=	IC50	nM	2.8	CHEMBL4895	Homo sapiens	IC50	nM	2.8
	23209594	CHEMBL4822427	Inhibition of recombinant human Axl expressed in mouse BaF3 cells assessed as reduction in cell viability incubated for 2 days by cell titer glo assay	B	CC(C)n1cc(C(=O)Nc2cc(F)c(Oc3ccnc(NC(=O)N4CCC(N5CCN(C)CC5)CC4)c3)cc2F)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4852684	=	IC50	nM	1.9	CHEMBL4895	Homo sapiens	IC50	nM	1.9
	23209595	CHEMBL4822427	Inhibition of recombinant human Axl expressed in mouse BaF3 cells assessed as reduction in cell viability incubated for 2 days by cell titer glo assay	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4cc(F)c(NC(=O)c5cc6c(n(-c7ccccc7)c5=O)CCCC6=O)cc4F)ccn3)CC2)CC1		CHEMBL4849679	=	IC50	nM	16.0	CHEMBL4895	Homo sapiens	IC50	nM	16.0
	23209596	CHEMBL4822427	Inhibition of recombinant human Axl expressed in mouse BaF3 cells assessed as reduction in cell viability incubated for 2 days by cell titer glo assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3cc(NC(=O)C4CC4)ncn3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4845957	=	IC50	nM	9.0	CHEMBL4895	Homo sapiens	IC50	nM	9.0
	23209597	CHEMBL4822427	Inhibition of recombinant human Axl expressed in mouse BaF3 cells assessed as reduction in cell viability incubated for 2 days by cell titer glo assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3cc(NC(=O)N4CCC4)ncn3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4867664	=	IC50	nM	11.0	CHEMBL4895	Homo sapiens	IC50	nM	11.0
	23209598	CHEMBL4822427	Inhibition of recombinant human Axl expressed in mouse BaF3 cells assessed as reduction in cell viability incubated for 2 days by cell titer glo assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3cc(NC(=O)N4CCCC4)ncn3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4849099	=	IC50	nM	15.0	CHEMBL4895	Homo sapiens	IC50	nM	15.0
	23209599	CHEMBL4822427	Inhibition of recombinant human Axl expressed in mouse BaF3 cells assessed as reduction in cell viability incubated for 2 days by cell titer glo assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3cc(NC(=O)N4CC(O)C4)ncn3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4864028	=	IC50	nM	20.0	CHEMBL4895	Homo sapiens	IC50	nM	20.0
	23209600	CHEMBL4822427	Inhibition of recombinant human Axl expressed in mouse BaF3 cells assessed as reduction in cell viability incubated for 2 days by cell titer glo assay	B	CNC1CN(C(=O)Nc2cc(Oc3ccc(NC(=O)c4cn(C(C)C)c(=O)n(-c5ccc(F)cc5)c4=O)cc3)ncn2)C1		CHEMBL4868163	=	IC50	nM	40.0	CHEMBL4895	Homo sapiens	IC50	nM	40.0
	23209601	CHEMBL4822427	Inhibition of recombinant human Axl expressed in mouse BaF3 cells assessed as reduction in cell viability incubated for 2 days by cell titer glo assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3cc(NC(=O)N4CC(N5CCCC5)C4)ncn3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4861060	=	IC50	nM	49.0	CHEMBL4895	Homo sapiens	IC50	nM	49.0
	23209602	CHEMBL4822427	Inhibition of recombinant human Axl expressed in mouse BaF3 cells assessed as reduction in cell viability incubated for 2 days by cell titer glo assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3cc(NC(=O)N4CCC(N5CCN(C)CC5)CC4)ncn3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4846932	=	IC50	nM	15.0	CHEMBL4895	Homo sapiens	IC50	nM	15.0
	23209603	CHEMBL4822427	Inhibition of recombinant human Axl expressed in mouse BaF3 cells assessed as reduction in cell viability incubated for 2 days by cell titer glo assay	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)c5cn(C)c(=O)n(-c6ccc(F)cc6)c5=O)cc4)ncn3)CC2)CC1		CHEMBL4867209	=	IC50	nM	173.0	CHEMBL4895	Homo sapiens	IC50	nM	173.0
	23209604	CHEMBL4822427	Inhibition of recombinant human Axl expressed in mouse BaF3 cells assessed as reduction in cell viability incubated for 2 days by cell titer glo assay	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)c5cn(C6CC6)c(=O)n(-c6ccc(F)cc6)c5=O)cc4)ncn3)CC2)CC1		CHEMBL4873739	=	IC50	nM	51.0	CHEMBL4895	Homo sapiens	IC50	nM	51.0
	23209605	CHEMBL4822427	Inhibition of recombinant human Axl expressed in mouse BaF3 cells assessed as reduction in cell viability incubated for 2 days by cell titer glo assay	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)c5cn(C6CCCC6)c(=O)n(-c6ccc(F)cc6)c5=O)cc4)ncn3)CC2)CC1		CHEMBL4853815	=	IC50	nM	6.3	CHEMBL4895	Homo sapiens	IC50	nM	6.3
	23216008	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	Cc1c(C(=O)Nc2ccc(Oc3ccncc3-c3cnn(C)c3)cc2)c(=O)n(-c2ccccc2)n1C		CHEMBL4845715	=	IC50	nM	253.9	CHEMBL4895	Homo sapiens	IC50	nM	253.9
	23216009	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CCOc1cn(-c2ccc(F)cc2)nc1C(=O)Nc1ccc(Oc2ccncc2-c2cnn(C)c2)cc1		CHEMBL4848709	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	nM	1000.0
	23216010	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	Cc1ncc(C(=O)Nc2ccc(Oc3ccncc3-c3cnn(C)c3)cc2)c(=O)n1-c1ccc(F)cc1		CHEMBL4861226	=	IC50	nM	20.5	CHEMBL4895	Homo sapiens	IC50	nM	20.5
	23216011	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	Cc1nc(C)n(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccncc2-c2cnn(C)c2)cc1		CHEMBL4879206	=	IC50	nM	395.7	CHEMBL4895	Homo sapiens	IC50	nM	395.7
	23216012	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	Cn1cc(-c2cnccc2Oc2ccc(NC(=O)c3c[nH]c(=O)n(-c4ccc(F)cc4)c3=O)cc2)cn1		CHEMBL4856142	=	IC50	nM	13.0	CHEMBL4895	Homo sapiens	IC50	nM	13.0
	23216013	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	Cn1cc(-c2cnccc2Oc2ccc(NC(=O)c3cn(C)c(=O)n(-c4ccc(F)cc4)c3=O)cc2)cn1		CHEMBL4856829	=	IC50	nM	184.8	CHEMBL4895	Homo sapiens	IC50	nM	184.8
	23216014	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CCn1cc(C(=O)Nc2ccc(Oc3ccncc3-c3cnn(C)c3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4851321	=	IC50	nM	8.8	CHEMBL4895	Homo sapiens	IC50	nM	8.8
	23216015	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccncc3-c3cnn(C)c3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4875876	=	IC50	nM	8.7	CHEMBL4895	Homo sapiens	IC50	nM	8.7
	23216016	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	Cn1cc(-c2cnccc2Oc2ccc(NC(=O)c3cn(CC4CCOCC4)c(=O)n(-c4ccc(F)cc4)c3=O)cc2)cn1		CHEMBL4858649	=	IC50	nM	58.3	CHEMBL4895	Homo sapiens	IC50	nM	58.3
	23216017	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(C)n1nc(C(=O)Nc2ccc(Oc3ccncc3-c3cnn(C)c3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4856528	=	IC50	nM	178.6	CHEMBL4895	Homo sapiens	IC50	nM	178.6
	23216018	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	Cn1cc(-c2cnccc2Oc2ccc(NC(=O)C3=C(c4ccccc4)c4ccccc4C3=O)cc2)cn1		CHEMBL4848206	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	nM	1000.0
	23216019	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	Cn1cc(-c2cnccc2Oc2ccc(NC(=O)c3c4c(cn(-c5ccccc5)c3=O)C(=O)CCC4)cc2)cn1		CHEMBL4864950	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	nM	1000.0
	23216020	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	Cn1cc(-c2cnccc2Oc2ccc(NC(=O)c3cc4c(n(-c5ccc(F)cc5)c3=O)CCCC4=O)cc2)cn1		CHEMBL4853182	=	IC50	nM	16.8	CHEMBL4895	Homo sapiens	IC50	nM	16.8
	23216021	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	Cn1cc(-c2cnccc2Oc2ccc(NC(=O)C3Cc4ccncc4N(c4ccc(F)cc4)C3=O)cc2)cn1		CHEMBL4866212	=	IC50	nM	150.0	CHEMBL4895	Homo sapiens	IC50	nM	150.0
	23216022	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ccncc3-c3cnn(C)c3)cc1)c(C)n2C		CHEMBL4862247	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	nM	1000.0
	23216023	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	IC50	nM	4.6	CHEMBL4895	Homo sapiens	IC50	nM	4.6
	23216024	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	Nc1nc(Nc2ccc3c(c2)CC[C@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2		CHEMBL4857746	=	IC50	nM	4.8	CHEMBL4895	Homo sapiens	IC50	nM	4.8
	23216025	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(-c4cnn(C)c4)c3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4858048	=	IC50	nM	1.9	CHEMBL4895	Homo sapiens	IC50	nM	1.9
	23216026	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(-c4cnn(C)c4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4871310	=	IC50	nM	0.8	CHEMBL4895	Homo sapiens	IC50	nM	0.8
	23216027	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(-c4cnn(C)c4)c3)cc2F)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4867669	=	IC50	nM	5.5	CHEMBL4895	Homo sapiens	IC50	nM	5.5
	23216028	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(-c4cnn(C)c4)c3)c(Cl)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4864426	=	IC50	nM	21.9	CHEMBL4895	Homo sapiens	IC50	nM	21.9
	23216029	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	Cc1cc(NC(=O)c2cn(C(C)C)c(=O)n(-c3ccc(F)cc3)c2=O)ccc1Oc1ccnc(-c2cnn(C)c2)c1		CHEMBL4849593	=	IC50	nM	45.6	CHEMBL4895	Homo sapiens	IC50	nM	45.6
	23216030	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	COc1cc(NC(=O)c2cn(C(C)C)c(=O)n(-c3ccc(F)cc3)c2=O)ccc1Oc1ccnc(-c2cnn(C)c2)c1		CHEMBL4863885	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	nM	1000.0
	23216031	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(-c4cnn(C)c4)c3)c(F)c2F)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4846125	=	IC50	nM	4.9	CHEMBL4895	Homo sapiens	IC50	nM	4.9
	23216032	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(C)n1cc(C(=O)Nc2cc(F)c(Oc3ccnc(-c4cnn(C)c4)c3)cc2F)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4863290	=	IC50	nM	2.75	CHEMBL4895	Homo sapiens	IC50	nM	2.75
	23216033	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(C)n1cc(C(=O)Nc2cc(F)c(Oc3ccnc(-c4cnn(C)c4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4864676	=	IC50	nM	3.7	CHEMBL4895	Homo sapiens	IC50	nM	3.7
	23216034	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	Cc1nn(C)cc1-c1cc(Oc2ccc(NC(=O)c3cn(C(C)C)c(=O)n(-c4ccc(F)cc4)c3=O)cc2F)ccn1		CHEMBL4863687	=	IC50	nM	25.6	CHEMBL4895	Homo sapiens	IC50	nM	25.6
	23216035	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(-c4cnn(C5CC5)c4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4846678	=	IC50	nM	10.5	CHEMBL4895	Homo sapiens	IC50	nM	10.5
	23216036	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(-c4cnn(CC(C)(C)O)c4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4848473	=	IC50	nM	17.4	CHEMBL4895	Homo sapiens	IC50	nM	17.4
	23216037	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(-c4cnn(CCN5CCN(C)CC5)c4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4872759	=	IC50	nM	26.0	CHEMBL4895	Homo sapiens	IC50	nM	26.0
	23216038	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(-c4cn[nH]c4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4869458	=	IC50	nM	3.1	CHEMBL4895	Homo sapiens	IC50	nM	3.1
	23216039	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(=O)Nc1cc(Oc2ccc(NC(=O)c3cn(C(C)C)c(=O)n(-c4ccc(F)cc4)c3=O)cc2F)ccn1		CHEMBL4856526	=	IC50	nM	6.7	CHEMBL4895	Homo sapiens	IC50	nM	6.7
	23216040	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CCC(=O)Nc1cc(Oc2ccc(NC(=O)c3cn(C(C)C)c(=O)n(-c4ccc(F)cc4)c3=O)cc2F)ccn1		CHEMBL4855681	=	IC50	nM	5.8	CHEMBL4895	Homo sapiens	IC50	nM	5.8
	23216041	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4873571	=	IC50	nM	0.9	CHEMBL4895	Homo sapiens	IC50	nM	0.9
	23216042	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CCC4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4856234	=	IC50	nM	8.0	CHEMBL4895	Homo sapiens	IC50	nM	8.0
	23216043	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)N4CCCC4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4861161	=	IC50	nM	1.7	CHEMBL4895	Homo sapiens	IC50	nM	1.7
	23216044	CHEMBL4823577	Inhibition of AXL (unknown origin) using poly [Glu, Tyr] 4:1 as substrate incubated for 60 mins in presence of ATP by ELISA	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)N4CCOCC4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4875798	=	IC50	nM	8.6	CHEMBL4895	Homo sapiens	IC50	nM	8.6
	23222563	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CC(=O)N4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4852474	=	IC50	nM	26.0	CHEMBL4895	Homo sapiens	IC50	nM	26.0
	23222564	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CN(C)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4872079	=	IC50	nM	22.0	CHEMBL4895	Homo sapiens	IC50	nM	22.0
	23222565	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CCN(C)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4870149	=	IC50	nM	6.6	CHEMBL4895	Homo sapiens	IC50	nM	6.6
	23222566	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CN(C)CC4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4869791	=	IC50	nM	64.0	CHEMBL4895	Homo sapiens	IC50	nM	64.0
	23222567	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CN(C(=O)CN3CCOCC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4860065	=	IC50	nM	16.0	CHEMBL4895	Homo sapiens	IC50	nM	16.0
	23222568	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CN(C(=O)CCN3CCCC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4860139	=	IC50	nM	15.0	CHEMBL4895	Homo sapiens	IC50	nM	15.0
	23222569	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CN(C(=O)CN3CCN(C)CC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4875387	=	IC50	nM	6.0	CHEMBL4895	Homo sapiens	IC50	nM	6.0
	23222570	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CN(C(=O)CC3CCN(C)CC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4865150	=	IC50	nM	3.4	CHEMBL4895	Homo sapiens	IC50	nM	3.4
	23222571	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CN(C(=O)C3CC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4878216	=	IC50	nM	2.7	CHEMBL4895	Homo sapiens	IC50	nM	2.7
	23222572	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CN(CC3CCOCC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4861291	=	IC50	nM	8.6	CHEMBL4895	Homo sapiens	IC50	nM	8.6
	23222573	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CN(CC3CCN(C)CC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4878071	=	IC50	nM	6.2	CHEMBL4895	Homo sapiens	IC50	nM	6.2
	23222574	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CCN(C(=O)C3CCC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4872556	=	IC50	nM	5.3	CHEMBL4895	Homo sapiens	IC50	nM	5.3
	23222575	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CCN(C(=O)C3CCN(C)CC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4846861	=	IC50	nM	12.0	CHEMBL4895	Homo sapiens	IC50	nM	12.0
	23222576	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CCN(C(=O)CN3CCOCC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4875172	=	IC50	nM	17.0	CHEMBL4895	Homo sapiens	IC50	nM	17.0
	23222577	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CCN(C(=O)CCN3CCCC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4858522	=	IC50	nM	7.8	CHEMBL4895	Homo sapiens	IC50	nM	7.8
	23222578	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CCN(C(=O)CC3CCN(C)CC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4859147	=	IC50	nM	4.3	CHEMBL4895	Homo sapiens	IC50	nM	4.3
	23222579	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CCN(CC(=O)N3CCN(C)CC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4846790	=	IC50	nM	9.5	CHEMBL4895	Homo sapiens	IC50	nM	9.5
	23222580	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CCN(CC(=O)N3CCC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4851171	=	IC50	nM	14.0	CHEMBL4895	Homo sapiens	IC50	nM	14.0
	23222581	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CCN(CC3CCN(C)CC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4848465	=	IC50	nM	3.7	CHEMBL4895	Homo sapiens	IC50	nM	3.7
	23222582	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CCN(C3CCN(C)CC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4856749	=	IC50	nM	5.6	CHEMBL4895	Homo sapiens	IC50	nM	5.6
	23222583	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CCN(C3CCN(CC5CC5)CC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4866147	=	IC50	nM	3.5	CHEMBL4895	Homo sapiens	IC50	nM	3.5
	23222584	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CCN(CC3CN(C)C3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4859513	=	IC50	nM	6.3	CHEMBL4895	Homo sapiens	IC50	nM	6.3
	23222585	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ncnc4c3CCN(C3CN(C)C3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4850929	=	IC50	nM	3.8	CHEMBL4895	Homo sapiens	IC50	nM	3.8
	23222586	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CN1CCC(CN2CCc3c(ncnc3Oc3ccc(NC(=O)c4cn(C5CC5)c(=O)n(-c5ccc(F)cc5)c4=O)cc3F)C2)CC1		CHEMBL4870992	=	IC50	nM	32.0	CHEMBL4895	Homo sapiens	IC50	nM	32.0
	23222587	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CN1CCC(CN2CCc3c(ncnc3Oc3ccc(NC(=O)c4cn(CCF)c(=O)n(-c5ccc(F)cc5)c4=O)cc3F)C2)CC1		CHEMBL4874534	=	IC50	nM	8.5	CHEMBL4895	Homo sapiens	IC50	nM	8.5
	23222588	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)Cn1cc(C(=O)Nc2ccc(Oc3ncnc4c3CCN(CC3CCN(C)CC3)C4)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4870464	=	IC50	nM	5.5	CHEMBL4895	Homo sapiens	IC50	nM	5.5
	23222589	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CN1CCC(CN2CCc3c(ncnc3Oc3ccc(NC(=O)c4cn(CC5CCC5)c(=O)n(-c5ccc(F)cc5)c4=O)cc3F)C2)CC1		CHEMBL4864780	=	IC50	nM	2.4	CHEMBL4895	Homo sapiens	IC50	nM	2.4
	23222590	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CN1CCC(CN2CCc3c(ncnc3Oc3ccc(NC(=O)c4cn(CC5CC5)c(=O)n(-c5ccc(F)cc5)c4=O)cc3F)C2)CC1		CHEMBL4858396	=	IC50	nM	1.9	CHEMBL4895	Homo sapiens	IC50	nM	1.9
	23222591	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CN1CCC(CN2CCc3c(ncnc3Oc3ccc(NC(=O)c4cn(C5CCCC5)c(=O)n(-c5ccc(F)cc5)c4=O)cc3F)C2)CC1		CHEMBL4860541	=	IC50	nM	2.7	CHEMBL4895	Homo sapiens	IC50	nM	2.7
	23222592	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	Cc1ccc(-n2c(=O)c(C(=O)Nc3ccc(Oc4ncnc5c4CCN(CC4CCN(C)CC4)C5)c(F)c3)cn(CC3CC3)c2=O)nc1		CHEMBL4857544	=	IC50	nM	5.3	CHEMBL4895	Homo sapiens	IC50	nM	5.3
	23222593	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	Cc1ccc(-n2c(=O)c(C(=O)Nc3ccc(Oc4ncnc5c4CCN(CC4CCN(C)CC4)C5)c(F)c3)cn(C3CCCC3)c2=O)nc1		CHEMBL4860402	=	IC50	nM	5.2	CHEMBL4895	Homo sapiens	IC50	nM	5.2
	23222594	CHEMBL4824951	Inhibition of Axl (unknown origin) by cell free assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3cc(NC(=O)N4CCC(N5CCN(C)CC5)CC4)ncn3)cc2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4846932	=	IC50	nM	2.0	CHEMBL4895	Homo sapiens	IC50	nM	2.0
	23236078	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(-c3ccccc3Cl)cc2)o1		CHEMBL4754609	=	IC50	nM	398.11	CHEMBL4895	Homo sapiens	pIC50		6.4
	23236079	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccccc2)o1		CHEMBL4874826	<	IC50	nM	100000.0	CHEMBL4895	Homo sapiens	pIC50		4.0
	23236080	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(C3CC3)cc2)o1		CHEMBL4874378	=	IC50	nM	19952.62	CHEMBL4895	Homo sapiens	pIC50		4.7
	23236081	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(-c3ccccc3)cc2)o1		CHEMBL4850040	=	IC50	nM	3162.28	CHEMBL4895	Homo sapiens	pIC50		5.5
	23236082	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(-c3ccccc3F)cc2)o1		CHEMBL4869181	=	IC50	nM	1584.89	CHEMBL4895	Homo sapiens	pIC50		5.8
	23236083	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	COc1ccccc1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)cc1		CHEMBL4859554	=	IC50	nM	1584.89	CHEMBL4895	Homo sapiens	pIC50		5.8
	23236084	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	CN(Cc1ccc2nccn2c1)c1nnc(-c2ccc(-c3ccccc3C#N)cc2)o1		CHEMBL4869862	=	IC50	nM	3981.07	CHEMBL4895	Homo sapiens	pIC50		5.4
	23236085	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	Cc1ccccc1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)cc1		CHEMBL4863682	=	IC50	nM	630.96	CHEMBL4895	Homo sapiens	pIC50		6.2
	23236086	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	Cc1ncccc1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)cc1		CHEMBL4851329	=	IC50	nM	6309.57	CHEMBL4895	Homo sapiens	pIC50		5.2
	23236087	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	Cc1nn(C)c(C)c1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)cc1		CHEMBL4866573	=	IC50	nM	1258.93	CHEMBL4895	Homo sapiens	pIC50		5.9
	23236088	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	Cc1noc(C)c1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)cc1		CHEMBL4862829	=	IC50	nM	31622.78	CHEMBL4895	Homo sapiens	pIC50		4.5
	23236089	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	Cc1nn(C)c(C)c1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)c(F)c1		CHEMBL4849757	=	IC50	nM	1258.93	CHEMBL4895	Homo sapiens	pIC50		5.9
	23236090	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	Cc1nn(C)c(C)c1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)c(Cl)c1		CHEMBL4865752	=	IC50	nM	79.43	CHEMBL4895	Homo sapiens	pIC50		7.1
	23236091	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	COc1cc(-c2c(C)nn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4872116	=	IC50	nM	794.33	CHEMBL4895	Homo sapiens	pIC50		6.1
	23236092	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	Cc1cc(-c2c(C)nn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4855381	=	IC50	nM	79.43	CHEMBL4895	Homo sapiens	pIC50		7.1
	23236093	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	Cc1nn(C)c(C)c1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)c(C#N)c1		CHEMBL4877912	<	IC50	nM	100000.0	CHEMBL4895	Homo sapiens	pIC50		4.0
	23236094	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	Cc1cc(-c2c(C)nn(C)c2C)cnc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4852284	=	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	pIC50		6.0
	23236095	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	Cc1nc(-c2c(C)nn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4865034	=	IC50	nM	3162.28	CHEMBL4895	Homo sapiens	pIC50		5.5
	23236096	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	Cc1cc(-c2c(C)n[nH]c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4852533	=	IC50	nM	5011.87	CHEMBL4895	Homo sapiens	pIC50		5.3
	23236097	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	Cc1cc(-c2cnn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4873217	=	IC50	nM	100.0	CHEMBL4895	Homo sapiens	pIC50		7.0
	23236098	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	Cc1cc(-c2c(C)nn(C)c2C#N)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4875486	=	IC50	nM	39.81	CHEMBL4895	Homo sapiens	pIC50		7.4
	23236099	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	Cc1cc(-c2c(C#N)nn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4870528	=	IC50	nM	6309.57	CHEMBL4895	Homo sapiens	pIC50		5.2
	23236100	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	Cc1cc(-c2c(C)nn(C(F)F)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4877985	=	IC50	nM	63095.73	CHEMBL4895	Homo sapiens	pIC50		4.2
	23236101	CHEMBL4828158	Inhibition of AXL (unknown origin) by LC-MS analysis	B	Cc1cc(-c2c(C)nc(C)n2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4856195	=	IC50	nM	3981.07	CHEMBL4895	Homo sapiens	pIC50		5.4
	23236151	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1nn(C)c(C)c1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)cc1		CHEMBL4866573	=	IC50	nM	3162.28	CHEMBL4895	Homo sapiens	pIC50		5.5
	23236152	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1nn(C)c(C)c1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)c(F)c1		CHEMBL4849757	=	IC50	nM	3162.28	CHEMBL4895	Homo sapiens	pIC50		5.5
	23236153	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1nn(C)c(C)c1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)c(Cl)c1		CHEMBL4865752	=	IC50	nM	794.33	CHEMBL4895	Homo sapiens	pIC50		6.1
	23236154	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	COc1cc(-c2c(C)nn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4872116	=	IC50	nM	1995.26	CHEMBL4895	Homo sapiens	pIC50		5.7
	23236155	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2c(C)nn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4855381	=	IC50	nM	398.11	CHEMBL4895	Homo sapiens	pIC50		6.4
	23236156	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1nn(C)c(C)c1-c1ccc(-c2nnc(N(C)Cc3ccc4nccn4c3)o2)c(C#N)c1		CHEMBL4877912	<	IC50	nM	31622.78	CHEMBL4895	Homo sapiens	pIC50		4.5
	23236157	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2c(C)nn(C)c2C)cnc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4852284	=	IC50	nM	6309.57	CHEMBL4895	Homo sapiens	pIC50		5.2
	23236158	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1nc(-c2c(C)nn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4865034	=	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	pIC50		5.0
	23236159	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2c(C)n[nH]c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4852533	=	IC50	nM	15848.93	CHEMBL4895	Homo sapiens	pIC50		4.8
	23236160	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2cnn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4873217	=	IC50	nM	794.33	CHEMBL4895	Homo sapiens	pIC50		6.1
	23236161	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2c(C)nn(C)c2C#N)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4875486	=	IC50	nM	398.11	CHEMBL4895	Homo sapiens	pIC50		6.4
	23236162	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2c(C#N)nn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4870528	=	IC50	nM	6309.57	CHEMBL4895	Homo sapiens	pIC50		5.2
	23236163	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2c(C)nn(C(F)F)c2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4877985	<	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	pIC50		5.0
	23236164	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2c(C)nc(C)n2C)ccc1-c1nnc(N(C)Cc2ccc3nccn3c2)o1		CHEMBL4856195	=	IC50	nM	5011.87	CHEMBL4895	Homo sapiens	pIC50		5.3
	23236165	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2c(C)nn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3ncc(C(=O)N(C)C)n3c2)o1		CHEMBL4862672	=	IC50	nM	398.11	CHEMBL4895	Homo sapiens	pIC50		6.4
	23236166	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2c(C)nn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3ncc(-c4ccccc4)n3c2)o1		CHEMBL4853066	=	IC50	nM	199.53	CHEMBL4895	Homo sapiens	pIC50		6.7
	23236167	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2c(C)nn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3ncc(-c4cnn(C)c4)n3c2)o1		CHEMBL4852375	=	IC50	nM	63.1	CHEMBL4895	Homo sapiens	pIC50		7.2
	23236168	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2c(C)nn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3ncc(C4CCN(C)CC4)n3c2)o1		CHEMBL4858663	=	IC50	nM	1258.93	CHEMBL4895	Homo sapiens	pIC50		5.9
	23236169	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2c(C)nn(C)c2C)ccc1-c1nnc(N(C)Cc2ccc3ncc(-c4cnn(CCN(C)C)c4)n3c2)o1		CHEMBL4846456	=	IC50	nM	125.89	CHEMBL4895	Homo sapiens	pIC50		6.9
	23236170	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2c(C)nn(C)c2C)cnc1-c1nnc(N(C)Cc2ccc3ncc(-c4cnn(CCN(C)C)c4)n3c2)o1		CHEMBL4847257	=	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	pIC50		6.0
	23236171	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2c(C)nn(C)c2C)cnc1-c1nnc(N(C)Cc2ccc3ncc(-c4ccc(CN(C)C)cc4)n3c2)o1		CHEMBL4879190	=	IC50	nM	100.0	CHEMBL4895	Homo sapiens	pIC50		7.0
	23236172	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2c(C)nn(C)c2C)cnc1-c1nnc(N(C)Cc2ccc3ncc(-c4cccc(CN(C)C)c4)n3c2)o1		CHEMBL4873714	=	IC50	nM	316.23	CHEMBL4895	Homo sapiens	pIC50		6.5
	23236173	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2c(C)nn(C)c2C)cnc1-c1nnc(N(C)Cc2ccc3ncc(-c4ccc(CN(C)C)nc4)n3c2)o1		CHEMBL4854327	=	IC50	nM	1584.89	CHEMBL4895	Homo sapiens	pIC50		5.8
	23236174	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	Cc1cc(-c2c(C)nn(C)c2C)cnc1-c1nnc(N(C)Cc2ccc3ncc(-c4ccc(CN(C)C)cn4)n3c2)o1		CHEMBL4879167	=	IC50	nM	125.89	CHEMBL4895	Homo sapiens	pIC50		6.9
	23236175	CHEMBL4828161	Inhibition of FLAG-tagged AXL (unknown origin) transfected in Cos-7 cells assessed as phosphorylation level incubated for 1 hr by ELISA	B	CN1CCN(Cc2ccc(-c3ccc(CO[C@H]4CCC[C@@H]4NC(=O)c4cc(-c5cnn(C)c5)cnc4N)cc3)cc2)CC1		CHEMBL4857737	=	IC50	nM	31.62	CHEMBL4895	Homo sapiens	pIC50		7.5
	23251322	CHEMBL4831209	Binding affinity to human AXL at 1 uM by KINOMEscan scanMAX assay relative to control	B	O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312304	=	Activity	%	61.0	CHEMBL4895	Homo sapiens	Activity	%	61.0
	23251330	CHEMBL4831217	Binding affinity to human AXL by KINOMEscan scanMAX assay	B	O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312304	=	Kd	nM	1700.0	CHEMBL4895	Homo sapiens	Kd	nM	1700.0
	23251411	CHEMBL4831222	Binding affinity to AXL (unknown origin) assessed as change in melting temperature by SYPRO orange dye based DSF assay	B	O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1	Non standard unit for type	CHEMBL2312304	=	deltaTm	K	0.2	CHEMBL4895	Homo sapiens	deltaTm	K	0.2
	23251483	CHEMBL4831232	Inhibition of tracer K5 binding to NanoLuc-fused AXL (unknown origin) expressed in HEK293T cells measured after 2 hrs by NanoBRET assay	B	O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312304	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	23251484	CHEMBL4831232	Inhibition of tracer K5 binding to NanoLuc-fused AXL (unknown origin) expressed in HEK293T cells measured after 2 hrs by NanoBRET assay	B	O=C(NCCCN1CCCC1=O)c1cnc(NCc2ccc(Cl)cc2Cl)nc1NC1CCCC1		CHEMBL4847568	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	23251485	CHEMBL4831232	Inhibition of tracer K5 binding to NanoLuc-fused AXL (unknown origin) expressed in HEK293T cells measured after 2 hrs by NanoBRET assay	B	Cc1cc(Br)c(CNc2ncc(C(=O)NCCCN3CCOC3=O)c(NC3CCCCC3)n2)cc1Br		CHEMBL4876584	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	23251486	CHEMBL4831232	Inhibition of tracer K5 binding to NanoLuc-fused AXL (unknown origin) expressed in HEK293T cells measured after 2 hrs by NanoBRET assay	B	Cc1cc(Br)c(CNc2ncc(C(=O)NCCCN3CCOC3=O)c(NC3CCCC3)n2)cc1Br		CHEMBL4850857	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	23251487	CHEMBL4831232	Inhibition of tracer K5 binding to NanoLuc-fused AXL (unknown origin) expressed in HEK293T cells measured after 2 hrs by NanoBRET assay	B	CCN(Cc1ccc(Cl)cc1)c1ncc(C(=O)NCCCN2CCCC2=O)c(NC2CCCC2)n1		CHEMBL4764640	>	IC50	nM	10000.0	CHEMBL4895	Homo sapiens	IC50	uM	10.0
	23285061	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Cn1cc(-c2ccc(NC(=O)c3cn(CC4CCOCC4)cc(-c4ccccc4)c3=O)cc2)c2c(N)ncnc21		CHEMBL4871620	=	IC50	nM	1.0	CHEMBL4895	Homo sapiens	IC50	nM	1.0
	23285062	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Cn1cc(-c2ccc(NC(=O)c3cn(CC4CCOCC4)cc(-c4ccc(Cl)cc4)c3=O)cc2)c2c(N)ncnc21		CHEMBL4855261	=	IC50	nM	0.2	CHEMBL4895	Homo sapiens	IC50	nM	0.2
	23285063	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Cn1cc(-c2ccc(NC(=O)c3cn(CC4CCCCC4)cc(-c4ccc(F)cc4)c3=O)cc2)c2c(N)ncnc21		CHEMBL4849955	=	IC50	nM	2.3	CHEMBL4895	Homo sapiens	IC50	nM	2.3
	23285064	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Cn1cc(-c2ccc(NC(=O)c3cn(CC4CCOCC4)cc(-c4ccc(F)cc4)c3=O)cc2)c2c(N)ncnc21		CHEMBL4858468	=	IC50	nM	0.1	CHEMBL4895	Homo sapiens	IC50	nM	0.1
	23285065	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Cn1cc(-c2ccc(NC(=O)c3cn(CC4CCCO4)cc(-c4ccc(F)cc4)c3=O)cc2)c2c(N)ncnc21		CHEMBL4865357	=	IC50	nM	1.2	CHEMBL4895	Homo sapiens	IC50	nM	1.2
	23285066	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Cn1cc(-c2ccc(NC(=O)c3cn(C4CCOCC4)cc(-c4ccc(F)cc4)c3=O)cc2)c2c(N)ncnc21		CHEMBL4855494	=	IC50	nM	1.1	CHEMBL4895	Homo sapiens	IC50	nM	1.1
	23285067	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	COCCCn1cc(C(=O)Nc2ccc(-c3cn(C)c4ncnc(N)c34)cc2)c(=O)c(-c2ccc(F)cc2)c1		CHEMBL4851027	>	IC50	nM	10.0	CHEMBL4895	Homo sapiens	IC50	nM	10.0
	23285068	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	CN(C)C(=O)Cn1cc(C(=O)Nc2ccc(-c3cn(C)c4ncnc(N)c34)cc2)c(=O)c(-c2ccc(F)cc2)c1		CHEMBL4845677	=	IC50	nM	0.5	CHEMBL4895	Homo sapiens	IC50	nM	0.5
	23285069	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	CC(C)n1cc(C(=O)Nc2ccc(-c3cn(C)c4ncnc(N)c34)cc2)c(=O)c(-c2ccc(F)cc2)c1		CHEMBL4875762	=	IC50	nM	0.4	CHEMBL4895	Homo sapiens	IC50	nM	0.4
	23285070	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Cn1cc(C(=O)Nc2ccc(-c3cn(C)c4ncnc(N)c34)cc2)c(=O)c(-c2ccc(F)cc2)c1		CHEMBL4858746	=	IC50	nM	5.0	CHEMBL4895	Homo sapiens	IC50	nM	5.0
	23285071	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2		CHEMBL3809489	=	IC50	nM	5.3	CHEMBL4895	Homo sapiens	IC50	nM	5.3
	23285072	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Cn1cc(-c2ccc(NC(=O)c3cn(CC4CCOCC4)cc(-c4ccc(C(F)(F)F)cc4)c3=O)cc2)c2c(N)ncnc21		CHEMBL4873716	=	IC50	nM	0.4	CHEMBL4895	Homo sapiens	IC50	nM	0.4
	23285073	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Cn1cc(-c2ccc(NC(=O)c3cn(CC4CCOCC4)cc(-c4cccc(F)c4)c3=O)cc2)c2c(N)ncnc21		CHEMBL4853092	=	IC50	nM	3.0	CHEMBL4895	Homo sapiens	IC50	nM	3.0
	23285074	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Cn1cc(-c2ccc(NC(=O)c3cn(CC4CCOCC4)cc(-c4ccc(F)cc4F)c3=O)cc2)c2c(N)ncnc21		CHEMBL4851553	=	IC50	nM	0.8	CHEMBL4895	Homo sapiens	IC50	nM	0.8
	23285075	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Cn1cc(-c2ccc(NC(=O)c3cn(CC4CCOCC4)cc(-c4ccc(F)cc4)c3=O)c(F)c2)c2c(N)ncnc21		CHEMBL4877502	=	IC50	nM	0.2	CHEMBL4895	Homo sapiens	IC50	nM	0.2
	23285076	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Cn1cc(-c2ccc(NC(=O)c3cn(CC4CCOCC4)cc(-c4ccc(F)cc4)c3=O)cc2F)c2c(N)ncnc21		CHEMBL4866647	=	IC50	nM	0.8	CHEMBL4895	Homo sapiens	IC50	nM	0.8
	23285077	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Cc1cc(-c2cn(C)c3ncnc(N)c23)ccc1NC(=O)c1cn(CC2CCOCC2)cc(-c2ccc(F)cc2)c1=O		CHEMBL4856684	=	IC50	nM	4.0	CHEMBL4895	Homo sapiens	IC50	nM	4.0
	23285078	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Cn1cc(-c2ccc(NC(=O)c3cn(CC4CCOCC4)cc(-c4ccc(F)cc4)c3=O)c(Cl)c2)c2c(N)ncnc21		CHEMBL4847126	=	IC50	nM	3.7	CHEMBL4895	Homo sapiens	IC50	nM	3.7
	23285079	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Cn1cc(-c2cc(F)c(NC(=O)c3cn(CC4CCOCC4)cc(-c4ccc(F)cc4)c3=O)cc2F)c2c(N)ncnc21		CHEMBL4873311	=	IC50	nM	0.5	CHEMBL4895	Homo sapiens	IC50	nM	0.5
	23285080	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Cc1nc(N)c2c(-c3ccc(NC(=O)c4cn(CC5CCOCC5)cc(-c5ccc(F)cc5)c4=O)cc3)cn(C)c2n1		CHEMBL4846616	=	IC50	nM	5.1	CHEMBL4895	Homo sapiens	IC50	nM	5.1
	23285081	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Nc1ncnc2[nH]cc(-c3ccc(NC(=O)c4cn(CC5CCOCC5)cc(-c5ccc(F)cc5)c4=O)cc3)c12		CHEMBL4860162	=	IC50	nM	0.2	CHEMBL4895	Homo sapiens	IC50	nM	0.2
	23285082	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	CCCn1cc(-c2ccc(NC(=O)c3cn(CC4CCOCC4)cc(-c4ccc(F)cc4)c3=O)cc2)c2c(N)ncnc21		CHEMBL4864971	=	IC50	nM	1.8	CHEMBL4895	Homo sapiens	IC50	nM	1.8
	23285083	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	CN(C)CCn1cc(-c2ccc(NC(=O)c3cn(CC4CCOCC4)cc(-c4ccc(F)cc4)c3=O)cc2)c2c(N)ncnc21		CHEMBL4877967	=	IC50	nM	2.8	CHEMBL4895	Homo sapiens	IC50	nM	2.8
	23285084	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Nc1ncnc2c1c(-c1ccc(NC(=O)c3cn(CC4CCOCC4)cc(-c4ccc(F)cc4)c3=O)cc1)cn2CCN1CCOCC1		CHEMBL4865839	=	IC50	nM	2.7	CHEMBL4895	Homo sapiens	IC50	nM	2.7
	23285085	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	Nc1ncnc2[nH]cc(-c3cc(F)c(NC(=O)c4cn(CC5CCOCC5)cc(-c5ccc(F)cc5)c4=O)cc3F)c12		CHEMBL4869472	=	IC50	nM	0.4	CHEMBL4895	Homo sapiens	IC50	nM	0.4
	23285086	CHEMBL4838186	Inhibition of AXL (unknown origin) by ELISA	B	CC(C)n1cc(C(=O)Nc2cc(F)c(-c3c[nH]c4ncnc(N)c34)cc2F)c(=O)c(-c2ccc(F)cc2)c1		CHEMBL4871361	<	IC50	nM	0.2	CHEMBL4895	Homo sapiens	IC50	nM	0.2
	23285167	CHEMBL4838212	Inhibition of AXL (unknown origin)	B	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2		CHEMBL3809489	=	IC50	nM	14.0	CHEMBL4895	Homo sapiens	IC50	nM	14.0
	23287640	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCNCC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4850498	=	IC50	nM	240.0	CHEMBL4895	Homo sapiens	IC50	nM	240.0
	23287641	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCNC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4851303	=	IC50	nM	370.0	CHEMBL4895	Homo sapiens	IC50	nM	370.0
	23287642	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4862062	=	IC50	nM	370.0	CHEMBL4895	Homo sapiens	IC50	nM	370.0
	23287643	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(C)C)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4848248	=	IC50	nM	420.0	CHEMBL4895	Homo sapiens	IC50	nM	420.0
	23287644	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C4CCNCC4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4878118	=	IC50	nM	190.0	CHEMBL4895	Homo sapiens	IC50	nM	190.0
	23287645	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(CC4CCNCC4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4878774	=	IC50	nM	98.0	CHEMBL4895	Homo sapiens	IC50	nM	98.0
	23287646	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(S(C)(=O)=O)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4854016	=	IC50	nM	690.0	CHEMBL4895	Homo sapiens	IC50	nM	690.0
	23287647	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(S(=O)(=O)C4CCOCC4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4853524	=	IC50	nM	470.0	CHEMBL4895	Homo sapiens	IC50	nM	470.0
	23287648	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)C4CCOCC4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4847256	=	IC50	nM	400.0	CHEMBL4895	Homo sapiens	IC50	nM	400.0
	23287649	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)C4CCN(C)CC4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4877058	=	IC50	nM	140.0	CHEMBL4895	Homo sapiens	IC50	nM	140.0
	23287650	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)[C@H]4CCCN(C)C4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4847691	=	IC50	nM	91.0	CHEMBL4895	Homo sapiens	IC50	nM	91.0
	23287651	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)[C@@H]4CCCCN4C)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4857561	=	IC50	nM	220.0	CHEMBL4895	Homo sapiens	IC50	nM	220.0
	23287652	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4ccncc4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4867544	=	IC50	nM	240.0	CHEMBL4895	Homo sapiens	IC50	nM	240.0
	23287653	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4cccnc4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4854055	=	IC50	nM	500.0	CHEMBL4895	Homo sapiens	IC50	nM	500.0
	23287654	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4ccccn4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4875352	=	IC50	nM	580.0	CHEMBL4895	Homo sapiens	IC50	nM	580.0
	23287655	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4ccc(N(C)C)cc4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4861342	=	IC50	nM	680.0	CHEMBL4895	Homo sapiens	IC50	nM	680.0
	23287656	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4ccnc(C)c4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4862333	=	IC50	nM	210.0	CHEMBL4895	Homo sapiens	IC50	nM	210.0
	23287657	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4cc(C)nc(C)c4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4877347	=	IC50	nM	140.0	CHEMBL4895	Homo sapiens	IC50	nM	140.0
	23287658	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4cc(C)cc(C)c4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4866585	=	IC50	nM	1380.0	CHEMBL4895	Homo sapiens	IC50	nM	1380.0
	23287659	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(Cc4cc(C)nc(C)c4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4878347	=	IC50	nM	270.0	CHEMBL4895	Homo sapiens	IC50	nM	270.0
	23287660	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4cnccn4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4873478	=	IC50	nM	470.0	CHEMBL4895	Homo sapiens	IC50	nM	470.0
	23287661	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4cccnn4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4845859	=	IC50	nM	680.0	CHEMBL4895	Homo sapiens	IC50	nM	680.0
	23287662	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4ccnnc4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4851097	=	IC50	nM	280.0	CHEMBL4895	Homo sapiens	IC50	nM	280.0
	23287663	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4ncccn4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4846907	=	IC50	nM	670.0	CHEMBL4895	Homo sapiens	IC50	nM	670.0
	23287664	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4ccncn4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4854618	=	IC50	nM	340.0	CHEMBL4895	Homo sapiens	IC50	nM	340.0
	23287665	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4cncnc4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4877792	=	IC50	nM	450.0	CHEMBL4895	Homo sapiens	IC50	nM	450.0
	23287666	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4cscn4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4868941	=	IC50	nM	550.0	CHEMBL4895	Homo sapiens	IC50	nM	550.0
	23287667	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CCCCNc1ncc2c(C3CCN(C(=O)c4cc(C)nc(C)c4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4866538	=	IC50	nM	43.0	CHEMBL4895	Homo sapiens	IC50	nM	43.0
	23287668	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CC[C@H]1C[C@@H]1Nc1ncc2c(C3CCN(C(=O)c4cc(C)nc(C)c4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4857351	=	IC50	nM	48.0	CHEMBL4895	Homo sapiens	IC50	nM	48.0
	23287669	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	CC[C@@H]1C[C@H]1Nc1ncc2c(C3CCN(C(=O)c4cc(C)nc(C)c4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4856976	=	IC50	nM	24.0	CHEMBL4895	Homo sapiens	IC50	nM	24.0
	23287670	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	Cc1cc(C(=O)N2CCC(c3cn([C@H]4CC[C@H](O)CC4)c4nc(N[C@@H](C)c5ccccc5)ncc34)CC2)cc(C)n1		CHEMBL4875531	=	IC50	nM	990.0	CHEMBL4895	Homo sapiens	IC50	nM	990.0
	23287671	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	Cc1cc(C(=O)N2CCC(c3cn([C@H]4CC[C@H](O)CC4)c4nc(NCc5ccccc5)ncc34)CC2)cc(C)n1		CHEMBL4849169	=	IC50	nM	120.0	CHEMBL4895	Homo sapiens	IC50	nM	120.0
	23287672	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	Cc1cc(C(=O)N2CCC(c3cn([C@H]4CC[C@H](O)CC4)c4nc(NCC5CCCCC5)ncc34)CC2)cc(C)n1		CHEMBL4861169	=	IC50	nM	590.0	CHEMBL4895	Homo sapiens	IC50	nM	590.0
	23287673	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	Cc1cc(C(=O)N2CCC(c3cn([C@H]4CC[C@H](O)CC4)c4nc(N[C@@H]5CCc6ccccc65)ncc34)CC2)cc(C)n1		CHEMBL4855700	=	IC50	nM	1680.0	CHEMBL4895	Homo sapiens	IC50	nM	1680.0
	23287674	CHEMBL4838703	Inhibition of AXL (unknown origin)	B	Cc1cc(C(=O)N2CCC(c3cn([C@H]4CC[C@H](O)CC4)c4nc(N[C@H]5CCc6ccccc65)ncc34)CC2)cc(C)n1		CHEMBL4862025	=	IC50	nM	1860.0	CHEMBL4895	Homo sapiens	IC50	nM	1860.0
	23287792	CHEMBL4838709	Inhibition of N-terminal GST-tagged AXL (464 to 885 residues) (unknown origin) cytoplasmic domain expressed in Sf21 cells	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4cc(C)nc(C)c4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4877347	=	IC50	nM	26.1	CHEMBL4895	Homo sapiens	IC50	nM	26.1
	23287793	CHEMBL4838709	Inhibition of N-terminal GST-tagged AXL (464 to 885 residues) (unknown origin) cytoplasmic domain expressed in Sf21 cells	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4283353	=	IC50	nM	12.1	CHEMBL4895	Homo sapiens	IC50	nM	12.1
	23287858	CHEMBL4838731	ATP competitive inhibition of AXL (unknown origin)	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4cc(C)nc(C)c4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4877347	=	Ki	nM	97.5	CHEMBL4895	Homo sapiens	Ki	nM	97.5
	23297782	CHEMBL4841262	Inhibition of AXL (unknown origin)	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3Cl)cc12		CHEMBL4876497	>	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	nM	1000.0
	23298219	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cn1cc(-c2n[nH]c3cc(N)ccc23)cn1		CHEMBL4862650	=	IC50	nM	28800.0	CHEMBL4895	Homo sapiens	IC50	uM	28.8
	23298220	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cn1cc(-c2nn(C)c3cc(N)ccc23)cn1	Outside typical range	CHEMBL4858371	>	IC50	nM	384000.0	CHEMBL4895	Homo sapiens	IC50	uM	384.0
	23298221	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	CC(C)Nc1ccc2c(-c3cnn(C)c3)n[nH]c2c1		CHEMBL4868045	=	IC50	nM	46600.0	CHEMBL4895	Homo sapiens	IC50	uM	46.6
	23298222	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cn1cc(-c2n[nH]c3cc(Nc4ccccc4)ccc23)cn1	Outside typical range	CHEMBL4875665	=	IC50	nM	219000.0	CHEMBL4895	Homo sapiens	IC50	uM	219.0
	23298223	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cn1cc(-c2n[nH]c3cc(Br)ccc23)cn1		CHEMBL4875335	=	IC50	nM	950.0	CHEMBL4895	Homo sapiens	IC50	uM	0.95
	23298224	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cn1cc(-c2n[nH]c3cc(-c4ccccc4)ccc23)cn1		CHEMBL4851266	=	IC50	nM	12300.0	CHEMBL4895	Homo sapiens	IC50	uM	12.3
	23298225	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cn1cc(-c2n[nH]c3ccc(N)cc23)cn1		CHEMBL4859426	=	IC50	nM	8910.0	CHEMBL4895	Homo sapiens	IC50	uM	8.91
	23298226	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cn1cc(-c2n[nH]c3ccc(Nc4ccccc4)cc23)cn1		CHEMBL4863898	=	IC50	nM	580.0	CHEMBL4895	Homo sapiens	IC50	uM	0.58
	23298227	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cn1cc(-c2n[nH]c3ccc(Br)cc23)cn1		CHEMBL4854470	=	IC50	nM	1540.0	CHEMBL4895	Homo sapiens	IC50	uM	1.54
	23298228	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cn1cc(-c2n[nH]c3ccc(-c4ccccc4)cc23)cn1		CHEMBL4873207	=	IC50	nM	620.0	CHEMBL4895	Homo sapiens	IC50	uM	0.62
	23298229	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cn1cc(-c2n[nH]c3cc(Cl)c(Br)cc23)cn1		CHEMBL4863727	=	IC50	nM	850.0	CHEMBL4895	Homo sapiens	IC50	uM	0.85
	23298230	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	CNC1CCN(c2ccc3[nH]nc(-c4cnn(C)c4)c3c2)C1	Outside typical range	CHEMBL4864532	=	IC50	nM	432000.0	CHEMBL4895	Homo sapiens	IC50	uM	432.0
	23298231	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	CN1CCC(CNc2ccc3[nH]nc(-c4cnn(C)c4)c3c2)CC1	Outside typical range	CHEMBL4872275	=	IC50	nM	1850000.0	CHEMBL4895	Homo sapiens	IC50	uM	1850.0
	23298232	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	CN1CCC(Nc2ccc3[nH]nc(-c4cnn(C)c4)c3c2)CC1	Outside typical range	CHEMBL4849394	=	IC50	nM	207000.0	CHEMBL4895	Homo sapiens	IC50	uM	207.0
	23298233	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cn1cc(-c2n[nH]c3ccc(NC4CCNC4)cc23)cn1	Outside typical range	CHEMBL4875566	=	IC50	nM	132000.0	CHEMBL4895	Homo sapiens	IC50	uM	132.0
	23298234	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cn1cc(-c2n[nH]c3ccc(N[C@H]4CCNC4)cc23)cn1	Outside typical range	CHEMBL4867638	=	IC50	nM	239000.0	CHEMBL4895	Homo sapiens	IC50	uM	239.0
	23298235	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cn1cc(-c2n[nH]c3ccc(N[C@@H]4CCNC4)cc23)cn1		CHEMBL4864105	=	IC50	nM	37000.0	CHEMBL4895	Homo sapiens	IC50	uM	37.0
	23298236	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cn1cc(-c2n[nH]c3cc(Cl)c(N[C@@H]4CCNC4)cc23)cn1		CHEMBL4846408	=	IC50	nM	19000.0	CHEMBL4895	Homo sapiens	IC50	uM	19.0
	23298237	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	CN1CC[C@@H](Nc2cc3c(-c4cnn(C)c4)n[nH]c3cc2Cl)C1		CHEMBL4860788	=	IC50	nM	74000.0	CHEMBL4895	Homo sapiens	IC50	uM	74.0
	23298238	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cn1cc(-c2n[nH]c3cc(Cl)c(N[C@@H]4CCN(C5COC5)C4)cc23)cn1	Outside typical range	CHEMBL4863793	=	IC50	nM	320000.0	CHEMBL4895	Homo sapiens	IC50	uM	320.0
	23298239	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	FC(F)(F)n1cc(-c2n[nH]c3cc(Cl)c(N[C@@H]4CCN(C5COC5)C4)cc23)cn1	Outside typical range	CHEMBL4854205	=	IC50	nM	466000.0	CHEMBL4895	Homo sapiens	IC50	uM	466.0
	23298240	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	FCCn1cc(-c2n[nH]c3cc(Cl)c(N[C@@H]4CCNC4)cc23)cn1		CHEMBL4850427	=	IC50	nM	5000.0	CHEMBL4895	Homo sapiens	IC50	uM	5.0
	23298241	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Clc1cc2[nH]nc(-c3cnn(-c4ccccc4)c3)c2cc1N[C@@H]1CCNC1		CHEMBL4848476	=	IC50	nM	1700.0	CHEMBL4895	Homo sapiens	IC50	uM	1.7
	23298242	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Fc1ccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@@H]5CCNC5)cc34)cn2)cc1		CHEMBL4863561	=	IC50	nM	2300.0	CHEMBL4895	Homo sapiens	IC50	uM	2.3
	23298243	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	N#Cc1ccccc1-n1cc(-c2n[nH]c3cc(Cl)c(N[C@@H]4CCNC4)cc23)cn1		CHEMBL4855160	=	IC50	nM	3200.0	CHEMBL4895	Homo sapiens	IC50	uM	3.2
	23298244	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	N#Cc1cccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@@H]5CCNC5)cc34)cn2)c1		CHEMBL4848200	=	IC50	nM	2300.0	CHEMBL4895	Homo sapiens	IC50	uM	2.3
	23298245	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	N#Cc1ccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@@H]5CCNC5)cc34)cn2)cc1		CHEMBL4854580	=	IC50	nM	700.0	CHEMBL4895	Homo sapiens	IC50	uM	0.7
	23298246	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	COc1ccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@@H]5CCNC5)cc34)cn2)cc1		CHEMBL4871523	=	IC50	nM	300.0	CHEMBL4895	Homo sapiens	IC50	uM	0.3
	23298247	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	COc1ccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@H]5CNCC56CC6)cc34)cn2)cc1		CHEMBL4871278	=	IC50	nM	1000.0	CHEMBL4895	Homo sapiens	IC50	uM	1.0
	23298248	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	COc1ccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@@H]5CCN(C6COC6)C5)cc34)cn2)cc1		CHEMBL4847487	=	IC50	nM	41500.0	CHEMBL4895	Homo sapiens	IC50	uM	41.5
	23298249	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Brc1c[nH]c2ncccc12		CHEMBL4866966	=	IC50	nM	22800.0	CHEMBL4895	Homo sapiens	IC50	uM	22.8
	23298250	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cc1cnc2[nH]ccc2c1Cl		CHEMBL4204389	=	IC50	nM	20200.0	CHEMBL4895	Homo sapiens	IC50	uM	20.2
	23298251	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	O=C1CC(c2ccccc2)=NN1		CHEMBL4861042	=	IC50	nM	13000.0	CHEMBL4895	Homo sapiens	IC50	uM	13.0
	23298252	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Clc1ccnc2[nH]ccc12		CHEMBL4204893	=	IC50	nM	113000.0	CHEMBL4895	Homo sapiens	IC50	uM	113.0
	23298253	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	IC50	nM	391000.0	CHEMBL4895	Homo sapiens	IC50	uM	391.0
	23298254	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	COc1ccc2[nH]c(C)cc2c1		CHEMBL4850447	=	IC50	nM	38000.0	CHEMBL4895	Homo sapiens	IC50	uM	38.0
	23298255	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Nc1ccc(Br)c2ccncc12		CHEMBL4848146	=	IC50	nM	57000.0	CHEMBL4895	Homo sapiens	IC50	uM	57.0
	23298256	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Clc1ncnc2ccsc12		CHEMBL2113964	=	IC50	nM	302000.0	CHEMBL4895	Homo sapiens	IC50	uM	302.0
	23298257	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Brc1cnn2cccnc12		CHEMBL3246721	=	IC50	nM	330000.0	CHEMBL4895	Homo sapiens	IC50	uM	330.0
	23298258	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Nc1nc2ccc(F)cc2s1		CHEMBL98406	=	IC50	nM	363000.0	CHEMBL4895	Homo sapiens	IC50	uM	363.0
	23298259	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	FC(F)(F)c1cccc2[nH]ncc12	Outside typical range	CHEMBL4860490	=	IC50	nM	184000.0	CHEMBL4895	Homo sapiens	IC50	uM	184.0
	23298260	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cc1ccc(C)n1-c1ccsc1C(=O)O		CHEMBL4876336	=	IC50	nM	70000.0	CHEMBL4895	Homo sapiens	IC50	uM	70.0
	23298261	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Nc1cccc(-c2cccnc2)c1		CHEMBL1778131	=	IC50	nM	363000.0	CHEMBL4895	Homo sapiens	IC50	uM	363.0
	23298262	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	CSc1cc(-c2ccc(F)cc2)n[nH]1	Outside typical range	CHEMBL4868334	=	IC50	nM	331000.0	CHEMBL4895	Homo sapiens	IC50	uM	331.0
	23298263	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	c1cncc(-c2csc(-c3cccnc3)n2)c1		CHEMBL118266	=	IC50	nM	305000.0	CHEMBL4895	Homo sapiens	IC50	uM	305.0
	23298264	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Cc1ccc2nc(C(F)(F)F)cc(N3CCNCC3)c2c1		CHEMBL2441619	=	IC50	nM	204000.0	CHEMBL4895	Homo sapiens	IC50	uM	204.0
	23298265	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Brc1cccc2[nH]ncc12		CHEMBL246393	=	IC50	nM	178000.0	CHEMBL4895	Homo sapiens	IC50	uM	178.0
	23298266	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	COc1cc2[nH]ncc2cc1Br	Outside typical range	CHEMBL4845879	=	IC50	nM	227000.0	CHEMBL4895	Homo sapiens	IC50	uM	227.0
	23298267	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	O=C(O)c1ccc2cn[nH]c2c1	Outside typical range	CHEMBL4867341	>	IC50	nM	770000.0	CHEMBL4895	Homo sapiens	IC50	uM	770.0
	23298268	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	O=C(O)c1ccc2c(Br)n[nH]c2c1	Outside typical range	CHEMBL4875365	>	IC50	nM	770000.0	CHEMBL4895	Homo sapiens	IC50	uM	770.0
	23298269	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Nc1cccc2[nH]nc(Br)c12	Outside typical range	CHEMBL4867864	=	IC50	nM	486000.0	CHEMBL4895	Homo sapiens	IC50	uM	486.0
	23298270	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Nc1ccc2[nH]nc(Br)c2c1	Outside typical range	CHEMBL4871572	>	IC50	nM	770000.0	CHEMBL4895	Homo sapiens	IC50	uM	770.0
	23298271	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Nc1ccc2c(Br)n[nH]c2c1	Outside typical range	CHEMBL4847996	>	IC50	nM	770000.0	CHEMBL4895	Homo sapiens	IC50	uM	770.0
	23298272	CHEMBL4841505	Inhibition of Axl (unknown origin) using 5'FAM labeled KKKKEEIYFFF-NH2 peptide as substrate incubated for 1.5 hrs	B	Nc1ccc2c(-c3cccnc3)n[nH]c2c1		CHEMBL4849198	=	IC50	nM	28400.0	CHEMBL4895	Homo sapiens	IC50	uM	28.4
Not Determined	23298273	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	CNC1CCN(c2ccc3[nH]nc(-c4cnn(C)c4)c3c2)C1		CHEMBL4864532		IC50			CHEMBL4895	Homo sapiens	IC50		
Not Determined	23298274	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	CN1CCC(CNc2ccc3[nH]nc(-c4cnn(C)c4)c3c2)CC1		CHEMBL4872275		IC50			CHEMBL4895	Homo sapiens	IC50		
Not Determined	23298275	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	CN1CCC(Nc2ccc3[nH]nc(-c4cnn(C)c4)c3c2)CC1		CHEMBL4849394		IC50			CHEMBL4895	Homo sapiens	IC50		
Not Determined	23298276	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	Cn1cc(-c2n[nH]c3ccc(NC4CCNC4)cc23)cn1		CHEMBL4875566		IC50			CHEMBL4895	Homo sapiens	IC50		
	23298277	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	Cn1cc(-c2n[nH]c3ccc(N[C@H]4CCNC4)cc23)cn1		CHEMBL4867638	>	IC50	nM	50000.0	CHEMBL4895	Homo sapiens	IC50	uM	50.0
	23298278	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	Cn1cc(-c2n[nH]c3ccc(N[C@@H]4CCNC4)cc23)cn1		CHEMBL4864105	=	IC50	nM	20700.0	CHEMBL4895	Homo sapiens	IC50	uM	20.7
	23298279	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	Cn1cc(-c2n[nH]c3cc(Cl)c(N[C@@H]4CCNC4)cc23)cn1		CHEMBL4846408	=	IC50	nM	3130.0	CHEMBL4895	Homo sapiens	IC50	uM	3.13
	23298280	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	CN1CC[C@@H](Nc2cc3c(-c4cnn(C)c4)n[nH]c3cc2Cl)C1		CHEMBL4860788	=	IC50	nM	8960.0	CHEMBL4895	Homo sapiens	IC50	uM	8.96
	23298281	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	Cn1cc(-c2n[nH]c3cc(Cl)c(N[C@@H]4CCN(C5COC5)C4)cc23)cn1		CHEMBL4863793	=	IC50	nM	24700.0	CHEMBL4895	Homo sapiens	IC50	uM	24.7
	23298282	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	FC(F)(F)n1cc(-c2n[nH]c3cc(Cl)c(N[C@@H]4CCN(C5COC5)C4)cc23)cn1		CHEMBL4854205	=	IC50	nM	26300.0	CHEMBL4895	Homo sapiens	IC50	uM	26.3
	23298283	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	FCCn1cc(-c2n[nH]c3cc(Cl)c(N[C@@H]4CCNC4)cc23)cn1		CHEMBL4850427	=	IC50	nM	3460.0	CHEMBL4895	Homo sapiens	IC50	uM	3.46
	23298284	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	Clc1cc2[nH]nc(-c3cnn(-c4ccccc4)c3)c2cc1N[C@@H]1CCNC1		CHEMBL4848476	=	IC50	nM	668.0	CHEMBL4895	Homo sapiens	IC50	uM	0.6679999999999999
	23298285	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	Fc1ccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@@H]5CCNC5)cc34)cn2)cc1		CHEMBL4863561	=	IC50	nM	684.0	CHEMBL4895	Homo sapiens	IC50	uM	0.684
	23298286	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	N#Cc1ccccc1-n1cc(-c2n[nH]c3cc(Cl)c(N[C@@H]4CCNC4)cc23)cn1		CHEMBL4855160	=	IC50	nM	3540.0	CHEMBL4895	Homo sapiens	IC50	uM	3.54
	23298287	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	N#Cc1cccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@@H]5CCNC5)cc34)cn2)c1		CHEMBL4848200	=	IC50	nM	2020.0	CHEMBL4895	Homo sapiens	IC50	uM	2.02
	23298288	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	N#Cc1ccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@@H]5CCNC5)cc34)cn2)cc1		CHEMBL4854580	=	IC50	nM	880.0	CHEMBL4895	Homo sapiens	IC50	uM	0.88
	23298289	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	COc1ccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@@H]5CCNC5)cc34)cn2)cc1		CHEMBL4871523	=	IC50	nM	374.0	CHEMBL4895	Homo sapiens	IC50	uM	0.374
	23298290	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	COc1ccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@H]5CNCC56CC6)cc34)cn2)cc1		CHEMBL4871278	=	IC50	nM	883.0	CHEMBL4895	Homo sapiens	IC50	uM	0.883
	23298291	CHEMBL4841506	Displacement of K5 tracer from Axl (unknown origin) expressed in human HEK293 cells cotransfected with NanoLuc measured after 2 hrs by NanoBRET assay	B	COc1ccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@@H]5CCN(C6COC6)C5)cc34)cn2)cc1		CHEMBL4847487	=	IC50	nM	11400.0	CHEMBL4895	Homo sapiens	IC50	uM	11.4
Dose-Dependent Effect	23298299	CHEMBL4841508	Inhibition of Axl in human SK-OV-3 cells assessed as reduction in phosphorylated Axl level measured after 1 hr by Western blot analysis	B	Cn1cc(-c2n[nH]c3cc(Cl)c(N[C@@H]4CCNC4)cc23)cn1		CHEMBL4846408		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Dose-Dependent Effect	23298300	CHEMBL4841508	Inhibition of Axl in human SK-OV-3 cells assessed as reduction in phosphorylated Axl level measured after 1 hr by Western blot analysis	B	COc1ccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@@H]5CCNC5)cc34)cn2)cc1		CHEMBL4871523		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Dose-Dependent Effect	23298301	CHEMBL4841508	Inhibition of Axl in human SK-OV-3 cells assessed as reduction in phosphorylated Axl level measured after 1 hr by Western blot analysis	B	COc1ccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@@H]5CCN(C6COC6)C5)cc34)cn2)cc1		CHEMBL4847487		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Active	23298356	CHEMBL4841523	Inhibition of Axl in human SK-OV-3 cells assessed as reduction in phosphorylated ERK1/2 level at 1 to 10 uM measured after 1 hr by Western blot analysis	B	Cn1cc(-c2n[nH]c3cc(Cl)c(N[C@@H]4CCNC4)cc23)cn1		CHEMBL4846408		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Active	23298357	CHEMBL4841523	Inhibition of Axl in human SK-OV-3 cells assessed as reduction in phosphorylated ERK1/2 level at 1 to 10 uM measured after 1 hr by Western blot analysis	B	COc1ccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@@H]5CCNC5)cc34)cn2)cc1		CHEMBL4871523		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
Active	23298358	CHEMBL4841523	Inhibition of Axl in human SK-OV-3 cells assessed as reduction in phosphorylated ERK1/2 level at 1 to 10 uM measured after 1 hr by Western blot analysis	B	COc1ccc(-n2cc(-c3n[nH]c4cc(Cl)c(N[C@@H]5CCN(C6COC6)C5)cc34)cn2)cc1		CHEMBL4847487		Inhibition	%		CHEMBL4895	Homo sapiens	INH		
	23299262	CHEMBL4841731	Inhibition of AXL (unknown origin) at 1000 nM relative to control	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4860038	=	Inhibition	%	20.0	CHEMBL4895	Homo sapiens	INH	%	20.0
	23299263	CHEMBL4841731	Inhibition of AXL (unknown origin) at 1000 nM relative to control	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Inhibition	%	67.0	CHEMBL4895	Homo sapiens	INH	%	67.0
Not Active	23317288	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23317756	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23318429	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23318906	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23319546	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23320018	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	87.2	CHEMBL4895	Homo sapiens	% Control	%	87.2
Not Active	23320696	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23321164	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23321794	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	83.0	CHEMBL4895	Homo sapiens	% Control	%	83.0
Not Active	23322262	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	93.0	CHEMBL4895	Homo sapiens	% Control	%	93.0
Not Active	23322951	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23323419	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23323954	CHEMBL4880573	Axl (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	12.0	CHEMBL4895	Homo sapiens	% inhibition	%	12.0
Not Active	23324273	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23324908	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23325376	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23326023	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	93.0	CHEMBL4895	Homo sapiens	% Control	%	93.0
Not Active	23326491	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	89.0	CHEMBL4895	Homo sapiens	% Control	%	89.0
Not Active	23327191	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23327659	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23328246	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23328714	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23329254	CHEMBL4880961	Axl(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	91.0	CHEMBL4895	Homo sapiens	% residual kinase activity	%	91.0
Not Active	23329660	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	78.0	CHEMBL4895	Homo sapiens	% Control	%	78.0
Not Active	23330128	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23330884	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23331352	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23331939	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	80.5	CHEMBL4895	Homo sapiens	% Control	%	80.5
Not Active	23332407	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23333123	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23333664	CHEMBL4881467	Axl(h) Eurofins Kinase panel	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% residual kinase activity	%	88.0	CHEMBL4895	Homo sapiens	% residual kinase activity	%	88.0
Not Active	23333762	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	93.0	CHEMBL4895	Homo sapiens	% Control	%	93.0
Not Active	23334230	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23334867	CHEMBL4881491	Axl (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	85.0	CHEMBL4895	Homo sapiens	% inhibition	%	85.0
Not Active	23335209	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	93.0	CHEMBL4895	Homo sapiens	% Control	%	93.0
Not Active	23335677	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23336304	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	87.0	CHEMBL4895	Homo sapiens	% Control	%	87.0
Not Active	23336772	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	88.0	CHEMBL4895	Homo sapiens	% Control	%	88.0
Not Active	23337519	CHEMBL4881890	AXL Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	95.5	CHEMBL4895	Homo sapiens	% Ctrl	%	95.5
Not Active	23337853	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	98.0	CHEMBL4895	Homo sapiens	% Control	%	98.0
Not Active	23338321	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	93.0	CHEMBL4895	Homo sapiens	% Control	%	93.0
Not Active	23338933	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	89.0	CHEMBL4895	Homo sapiens	% Control	%	89.0
Not Active	23339401	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23340038	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23340506	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	95.0	CHEMBL4895	Homo sapiens	% Control	%	95.0
Not Active	23341163	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23341631	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23342247	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	87.0	CHEMBL4895	Homo sapiens	% Control	%	87.0
Not Active	23342715	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23343345	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	89.0	CHEMBL4895	Homo sapiens	% Control	%	89.0
Not Active	23343813	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	89.0	CHEMBL4895	Homo sapiens	% Control	%	89.0
Not Active	23344451	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	91.0	CHEMBL4895	Homo sapiens	% Control	%	91.0
Not Active	23345024	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	97.0	CHEMBL4895	Homo sapiens	% Control	%	97.0
Not Active	23345492	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	95.0	CHEMBL4895	Homo sapiens	% Control	%	95.0
Not Active	23346069	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23346538	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23347148	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	77.9	CHEMBL4895	Homo sapiens	% Control	%	77.9
Not Active	23347629	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23348208	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23348676	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23349263	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23349881	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	98.0	CHEMBL4895	Homo sapiens	% Control	%	98.0
Not Active	23350349	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	93.0	CHEMBL4895	Homo sapiens	% Control	%	93.0
Not Active	23350954	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23351422	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23351968	CHEMBL4882661	AXL Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	4.793	CHEMBL4895	Homo sapiens	% Inhibition	%	4.7933
Not Active	23352446	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23352914	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23353796	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23354264	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23354996	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	90.0	CHEMBL4895	Homo sapiens	% Control	%	90.0
Not Active	23355464	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	63.0	CHEMBL4895	Homo sapiens	% Control	%	63.0
Not Active	23356100	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23356568	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23357177	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23357824	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23358292	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23358878	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	84.2	CHEMBL4895	Homo sapiens	% Control	%	84.2
Not Active	23359476	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23359944	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23360529	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	93.0	CHEMBL4895	Homo sapiens	% Control	%	93.0
Not Active	23360997	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	69.0	CHEMBL4895	Homo sapiens	% Control	%	69.0
Not Active	23361570	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	80.0	CHEMBL4895	Homo sapiens	% Control	%	80.0
Not Active	23362106	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	99.0	CHEMBL4895	Homo sapiens	% Control	%	99.0
Not Active	23362574	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23363216	CHEMBL4883224	AXL Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1	Outside typical range	CHEMBL4531334		Inhibition	%	-13.72	CHEMBL4895	Homo sapiens	% inhibition	%	-13.7152
Not Active	23363217	CHEMBL4883224	AXL Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1	Outside typical range	CHEMBL4531334		Inhibition	%	-10.19	CHEMBL4895	Homo sapiens	% inhibition	%	-10.1855
Not Active	23364216	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	94.0	CHEMBL4895	Homo sapiens	% Control	%	94.0
Not Active	23364684	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	88.0	CHEMBL4895	Homo sapiens	% Control	%	88.0
Not Active	23365423	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	92.0	CHEMBL4895	Homo sapiens	% Control	%	92.0
Not Active	23365966	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	79.0	CHEMBL4895	Homo sapiens	% Control	%	79.0
Not Active	23366556	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	87.0	CHEMBL4895	Homo sapiens	% Control	%	87.0
Not Active	23367024	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	95.0	CHEMBL4895	Homo sapiens	% Control	%	95.0
Not Active	23367477	CHEMBL4883830	AXL ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	100.0	CHEMBL4895	Homo sapiens	% Residual activity with Skepinone-L	%	100.0
Not Active	23367902	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	76.0	CHEMBL4895	Homo sapiens	% Control	%	76.0
Not Active	23368370	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	77.0	CHEMBL4895	Homo sapiens	% Control	%	77.0
Not Active	23368969	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23369437	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	57.0	CHEMBL4895	Homo sapiens	% Control	%	57.0
Not Active	23369982	CHEMBL4884226	Axl(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	100.0	CHEMBL4895	Homo sapiens	% residual kinase activity	%	100.0
Not Active	23370405	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23370873	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23371682	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	96.0	CHEMBL4895	Homo sapiens	% Control	%	96.0
Not Active	23372150	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	79.0	CHEMBL4895	Homo sapiens	% Control	%	79.0
	23372663	CHEMBL4884628	Axl(AXL1LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4895	Homo sapiens	pIC50		6.0
	23373072	CHEMBL4884919	Axl(AXL1LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4895	Homo sapiens	pIC50		6.0
	23373433	CHEMBL4885210	Axl(AXL1LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4895	Homo sapiens	pIC50		6.0
Not Active	23374920	CHEMBL4885914	Axl Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	17.0	CHEMBL4895	Homo sapiens	% Inhibition	%	17.0
Not Active	23375577	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	96.0	CHEMBL4895	Homo sapiens	% Control	%	96.0
Not Active	23376045	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23376623	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23377092	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	92.0	CHEMBL4895	Homo sapiens	% Control	%	92.0
Not Active	23377950	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	90.0	CHEMBL4895	Homo sapiens	% Control	%	90.0
Not Active	23378418	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	67.0	CHEMBL4895	Homo sapiens	% Control	%	67.0
Not Active	23379585	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	91.0	CHEMBL4895	Homo sapiens	% Control	%	91.0
Not Active	23380053	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	78.0	CHEMBL4895	Homo sapiens	% Control	%	78.0
Not Active	23380747	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23381395	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23381863	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4895	Homo sapiens	% Control	%	100.0
Not Active	23382487	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	51.0	CHEMBL4895	Homo sapiens	% Control	%	51.0
Slightly Active	23382955	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	21.0	CHEMBL4895	Homo sapiens	% Control	%	21.0
Not Active	23383705	CHEMBL4887356	AXL Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	98.0	CHEMBL4895	Homo sapiens	% Ctrl	%	98.0
Not Active	23383706	CHEMBL4887356	AXL Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	85.0	CHEMBL4895	Homo sapiens	% Ctrl	%	85.0
Not Active	23384188	CHEMBL4887783	Axl(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	12.63	CHEMBL4895	Homo sapiens	% inhibition	%	12.63
Not Active	23384870	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	76.0	CHEMBL4895	Homo sapiens	% Control	%	76.0
Not Active	23385337	CHEMBL4879594	KinomeScan assay: inhibition of AXL	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	77.0	CHEMBL4895	Homo sapiens	% Control	%	77.0
